data_6yi2_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6yi2 _Structure_validation_residue.Date_analyzed 2020-10-23 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 670' ' ' TYR . . . . . 0.439 ' CD2' HD12 ' A' ' 698' ' ' LEU . 85.8 m-85 . . . . . 0 N--CA 1.454 -0.263 0 CA-C-O 121.081 0.467 . . . . 2.3 111.465 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -106.82 151.27 25.42 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.579 -0.737 . . . . 3.13 110.234 -175.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . . . . . . . . . 41.8 mt -76.0 136.28 39.99 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.025 0.44 . . . . 1.6 111.053 -176.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 673' ' ' GLY . . . . . . . . . . . . . . . 96.9 -3.08 62.27 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.601 -0.727 . . . . 0.66 112.167 -178.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 674' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -79.14 145.52 33.67 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.001 0.429 . . . . 2.74 110.385 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 675' ' ' ARG . . . . . . . . . . . . . 23.4 mmt180 -97.38 126.22 42.48 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.54 -0.754 . . . . 4.73 109.086 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 676' ' ' VAL . . . . . 0.428 ' HB ' HD13 ' A' ' 717' ' ' LEU . 35.7 m -117.17 162.1 15.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 120.828 0.347 . . . . 1.18 111.443 -175.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 677' ' ' ARG . . . . . . . . . . . . . 47.5 ttt180 -138.59 125.86 21.61 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.539 -0.755 . . . . 3.6 109.753 -176.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 678' ' ' HIS . . . . . 0.478 ' CD2' HD12 ' A' ' 717' ' ' LEU . 0.0 OUTLIER -147.5 132.65 18.33 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 110.423 -0.214 . . . . 2.48 110.423 178.092 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 679' ' ' ALA . . . . . . . . . . . . . . . -66.45 -14.57 62.39 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.938 0.399 . . . . 1.91 111.95 -176.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 680' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -82.84 -37.78 23.94 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.142 -0.481 . . . . 3.47 111.963 -178.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 681' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -125.25 -11.8 6.91 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.043 0.386 . . . . 2.31 112.043 -171.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 682' ' ' GLY . . . . . . . . . . . . . . . 98.97 -152.71 19.7 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.294 -0.722 . . . . 0.82 111.294 -175.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 683' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -104.74 147.19 27.96 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.526 -0.546 . . . . 2.11 109.526 178.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 684' ' ' GLY . . . . . . . . . . . . . . . -151.6 173.67 30.88 Favored Glycine 0 N--CA 1.441 -0.967 0 C-N-CA 119.641 -1.266 . . . . 0.43 112.464 -177.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 685' ' ' THR . . . . . . . . . . . . . 35.2 m -118.44 124.3 47.31 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.941 -0.392 . . . . 1.21 109.941 176.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 35.5 mt -72.33 104.88 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.2 -0.455 . . . . 1.07 109.837 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 687' ' ' VAL . . . . . . . . . . . . . 28.7 m -94.9 -23.81 5.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.302 -0.408 . . . . 1.13 111.512 -175.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 688' ' ' ASN . . . . . 0.417 ' HB3' ' HB2' ' A' ' 699' ' ' GLN . 63.0 t30 -151.24 165.0 35.31 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.466 -0.334 . . . . 2.15 110.196 -178.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 689' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.59 156.59 38.26 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.464 -0.569 . . . . 2.7 109.464 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 690' ' ' GLU . . . . . 0.461 ' O ' ' HA ' ' A' ' 696' ' ' SER . 45.9 mt-10 -125.95 123.76 39.26 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.539 -0.3 . . . . 2.02 110.752 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . 69.28 -160.96 52.53 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 121.083 -0.58 . . . . 1.14 112.728 178.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 66.9 m -152.03 157.43 41.66 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.257 -0.275 . . . . 2.41 110.257 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 89.67 -142.39 16.61 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.835 -0.698 . . . . 1.46 112.313 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 694' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -74.04 -31.46 62.9 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.042 0.449 . . . . 2.85 110.635 -178.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 695' ' ' HIS . . . . . . . . . . . . . 35.4 m170 -91.6 16.11 11.19 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.813 -0.631 . . . . 3.85 110.661 -176.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 696' ' ' SER . . . . . 0.461 ' HA ' ' O ' ' A' ' 690' ' ' GLU . 20.8 t -81.97 130.47 35.09 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.437 -0.579 . . . . 2.05 109.437 177.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 697' ' ' ARG . . . . . . . . . . . . . 23.9 mtm180 -114.51 133.72 55.56 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.226 -0.657 . . . . 3.16 109.226 177.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 698' ' ' LEU . . . . . 0.439 HD12 ' CD2' ' A' ' 670' ' ' TYR . 9.3 mt -106.14 130.65 53.99 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 120.632 0.253 . . . . 1.25 110.449 -177.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 699' ' ' GLN . . . . . 0.493 ' HA ' ' O ' ' A' ' 708' ' ' LYS . 3.8 mp0 -95.55 100.63 12.35 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.754 0.788 . . . . 2.54 109.264 175.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 700' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 707' ' ' ILE . 19.5 t -101.71 124.14 55.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 114.729 -1.123 . . . . 1.08 110.815 -172.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -84.83 94.82 8.81 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.233 -0.439 . . . . 1.14 110.16 177.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 702' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -78.64 122.56 26.1 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.677 -0.49 . . . . 2.06 109.677 177.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -69.15 -13.19 62.28 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.941 -0.572 . . . . 2.83 111.468 -174.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -101.06 8.68 57.65 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.749 -0.739 . . . . 0.78 112.612 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 705' ' ' GLN . . . . . . . . . . . . . 23.2 tp60 -158.45 -75.64 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.958 0.379 . . . . 3.15 111.047 178.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 706' ' ' GLY . . . . . . . . . . . . . . . 170.36 -167.02 40.19 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 121.013 -0.613 . . . . 0.79 112.025 -178.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 707' ' ' ILE . . . . . 0.488 ' HA ' ' O ' ' A' ' 700' ' ' VAL . 71.4 mt -79.53 126.22 39.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.158 0.504 . . . . 1.43 110.796 -178.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 708' ' ' LYS . . . . . 0.493 ' O ' ' HA ' ' A' ' 699' ' ' GLN . 63.6 mttm -125.77 159.4 32.46 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.785 -0.643 . . . . 1.91 110.693 -179.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 709' ' ' TRP . . . . . . . . . . . . . 14.6 p-90 -100.7 116.28 32.23 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.945 -0.57 . . . . 0.97 110.265 178.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -117.76 114.38 23.22 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.016 -0.538 . . . . 1.25 110.206 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 46.5 t -63.86 110.06 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.589 -0.522 . . . . 1.25 109.589 177.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 712' ' ' ALA . . . . . . . . . . . . . . . -45.15 -43.24 9.74 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 113.502 0.927 . . . . 1.3 113.502 -168.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -64.18 -36.99 85.84 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 111.975 0.361 . . . . 1.62 111.975 -177.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 714' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -102.5 -9.79 19.91 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.967 0.413 . . . . 2.77 110.815 -177.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 715' ' ' ALA . . . . . 0.406 ' HB3' ' CD2' ' A' ' 717' ' ' LEU . . . -67.74 -62.6 1.33 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.801 -0.636 . . . . 1.37 109.941 178.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 716' ' ' ARG . . . . . . . . . . . . . 59.9 mtt180 56.03 66.4 1.21 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.506 0.67 . . . . 5.14 110.52 175.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . 0.478 HD12 ' CD2' ' A' ' 678' ' ' HIS . 4.6 mm? -89.21 145.15 25.6 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.189 -0.914 . . . . 1.42 110.334 -177.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 718' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -97.27 134.68 40.24 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.211 -0.663 . . . . 2.13 109.211 176.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 719' ' ' SER . . . . . . . . . . . . . 13.5 m -75.81 128.37 34.99 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.58 -0.282 . . . . 2.19 110.43 -178.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 720' ' ' VAL . . . . . . . . . . . . . 17.6 t . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.498 -0.763 . . . . 2.06 109.77 177.717 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 670' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 . . . . . 0 N--CA 1.447 -0.58 0 N-CA-C 110.113 -0.329 . . . . 2.3 110.113 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 671' ' ' LYS . . . . . 0.401 ' HG2' ' HB2' ' A' ' 674' ' ' GLN . 20.7 pttp -138.86 160.2 40.3 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.313 -0.625 . . . . 3.13 109.313 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . . . . . . . . . 29.7 mt -72.08 133.08 45.02 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.962 -0.384 . . . . 1.6 109.962 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 673' ' ' GLY . . . . . . . . . . . . . . . 86.94 8.17 76.44 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.791 -0.719 . . . . 0.66 111.764 -175.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 674' ' ' GLN . . . . . 0.401 ' HB2' ' HG2' ' A' ' 671' ' ' LYS . 33.2 tt0 -85.87 142.86 28.58 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.949 -0.389 . . . . 2.74 109.949 178.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 675' ' ' ARG . . . . . 0.464 ' HD2' ' N ' ' A' ' 675' ' ' ARG . 3.7 mpt_? -100.78 127.48 47.19 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.147 0.499 . . . . 4.73 110.328 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 676' ' ' VAL . . . . . 0.483 ' HB ' ' HB3' ' A' ' 717' ' ' LEU . 27.1 m -117.23 154.1 18.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.587 -0.733 . . . . 1.18 110.917 -177.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 677' ' ' ARG . . . . . 0.405 ' CG ' ' HB3' ' A' ' 683' ' ' GLU . 26.9 mtt180 -127.18 136.95 52.77 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.996 -0.547 . . . . 3.6 110.957 177.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -138.94 142.59 38.43 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.503 -0.772 . . . . 2.48 109.333 172.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 679' ' ' ALA . . . . . . . . . . . . . . . -49.46 -52.47 28.87 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.612 0.597 . . . . 1.91 112.612 -172.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 680' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -91.07 -37.05 13.66 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.47 -0.332 . . . . 3.47 111.809 -170.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 681' ' ' PHE . . . . . . . . . . . . . 9.3 m-30 -81.2 -11.32 59.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.841 0.353 . . . . 2.31 111.273 -178.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 682' ' ' GLY . . . . . . . . . . . . . . . 86.32 -111.84 3.67 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.508 -0.853 . . . . 0.82 111.636 178.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 683' ' ' GLU . . . . . 0.405 ' HB3' ' CG ' ' A' ' 677' ' ' ARG . 10.4 pt-20 -155.66 148.43 24.2 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.725 0.298 . . . . 2.11 110.443 178.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 684' ' ' GLY . . . . . . . . . . . . . . . -152.41 -177.31 25.94 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.647 -0.787 . . . . 0.43 111.531 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 685' ' ' THR . . . . . . . . . . . . . 58.5 m -119.44 130.14 55.11 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.827 0.346 . . . . 1.21 110.414 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 686' ' ' ILE . . . . . 0.408 HG12 HG21 ' A' ' 700' ' ' VAL . 48.8 mt -73.86 104.61 2.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.082 -0.508 . . . . 1.07 110.123 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 687' ' ' VAL . . . . . . . . . . . . . 30.3 m -89.63 -26.12 5.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.416 -0.356 . . . . 1.13 111.018 -177.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -152.42 162.41 41.22 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.361 -0.382 . . . . 2.15 110.482 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 689' ' ' MET . . . . . . . . . . . . . 22.1 ptp -147.1 146.18 29.86 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.03 -0.532 . . . . 2.7 109.905 178.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 690' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -120.81 156.01 32.83 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.882 -0.599 . . . . 2.02 109.832 -176.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . 80.62 -169.42 52.34 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.57 -0.824 . . . . 1.14 111.791 -178.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 21.2 p -157.73 99.86 1.73 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.665 0.269 . . . . 2.41 110.368 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 118.74 -136.84 12.39 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.426 -0.892 . . . . 1.46 112.555 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 694' ' ' GLU . . . . . 0.489 ' O ' ' HB2' ' A' ' 713' ' ' ALA . 45.2 tt0 -64.38 -53.18 52.56 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.747 0.308 . . . . 2.85 111.573 -175.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 695' ' ' HIS . . . . . . . . . . . . . 41.9 m-70 -85.24 37.37 0.67 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.862 0.363 . . . . 3.85 111.904 -175.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 696' ' ' SER . . . . . . . . . . . . . 16.9 p -81.67 151.32 27.62 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 110.004 -0.369 . . . . 2.05 110.004 177.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 697' ' ' ARG . . . . . . . . . . . . . 32.2 mtm180 -121.47 129.51 53.0 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.646 -0.501 . . . . 3.16 109.646 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 14.3 mt -101.65 138.87 38.06 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 110.275 -0.268 . . . . 1.25 110.275 -177.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 699' ' ' GLN . . . . . 0.493 ' HA ' ' O ' ' A' ' 708' ' ' LYS . 1.3 mp0 -103.84 103.93 13.86 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.562 0.696 . . . . 2.54 109.278 173.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 700' ' ' VAL . . . . . 0.408 HG21 HG12 ' A' ' 686' ' ' ILE . 38.7 t -101.74 123.07 54.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 114.729 -1.123 . . . . 1.08 110.75 -172.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -83.12 94.31 7.8 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.199 -0.455 . . . . 1.14 110.569 178.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 702' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -81.02 126.67 31.69 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.46 -0.57 . . . . 2.06 109.46 175.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -70.55 -17.27 62.93 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.141 -0.481 . . . . 2.83 110.619 -176.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -82.76 -11.24 81.97 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.895 -0.669 . . . . 0.78 113.21 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 705' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -153.55 -68.54 0.15 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 117.294 0.547 . . . . 3.15 111.652 -178.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 706' ' ' GLY . . . . . . . . . . . . . . . 173.15 -165.87 38.2 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.519 -0.848 . . . . 0.79 112.437 -178.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 707' ' ' ILE . . . . . 0.404 ' HA ' ' O ' ' A' ' 700' ' ' VAL . 61.5 mt -79.56 120.34 30.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.931 0.396 . . . . 1.43 110.758 -178.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 708' ' ' LYS . . . . . 0.493 ' O ' ' HA ' ' A' ' 699' ' ' GLN . 96.1 mttt -114.54 159.47 20.35 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.108 -0.497 . . . . 1.91 111.375 -177.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 709' ' ' TRP . . . . . . . . . . . . . 24.3 p-90 -98.37 118.61 35.42 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.253 -0.885 . . . . 0.97 110.162 178.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -121.1 109.45 15.03 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.123 -0.49 . . . . 1.25 110.273 178.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 48.4 t -66.82 106.06 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.25 -0.648 . . . . 1.25 109.25 176.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 712' ' ' ALA . . . . . . . . . . . . . . . -48.13 -47.01 34.95 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.995 0.739 . . . . 1.3 112.995 -167.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 713' ' ' ALA . . . . . 0.489 ' HB2' ' O ' ' A' ' 694' ' ' GLU . . . -62.07 -18.11 59.62 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.606 0.595 . . . . 1.62 112.606 -176.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 714' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -126.57 9.03 7.07 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.145 0.497 . . . . 2.77 110.388 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 715' ' ' ALA . . . . . 0.417 ' HB3' ' CD2' ' A' ' 717' ' ' LEU . . . -93.2 -52.39 4.57 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.851 -0.613 . . . . 1.37 110.43 -179.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 716' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 53.67 73.99 0.34 Allowed 'General case' 0 C--O 1.232 0.17 0 O-C-N 123.778 0.674 . . . . 5.14 110.683 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . 0.483 ' HB3' ' HB ' ' A' ' 676' ' ' VAL . 3.9 mm? -97.05 130.4 44.36 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.12 -0.491 . . . . 1.42 110.562 -178.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 718' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -81.56 144.24 31.43 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.0 -0.545 . . . . 2.13 109.948 -178.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 719' ' ' SER . . . . . . . . . . . . . 10.4 p -82.13 119.91 24.64 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.978 -0.555 . . . . 2.19 110.774 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 720' ' ' VAL . . . . . . . . . . . . . 56.7 t . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.416 -0.802 . . . . 2.06 110.346 176.746 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 670' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 . . . . . 0 N--CA 1.454 -0.225 0 CA-C-O 120.676 0.275 . . . . 2.3 110.906 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -120.81 140.82 51.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.084 -0.507 . . . . 3.13 110.139 -176.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . . . . . . . . . 64.1 mt -69.63 141.91 53.57 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.238 -0.437 . . . . 1.6 110.819 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 673' ' ' GLY . . . . . . . . . . . . . . . 93.29 -11.18 72.21 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.945 -0.645 . . . . 0.66 111.849 -178.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 674' ' ' GLN . . . . . . . . . . . . . 21.7 tp60 -79.93 143.09 34.51 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.561 -0.533 . . . . 2.74 109.561 178.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 675' ' ' ARG . . . . . 0.697 ' HB2' ' OXT' ' A' ' 720' ' ' VAL . 36.8 mtm180 -96.76 141.51 29.9 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.567 -0.531 . . . . 4.73 109.567 177.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 676' ' ' VAL . . . . . 0.444 ' HB ' HD11 ' A' ' 717' ' ' LEU . 27.6 m -120.77 155.6 24.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 115.748 -0.66 . . . . 1.18 110.558 -177.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 677' ' ' ARG . . . . . . . . . . . . . 50.5 ttp180 -130.5 130.28 43.97 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.179 -0.464 . . . . 3.6 110.49 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -136.07 131.88 35.44 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.774 -0.824 . . . . 2.48 108.774 177.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 679' ' ' ALA . . . . . . . . . . . . . . . -64.89 -26.71 68.44 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.928 0.394 . . . . 1.91 111.803 -170.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 680' ' ' LYS . . . . . 0.429 ' HD2' ' N ' ' A' ' 680' ' ' LYS . 0.6 OUTLIER -93.8 -31.78 14.24 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.011 -0.54 . . . . 3.47 112.094 -177.926 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 681' ' ' PHE . . . . . . . . . . . . . 22.6 m-30 -103.43 -11.52 17.79 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.724 0.639 . . . . 2.31 112.724 -174.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 682' ' ' GLY . . . . . . . . . . . . . . . 96.86 -129.12 9.79 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.349 -0.929 . . . . 0.82 111.728 -178.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 683' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -145.66 148.97 33.65 Favored 'General case' 0 C--N 1.319 -0.731 0 O-C-N 122.499 -0.412 . . . . 2.11 109.93 178.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 684' ' ' GLY . . . . . 0.416 ' CA ' ' HA ' ' A' ' 702' ' ' PHE . . . -153.94 179.42 30.2 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.204 -0.998 . . . . 0.43 112.509 -178.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 685' ' ' THR . . . . . . . . . . . . . 42.5 m -116.2 127.96 55.21 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 110.107 -0.331 . . . . 1.21 110.107 178.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 38.2 mt -72.02 104.27 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.62 -0.511 . . . . 1.07 109.62 178.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 687' ' ' VAL . . . . . . . . . . . . . 27.5 m -95.12 -24.96 4.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 120.892 0.377 . . . . 1.13 111.314 -175.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -151.44 161.98 41.75 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.59 -0.522 . . . . 2.15 109.59 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 689' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -151.27 153.51 35.0 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 110.081 -0.34 . . . . 2.7 110.081 177.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 690' ' ' GLU . . . . . 0.443 ' O ' ' HA ' ' A' ' 696' ' ' SER . 38.7 mt-10 -126.74 126.04 42.79 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.916 -0.584 . . . . 2.02 110.976 -178.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . 76.81 176.7 43.72 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.868 -0.682 . . . . 1.14 113.487 173.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 9.3 p -141.38 152.93 44.76 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.087 -0.338 . . . . 2.41 110.087 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 88.55 -134.8 12.65 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.729 -0.748 . . . . 1.46 111.806 -178.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 694' ' ' GLU . . . . . 0.435 ' HA ' ' HB3' ' A' ' 713' ' ' ALA . 37.0 tt0 -80.08 -31.95 39.28 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.287 0.565 . . . . 2.85 110.14 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 695' ' ' HIS . . . . . . . . . . . . . 31.4 m-70 -87.18 37.88 0.79 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.739 -0.664 . . . . 3.85 110.82 -178.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 696' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 690' ' ' GLU . 55.7 p -109.41 134.23 52.1 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.019 0.438 . . . . 2.05 110.667 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 697' ' ' ARG . . . . . . . . . . . . . 21.5 mtm180 -125.68 141.59 51.94 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.515 -0.55 . . . . 3.16 109.515 176.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 17.3 mt -107.71 136.61 47.16 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 109.88 -0.415 . . . . 1.25 109.88 178.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 699' ' ' GLN . . . . . 0.476 ' HG2' ' CG2' ' A' ' 707' ' ' ILE . 56.2 tt0 -100.86 100.27 10.89 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 108.573 -0.899 . . . . 2.54 108.573 176.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 41.2 t -102.6 124.14 56.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.415 -0.811 . . . . 1.08 111.59 -171.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -88.37 96.84 10.74 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.077 -0.511 . . . . 1.14 109.973 176.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 702' ' ' PHE . . . . . 0.416 ' HA ' ' CA ' ' A' ' 684' ' ' GLY . 64.1 m-85 -73.11 149.73 42.82 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.064 -0.516 . . . . 2.06 111.012 -177.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 23.6 tp60 -49.22 -50.23 39.39 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.678 0.621 . . . . 2.83 112.678 -170.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -134.03 19.16 4.17 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 119.617 -1.278 . . . . 0.78 113.9 -176.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 705' ' ' GLN . . . . . 0.48 ' O ' ' HE2' ' A' ' 708' ' ' LYS . 1.5 mp0 -124.98 10.87 8.25 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 117.67 0.735 . . . . 3.15 111.801 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 706' ' ' GLY . . . . . . . . . . . . . . . 80.85 -166.62 49.02 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.306 -0.949 . . . . 0.79 112.702 178.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 707' ' ' ILE . . . . . 0.476 ' CG2' ' HG2' ' A' ' 699' ' ' GLN . 29.2 mt -97.87 130.44 46.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 120.638 0.256 . . . . 1.43 111.171 -176.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 708' ' ' LYS . . . . . 0.48 ' HE2' ' O ' ' A' ' 705' ' ' GLN . 4.6 mptp? -118.09 169.58 9.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.979 0.419 . . . . 1.91 111.192 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 709' ' ' TRP . . . . . . . . . . . . . 22.7 p-90 -113.3 119.77 38.84 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.36 -0.836 . . . . 0.97 109.859 176.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 710' ' ' LEU . . . . . 0.418 HD21 ' N ' ' A' ' 710' ' ' LEU . 3.2 mm? -120.71 116.18 24.77 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.427 -0.351 . . . . 1.25 110.486 -177.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 40.6 t -65.7 108.79 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.444 -0.576 . . . . 1.25 109.444 176.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 712' ' ' ALA . . . . . . . . . . . . . . . -57.07 -34.01 67.84 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.894 -0.594 . . . . 1.3 112.418 -169.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 713' ' ' ALA . . . . . 0.435 ' HB3' ' HA ' ' A' ' 694' ' ' GLU . . . -65.66 -25.4 67.33 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.776 0.322 . . . . 1.62 111.757 -178.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 714' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -121.77 8.2 9.98 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.469 -0.332 . . . . 2.77 111.038 -176.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 715' ' ' ALA . . . . . 0.459 ' HB1' ' CD2' ' A' ' 717' ' ' LEU . . . -88.72 -57.97 2.72 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.174 -0.466 . . . . 1.37 111.56 -175.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 716' ' ' ARG . . . . . . . . . . . . . 26.1 tpt180 55.63 72.37 0.49 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.494 0.664 . . . . 5.14 111.038 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . 0.459 ' CD2' ' HB1' ' A' ' 715' ' ' ALA . 4.3 mm? -90.88 142.86 27.32 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.633 -0.712 . . . . 1.42 111.148 -178.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 718' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -84.32 148.66 26.53 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.542 -0.753 . . . . 2.13 109.313 175.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 719' ' ' SER . . . . . . . . . . . . . 19.6 m -92.39 121.91 34.33 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.766 0.317 . . . . 2.19 110.79 -178.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 720' ' ' VAL . . . . . 0.697 ' OXT' ' HB2' ' A' ' 675' ' ' ARG . 9.3 p . . . . . 0 C--O 1.247 0.971 0 CA-C-O 118.758 -0.639 . . . . 2.06 110.378 178.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 670' ' ' TYR . . . . . 0.529 ' CE2' ' HB2' ' A' ' 717' ' ' LEU . 93.4 m-85 . . . . . 0 C--O 1.234 0.266 0 CA-C-O 120.853 0.359 . . . . 2.3 110.863 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -125.42 162.29 25.16 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.966 -0.561 . . . . 3.13 110.503 -175.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . . . . . . . . . 7.6 mp -79.67 143.48 34.59 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.89 0.376 . . . . 1.6 110.452 177.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 673' ' ' GLY . . . . . . . . . . . . . . . 84.46 3.01 88.81 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.767 -0.652 . . . . 0.66 111.542 -177.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 674' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -86.62 145.5 26.7 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.557 -0.321 . . . . 2.74 110.228 -178.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 675' ' ' ARG . . . . . . . . . . . . . 30.9 ttm180 -106.48 125.04 50.49 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.219 0.533 . . . . 4.73 109.902 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 676' ' ' VAL . . . . . 0.409 ' HB ' ' HB3' ' A' ' 717' ' ' LEU . 34.7 m -117.57 163.32 14.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.456 -0.793 . . . . 1.18 111.147 -174.221 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 677' ' ' ARG . . . . . 0.472 ' HB2' HG22 ' A' ' 720' ' ' VAL . 55.8 ttp180 -134.72 121.16 20.37 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.043 -0.526 . . . . 3.6 109.98 176.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 678' ' ' HIS . . . . . 0.451 ' HB2' ' CD1' ' A' ' 717' ' ' LEU . 51.5 t60 -134.25 122.65 23.04 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.094 -0.706 . . . . 2.48 109.094 179.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 679' ' ' ALA . . . . . . . . . . . . . . . -58.41 -20.8 47.39 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.009 0.744 . . . . 1.91 113.009 -169.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 680' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -86.28 -33.46 20.66 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 111.938 0.347 . . . . 3.47 111.938 -177.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 681' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -116.97 -12.41 10.69 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.438 0.533 . . . . 2.31 112.438 -175.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 682' ' ' GLY . . . . . . . . . . . . . . . 99.03 -156.51 20.06 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.793 -0.717 . . . . 0.82 111.548 -178.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 683' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -105.51 143.24 33.95 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.866 -0.42 . . . . 2.11 109.866 176.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 684' ' ' GLY . . . . . . . . . . . . . . . -153.79 175.14 32.22 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.218 -0.991 . . . . 0.43 112.486 -177.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 685' ' ' THR . . . . . . . . . . . . . 84.9 m -111.89 123.97 51.37 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.724 0.297 . . . . 1.21 110.364 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 44.7 mt -68.76 106.5 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.56 -0.533 . . . . 1.07 109.56 178.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 687' ' ' VAL . . . . . . . . . . . . . 26.9 m -99.58 -19.05 6.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.326 -0.397 . . . . 1.13 111.454 -174.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 688' ' ' ASN . . . . . 0.443 ' HB3' ' HB2' ' A' ' 699' ' ' GLN . 18.1 t-20 -156.58 162.33 39.9 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.542 -0.54 . . . . 2.15 109.542 -178.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 689' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -148.97 146.82 28.0 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.021 -0.733 . . . . 2.7 109.021 176.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 690' ' ' GLU . . . . . 0.426 ' OE2' ' HD2' ' A' ' 697' ' ' ARG . 36.4 mt-10 -119.93 122.85 42.14 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.635 0.255 . . . . 2.02 111.237 -174.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . 68.99 -172.7 36.49 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.144 -0.55 . . . . 1.14 113.235 175.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 8.5 p -139.71 165.67 26.66 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.397 -0.223 . . . . 2.41 110.397 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 81.0 -150.65 30.88 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 121.095 -0.574 . . . . 1.46 112.615 178.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 694' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -64.47 -40.99 96.73 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.833 0.349 . . . . 2.85 111.157 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 695' ' ' HIS . . . . . . . . . . . . . 27.6 p-80 -86.66 21.97 2.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.283 -0.417 . . . . 3.85 111.293 -177.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 696' ' ' SER . . . . . . . . . . . . . 19.2 t -82.05 141.36 33.26 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.38 -0.6 . . . . 2.05 109.38 176.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 697' ' ' ARG . . . . . 0.426 ' HD2' ' OE2' ' A' ' 690' ' ' GLU . 41.6 mtt180 -122.69 152.77 40.22 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.668 -0.493 . . . . 3.16 109.668 178.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 11.2 mt -118.22 130.38 56.04 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.198 -0.668 . . . . 1.25 109.198 174.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 699' ' ' GLN . . . . . 0.443 ' HB2' ' HB3' ' A' ' 688' ' ' ASN . 30.5 mt-30 -97.49 101.49 13.03 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.746 0.784 . . . . 2.54 109.618 175.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 700' ' ' VAL . . . . . 0.442 ' HB ' ' CE1' ' A' ' 702' ' ' PHE . 15.9 t -100.13 123.19 52.83 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 114.674 -1.148 . . . . 1.08 110.35 -174.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -86.49 94.3 9.38 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.402 -0.592 . . . . 1.14 109.402 176.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 702' ' ' PHE . . . . . 0.442 ' CE1' ' HB ' ' A' ' 700' ' ' VAL . 92.7 m-85 -77.14 117.11 18.36 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.832 -0.622 . . . . 2.06 109.743 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -60.79 -21.51 63.16 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.854 -0.612 . . . . 2.83 112.088 -174.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -83.92 -20.04 60.2 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.67 -0.776 . . . . 0.78 112.481 178.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 705' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -135.26 -82.9 0.41 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.864 0.364 . . . . 3.15 111.4 -177.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 706' ' ' GLY . . . . . . . . . . . . . . . 179.49 -156.58 18.64 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 121.119 -0.562 . . . . 0.79 111.77 -177.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 707' ' ' ILE . . . . . 0.437 ' HA ' ' O ' ' A' ' 700' ' ' VAL . 61.5 mt -85.17 126.83 40.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 120.982 0.42 . . . . 1.43 111.205 -176.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 708' ' ' LYS . . . . . 0.433 ' O ' ' HA ' ' A' ' 699' ' ' GLN . 4.5 mptp? -121.47 161.4 22.32 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.891 -0.595 . . . . 1.91 109.779 176.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 709' ' ' TRP . . . . . . . . . . . . . 17.7 p-90 -105.86 115.29 29.98 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.233 0.539 . . . . 0.97 109.657 177.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -112.75 114.62 27.27 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 116.137 -0.483 . . . . 1.25 110.244 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 49.1 t -65.1 115.68 3.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.664 -0.495 . . . . 1.25 109.664 178.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 712' ' ' ALA . . . . . . . . . . . . . . . -54.62 -32.57 59.12 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.849 0.685 . . . . 1.3 112.849 -170.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -66.34 -25.62 66.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.932 0.396 . . . . 1.62 111.545 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 714' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -133.95 29.44 3.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.141 0.496 . . . . 2.77 109.723 -177.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 715' ' ' ALA . . . . . 0.497 ' HB1' ' CD2' ' A' ' 717' ' ' LEU . . . -80.01 -57.49 3.61 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.553 -0.749 . . . . 1.37 111.094 -174.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 716' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 58.3 69.34 0.74 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.63 0.729 . . . . 5.14 111.031 178.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . 0.529 ' HB2' ' CE2' ' A' ' 670' ' ' TYR . 3.6 mm? -105.74 122.92 47.06 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.876 -0.602 . . . . 1.42 110.278 177.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 718' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -91.05 130.94 36.91 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.763 -0.653 . . . . 2.13 109.787 -179.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 719' ' ' SER . . . . . . . . . . . . . 15.5 p -64.9 125.63 25.47 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.901 -0.407 . . . . 2.19 109.901 176.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 720' ' ' VAL . . . . . 0.472 HG22 ' HB2' ' A' ' 677' ' ' ARG . 10.9 t . . . . . 0 C--O 1.246 0.921 0 CA-C-O 118.803 -0.618 . . . . 2.06 110.528 -177.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 670' ' ' TYR . . . . . 0.518 ' CD1' HD12 ' A' ' 698' ' ' LEU . 94.1 m-85 . . . . . 0 N--CA 1.448 -0.543 0 N-CA-C 110.163 -0.31 . . . . 2.3 110.163 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 671' ' ' LYS . . . . . 0.455 ' HG2' HE21 ' A' ' 674' ' ' GLN . 21.2 ptmt -140.33 155.98 46.6 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.392 -0.367 . . . . 3.13 110.244 -176.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . . . . . . . . . 59.6 mt -78.65 140.99 38.32 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.136 -0.484 . . . . 1.6 110.478 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 673' ' ' GLY . . . . . . . . . . . . . . . 84.07 5.74 87.27 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.814 -0.63 . . . . 0.66 111.803 -177.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 674' ' ' GLN . . . . . 0.455 HE21 ' HG2' ' A' ' 671' ' ' LYS . 6.7 tt0 -83.28 142.89 30.77 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.022 -0.362 . . . . 2.74 110.022 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 675' ' ' ARG . . . . . . . . . . . . . 26.8 mmm180 -93.26 120.11 33.17 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.848 -0.614 . . . . 4.73 109.841 178.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 676' ' ' VAL . . . . . 0.454 ' HB ' ' HB3' ' A' ' 717' ' ' LEU . 34.2 m -117.27 154.74 19.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.883 -0.599 . . . . 1.18 110.695 -177.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 677' ' ' ARG . . . . . . . . . . . . . 52.1 ttp180 -131.79 137.91 48.34 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.955 -0.566 . . . . 3.6 110.014 178.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 678' ' ' HIS . . . . . 0.425 ' CD2' HD12 ' A' ' 717' ' ' LEU . 0.0 OUTLIER -139.99 155.21 47.22 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.129 -0.487 . . . . 2.48 110.464 174.089 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 679' ' ' ALA . . . . . . . . . . . . . . . -56.12 -53.9 51.56 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.673 0.62 . . . . 1.91 112.673 -173.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 680' ' ' LYS . . . . . . . . . . . . . 2.7 mtpm? -92.66 -30.67 15.46 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.957 -0.565 . . . . 3.47 111.743 -171.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 681' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -87.42 -11.85 47.93 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.342 -0.39 . . . . 2.31 111.34 -177.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 682' ' ' GLY . . . . . . . . . . . . . . . 84.47 -112.49 3.62 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.582 -0.818 . . . . 0.82 111.992 178.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 683' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -151.12 149.14 29.13 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.738 -0.468 . . . . 2.11 109.738 177.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 684' ' ' GLY . . . . . . . . . . . . . . . -160.55 -179.46 35.34 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.016 -1.088 . . . . 0.43 113.011 -178.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 685' ' ' THR . . . . . . . . . . . . . 64.6 m -110.83 130.02 55.7 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.738 -0.467 . . . . 1.21 109.738 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 686' ' ' ILE . . . . . 0.432 HG12 HG23 ' A' ' 700' ' ' VAL . 31.1 mt -72.74 103.52 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.171 -0.678 . . . . 1.07 109.171 175.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 687' ' ' VAL . . . . . . . . . . . . . 27.5 m -93.11 -26.28 4.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.18 0.514 . . . . 1.13 111.028 -175.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 688' ' ' ASN . . . . . 0.454 ' HB3' ' HB3' ' A' ' 699' ' ' GLN . 20.1 t-20 -146.07 161.74 39.46 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.916 -0.584 . . . . 2.15 109.676 177.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 689' ' ' MET . . . . . . . . . . . . . 26.7 ptm -153.16 143.68 22.6 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.55 -0.537 . . . . 2.7 109.55 177.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 690' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -108.73 122.79 47.89 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.756 -0.656 . . . . 2.02 110.456 -176.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . 67.64 -168.79 38.83 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.964 -0.636 . . . . 1.14 112.558 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 56.1 m -154.92 131.78 10.77 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.133 -0.321 . . . . 2.41 110.133 178.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 109.36 -142.74 16.33 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.713 -0.756 . . . . 1.46 112.021 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 694' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -66.54 -34.83 78.78 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.036 0.446 . . . . 2.85 111.109 -178.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 695' ' ' HIS . . . . . . . . . . . . . 55.8 m80 -95.36 31.03 2.05 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.253 -0.43 . . . . 3.85 110.902 -178.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 696' ' ' SER . . . . . . . . . . . . . 16.7 t -97.56 138.74 34.51 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.252 0.549 . . . . 2.05 110.902 -178.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 697' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -123.02 159.81 27.63 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.967 -0.753 . . . . 3.16 108.967 174.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 698' ' ' LEU . . . . . 0.518 HD12 ' CD1' ' A' ' 670' ' ' TYR . 35.6 mt -122.75 149.39 44.17 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 109.935 -0.394 . . . . 1.25 109.935 178.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 699' ' ' GLN . . . . . 0.454 ' HB3' ' HB3' ' A' ' 688' ' ' ASN . 15.1 tt0 -117.63 96.02 5.2 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.229 -1.026 . . . . 2.54 108.229 173.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 700' ' ' VAL . . . . . 0.432 HG23 HG12 ' A' ' 686' ' ' ILE . 35.3 t -100.64 134.5 40.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.551 -0.75 . . . . 1.08 111.103 -172.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -96.33 94.41 7.44 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.988 -0.551 . . . . 1.14 110.09 176.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 702' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -78.78 136.88 37.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.103 0.478 . . . . 2.06 110.691 -177.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -71.43 -21.22 62.01 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.609 -0.723 . . . . 2.83 112.473 -171.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -106.57 2.76 36.67 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.276 -0.964 . . . . 0.78 113.336 -175.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 705' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -146.64 -54.15 0.24 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 117.017 0.408 . . . . 3.15 111.447 -177.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 706' ' ' GLY . . . . . . . . . . . . . . . 139.57 -159.26 25.79 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.282 -0.961 . . . . 0.79 112.433 179.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 58.7 mt -79.08 134.25 28.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 120.847 0.356 . . . . 1.43 111.082 -176.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 708' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -137.75 159.59 41.55 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.884 -0.598 . . . . 1.91 111.333 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 709' ' ' TRP . . . . . 0.443 ' C ' HD21 ' A' ' 710' ' ' LEU . 33.0 p-90 -98.92 129.75 45.27 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.384 -0.825 . . . . 0.97 109.363 174.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 710' ' ' LEU . . . . . 0.443 HD21 ' C ' ' A' ' 709' ' ' TRP . 3.1 mm? -127.4 125.69 41.09 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 110.27 -0.27 . . . . 1.25 110.27 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 54.9 t -73.24 104.17 2.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.188 -0.671 . . . . 1.25 109.188 174.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 712' ' ' ALA . . . . . . . . . . . . . . . -56.81 -31.16 64.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.841 -0.618 . . . . 1.3 111.998 -171.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -58.96 -32.97 70.11 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.245 -0.434 . . . . 1.62 112.032 -178.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 714' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -127.73 19.21 6.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.134 0.492 . . . . 2.77 110.699 -178.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 715' ' ' ALA . . . . . 0.469 ' HB3' ' CD2' ' A' ' 717' ' ' LEU . . . -77.32 -53.82 7.23 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.703 -0.68 . . . . 1.37 111.067 -177.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 716' ' ' ARG . . . . . . . . . . . . . 25.4 tpt85 48.98 65.56 1.34 Allowed 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.864 0.84 . . . . 5.14 110.72 -176.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . 0.469 ' CD2' ' HB3' ' A' ' 715' ' ' ALA . 4.5 mm? -81.34 139.23 35.48 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.207 -0.906 . . . . 1.42 109.472 175.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 718' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -92.79 119.86 32.57 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.137 -0.69 . . . . 2.13 109.137 178.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 719' ' ' SER . . . . . . . . . . . . . 9.7 t -68.99 124.57 24.12 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.859 -0.422 . . . . 2.19 109.859 -178.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 720' ' ' VAL . . . . . . . . . . . . . 4.9 p . . . . . 0 C--O 1.248 0.974 0 CA-C-N 116.095 -0.502 . . . . 2.06 110.664 -177.055 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 670' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 . . . . . 0 C--O 1.232 0.159 0 N-CA-C 110.068 -0.345 . . . . 2.3 110.068 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -118.12 152.3 35.89 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.275 -0.421 . . . . 3.13 110.983 -176.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . . . . . . . . . 70.0 mt -79.25 133.51 36.66 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.094 -0.503 . . . . 1.6 110.053 176.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 673' ' ' GLY . . . . . . . . . . . . . . . 94.42 1.23 64.45 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.841 -0.695 . . . . 0.66 111.699 -174.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 674' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -81.29 144.63 31.39 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 110.021 -0.362 . . . . 2.74 110.021 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 675' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.47 128.65 50.6 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.086 -0.709 . . . . 4.73 109.086 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 676' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 683' ' ' GLU . 35.8 m -119.7 152.23 22.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 115.814 -0.63 . . . . 1.18 111.465 -173.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 677' ' ' ARG . . . . . 0.429 ' HG3' HG23 ' A' ' 720' ' ' VAL . 32.6 mtp180 -123.06 124.28 42.75 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.28 0.562 . . . . 3.6 110.813 175.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 678' ' ' HIS . . . . . 0.528 ' HB2' ' CD1' ' A' ' 717' ' ' LEU . 43.4 t60 -139.42 104.66 5.02 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.212 -0.904 . . . . 2.48 109.148 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 679' ' ' ALA . . . . . . . . . . . . . . . -40.42 -38.15 0.78 Allowed 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 114.086 1.143 . . . . 1.91 114.086 -170.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 680' ' ' LYS . . . . . . . . . . . . . 18.7 mmtm -75.8 -31.18 59.33 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.646 -0.252 . . . . 3.47 111.542 -172.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 681' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -116.61 -13.08 10.86 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.85 -0.34 . . . . 2.31 111.816 -176.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 682' ' ' GLY . . . . . . . . . . . . . . . 97.82 -155.36 20.42 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.902 -0.666 . . . . 0.82 111.842 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 683' ' ' GLU . . . . . 0.47 ' HA ' ' O ' ' A' ' 676' ' ' VAL . 0.5 OUTLIER -109.53 147.57 32.72 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.003 0.43 . . . . 2.11 110.61 179.075 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 684' ' ' GLY . . . . . . . . . . . . . . . -156.49 179.48 32.31 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 120.594 -0.812 . . . . 0.43 111.999 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 685' ' ' THR . . . . . . . . . . . . . 71.3 m -115.06 127.36 55.58 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.764 0.316 . . . . 1.21 110.201 179.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 33.6 mt -71.63 104.93 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.182 -0.463 . . . . 1.07 109.759 178.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 687' ' ' VAL . . . . . . . . . . . . . 29.3 m -95.54 -26.61 4.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.862 0.363 . . . . 1.13 111.263 -176.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 688' ' ' ASN . . . . . 0.433 ' HB3' ' HB2' ' A' ' 699' ' ' GLN . 21.2 t-20 -146.38 163.47 35.5 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.598 -0.519 . . . . 2.15 109.598 -179.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 689' ' ' MET . . . . . . . . . . . . . 18.0 ptp -158.3 157.39 32.38 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.956 -0.387 . . . . 2.7 109.956 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 690' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -129.15 123.53 32.35 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.435 -0.348 . . . . 2.02 111.405 -177.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . 62.31 -162.83 27.78 Favored Glycine 0 N--CA 1.452 -0.3 0 CA-C-N 115.692 -0.685 . . . . 1.14 113.748 172.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 39.7 m -151.81 170.44 19.78 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.262 -0.644 . . . . 2.41 109.262 177.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 90.38 -139.47 14.96 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.399 -0.905 . . . . 1.46 112.456 177.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 694' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -83.29 -24.7 32.08 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.011 0.434 . . . . 2.85 110.596 -178.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 695' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -102.13 35.52 2.37 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.435 0.636 . . . . 3.85 110.383 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 696' ' ' SER . . . . . 0.476 ' OG ' ' HB1' ' A' ' 712' ' ' ALA . 16.3 p -90.81 135.51 33.68 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.396 -0.82 . . . . 2.05 110.258 179.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 697' ' ' ARG . . . . . . . . . . . . . 34.2 mtp180 -127.69 146.53 50.53 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.595 -0.52 . . . . 3.16 109.595 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 15.5 mt -123.51 130.97 53.47 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.756 -0.461 . . . . 1.25 109.756 178.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 699' ' ' GLN . . . . . 0.464 ' HA ' ' O ' ' A' ' 708' ' ' LYS . 2.1 mp0 -99.14 107.92 20.41 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.468 0.651 . . . . 2.54 109.433 175.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 42.1 t -107.13 125.7 63.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 114.913 -1.04 . . . . 1.08 111.097 -172.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -87.3 94.65 9.73 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.152 -0.476 . . . . 1.14 109.844 176.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 702' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -74.44 135.91 42.33 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.15 0.5 . . . . 2.06 110.345 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -68.62 -31.13 70.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.246 -0.888 . . . . 2.83 111.211 -175.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -81.49 -37.52 17.14 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.729 -0.748 . . . . 0.78 112.795 -178.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 705' ' ' GLN . . . . . 0.409 ' OE1' ' HA ' ' A' ' 705' ' ' GLN . 17.7 mm-40 -113.69 -76.04 0.59 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.041 0.385 . . . . 3.15 112.041 -176.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 706' ' ' GLY . . . . . . . . . . . . . . . 167.87 -158.1 30.74 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.738 -0.744 . . . . 0.79 112.166 -177.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 64.5 mt -78.46 122.97 34.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.056 0.455 . . . . 1.43 111.13 -176.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 708' ' ' LYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 699' ' ' GLN . 86.2 mttt -129.25 168.66 15.87 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.918 -0.583 . . . . 1.91 110.866 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 709' ' ' TRP . . . . . 0.517 ' C ' HD21 ' A' ' 710' ' ' LEU . 57.0 p-90 -105.24 131.93 52.09 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.434 -0.803 . . . . 0.97 109.782 178.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 710' ' ' LEU . . . . . 0.517 HD21 ' C ' ' A' ' 709' ' ' TRP . 3.6 mm? -130.29 109.49 10.8 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.742 -0.466 . . . . 1.25 109.742 177.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 59.4 t -64.48 109.41 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.382 -0.599 . . . . 1.25 109.382 177.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 712' ' ' ALA . . . . . 0.476 ' HB1' ' OG ' ' A' ' 696' ' ' SER . . . -55.35 -33.89 63.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.774 -0.648 . . . . 1.3 112.51 -169.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -64.58 -20.26 66.15 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.288 -0.415 . . . . 1.62 111.72 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 714' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -131.49 15.4 4.97 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.965 0.412 . . . . 2.77 110.19 -179.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 715' ' ' ALA . . . . . 0.538 ' HB1' ' CD2' ' A' ' 717' ' ' LEU . . . -85.28 -60.41 2.04 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.016 -0.538 . . . . 1.37 111.454 -173.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 716' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 58.82 77.76 0.29 Allowed 'General case' 0 C--O 1.235 0.341 0 CA-C-O 121.49 0.662 . . . . 5.14 110.945 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . 0.538 ' CD2' ' HB1' ' A' ' 715' ' ' ALA . 3.8 mm? -103.02 129.13 49.68 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.616 -0.72 . . . . 1.42 110.911 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 718' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -86.34 125.42 33.62 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.83 -0.623 . . . . 2.13 109.416 175.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 719' ' ' SER . . . . . . . . . . . . . 34.6 t -70.68 131.18 43.51 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.685 0.279 . . . . 2.19 110.323 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 720' ' ' VAL . . . . . 0.429 HG23 ' HG3' ' A' ' 677' ' ' ARG . 17.5 t . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.671 -0.681 . . . . 2.06 109.988 177.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 670' ' ' TYR . . . . . 0.54 ' CD1' HD13 ' A' ' 698' ' ' LEU . 57.1 m-85 . . . . . 0 N--CA 1.448 -0.56 0 N-CA-C 109.603 -0.517 . . . . 2.3 109.603 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 10.4 mtmp? -100.04 143.03 30.72 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.889 0.376 . . . . 3.13 110.553 -177.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . . . . . . . . . 52.4 mt -81.13 137.41 35.95 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.107 -0.497 . . . . 1.6 110.405 -179.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 673' ' ' GLY . . . . . . . . . . . . . . . 88.35 11.82 66.13 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 110.831 -0.907 . . . . 0.66 110.831 -173.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 674' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -94.76 144.07 25.94 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.891 0.376 . . . . 2.74 110.526 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 675' ' ' ARG . . . . . 0.424 ' HD3' ' O ' ' A' ' 684' ' ' GLY . 11.0 tpp85 -97.95 123.82 42.12 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.622 -0.717 . . . . 4.73 109.835 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 676' ' ' VAL . . . . . 0.415 ' HB ' HD11 ' A' ' 717' ' ' LEU . 27.2 m -115.84 161.94 14.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.071 -0.513 . . . . 1.18 110.425 -177.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 677' ' ' ARG . . . . . 0.42 ' HG3' ' HG2' ' A' ' 683' ' ' GLU . 21.5 ttt180 -135.38 131.1 35.91 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.27 -0.423 . . . . 3.6 111.123 178.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 678' ' ' HIS . . . . . 0.467 ' CD2' HD13 ' A' ' 717' ' ' LEU . 0.0 OUTLIER -141.42 147.22 37.6 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.51 -0.768 . . . . 2.48 109.25 175.034 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 679' ' ' ALA . . . . . . . . . . . . . . . -76.85 -26.23 54.05 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.108 0.411 . . . . 1.91 112.108 -169.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 680' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -87.98 -37.81 16.06 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.036 0.384 . . . . 3.47 112.036 -176.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 681' ' ' PHE . . . . . . . . . . . . . 19.2 m-30 -106.71 -11.26 15.86 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 111.814 0.301 . . . . 2.31 111.814 -176.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 682' ' ' GLY . . . . . . . . . . . . . . . 90.53 -156.42 24.81 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.551 -0.833 . . . . 0.82 111.777 -177.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 683' ' ' GLU . . . . . 0.42 ' HG2' ' HG3' ' A' ' 677' ' ' ARG . 27.6 mt-10 -103.6 144.69 31.1 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.9 -0.407 . . . . 2.11 109.9 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 684' ' ' GLY . . . . . 0.424 ' O ' ' HD3' ' A' ' 675' ' ' ARG . . . -148.64 170.88 29.07 Favored Glycine 0 C--N 1.313 -0.742 0 C-N-CA 120.224 -0.989 . . . . 0.43 112.696 -177.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 685' ' ' THR . . . . . . . . . . . . . 32.8 m -113.83 124.67 52.78 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.872 0.368 . . . . 1.21 110.213 178.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 28.3 mt -73.64 104.7 2.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.259 -0.428 . . . . 1.07 109.912 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 687' ' ' VAL . . . . . . . . . . . . . 29.0 m -93.49 -25.63 4.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.732 0.301 . . . . 1.13 111.578 -175.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -152.14 163.93 38.36 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.446 -0.343 . . . . 2.15 110.138 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 689' ' ' MET . . . . . . . . . . . . . 5.1 ppp? -151.91 163.86 38.35 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.496 -0.557 . . . . 2.7 109.496 177.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 690' ' ' GLU . . . . . 0.416 ' CG ' ' HB2' ' A' ' 697' ' ' ARG . 10.7 pt-20 -146.91 155.13 42.05 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.406 -0.361 . . . . 2.02 110.579 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . 78.23 -159.29 46.82 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.963 -0.636 . . . . 1.14 112.485 177.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 29.6 t -161.81 149.43 14.62 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 110.259 -0.275 . . . . 2.41 110.259 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 62.86 -127.52 38.88 Favored Glycine 0 N--CA 1.452 -0.262 0 CA-C-N 116.072 -0.513 . . . . 1.46 113.574 175.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 694' ' ' GLU . . . . . 0.41 ' HA ' ' HB3' ' A' ' 713' ' ' ALA . 42.0 mt-10 -80.58 -15.79 55.77 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.775 0.322 . . . . 2.85 111.417 -175.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 695' ' ' HIS . . . . . . . . . . . . . 18.5 p-80 -109.9 34.71 3.7 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.322 0.582 . . . . 3.85 110.306 178.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 696' ' ' SER . . . . . . . . . . . . . 77.9 p -101.31 145.73 28.49 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.733 -0.667 . . . . 2.05 110.507 178.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 697' ' ' ARG . . . . . 0.416 ' HB2' ' CG ' ' A' ' 690' ' ' GLU . 96.8 mtt180 -125.33 151.05 46.57 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.658 -0.497 . . . . 3.16 109.658 175.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 698' ' ' LEU . . . . . 0.54 HD13 ' CD1' ' A' ' 670' ' ' TYR . 15.5 mt -117.36 146.33 43.47 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.719 -0.474 . . . . 1.25 109.719 178.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 699' ' ' GLN . . . . . 0.507 ' HA ' ' O ' ' A' ' 708' ' ' LYS . 19.0 mt-30 -107.94 99.09 8.57 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.76 0.791 . . . . 2.54 109.27 169.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 700' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 707' ' ' ILE . 20.8 t -100.02 122.72 52.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 114.38 -1.282 . . . . 1.08 110.565 -173.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -85.5 94.31 8.99 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.722 -0.473 . . . . 1.14 109.722 177.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 702' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -74.0 127.02 31.8 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.957 0.408 . . . . 2.06 110.002 178.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -62.43 -26.67 68.62 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.473 -0.785 . . . . 2.83 112.175 -169.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -96.05 -7.25 58.64 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.586 -0.816 . . . . 0.78 113.138 -178.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 705' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -134.59 -79.19 0.45 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 117.184 0.492 . . . . 3.15 111.344 -178.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 706' ' ' GLY . . . . . . . . . . . . . . . 168.71 -164.26 37.89 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.706 -0.759 . . . . 0.79 112.309 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 707' ' ' ILE . . . . . 0.449 ' HA ' ' O ' ' A' ' 700' ' ' VAL . 61.3 mt -75.89 127.85 37.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.936 0.398 . . . . 1.43 110.883 -178.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 708' ' ' LYS . . . . . 0.507 ' O ' ' HA ' ' A' ' 699' ' ' GLN . 68.1 mttm -127.31 158.97 35.81 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.656 -0.702 . . . . 1.91 110.733 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 709' ' ' TRP . . . . . . . . . . . . . 13.8 p-90 -99.41 111.93 24.2 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.608 0.718 . . . . 0.97 110.222 179.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -117.04 115.22 24.99 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.861 -0.609 . . . . 1.25 110.443 -178.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 46.8 t -63.1 105.48 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.218 -0.66 . . . . 1.25 109.218 174.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 712' ' ' ALA . . . . . . . . . . . . . . . -48.62 -46.92 40.4 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 113.216 0.821 . . . . 1.3 113.216 -167.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 713' ' ' ALA . . . . . 0.41 ' HB3' ' HA ' ' A' ' 694' ' ' GLU . . . -64.11 -28.59 69.88 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.262 -0.427 . . . . 1.62 112.051 -175.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 714' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -111.35 2.47 17.63 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.281 0.563 . . . . 2.77 110.656 -178.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 715' ' ' ALA . . . . . 0.436 ' HB3' ' CD2' ' A' ' 717' ' ' LEU . . . -84.3 -50.82 7.5 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.509 -0.769 . . . . 1.37 109.617 177.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 716' ' ' ARG . . . . . 0.589 ' HA ' ' HE ' ' A' ' 716' ' ' ARG . 1.3 mmp_? 51.41 67.52 0.94 Allowed 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.596 -0.729 . . . . 5.14 110.83 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . 0.467 HD13 ' CD2' ' A' ' 678' ' ' HIS . 4.6 mm? -86.05 152.34 22.97 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.328 -0.851 . . . . 1.42 109.597 177.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 718' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -114.26 128.38 56.33 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.7 -0.481 . . . . 2.13 109.7 178.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 719' ' ' SER . . . . . . . . . . . . . 25.3 m -66.8 123.55 20.45 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.88 -0.415 . . . . 2.19 109.88 176.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 720' ' ' VAL . . . . . . . . . . . . . 3.2 p . . . . . 0 C--O 1.248 1.003 0 CA-C-N 116.463 -0.335 . . . . 2.06 111.038 -177.354 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 670' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 . . . . . 0 N--CA 1.452 -0.34 0 CA-C-O 120.76 0.314 . . . . 2.3 110.41 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -134.77 162.49 32.22 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.95 -0.568 . . . . 3.13 110.297 -174.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . . . . . . . . . 35.5 mt -77.86 134.45 37.95 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.845 0.355 . . . . 1.6 110.293 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 673' ' ' GLY . . . . . . . . . . . . . . . 88.38 -0.27 83.17 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 111.415 -0.674 . . . . 0.66 111.415 -176.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 674' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -82.61 148.45 27.99 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.717 0.294 . . . . 2.74 110.21 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 675' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -103.34 132.4 49.62 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.129 -0.487 . . . . 4.73 110.121 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 676' ' ' VAL . . . . . 0.439 ' HB ' HD11 ' A' ' 717' ' ' LEU . 29.9 m -117.01 153.39 18.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.582 -0.735 . . . . 1.18 110.448 -177.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 677' ' ' ARG . . . . . . . . . . . . . 42.3 ttt180 -126.79 129.31 48.08 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.328 -0.396 . . . . 3.6 110.376 179.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -140.79 121.55 14.37 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.089 -0.708 . . . . 2.48 109.089 177.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 679' ' ' ALA . . . . . . . . . . . . . . . -58.73 -18.5 32.0 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.127 0.417 . . . . 1.91 112.127 -175.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 680' ' ' LYS . . . . . 0.507 ' HD2' ' N ' ' A' ' 680' ' ' LYS . 0.3 OUTLIER -91.07 -35.52 14.56 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.243 -0.435 . . . . 3.47 112.088 -177.515 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 681' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -113.25 -11.46 13.22 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.787 0.327 . . . . 2.31 111.796 -174.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 682' ' ' GLY . . . . . . . . . . . . . . . 92.98 -156.5 22.96 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 111.467 -0.653 . . . . 0.82 111.467 -174.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 683' ' ' GLU . . . . . 0.418 ' HA ' ' O ' ' A' ' 676' ' ' VAL . 12.1 pt-20 -109.13 147.73 31.99 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.777 -0.453 . . . . 2.11 109.777 177.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 684' ' ' GLY . . . . . . . . . . . . . . . -151.15 173.54 30.59 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.428 -0.891 . . . . 0.43 112.286 -177.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 685' ' ' THR . . . . . . . . . . . . . 16.5 m -110.78 125.88 54.02 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.548 0.213 . . . . 1.21 110.687 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 50.6 mt -74.39 107.38 4.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.975 -0.379 . . . . 1.07 109.975 177.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 687' ' ' VAL . . . . . . . . . . . . . 29.9 m -93.63 -31.92 4.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 120.873 0.368 . . . . 1.13 111.073 -177.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -143.0 159.81 41.54 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.112 -0.495 . . . . 2.15 110.243 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 689' ' ' MET . . . . . . . . . . . . . 5.3 ppp? -149.05 142.85 25.63 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.97 0.414 . . . . 2.7 110.262 179.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 690' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -114.72 123.62 49.72 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.814 -0.63 . . . . 2.02 110.63 -175.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . 84.62 -152.16 27.28 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.827 -0.701 . . . . 1.14 113.193 174.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 17.5 p -173.7 126.14 0.39 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 123.168 0.587 . . . . 2.41 109.569 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 111.77 -143.74 17.46 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.765 -0.731 . . . . 1.46 111.703 -175.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 694' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -72.8 -48.6 36.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.083 0.468 . . . . 2.85 111.327 -177.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 695' ' ' HIS . . . . . . . . . . . . . 57.9 m-70 -81.92 37.5 0.48 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.968 -0.56 . . . . 3.85 111.415 -173.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 696' ' ' SER . . . . . . . . . . . . . 4.6 m -98.31 143.97 28.22 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.22 -0.446 . . . . 2.05 110.163 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 697' ' ' ARG . . . . . . . . . . . . . 40.9 mtm180 -117.64 135.79 53.75 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.553 -0.536 . . . . 3.16 109.553 175.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 15.9 mt -107.3 131.25 54.43 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.86 -0.422 . . . . 1.25 109.86 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 699' ' ' GLN . . . . . 0.436 ' HA ' ' O ' ' A' ' 708' ' ' LYS . 5.8 mp0 -93.75 101.52 13.64 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.485 0.659 . . . . 2.54 109.498 174.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 22.0 t -101.98 124.41 55.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-N 115.045 -0.98 . . . . 1.08 110.437 -175.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -88.11 101.44 13.81 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.986 -0.552 . . . . 1.14 110.168 178.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 702' ' ' PHE . . . . . 0.444 ' CD1' ' HD2' ' A' ' 708' ' ' LYS . 91.9 m-85 -87.43 120.25 28.54 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.706 -0.479 . . . . 2.06 109.706 176.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -71.2 -11.3 60.86 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.161 0.505 . . . . 2.83 111.064 -174.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -88.24 -13.12 64.36 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.951 -0.643 . . . . 0.78 113.122 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 705' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -150.78 -55.61 0.15 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 117.568 0.684 . . . . 3.15 111.912 -177.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 706' ' ' GLY . . . . . . . . . . . . . . . 163.78 -167.79 38.05 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.606 -0.806 . . . . 0.79 112.266 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 61.6 mt -78.02 141.85 14.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.73 0.3 . . . . 1.43 110.383 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 708' ' ' LYS . . . . . 0.444 ' HD2' ' CD1' ' A' ' 702' ' ' PHE . 67.1 mttm -132.66 161.75 33.14 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.033 0.444 . . . . 1.91 111.004 178.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 709' ' ' TRP . . . . . . . . . . . . . 20.5 p-90 -108.68 119.94 41.0 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.288 -0.869 . . . . 0.97 109.124 174.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -120.12 115.13 23.07 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.436 -0.347 . . . . 1.25 110.416 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 48.3 t -66.5 109.42 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.026 -0.731 . . . . 1.25 109.026 175.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 712' ' ' ALA . . . . . . . . . . . . . . . -45.42 -48.63 13.65 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 113.283 0.845 . . . . 1.3 113.283 -168.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -66.24 -31.43 72.24 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.363 0.505 . . . . 1.62 112.363 -175.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 714' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -97.99 -20.79 17.19 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.979 0.419 . . . . 2.77 110.77 -177.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 715' ' ' ALA . . . . . 0.458 ' HB1' ' CD2' ' A' ' 717' ' ' LEU . . . -72.44 -54.55 9.01 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.737 -0.665 . . . . 1.37 110.777 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 716' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 57.17 76.43 0.32 Allowed 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.438 0.637 . . . . 5.14 110.6 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . 0.458 ' CD2' ' HB1' ' A' ' 715' ' ' ALA . 4.4 mm? -97.19 142.4 29.15 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.607 -0.724 . . . . 1.42 110.955 -178.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 718' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -101.89 130.32 48.34 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.678 -0.86 . . . . 2.13 108.678 175.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 719' ' ' SER . . . . . . . . . . . . . 23.2 t -71.05 130.9 42.73 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.878 0.371 . . . . 2.19 110.403 -177.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 720' ' ' VAL . . . . . . . . . . . . . 46.2 t . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.398 -0.81 . . . . 2.06 110.627 -179.118 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 670' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 . . . . . 0 N--CA 1.453 -0.287 0 CA-C-O 120.951 0.405 . . . . 2.3 110.529 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 48.8 mtpt -128.54 155.86 44.21 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.876 -0.602 . . . . 3.13 110.408 -178.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . 0.532 HD23 ' SD ' ' A' ' 689' ' ' MET . 52.0 mt -79.38 134.17 36.58 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.199 -0.455 . . . . 1.6 110.098 177.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 673' ' ' GLY . . . . . . . . . . . . . . . 88.9 15.36 59.54 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.856 -0.687 . . . . 0.66 111.747 -175.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 674' ' ' GLN . . . . . . . . . . . . . 43.9 tp60 -94.49 144.79 25.28 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.286 -0.264 . . . . 2.74 110.286 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 675' ' ' ARG . . . . . . . . . . . . . 19.5 mtm180 -92.0 124.74 36.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.229 -0.441 . . . . 4.73 109.855 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 676' ' ' VAL . . . . . 0.427 ' HB ' HD12 ' A' ' 717' ' ' LEU . 29.0 m -117.91 154.56 19.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-O 120.792 0.33 . . . . 1.18 110.935 -179.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 677' ' ' ARG . . . . . 0.495 ' HB2' HG21 ' A' ' 720' ' ' VAL . 28.3 ttt-85 -130.77 131.61 44.81 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.858 -0.61 . . . . 3.6 109.812 178.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 678' ' ' HIS . . . . . 0.511 ' HB2' ' CD1' ' A' ' 717' ' ' LEU . 20.2 t60 -149.89 113.44 4.99 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.543 -0.54 . . . . 2.48 109.543 176.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 679' ' ' ALA . . . . . . . . . . . . . . . -49.79 -25.68 3.27 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 113.379 0.881 . . . . 1.91 113.379 -173.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 680' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -75.49 -33.19 60.76 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.762 -0.199 . . . . 3.47 111.411 -174.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 681' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -125.75 -13.13 6.48 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.745 0.307 . . . . 2.31 111.821 -174.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 682' ' ' GLY . . . . . . . . . . . . . . . 104.75 -153.59 17.43 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.855 -0.688 . . . . 0.82 111.786 -178.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 683' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -114.51 148.35 38.04 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.854 -0.425 . . . . 2.11 109.854 178.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 684' ' ' GLY . . . . . . . . . . . . . . . -156.66 -178.71 31.03 Favored Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 119.784 -1.198 . . . . 0.43 112.848 -178.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 685' ' ' THR . . . . . . . . . . . . . 12.6 m -113.97 125.62 54.22 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 110.266 -0.272 . . . . 1.21 110.266 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 46.4 mt -70.44 104.92 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.736 -0.468 . . . . 1.07 109.736 177.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 687' ' ' VAL . . . . . . . . . . . . . 27.1 m -93.82 -23.93 5.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 120.978 0.418 . . . . 1.13 111.061 -177.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 688' ' ' ASN . . . . . 0.446 ' HB3' ' HB2' ' A' ' 699' ' ' GLN . 8.5 t30 -151.33 161.3 42.95 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.48 -0.563 . . . . 2.15 109.48 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 689' ' ' MET . . . . . 0.532 ' SD ' HD23 ' A' ' 672' ' ' LEU . 0.0 OUTLIER -157.34 157.89 34.95 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 110.038 -0.356 . . . . 2.7 110.038 178.616 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 690' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -125.2 122.29 36.59 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.631 -0.507 . . . . 2.02 109.631 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . 74.84 -169.34 54.52 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.821 -0.704 . . . . 1.14 112.422 -177.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 49.6 m -155.72 96.37 1.75 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.803 0.335 . . . . 2.41 110.168 177.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 153.12 -130.14 2.92 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.902 -0.666 . . . . 1.46 112.729 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 694' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -84.18 -57.61 3.1 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.579 0.585 . . . . 2.85 112.579 -173.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 695' ' ' HIS . . . . . . . . . . . . . 16.2 p-80 -84.5 21.64 1.44 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.533 0.682 . . . . 3.85 110.855 -174.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 696' ' ' SER . . . . . . . . . . . . . 14.3 m -84.77 152.74 23.46 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.095 -0.957 . . . . 2.05 110.513 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 697' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -116.04 145.28 43.12 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 110.151 -0.314 . . . . 3.16 110.151 176.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 16.6 mt -118.23 135.81 54.04 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.708 -0.479 . . . . 1.25 109.708 178.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 699' ' ' GLN . . . . . 0.51 ' HA ' ' O ' ' A' ' 708' ' ' LYS . 24.6 mp0 -102.97 105.92 16.35 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.708 0.766 . . . . 2.54 109.907 174.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 700' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 707' ' ' ILE . 27.3 t -104.23 125.23 59.02 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 114.545 -1.207 . . . . 1.08 110.69 -174.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -87.76 94.3 9.71 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.155 -0.475 . . . . 1.14 109.742 175.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 702' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -75.94 132.71 40.42 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.014 -0.539 . . . . 2.06 110.203 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -68.59 -25.17 64.74 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.556 -0.747 . . . . 2.83 111.174 -175.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -91.16 1.94 78.02 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.686 -0.768 . . . . 0.78 113.264 -177.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 705' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -157.21 -80.04 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 117.176 0.488 . . . . 3.15 111.421 177.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 706' ' ' GLY . . . . . . . . . . . . . . . 179.65 -157.44 20.39 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.432 -0.889 . . . . 0.79 112.459 -178.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 707' ' ' ILE . . . . . 0.451 ' HA ' ' O ' ' A' ' 700' ' ' VAL . 60.3 mt -80.88 135.95 24.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.781 0.324 . . . . 1.43 111.039 -177.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 708' ' ' LYS . . . . . 0.51 ' O ' ' HA ' ' A' ' 699' ' ' GLN . 63.8 mttm -135.86 159.4 41.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.87 -0.605 . . . . 1.91 110.561 178.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 709' ' ' TRP . . . . . . . . . . . . . 12.3 p-90 -101.8 121.2 41.63 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.726 -0.67 . . . . 0.97 109.568 177.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -118.1 113.05 21.01 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.311 -0.404 . . . . 1.25 110.141 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 99.3 t -66.24 110.63 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.487 -0.56 . . . . 1.25 109.487 175.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 712' ' ' ALA . . . . . . . . . . . . . . . -41.81 -47.12 4.09 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 113.874 1.065 . . . . 1.3 113.874 -169.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -60.01 -35.75 75.75 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.49 0.552 . . . . 1.62 112.49 -177.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 714' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -100.64 -13.62 18.47 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.28 0.562 . . . . 2.77 110.291 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 715' ' ' ALA . . . . . 0.572 ' HB3' ' CD2' ' A' ' 717' ' ' LEU . . . -70.65 -59.59 2.74 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.298 -0.864 . . . . 1.37 110.397 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 716' ' ' ARG . . . . . . . . . . . . . 19.9 mtp180 50.23 66.65 1.09 Allowed 'General case' 0 N--CA 1.464 0.227 0 O-C-N 123.858 0.724 . . . . 5.14 111.363 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . 0.572 ' CD2' ' HB3' ' A' ' 715' ' ' ALA . 4.1 mm? -87.94 140.28 29.66 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.168 0.509 . . . . 1.42 111.396 -176.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 718' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -101.24 134.99 43.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.523 -0.762 . . . . 2.13 108.988 174.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 719' ' ' SER . . . . . . . . . . . . . 20.6 t -78.04 133.72 37.9 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.691 0.281 . . . . 2.19 110.65 -175.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 720' ' ' VAL . . . . . 0.495 HG21 ' HB2' ' A' ' 677' ' ' ARG . 16.9 t . . . . . 0 C--O 1.251 1.132 0 CA-C-O 118.461 -0.78 . . . . 2.06 110.096 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 670' ' ' TYR . . . . . 0.428 ' CE1' ' HB2' ' A' ' 717' ' ' LEU . 72.7 m-85 . . . . . 0 N--CA 1.445 -0.678 0 CA-C-O 121.069 0.461 . . . . 2.3 110.433 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -119.82 162.8 18.5 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.506 -0.77 . . . . 3.13 110.281 -173.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . . . . . . . . . 30.3 mt -79.22 137.37 37.39 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.332 -0.395 . . . . 1.6 110.053 177.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 673' ' ' GLY . . . . . . . . . . . . . . . 86.82 -3.11 87.24 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.862 -0.685 . . . . 0.66 111.523 -177.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 674' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -80.34 142.62 34.28 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.828 -0.434 . . . . 2.74 109.828 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 675' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -101.95 133.27 47.0 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.016 -0.538 . . . . 4.73 109.958 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 676' ' ' VAL . . . . . 0.445 ' HB ' ' HB3' ' A' ' 717' ' ' LEU . 28.8 m -121.08 152.03 24.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 115.727 -0.669 . . . . 1.18 111.022 -175.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 677' ' ' ARG . . . . . 0.431 ' HB2' HG22 ' A' ' 720' ' ' VAL . 27.9 ttp85 -123.3 123.59 41.08 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.963 -0.755 . . . . 3.6 108.963 176.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 678' ' ' HIS . . . . . 0.53 ' HB2' ' CD1' ' A' ' 717' ' ' LEU . 52.6 t60 -128.89 122.68 30.83 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 110.05 -0.352 . . . . 2.48 110.05 -179.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 679' ' ' ALA . . . . . . . . . . . . . . . -40.92 -45.85 2.64 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.545 0.943 . . . . 1.91 113.545 -172.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 680' ' ' LYS . . . . . . . . . . . . . 31.0 mtpt -92.62 -27.43 17.33 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.659 -0.7 . . . . 3.47 112.819 -168.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 681' ' ' PHE . . . . . . . . . . . . . 20.3 m-30 -106.29 -12.34 15.73 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.02 0.378 . . . . 2.31 112.02 -176.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 682' ' ' GLY . . . . . . . . . . . . . . . 90.08 -155.39 24.43 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.373 -0.918 . . . . 0.82 111.206 -174.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 683' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -111.91 152.67 27.74 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 117.116 0.458 . . . . 2.11 110.844 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 684' ' ' GLY . . . . . . . . . . . . . . . -157.18 -177.32 30.19 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 121.004 -0.617 . . . . 0.43 111.78 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 685' ' ' THR . . . . . . . . . . . . . 41.8 m -118.43 125.8 50.71 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.771 0.32 . . . . 1.21 110.991 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 686' ' ' ILE . . . . . 0.409 HG12 HG22 ' A' ' 700' ' ' VAL . 44.3 mt -71.57 110.23 4.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 120.805 0.336 . . . . 1.07 110.179 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 687' ' ' VAL . . . . . . . . . . . . . 30.1 m -97.07 -27.61 3.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.487 -0.324 . . . . 1.13 111.642 -176.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -149.66 158.2 43.95 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.067 -0.346 . . . . 2.15 110.067 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 689' ' ' MET . . . . . . . . . . . . . 5.2 ppp? -150.8 143.02 24.18 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.021 -0.536 . . . . 2.7 109.666 178.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 690' ' ' GLU . . . . . 0.435 ' O ' ' HA ' ' A' ' 696' ' ' SER . 45.0 mt-10 -121.54 140.94 51.57 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.965 -0.561 . . . . 2.02 110.893 -174.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . 68.13 -157.9 52.28 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 121.053 -0.594 . . . . 1.14 112.73 176.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 52.0 m -155.06 136.66 14.28 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.715 0.293 . . . . 2.41 110.561 178.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 83.51 -138.66 17.96 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 121.082 -0.58 . . . . 1.46 112.873 176.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 694' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -63.36 -37.17 86.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.898 0.38 . . . . 2.85 110.9 -178.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 695' ' ' HIS . . . . . . . . . . . . . 33.6 t-80 -86.79 15.75 5.48 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.267 0.556 . . . . 3.85 110.674 -177.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 696' ' ' SER . . . . . 0.435 ' HA ' ' O ' ' A' ' 690' ' ' GLU . 19.6 t -92.78 142.17 27.64 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.939 0.399 . . . . 2.05 110.417 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 697' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -123.64 134.82 53.7 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.617 -0.512 . . . . 3.16 109.617 174.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 8.6 mt -108.21 133.53 52.33 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 109.649 -0.5 . . . . 1.25 109.649 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 699' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -101.8 106.02 16.95 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.418 0.628 . . . . 2.54 110.017 174.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 700' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 707' ' ' ILE . 40.0 t -99.28 123.33 51.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.097 -0.956 . . . . 1.08 110.598 -176.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -82.86 94.95 7.79 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.767 -0.651 . . . . 1.14 109.823 176.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 702' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -76.11 126.36 30.86 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.622 -0.717 . . . . 2.06 109.966 178.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -64.74 -18.55 65.14 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.716 -0.674 . . . . 2.83 112.041 -173.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -134.92 40.27 1.58 Allowed Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.472 -0.87 . . . . 0.78 112.457 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 705' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -166.78 -23.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.836 0.35 . . . . 3.15 111.029 -178.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 706' ' ' GLY . . . . . . . . . . . . . . . 101.38 -169.4 20.52 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.546 -0.835 . . . . 0.79 112.038 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 707' ' ' ILE . . . . . 0.512 ' C ' ' HE2' ' A' ' 708' ' ' LYS . 47.0 mt -89.26 117.34 32.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 O-C-N 122.564 -0.374 . . . . 1.43 110.88 -178.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 708' ' ' LYS . . . . . 0.512 ' HE2' ' C ' ' A' ' 707' ' ' ILE . 0.4 OUTLIER -108.74 165.22 11.72 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.299 -0.41 . . . . 1.91 110.265 176.794 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 709' ' ' TRP . . . . . . . . . . . . . 8.1 p-90 -104.91 119.96 40.27 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.706 -0.679 . . . . 0.97 109.858 177.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -115.85 109.84 18.2 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.176 -0.465 . . . . 1.25 110.425 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 57.8 t -61.59 119.24 5.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.395 -0.594 . . . . 1.25 109.395 174.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 712' ' ' ALA . . . . . . . . . . . . . . . -54.99 -25.38 29.48 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.925 0.713 . . . . 1.3 112.925 -172.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -71.02 -25.66 62.77 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.855 0.36 . . . . 1.62 111.6 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 714' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -129.22 16.09 6.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.351 -0.386 . . . . 2.77 110.521 -177.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 715' ' ' ALA . . . . . 0.492 ' HB2' ' CD2' ' A' ' 717' ' ' LEU . . . -70.18 -58.14 4.12 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.078 -0.51 . . . . 1.37 111.101 -175.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 716' ' ' ARG . . . . . . . . . . . . . 74.3 mtt180 57.06 62.14 2.33 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.208 0.528 . . . . 5.14 111.177 175.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . 0.53 ' CD1' ' HB2' ' A' ' 678' ' ' HIS . 3.1 mm? -102.55 129.67 49.17 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.108 -0.496 . . . . 1.42 110.761 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 718' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -93.1 115.16 27.83 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.969 -0.752 . . . . 2.13 108.969 175.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 719' ' ' SER . . . . . . . . . . . . . 1.5 p -62.21 135.01 57.3 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.884 0.373 . . . . 2.19 111.007 -177.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 720' ' ' VAL . . . . . 0.431 HG22 ' HB2' ' A' ' 677' ' ' ARG . 3.4 t . . . . . 0 C--O 1.251 1.167 0 CA-C-O 118.389 -0.815 . . . . 2.06 109.705 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 3.1 ptp180 . . . . . 0 N--CA 1.484 1.264 0 CA-C-O 120.661 0.267 . . . . 27.62 111.376 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 646' ' ' LEU . . . . . . . . . . . . . 27.5 tp 53.09 52.95 12.75 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.983 -0.553 . . . . 26.92 111.205 178.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 647' ' ' ARG . . . . . . . . . . . . . 26.2 ptt180 -70.28 140.82 52.4 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.319 -0.4 . . . . 24.69 110.458 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 648' ' ' ALA . . . . . . . . . . . . . . . -88.09 76.29 8.55 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.097 0.475 . . . . 23.98 110.925 -178.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 649' ' ' THR . . . . . . . . . . . . . 14.1 t -107.46 -179.75 4.01 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.945 -0.57 . . . . 23.65 110.013 178.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 650' ' ' VAL . . . . . . . . . . . . . 29.7 m -69.75 136.31 26.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.109 0.481 . . . . 23.57 110.889 -178.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 651' ' ' SER . . . . . . . . . . . . . 49.9 m -85.56 -13.29 49.33 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.078 -0.51 . . . . 22.02 110.203 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 652' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -79.37 132.4 62.59 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 109.031 -0.729 . . . . 21.94 109.031 175.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 653' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -70.4 66.32 2.15 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.706 2.27 . . . . 20.17 112.418 178.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 654' ' ' VAL . . . . . . . . . . . . . 8.5 p -138.72 137.94 42.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.957 -0.565 . . . . 20.53 110.157 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 655' ' ' SER . . . . . . . . . . . . . 14.9 t -69.03 126.86 31.13 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.275 -0.639 . . . . 18.62 109.275 176.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 656' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -68.13 101.49 1.17 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.699 0.761 . . . . 16.76 110.207 -178.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 657' ' ' GLN . . . . . 0.604 ' O ' ' HD3' ' A' ' 716' ' ' ARG . 53.1 mt-30 -106.22 137.34 44.33 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.334 -0.848 . . . . 18.33 109.886 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 658' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -170.3 164.16 8.88 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.439 -0.578 . . . . 15.71 109.439 -178.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 659' ' ' MET . . . . . . . . . . . . . 54.1 ttm -73.91 96.49 2.62 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.702 -0.481 . . . . 15.12 109.702 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . 134.96 10.77 1.49 Allowed Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.774 -0.648 . . . . 12.85 112.216 -175.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 661' ' ' THR . . . . . . . . . . . . . 6.9 p -72.94 144.7 85.62 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.609 0.243 . . . . 10.68 111.079 177.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 662' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -73.57 49.88 1.89 Allowed 'Trans proline' 0 CA--C 1.531 0.344 0 C-N-CA 123.074 2.516 . . . . 11.11 112.474 178.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 663' ' ' MET . . . . . . . . . . . . . 25.4 ttt -92.75 127.49 38.27 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.785 -0.643 . . . . 9.83 109.994 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 664' ' ' VAL . . . . . . . . . . . . . 43.1 t -65.42 126.86 25.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.127 -0.488 . . . . 7.26 110.098 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 665' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 60.41 46.59 9.69 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.745 -0.661 . . . . 7.07 110.712 -175.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 666' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -65.82 145.74 55.59 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.675 -0.693 . . . . 7.24 109.938 177.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 667' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -80.67 152.91 28.21 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.069 0.462 . . . . 5.49 110.735 -176.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 668' ' ' SER . . . . . . . . . . . . . 47.3 m -112.67 31.42 6.37 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.855 -0.795 . . . . 4.8 108.855 173.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 669' ' ' GLY . . . . . . . . . . . . . . . 142.37 126.44 2.1 Favored Glycine 0 N--CA 1.438 -1.17 0 CA-C-N 114.801 -1.09 . . . . 2.2 110.854 -173.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 670' ' ' TYR . . . . . 0.439 ' CD2' HD12 ' A' ' 698' ' ' LEU . 85.8 m-85 -67.05 144.51 56.11 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.081 0.467 . . . . 2.3 111.465 -176.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -106.82 151.27 25.42 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.579 -0.737 . . . . 3.13 110.234 -175.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . . . . . . . . . 41.8 mt -76.0 136.28 39.99 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.025 0.44 . . . . 1.6 111.053 -176.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 673' ' ' GLY . . . . . . . . . . . . . . . 96.9 -3.08 62.27 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.601 -0.727 . . . . 0.66 112.167 -178.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 674' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -79.14 145.52 33.67 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.001 0.429 . . . . 2.74 110.385 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 675' ' ' ARG . . . . . . . . . . . . . 23.4 mmt180 -97.38 126.22 42.48 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.54 -0.754 . . . . 4.73 109.086 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 676' ' ' VAL . . . . . 0.428 ' HB ' HD13 ' A' ' 717' ' ' LEU . 35.7 m -117.17 162.1 15.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 120.828 0.347 . . . . 1.18 111.443 -175.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 677' ' ' ARG . . . . . . . . . . . . . 47.5 ttt180 -138.59 125.86 21.61 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.539 -0.755 . . . . 3.6 109.753 -176.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 678' ' ' HIS . . . . . 0.478 ' CD2' HD12 ' A' ' 717' ' ' LEU . 0.0 OUTLIER -147.5 132.65 18.33 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 110.423 -0.214 . . . . 2.48 110.423 178.092 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 679' ' ' ALA . . . . . . . . . . . . . . . -66.45 -14.57 62.39 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.938 0.399 . . . . 1.91 111.95 -176.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 680' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -82.84 -37.78 23.94 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.142 -0.481 . . . . 3.47 111.963 -178.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 681' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -125.25 -11.8 6.91 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.043 0.386 . . . . 2.31 112.043 -171.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 682' ' ' GLY . . . . . . . . . . . . . . . 98.97 -152.71 19.7 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.294 -0.722 . . . . 0.82 111.294 -175.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 683' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -104.74 147.19 27.96 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.526 -0.546 . . . . 2.11 109.526 178.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 684' ' ' GLY . . . . . . . . . . . . . . . -151.6 173.67 30.88 Favored Glycine 0 N--CA 1.441 -0.967 0 C-N-CA 119.641 -1.266 . . . . 0.43 112.464 -177.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 685' ' ' THR . . . . . . . . . . . . . 35.2 m -118.44 124.3 47.31 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.941 -0.392 . . . . 1.21 109.941 176.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 35.5 mt -72.33 104.88 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.2 -0.455 . . . . 1.07 109.837 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 687' ' ' VAL . . . . . . . . . . . . . 28.7 m -94.9 -23.81 5.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.302 -0.408 . . . . 1.13 111.512 -175.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 688' ' ' ASN . . . . . 0.417 ' HB3' ' HB2' ' A' ' 699' ' ' GLN . 63.0 t30 -151.24 165.0 35.31 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.466 -0.334 . . . . 2.15 110.196 -178.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 689' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.59 156.59 38.26 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.464 -0.569 . . . . 2.7 109.464 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 690' ' ' GLU . . . . . 0.461 ' O ' ' HA ' ' A' ' 696' ' ' SER . 45.9 mt-10 -125.95 123.76 39.26 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.539 -0.3 . . . . 2.02 110.752 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . 69.28 -160.96 52.53 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 121.083 -0.58 . . . . 1.14 112.728 178.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 66.9 m -152.03 157.43 41.66 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.257 -0.275 . . . . 2.41 110.257 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 89.67 -142.39 16.61 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.835 -0.698 . . . . 1.46 112.313 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 694' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -74.04 -31.46 62.9 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.042 0.449 . . . . 2.85 110.635 -178.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 695' ' ' HIS . . . . . . . . . . . . . 35.4 m170 -91.6 16.11 11.19 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.813 -0.631 . . . . 3.85 110.661 -176.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 696' ' ' SER . . . . . 0.461 ' HA ' ' O ' ' A' ' 690' ' ' GLU . 20.8 t -81.97 130.47 35.09 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.437 -0.579 . . . . 2.05 109.437 177.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 697' ' ' ARG . . . . . . . . . . . . . 23.9 mtm180 -114.51 133.72 55.56 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.226 -0.657 . . . . 3.16 109.226 177.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 698' ' ' LEU . . . . . 0.439 HD12 ' CD2' ' A' ' 670' ' ' TYR . 9.3 mt -106.14 130.65 53.99 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 120.632 0.253 . . . . 1.25 110.449 -177.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 699' ' ' GLN . . . . . 0.493 ' HA ' ' O ' ' A' ' 708' ' ' LYS . 3.8 mp0 -95.55 100.63 12.35 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.754 0.788 . . . . 2.54 109.264 175.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 700' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 707' ' ' ILE . 19.5 t -101.71 124.14 55.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 114.729 -1.123 . . . . 1.08 110.815 -172.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -84.83 94.82 8.81 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.233 -0.439 . . . . 1.14 110.16 177.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 702' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -78.64 122.56 26.1 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.677 -0.49 . . . . 2.06 109.677 177.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -69.15 -13.19 62.28 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.941 -0.572 . . . . 2.83 111.468 -174.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -101.06 8.68 57.65 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.749 -0.739 . . . . 0.78 112.612 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 705' ' ' GLN . . . . . . . . . . . . . 23.2 tp60 -158.45 -75.64 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.958 0.379 . . . . 3.15 111.047 178.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . . . . . . . . . . . 170.36 -167.02 40.19 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 121.013 -0.613 . . . . 0.79 112.025 -178.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 707' ' ' ILE . . . . . 0.488 ' HA ' ' O ' ' A' ' 700' ' ' VAL . 71.4 mt -79.53 126.22 39.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.158 0.504 . . . . 1.43 110.796 -178.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 708' ' ' LYS . . . . . 0.493 ' O ' ' HA ' ' A' ' 699' ' ' GLN . 63.6 mttm -125.77 159.4 32.46 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.785 -0.643 . . . . 1.91 110.693 -179.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 709' ' ' TRP . . . . . . . . . . . . . 14.6 p-90 -100.7 116.28 32.23 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.945 -0.57 . . . . 0.97 110.265 178.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -117.76 114.38 23.22 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.016 -0.538 . . . . 1.25 110.206 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 46.5 t -63.86 110.06 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.589 -0.522 . . . . 1.25 109.589 177.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 712' ' ' ALA . . . . . . . . . . . . . . . -45.15 -43.24 9.74 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 113.502 0.927 . . . . 1.3 113.502 -168.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -64.18 -36.99 85.84 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 111.975 0.361 . . . . 1.62 111.975 -177.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 714' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -102.5 -9.79 19.91 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.967 0.413 . . . . 2.77 110.815 -177.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 715' ' ' ALA . . . . . 0.406 ' HB3' ' CD2' ' A' ' 717' ' ' LEU . . . -67.74 -62.6 1.33 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.801 -0.636 . . . . 1.37 109.941 178.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 716' ' ' ARG . . . . . 0.604 ' HD3' ' O ' ' A' ' 657' ' ' GLN . 59.9 mtt180 56.03 66.4 1.21 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.506 0.67 . . . . 5.14 110.52 175.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . 0.478 HD12 ' CD2' ' A' ' 678' ' ' HIS . 4.6 mm? -89.21 145.15 25.6 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.189 -0.914 . . . . 1.42 110.334 -177.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 718' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -97.27 134.68 40.24 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.211 -0.663 . . . . 2.13 109.211 176.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 719' ' ' SER . . . . . . . . . . . . . 13.5 m -75.81 128.37 34.99 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.58 -0.282 . . . . 2.19 110.43 -178.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 720' ' ' VAL . . . . . . . . . . . . . 17.6 t . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.498 -0.763 . . . . 2.06 109.77 177.717 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 . . . . . 0 N--CA 1.483 1.193 0 N-CA-C 110.013 -0.366 . . . . 27.62 110.013 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 646' ' ' LEU . . . . . . . . . . . . . 43.4 mt -124.3 105.43 9.46 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.614 0.245 . . . . 26.92 110.853 -174.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 647' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 -83.14 -54.12 5.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.151 0.5 . . . . 24.69 110.332 177.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 648' ' ' ALA . . . . . . . . . . . . . . . -147.97 54.76 1.04 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.658 -0.701 . . . . 23.98 109.139 178.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 649' ' ' THR . . . . . . . . . . . . . 11.8 m -87.97 105.61 17.57 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.358 -0.837 . . . . 23.65 111.315 -174.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 650' ' ' VAL . . . . . . . . . . . . . 60.9 t 70.75 -73.59 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 115.261 -0.881 . . . . 23.57 112.081 176.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 651' ' ' SER . . . . . . . . . . . . . 32.9 t -155.44 137.96 15.03 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.888 0.375 . . . . 22.02 110.952 -176.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 652' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -162.83 145.52 8.35 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.606 -0.725 . . . . 21.94 109.07 174.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 653' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_exo -52.09 111.92 0.73 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.046 2.497 . . . . 20.17 112.363 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 654' ' ' VAL . . . . . . . . . . . . . 26.4 t 57.58 78.14 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 115.362 -0.835 . . . . 20.53 110.714 -177.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 655' ' ' SER . . . . . . . . . . . . . 18.8 m -75.54 132.03 40.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.955 -0.566 . . . . 18.62 109.505 177.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 656' ' ' HIS . . . . . . . . . . . . . 42.8 m80 -99.84 101.62 12.81 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.971 0.415 . . . . 16.76 110.548 -178.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 657' ' ' GLN . . . . . . . . . . . . . 25.6 mp0 -73.59 -39.78 64.35 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.816 -0.629 . . . . 18.33 110.505 -178.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 658' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -115.08 30.66 7.21 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.759 -0.655 . . . . 15.71 110.466 -178.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 659' ' ' MET . . . . . . . . . . . . . 65.3 mtt 62.15 -162.35 0.28 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.383 -0.826 . . . . 15.12 110.978 178.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . 149.58 -31.59 1.13 Allowed Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.776 -0.726 . . . . 12.85 112.239 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 661' ' ' THR . . . . . . . . . . . . . 12.1 p -88.62 128.58 52.13 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-O 120.586 0.231 . . . . 10.68 110.858 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 662' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -68.78 113.42 3.2 Favored 'Trans proline' 0 C--O 1.233 0.269 0 C-N-CA 122.616 2.211 . . . . 11.11 111.917 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 663' ' ' MET . . . . . . . . . . . . . 48.3 ttp -83.99 46.64 1.21 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.724 0.773 . . . . 9.83 110.03 -178.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 664' ' ' VAL . . . . . . . . . . . . . 4.2 p -81.8 90.49 2.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 122.041 0.924 . . . . 7.26 110.412 -178.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 665' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -156.28 145.73 20.78 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.426 -0.806 . . . . 7.07 110.931 -176.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 666' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -101.97 91.38 4.32 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.771 -0.825 . . . . 7.24 108.771 173.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 667' ' ' ASP . . . . . 0.406 ' HB3' ' CE1' ' A' ' 670' ' ' TYR . 51.6 m-20 71.92 121.9 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 O-C-N 124.055 0.847 . . . . 5.49 110.494 -176.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 668' ' ' SER . . . . . . . . . . . . . 16.7 m -62.21 -31.37 71.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.525 -0.762 . . . . 4.8 111.611 -175.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 669' ' ' GLY . . . . . . . . . . . . . . . 139.32 111.05 0.94 Allowed Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.463 -0.875 . . . . 2.2 112.414 177.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 670' ' ' TYR . . . . . 0.406 ' CE1' ' HB3' ' A' ' 667' ' ' ASP . 77.0 m-85 -95.3 146.21 24.53 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 110.113 -0.329 . . . . 2.3 110.113 178.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 671' ' ' LYS . . . . . 0.401 ' HG2' ' HB2' ' A' ' 674' ' ' GLN . 20.7 pttp -138.86 160.2 40.3 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.313 -0.625 . . . . 3.13 109.313 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . . . . . . . . . 29.7 mt -72.08 133.08 45.02 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.962 -0.384 . . . . 1.6 109.962 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 673' ' ' GLY . . . . . . . . . . . . . . . 86.94 8.17 76.44 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.791 -0.719 . . . . 0.66 111.764 -175.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 674' ' ' GLN . . . . . 0.401 ' HB2' ' HG2' ' A' ' 671' ' ' LYS . 33.2 tt0 -85.87 142.86 28.58 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.949 -0.389 . . . . 2.74 109.949 178.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 675' ' ' ARG . . . . . 0.464 ' HD2' ' N ' ' A' ' 675' ' ' ARG . 3.7 mpt_? -100.78 127.48 47.19 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.147 0.499 . . . . 4.73 110.328 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 676' ' ' VAL . . . . . 0.483 ' HB ' ' HB3' ' A' ' 717' ' ' LEU . 27.1 m -117.23 154.1 18.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.587 -0.733 . . . . 1.18 110.917 -177.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 677' ' ' ARG . . . . . 0.405 ' CG ' ' HB3' ' A' ' 683' ' ' GLU . 26.9 mtt180 -127.18 136.95 52.77 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.996 -0.547 . . . . 3.6 110.957 177.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -138.94 142.59 38.43 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.503 -0.772 . . . . 2.48 109.333 172.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 679' ' ' ALA . . . . . . . . . . . . . . . -49.46 -52.47 28.87 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.612 0.597 . . . . 1.91 112.612 -172.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 680' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -91.07 -37.05 13.66 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.47 -0.332 . . . . 3.47 111.809 -170.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 681' ' ' PHE . . . . . . . . . . . . . 9.3 m-30 -81.2 -11.32 59.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.841 0.353 . . . . 2.31 111.273 -178.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 682' ' ' GLY . . . . . . . . . . . . . . . 86.32 -111.84 3.67 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.508 -0.853 . . . . 0.82 111.636 178.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 683' ' ' GLU . . . . . 0.405 ' HB3' ' CG ' ' A' ' 677' ' ' ARG . 10.4 pt-20 -155.66 148.43 24.2 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.725 0.298 . . . . 2.11 110.443 178.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 684' ' ' GLY . . . . . . . . . . . . . . . -152.41 -177.31 25.94 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.647 -0.787 . . . . 0.43 111.531 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 685' ' ' THR . . . . . . . . . . . . . 58.5 m -119.44 130.14 55.11 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.827 0.346 . . . . 1.21 110.414 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 686' ' ' ILE . . . . . 0.408 HG12 HG21 ' A' ' 700' ' ' VAL . 48.8 mt -73.86 104.61 2.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.082 -0.508 . . . . 1.07 110.123 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 687' ' ' VAL . . . . . . . . . . . . . 30.3 m -89.63 -26.12 5.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.416 -0.356 . . . . 1.13 111.018 -177.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -152.42 162.41 41.22 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.361 -0.382 . . . . 2.15 110.482 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 689' ' ' MET . . . . . . . . . . . . . 22.1 ptp -147.1 146.18 29.86 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.03 -0.532 . . . . 2.7 109.905 178.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 690' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -120.81 156.01 32.83 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.882 -0.599 . . . . 2.02 109.832 -176.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . 80.62 -169.42 52.34 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.57 -0.824 . . . . 1.14 111.791 -178.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 21.2 p -157.73 99.86 1.73 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.665 0.269 . . . . 2.41 110.368 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 118.74 -136.84 12.39 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.426 -0.892 . . . . 1.46 112.555 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 694' ' ' GLU . . . . . 0.489 ' O ' ' HB2' ' A' ' 713' ' ' ALA . 45.2 tt0 -64.38 -53.18 52.56 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.747 0.308 . . . . 2.85 111.573 -175.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 695' ' ' HIS . . . . . . . . . . . . . 41.9 m-70 -85.24 37.37 0.67 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.862 0.363 . . . . 3.85 111.904 -175.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 696' ' ' SER . . . . . . . . . . . . . 16.9 p -81.67 151.32 27.62 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 110.004 -0.369 . . . . 2.05 110.004 177.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 697' ' ' ARG . . . . . . . . . . . . . 32.2 mtm180 -121.47 129.51 53.0 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.646 -0.501 . . . . 3.16 109.646 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 14.3 mt -101.65 138.87 38.06 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 110.275 -0.268 . . . . 1.25 110.275 -177.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 699' ' ' GLN . . . . . 0.493 ' HA ' ' O ' ' A' ' 708' ' ' LYS . 1.3 mp0 -103.84 103.93 13.86 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.562 0.696 . . . . 2.54 109.278 173.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 700' ' ' VAL . . . . . 0.408 HG21 HG12 ' A' ' 686' ' ' ILE . 38.7 t -101.74 123.07 54.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 114.729 -1.123 . . . . 1.08 110.75 -172.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -83.12 94.31 7.8 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.199 -0.455 . . . . 1.14 110.569 178.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 702' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -81.02 126.67 31.69 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.46 -0.57 . . . . 2.06 109.46 175.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -70.55 -17.27 62.93 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.141 -0.481 . . . . 2.83 110.619 -176.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -82.76 -11.24 81.97 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.895 -0.669 . . . . 0.78 113.21 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 705' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -153.55 -68.54 0.15 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 117.294 0.547 . . . . 3.15 111.652 -178.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . . . . . . . . . . . 173.15 -165.87 38.2 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.519 -0.848 . . . . 0.79 112.437 -178.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 707' ' ' ILE . . . . . 0.404 ' HA ' ' O ' ' A' ' 700' ' ' VAL . 61.5 mt -79.56 120.34 30.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.931 0.396 . . . . 1.43 110.758 -178.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 708' ' ' LYS . . . . . 0.493 ' O ' ' HA ' ' A' ' 699' ' ' GLN . 96.1 mttt -114.54 159.47 20.35 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.108 -0.497 . . . . 1.91 111.375 -177.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 709' ' ' TRP . . . . . . . . . . . . . 24.3 p-90 -98.37 118.61 35.42 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.253 -0.885 . . . . 0.97 110.162 178.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -121.1 109.45 15.03 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.123 -0.49 . . . . 1.25 110.273 178.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 48.4 t -66.82 106.06 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.25 -0.648 . . . . 1.25 109.25 176.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 712' ' ' ALA . . . . . . . . . . . . . . . -48.13 -47.01 34.95 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.995 0.739 . . . . 1.3 112.995 -167.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 713' ' ' ALA . . . . . 0.489 ' HB2' ' O ' ' A' ' 694' ' ' GLU . . . -62.07 -18.11 59.62 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.606 0.595 . . . . 1.62 112.606 -176.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 714' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -126.57 9.03 7.07 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.145 0.497 . . . . 2.77 110.388 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 715' ' ' ALA . . . . . 0.417 ' HB3' ' CD2' ' A' ' 717' ' ' LEU . . . -93.2 -52.39 4.57 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.851 -0.613 . . . . 1.37 110.43 -179.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 716' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 53.67 73.99 0.34 Allowed 'General case' 0 C--O 1.232 0.17 0 O-C-N 123.778 0.674 . . . . 5.14 110.683 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . 0.483 ' HB3' ' HB ' ' A' ' 676' ' ' VAL . 3.9 mm? -97.05 130.4 44.36 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.12 -0.491 . . . . 1.42 110.562 -178.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 718' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -81.56 144.24 31.43 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.0 -0.545 . . . . 2.13 109.948 -178.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 719' ' ' SER . . . . . . . . . . . . . 10.4 p -82.13 119.91 24.64 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.978 -0.555 . . . . 2.19 110.774 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 720' ' ' VAL . . . . . . . . . . . . . 56.7 t . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.416 -0.802 . . . . 2.06 110.346 176.746 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 28.4 tpt180 . . . . . 0 N--CA 1.485 1.281 0 CA-C-O 120.471 0.177 . . . . 27.62 111.101 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 646' ' ' LEU . . . . . . . . . . . . . 64.4 tp -68.17 -62.83 1.22 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.64 0.257 . . . . 26.92 111.289 -175.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 647' ' ' ARG . . . . . . . . . . . . . 33.8 ptt180 -90.23 32.52 0.93 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.326 0.584 . . . . 24.69 110.378 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 648' ' ' ALA . . . . . . . . . . . . . . . -84.45 107.97 17.0 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.9 -0.591 . . . . 23.98 110.276 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 649' ' ' THR . . . . . . . . . . . . . 7.7 m -83.46 61.68 6.34 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.504 0.668 . . . . 23.65 109.998 178.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 650' ' ' VAL . . . . . . . . . . . . . 46.9 t -85.65 85.95 2.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.733 -0.667 . . . . 23.57 109.824 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 651' ' ' SER . . . . . . . . . . . . . 64.0 m -87.74 31.93 0.75 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.342 0.592 . . . . 22.02 110.651 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 652' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -106.79 114.66 61.5 Favored Pre-proline 0 N--CA 1.448 -0.532 0 CA-C-N 115.429 -0.805 . . . . 21.94 110.022 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 653' ' ' PRO . . . . . 0.44 ' O ' ' HB ' ' A' ' 654' ' ' VAL . 41.6 Cg_endo -67.81 163.43 35.45 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.564 2.176 . . . . 20.17 111.508 178.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 654' ' ' VAL . . . . . 0.44 ' HB ' ' O ' ' A' ' 653' ' ' PRO . 95.6 t 76.06 -32.37 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 122.857 0.463 . . . . 20.53 111.467 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 655' ' ' SER . . . . . 0.435 ' H ' ' C ' ' A' ' 653' ' ' PRO . 9.9 t -79.31 84.53 5.23 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.352 0.596 . . . . 18.62 110.961 -177.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 656' ' ' HIS . . . . . . . . . . . . . 18.6 p80 -94.97 147.38 23.46 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.195 -0.669 . . . . 16.76 109.195 175.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 657' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 57.32 62.5 2.16 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 121.512 0.672 . . . . 18.33 109.463 -175.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 658' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -91.38 65.9 5.4 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.885 -0.598 . . . . 15.71 110.25 -176.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 659' ' ' MET . . . . . . . . . . . . . 13.8 tpt -95.78 -30.43 13.71 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.158 0.504 . . . . 15.12 109.971 176.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . -169.48 -165.62 27.16 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 111.266 -0.734 . . . . 12.85 111.266 177.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 661' ' ' THR . . . . . . . . . . . . . 2.1 p -115.12 106.72 50.93 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 116.72 0.26 . . . . 10.68 111.014 177.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 662' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -67.56 -21.8 45.53 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.676 2.251 . . . . 11.11 112.284 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 663' ' ' MET . . . . . . . . . . . . . 23.8 mmt -127.71 132.67 49.59 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.307 -0.627 . . . . 9.83 109.307 177.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 664' ' ' VAL . . . . . 0.491 HG23 ' H ' ' A' ' 665' ' ' GLU . 2.4 m -111.96 -63.85 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 112.018 0.377 . . . . 7.26 112.018 -177.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 665' ' ' GLU . . . . . 0.491 ' H ' HG23 ' A' ' 664' ' ' VAL . 2.7 mp0 50.44 59.54 4.5 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.11 0.481 . . . . 7.07 110.744 -177.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 666' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -124.41 -167.53 1.67 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.955 -0.566 . . . . 7.24 109.734 -176.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 667' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.65 170.95 3.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.033 0.444 . . . . 5.49 111.192 178.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 668' ' ' SER . . . . . . . . . . . . . 23.6 t -80.17 -22.77 41.6 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.12 -0.491 . . . . 4.8 110.09 178.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 669' ' ' GLY . . . . . . . . . . . . . . . -102.27 -168.37 26.87 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.867 -0.682 . . . . 2.2 111.674 177.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 670' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -116.41 165.98 12.59 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 120.676 0.275 . . . . 2.3 110.906 -177.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -120.81 140.82 51.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.084 -0.507 . . . . 3.13 110.139 -176.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . . . . . . . . . 64.1 mt -69.63 141.91 53.57 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.238 -0.437 . . . . 1.6 110.819 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 673' ' ' GLY . . . . . . . . . . . . . . . 93.29 -11.18 72.21 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.945 -0.645 . . . . 0.66 111.849 -178.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 674' ' ' GLN . . . . . . . . . . . . . 21.7 tp60 -79.93 143.09 34.51 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.561 -0.533 . . . . 2.74 109.561 178.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 675' ' ' ARG . . . . . 0.697 ' HB2' ' OXT' ' A' ' 720' ' ' VAL . 36.8 mtm180 -96.76 141.51 29.9 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.567 -0.531 . . . . 4.73 109.567 177.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 676' ' ' VAL . . . . . 0.444 ' HB ' HD11 ' A' ' 717' ' ' LEU . 27.6 m -120.77 155.6 24.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 115.748 -0.66 . . . . 1.18 110.558 -177.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 677' ' ' ARG . . . . . . . . . . . . . 50.5 ttp180 -130.5 130.28 43.97 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.179 -0.464 . . . . 3.6 110.49 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -136.07 131.88 35.44 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.774 -0.824 . . . . 2.48 108.774 177.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 679' ' ' ALA . . . . . . . . . . . . . . . -64.89 -26.71 68.44 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.928 0.394 . . . . 1.91 111.803 -170.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 680' ' ' LYS . . . . . 0.429 ' HD2' ' N ' ' A' ' 680' ' ' LYS . 0.6 OUTLIER -93.8 -31.78 14.24 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.011 -0.54 . . . . 3.47 112.094 -177.926 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 681' ' ' PHE . . . . . . . . . . . . . 22.6 m-30 -103.43 -11.52 17.79 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.724 0.639 . . . . 2.31 112.724 -174.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 682' ' ' GLY . . . . . . . . . . . . . . . 96.86 -129.12 9.79 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.349 -0.929 . . . . 0.82 111.728 -178.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 683' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -145.66 148.97 33.65 Favored 'General case' 0 C--N 1.319 -0.731 0 O-C-N 122.499 -0.412 . . . . 2.11 109.93 178.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 684' ' ' GLY . . . . . 0.416 ' CA ' ' HA ' ' A' ' 702' ' ' PHE . . . -153.94 179.42 30.2 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.204 -0.998 . . . . 0.43 112.509 -178.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 685' ' ' THR . . . . . . . . . . . . . 42.5 m -116.2 127.96 55.21 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 110.107 -0.331 . . . . 1.21 110.107 178.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 38.2 mt -72.02 104.27 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.62 -0.511 . . . . 1.07 109.62 178.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 687' ' ' VAL . . . . . . . . . . . . . 27.5 m -95.12 -24.96 4.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 120.892 0.377 . . . . 1.13 111.314 -175.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -151.44 161.98 41.75 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.59 -0.522 . . . . 2.15 109.59 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 689' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -151.27 153.51 35.0 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 110.081 -0.34 . . . . 2.7 110.081 177.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 690' ' ' GLU . . . . . 0.443 ' O ' ' HA ' ' A' ' 696' ' ' SER . 38.7 mt-10 -126.74 126.04 42.79 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.916 -0.584 . . . . 2.02 110.976 -178.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . 76.81 176.7 43.72 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.868 -0.682 . . . . 1.14 113.487 173.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 9.3 p -141.38 152.93 44.76 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.087 -0.338 . . . . 2.41 110.087 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 88.55 -134.8 12.65 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.729 -0.748 . . . . 1.46 111.806 -178.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 694' ' ' GLU . . . . . 0.435 ' HA ' ' HB3' ' A' ' 713' ' ' ALA . 37.0 tt0 -80.08 -31.95 39.28 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.287 0.565 . . . . 2.85 110.14 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 695' ' ' HIS . . . . . . . . . . . . . 31.4 m-70 -87.18 37.88 0.79 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.739 -0.664 . . . . 3.85 110.82 -178.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 696' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 690' ' ' GLU . 55.7 p -109.41 134.23 52.1 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.019 0.438 . . . . 2.05 110.667 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 697' ' ' ARG . . . . . . . . . . . . . 21.5 mtm180 -125.68 141.59 51.94 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.515 -0.55 . . . . 3.16 109.515 176.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 17.3 mt -107.71 136.61 47.16 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 109.88 -0.415 . . . . 1.25 109.88 178.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 699' ' ' GLN . . . . . 0.476 ' HG2' ' CG2' ' A' ' 707' ' ' ILE . 56.2 tt0 -100.86 100.27 10.89 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 108.573 -0.899 . . . . 2.54 108.573 176.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 41.2 t -102.6 124.14 56.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.415 -0.811 . . . . 1.08 111.59 -171.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -88.37 96.84 10.74 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.077 -0.511 . . . . 1.14 109.973 176.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 702' ' ' PHE . . . . . 0.416 ' HA ' ' CA ' ' A' ' 684' ' ' GLY . 64.1 m-85 -73.11 149.73 42.82 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.064 -0.516 . . . . 2.06 111.012 -177.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 23.6 tp60 -49.22 -50.23 39.39 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.678 0.621 . . . . 2.83 112.678 -170.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -134.03 19.16 4.17 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 119.617 -1.278 . . . . 0.78 113.9 -176.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 705' ' ' GLN . . . . . 0.48 ' O ' ' HE2' ' A' ' 708' ' ' LYS . 1.5 mp0 -124.98 10.87 8.25 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 117.67 0.735 . . . . 3.15 111.801 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . . . . . . . . . . . 80.85 -166.62 49.02 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.306 -0.949 . . . . 0.79 112.702 178.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 707' ' ' ILE . . . . . 0.476 ' CG2' ' HG2' ' A' ' 699' ' ' GLN . 29.2 mt -97.87 130.44 46.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 120.638 0.256 . . . . 1.43 111.171 -176.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 708' ' ' LYS . . . . . 0.48 ' HE2' ' O ' ' A' ' 705' ' ' GLN . 4.6 mptp? -118.09 169.58 9.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.979 0.419 . . . . 1.91 111.192 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 709' ' ' TRP . . . . . . . . . . . . . 22.7 p-90 -113.3 119.77 38.84 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.36 -0.836 . . . . 0.97 109.859 176.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . 0.418 HD21 ' N ' ' A' ' 710' ' ' LEU . 3.2 mm? -120.71 116.18 24.77 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.427 -0.351 . . . . 1.25 110.486 -177.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 40.6 t -65.7 108.79 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.444 -0.576 . . . . 1.25 109.444 176.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 712' ' ' ALA . . . . . . . . . . . . . . . -57.07 -34.01 67.84 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.894 -0.594 . . . . 1.3 112.418 -169.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 713' ' ' ALA . . . . . 0.435 ' HB3' ' HA ' ' A' ' 694' ' ' GLU . . . -65.66 -25.4 67.33 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.776 0.322 . . . . 1.62 111.757 -178.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 714' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -121.77 8.2 9.98 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.469 -0.332 . . . . 2.77 111.038 -176.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 715' ' ' ALA . . . . . 0.459 ' HB1' ' CD2' ' A' ' 717' ' ' LEU . . . -88.72 -57.97 2.72 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.174 -0.466 . . . . 1.37 111.56 -175.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 716' ' ' ARG . . . . . . . . . . . . . 26.1 tpt180 55.63 72.37 0.49 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.494 0.664 . . . . 5.14 111.038 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . 0.459 ' CD2' ' HB1' ' A' ' 715' ' ' ALA . 4.3 mm? -90.88 142.86 27.32 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.633 -0.712 . . . . 1.42 111.148 -178.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 718' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -84.32 148.66 26.53 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.542 -0.753 . . . . 2.13 109.313 175.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 719' ' ' SER . . . . . . . . . . . . . 19.6 m -92.39 121.91 34.33 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.766 0.317 . . . . 2.19 110.79 -178.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 720' ' ' VAL . . . . . 0.697 ' OXT' ' HB2' ' A' ' 675' ' ' ARG . 9.3 p . . . . . 0 C--O 1.247 0.971 0 CA-C-O 118.758 -0.639 . . . . 2.06 110.378 178.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 34.6 ttm180 . . . . . 0 N--CA 1.481 1.098 0 CA-C-O 121.017 0.437 . . . . 27.62 110.199 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 646' ' ' LEU . . . . . . . . . . . . . 96.1 mt -83.8 -20.97 32.32 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.11 -0.496 . . . . 26.92 110.995 -178.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 647' ' ' ARG . . . . . . . . . . . . . 12.0 ptp180 -145.23 138.29 26.38 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.331 -0.395 . . . . 24.69 110.935 -178.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 648' ' ' ALA . . . . . . . . . . . . . . . -117.51 -65.92 1.13 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.0 -0.545 . . . . 23.98 109.725 175.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 649' ' ' THR . . . . . . . . . . . . . 14.9 t 178.46 153.19 0.34 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.979 -0.555 . . . . 23.65 110.418 176.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 650' ' ' VAL . . . . . . . . . . . . . 9.2 p -131.35 1.05 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.626 0.727 . . . . 23.57 109.167 174.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 651' ' ' SER . . . . . . . . . . . . . 68.1 p -72.11 143.22 49.08 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.249 -0.887 . . . . 22.02 111.452 -174.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 652' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -120.99 129.15 25.43 Favored Pre-proline 0 C--N 1.32 -0.676 0 N-CA-C 109.148 -0.686 . . . . 21.94 109.148 175.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 653' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.92 51.57 2.0 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.766 2.311 . . . . 20.17 113.417 -176.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 654' ' ' VAL . . . . . . . . . . . . . 8.4 p -84.96 -27.39 6.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.335 -0.848 . . . . 20.53 109.098 175.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 655' ' ' SER . . . . . . . . . . . . . 40.9 m -100.39 61.54 1.05 Allowed 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.079 -0.964 . . . . 18.62 109.105 173.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 656' ' ' HIS . . . . . 0.5 ' CE1' ' HA ' ' A' ' 659' ' ' MET . 20.5 t60 -77.12 100.95 5.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.625 -0.716 . . . . 16.76 110.504 -175.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 657' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -129.53 -50.38 1.17 Allowed 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.889 -0.782 . . . . 18.33 108.889 175.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 658' ' ' ARG . . . . . . . . . . . . . 56.9 mtm180 -107.07 46.77 0.91 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.305 -0.861 . . . . 15.71 109.195 172.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 659' ' ' MET . . . . . 0.5 ' HA ' ' CE1' ' A' ' 656' ' ' HIS . 1.5 mpt? 73.88 -45.71 0.61 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 114.618 -1.174 . . . . 15.12 111.986 -178.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . 95.71 28.67 9.3 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 110.719 -0.952 . . . . 12.85 110.719 -178.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 661' ' ' THR . . . . . . . . . . . . . 3.8 t -71.76 136.31 83.01 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.282 -0.459 . . . . 10.68 111.113 -177.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 662' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -74.84 -13.82 21.69 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.611 2.207 . . . . 11.11 111.436 175.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 663' ' ' MET . . . . . . . . . . . . . 15.5 tpt -115.89 113.82 23.85 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.496 -0.774 . . . . 9.83 109.823 178.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 664' ' ' VAL . . . . . . . . . . . . . 47.2 t -69.94 126.49 30.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.05 -0.523 . . . . 7.26 110.198 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 665' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -68.56 -31.78 71.24 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.915 -0.584 . . . . 7.07 110.376 -177.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 666' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 -100.9 52.49 0.85 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.065 -0.717 . . . . 7.24 109.065 174.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 667' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -60.28 -58.15 9.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.388 -0.824 . . . . 5.49 112.444 -172.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 668' ' ' SER . . . . . . . . . . . . . 9.2 t -117.68 -10.49 10.54 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.804 -0.359 . . . . 4.8 111.492 -173.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 669' ' ' GLY . . . . . . . . . . . . . . . 105.2 160.4 23.41 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.356 -0.926 . . . . 2.2 111.743 -178.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 670' ' ' TYR . . . . . 0.529 ' CE2' ' HB2' ' A' ' 717' ' ' LEU . 93.4 m-85 -93.25 141.8 28.03 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 120.853 0.359 . . . . 2.3 110.863 -177.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -125.42 162.29 25.16 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.966 -0.561 . . . . 3.13 110.503 -175.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . . . . . . . . . 7.6 mp -79.67 143.48 34.59 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.89 0.376 . . . . 1.6 110.452 177.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 673' ' ' GLY . . . . . . . . . . . . . . . 84.46 3.01 88.81 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.767 -0.652 . . . . 0.66 111.542 -177.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 674' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -86.62 145.5 26.7 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.557 -0.321 . . . . 2.74 110.228 -178.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 675' ' ' ARG . . . . . . . . . . . . . 30.9 ttm180 -106.48 125.04 50.49 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.219 0.533 . . . . 4.73 109.902 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 676' ' ' VAL . . . . . 0.409 ' HB ' ' HB3' ' A' ' 717' ' ' LEU . 34.7 m -117.57 163.32 14.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.456 -0.793 . . . . 1.18 111.147 -174.221 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 677' ' ' ARG . . . . . 0.472 ' HB2' HG22 ' A' ' 720' ' ' VAL . 55.8 ttp180 -134.72 121.16 20.37 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.043 -0.526 . . . . 3.6 109.98 176.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 678' ' ' HIS . . . . . 0.451 ' HB2' ' CD1' ' A' ' 717' ' ' LEU . 51.5 t60 -134.25 122.65 23.04 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.094 -0.706 . . . . 2.48 109.094 179.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 679' ' ' ALA . . . . . . . . . . . . . . . -58.41 -20.8 47.39 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.009 0.744 . . . . 1.91 113.009 -169.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 680' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -86.28 -33.46 20.66 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 111.938 0.347 . . . . 3.47 111.938 -177.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 681' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -116.97 -12.41 10.69 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.438 0.533 . . . . 2.31 112.438 -175.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 682' ' ' GLY . . . . . . . . . . . . . . . 99.03 -156.51 20.06 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.793 -0.717 . . . . 0.82 111.548 -178.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 683' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -105.51 143.24 33.95 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.866 -0.42 . . . . 2.11 109.866 176.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 684' ' ' GLY . . . . . . . . . . . . . . . -153.79 175.14 32.22 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.218 -0.991 . . . . 0.43 112.486 -177.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 685' ' ' THR . . . . . . . . . . . . . 84.9 m -111.89 123.97 51.37 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.724 0.297 . . . . 1.21 110.364 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 44.7 mt -68.76 106.5 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.56 -0.533 . . . . 1.07 109.56 178.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 687' ' ' VAL . . . . . . . . . . . . . 26.9 m -99.58 -19.05 6.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.326 -0.397 . . . . 1.13 111.454 -174.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 688' ' ' ASN . . . . . 0.443 ' HB3' ' HB2' ' A' ' 699' ' ' GLN . 18.1 t-20 -156.58 162.33 39.9 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.542 -0.54 . . . . 2.15 109.542 -178.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 689' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -148.97 146.82 28.0 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.021 -0.733 . . . . 2.7 109.021 176.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 690' ' ' GLU . . . . . 0.426 ' OE2' ' HD2' ' A' ' 697' ' ' ARG . 36.4 mt-10 -119.93 122.85 42.14 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.635 0.255 . . . . 2.02 111.237 -174.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . 68.99 -172.7 36.49 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.144 -0.55 . . . . 1.14 113.235 175.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 8.5 p -139.71 165.67 26.66 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.397 -0.223 . . . . 2.41 110.397 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 81.0 -150.65 30.88 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 121.095 -0.574 . . . . 1.46 112.615 178.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 694' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -64.47 -40.99 96.73 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.833 0.349 . . . . 2.85 111.157 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 695' ' ' HIS . . . . . . . . . . . . . 27.6 p-80 -86.66 21.97 2.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.283 -0.417 . . . . 3.85 111.293 -177.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 696' ' ' SER . . . . . . . . . . . . . 19.2 t -82.05 141.36 33.26 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.38 -0.6 . . . . 2.05 109.38 176.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 697' ' ' ARG . . . . . 0.426 ' HD2' ' OE2' ' A' ' 690' ' ' GLU . 41.6 mtt180 -122.69 152.77 40.22 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.668 -0.493 . . . . 3.16 109.668 178.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 11.2 mt -118.22 130.38 56.04 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.198 -0.668 . . . . 1.25 109.198 174.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 699' ' ' GLN . . . . . 0.443 ' HB2' ' HB3' ' A' ' 688' ' ' ASN . 30.5 mt-30 -97.49 101.49 13.03 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.746 0.784 . . . . 2.54 109.618 175.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 700' ' ' VAL . . . . . 0.442 ' HB ' ' CE1' ' A' ' 702' ' ' PHE . 15.9 t -100.13 123.19 52.83 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 114.674 -1.148 . . . . 1.08 110.35 -174.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -86.49 94.3 9.38 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.402 -0.592 . . . . 1.14 109.402 176.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 702' ' ' PHE . . . . . 0.442 ' CE1' ' HB ' ' A' ' 700' ' ' VAL . 92.7 m-85 -77.14 117.11 18.36 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.832 -0.622 . . . . 2.06 109.743 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -60.79 -21.51 63.16 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.854 -0.612 . . . . 2.83 112.088 -174.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -83.92 -20.04 60.2 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.67 -0.776 . . . . 0.78 112.481 178.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 705' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -135.26 -82.9 0.41 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.864 0.364 . . . . 3.15 111.4 -177.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . . . . . . . . . . . 179.49 -156.58 18.64 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 121.119 -0.562 . . . . 0.79 111.77 -177.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 707' ' ' ILE . . . . . 0.437 ' HA ' ' O ' ' A' ' 700' ' ' VAL . 61.5 mt -85.17 126.83 40.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 120.982 0.42 . . . . 1.43 111.205 -176.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 708' ' ' LYS . . . . . 0.433 ' O ' ' HA ' ' A' ' 699' ' ' GLN . 4.5 mptp? -121.47 161.4 22.32 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.891 -0.595 . . . . 1.91 109.779 176.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 709' ' ' TRP . . . . . . . . . . . . . 17.7 p-90 -105.86 115.29 29.98 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.233 0.539 . . . . 0.97 109.657 177.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -112.75 114.62 27.27 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 116.137 -0.483 . . . . 1.25 110.244 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 49.1 t -65.1 115.68 3.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.664 -0.495 . . . . 1.25 109.664 178.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 712' ' ' ALA . . . . . . . . . . . . . . . -54.62 -32.57 59.12 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.849 0.685 . . . . 1.3 112.849 -170.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -66.34 -25.62 66.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.932 0.396 . . . . 1.62 111.545 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 714' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -133.95 29.44 3.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.141 0.496 . . . . 2.77 109.723 -177.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 715' ' ' ALA . . . . . 0.497 ' HB1' ' CD2' ' A' ' 717' ' ' LEU . . . -80.01 -57.49 3.61 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.553 -0.749 . . . . 1.37 111.094 -174.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 716' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 58.3 69.34 0.74 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.63 0.729 . . . . 5.14 111.031 178.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . 0.529 ' HB2' ' CE2' ' A' ' 670' ' ' TYR . 3.6 mm? -105.74 122.92 47.06 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.876 -0.602 . . . . 1.42 110.278 177.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 718' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -91.05 130.94 36.91 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.763 -0.653 . . . . 2.13 109.787 -179.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 719' ' ' SER . . . . . . . . . . . . . 15.5 p -64.9 125.63 25.47 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.901 -0.407 . . . . 2.19 109.901 176.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 720' ' ' VAL . . . . . 0.472 HG22 ' HB2' ' A' ' 677' ' ' ARG . 10.9 t . . . . . 0 C--O 1.246 0.921 0 CA-C-O 118.803 -0.618 . . . . 2.06 110.528 -177.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 645' ' ' ARG . . . . . 0.516 ' HD3' ' H2 ' ' A' ' 645' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.144 0 N-CA-C 111.463 0.171 . . . . 27.62 111.463 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 646' ' ' LEU . . . . . . . . . . . . . 68.6 tp -137.51 -71.47 0.43 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.682 0.277 . . . . 26.92 110.988 -177.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 647' ' ' ARG . . . . . . . . . . . . . 58.1 mtm180 -103.16 102.56 12.55 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.796 -0.446 . . . . 24.69 109.796 178.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 648' ' ' ALA . . . . . . . . . . . . . . . -67.72 129.11 38.91 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.013 -0.54 . . . . 23.98 111.167 -177.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 649' ' ' THR . . . . . . . . . . . . . 9.0 t -145.1 132.02 20.21 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.889 -0.596 . . . . 23.65 109.437 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 650' ' ' VAL . . . . . . . . . . . . . 46.3 t -80.3 -52.97 13.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.912 -0.585 . . . . 23.57 110.711 -176.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 651' ' ' SER . . . . . . . . . . . . . 16.8 p -160.06 -71.53 0.07 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.053 0.454 . . . . 22.02 110.79 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 652' ' ' ARG . . . . . . . . . . . . . 31.9 mmt180 -118.01 114.51 37.11 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.077 -0.511 . . . . 21.94 110.313 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 653' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -57.67 162.47 10.55 Favored 'Trans proline' 0 C--O 1.235 0.349 0 C-N-CA 123.06 2.507 . . . . 20.17 112.17 177.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 654' ' ' VAL . . . . . . . . . . . . . 37.0 t -76.98 79.64 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.356 0.598 . . . . 20.53 110.484 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 655' ' ' SER . . . . . . . . . . . . . 15.2 m -93.98 41.63 1.09 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.467 -0.788 . . . . 18.62 110.032 178.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 656' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -107.28 101.83 11.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.768 -0.651 . . . . 16.76 109.897 -178.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 657' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -109.69 152.86 25.06 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.123 -0.489 . . . . 18.33 110.457 -179.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 658' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -109.55 99.3 8.52 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.323 -0.399 . . . . 15.71 110.536 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 659' ' ' MET . . . . . . . . . . . . . 24.6 ttt -79.31 -24.15 43.03 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.293 0.568 . . . . 15.12 110.353 178.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . -94.94 25.18 25.04 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.89 -0.671 . . . . 12.85 111.753 -178.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 661' ' ' THR . . . . . . . . . . . . . 8.8 t -76.77 127.61 83.66 Favored Pre-proline 0 N--CA 1.449 -0.494 0 N-CA-C 110.147 -0.316 . . . . 10.68 110.147 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 662' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -71.16 150.67 60.07 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.348 2.032 . . . . 11.11 110.778 173.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 663' ' ' MET . . . . . . . . . . . . . 26.4 mmt 63.55 100.12 0.03 OUTLIER 'General case' 0 C--O 1.235 0.32 0 O-C-N 123.708 0.63 . . . . 9.83 110.754 -177.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 664' ' ' VAL . . . . . . . . . . . . . 59.4 t -66.24 100.7 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.546 -0.752 . . . . 7.26 110.784 -178.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 665' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -87.28 -12.48 46.48 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.047 -0.524 . . . . 7.07 111.0 -179.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 666' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -148.88 -62.84 0.24 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.222 -0.444 . . . . 7.24 110.219 177.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 667' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -150.59 169.66 21.01 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.978 -0.556 . . . . 5.49 110.087 178.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 668' ' ' SER . . . . . . . . . . . . . 11.9 m -92.9 25.75 3.05 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.246 -0.433 . . . . 4.8 111.777 -173.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 669' ' ' GLY . . . . . . . . . . . . . . . 137.78 -56.88 0.66 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.632 -0.794 . . . . 2.2 112.215 177.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 670' ' ' TYR . . . . . 0.518 ' CD1' HD12 ' A' ' 698' ' ' LEU . 94.1 m-85 -134.19 172.76 12.41 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 110.163 -0.31 . . . . 2.3 110.163 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 671' ' ' LYS . . . . . 0.455 ' HG2' HE21 ' A' ' 674' ' ' GLN . 21.2 ptmt -140.33 155.98 46.6 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.392 -0.367 . . . . 3.13 110.244 -176.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . . . . . . . . . 59.6 mt -78.65 140.99 38.32 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.136 -0.484 . . . . 1.6 110.478 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 673' ' ' GLY . . . . . . . . . . . . . . . 84.07 5.74 87.27 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.814 -0.63 . . . . 0.66 111.803 -177.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 674' ' ' GLN . . . . . 0.455 HE21 ' HG2' ' A' ' 671' ' ' LYS . 6.7 tt0 -83.28 142.89 30.77 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.022 -0.362 . . . . 2.74 110.022 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 675' ' ' ARG . . . . . . . . . . . . . 26.8 mmm180 -93.26 120.11 33.17 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.848 -0.614 . . . . 4.73 109.841 178.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 676' ' ' VAL . . . . . 0.454 ' HB ' ' HB3' ' A' ' 717' ' ' LEU . 34.2 m -117.27 154.74 19.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.883 -0.599 . . . . 1.18 110.695 -177.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 677' ' ' ARG . . . . . . . . . . . . . 52.1 ttp180 -131.79 137.91 48.34 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.955 -0.566 . . . . 3.6 110.014 178.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 678' ' ' HIS . . . . . 0.425 ' CD2' HD12 ' A' ' 717' ' ' LEU . 0.0 OUTLIER -139.99 155.21 47.22 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.129 -0.487 . . . . 2.48 110.464 174.089 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 679' ' ' ALA . . . . . . . . . . . . . . . -56.12 -53.9 51.56 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.673 0.62 . . . . 1.91 112.673 -173.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 680' ' ' LYS . . . . . . . . . . . . . 2.7 mtpm? -92.66 -30.67 15.46 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.957 -0.565 . . . . 3.47 111.743 -171.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 681' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -87.42 -11.85 47.93 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.342 -0.39 . . . . 2.31 111.34 -177.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 682' ' ' GLY . . . . . . . . . . . . . . . 84.47 -112.49 3.62 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.582 -0.818 . . . . 0.82 111.992 178.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 683' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -151.12 149.14 29.13 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.738 -0.468 . . . . 2.11 109.738 177.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 684' ' ' GLY . . . . . . . . . . . . . . . -160.55 -179.46 35.34 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.016 -1.088 . . . . 0.43 113.011 -178.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 685' ' ' THR . . . . . . . . . . . . . 64.6 m -110.83 130.02 55.7 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.738 -0.467 . . . . 1.21 109.738 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 686' ' ' ILE . . . . . 0.432 HG12 HG23 ' A' ' 700' ' ' VAL . 31.1 mt -72.74 103.52 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.171 -0.678 . . . . 1.07 109.171 175.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 687' ' ' VAL . . . . . . . . . . . . . 27.5 m -93.11 -26.28 4.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.18 0.514 . . . . 1.13 111.028 -175.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 688' ' ' ASN . . . . . 0.454 ' HB3' ' HB3' ' A' ' 699' ' ' GLN . 20.1 t-20 -146.07 161.74 39.46 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.916 -0.584 . . . . 2.15 109.676 177.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 689' ' ' MET . . . . . . . . . . . . . 26.7 ptm -153.16 143.68 22.6 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.55 -0.537 . . . . 2.7 109.55 177.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 690' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -108.73 122.79 47.89 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.756 -0.656 . . . . 2.02 110.456 -176.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . 67.64 -168.79 38.83 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.964 -0.636 . . . . 1.14 112.558 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 56.1 m -154.92 131.78 10.77 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.133 -0.321 . . . . 2.41 110.133 178.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 109.36 -142.74 16.33 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.713 -0.756 . . . . 1.46 112.021 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 694' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -66.54 -34.83 78.78 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.036 0.446 . . . . 2.85 111.109 -178.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 695' ' ' HIS . . . . . . . . . . . . . 55.8 m80 -95.36 31.03 2.05 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.253 -0.43 . . . . 3.85 110.902 -178.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 696' ' ' SER . . . . . . . . . . . . . 16.7 t -97.56 138.74 34.51 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.252 0.549 . . . . 2.05 110.902 -178.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 697' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -123.02 159.81 27.63 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.967 -0.753 . . . . 3.16 108.967 174.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 698' ' ' LEU . . . . . 0.518 HD12 ' CD1' ' A' ' 670' ' ' TYR . 35.6 mt -122.75 149.39 44.17 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 109.935 -0.394 . . . . 1.25 109.935 178.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 699' ' ' GLN . . . . . 0.454 ' HB3' ' HB3' ' A' ' 688' ' ' ASN . 15.1 tt0 -117.63 96.02 5.2 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.229 -1.026 . . . . 2.54 108.229 173.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 700' ' ' VAL . . . . . 0.432 HG23 HG12 ' A' ' 686' ' ' ILE . 35.3 t -100.64 134.5 40.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.551 -0.75 . . . . 1.08 111.103 -172.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -96.33 94.41 7.44 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.988 -0.551 . . . . 1.14 110.09 176.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 702' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -78.78 136.88 37.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.103 0.478 . . . . 2.06 110.691 -177.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -71.43 -21.22 62.01 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.609 -0.723 . . . . 2.83 112.473 -171.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -106.57 2.76 36.67 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.276 -0.964 . . . . 0.78 113.336 -175.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 705' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -146.64 -54.15 0.24 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 117.017 0.408 . . . . 3.15 111.447 -177.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . . . . . . . . . . . 139.57 -159.26 25.79 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.282 -0.961 . . . . 0.79 112.433 179.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 58.7 mt -79.08 134.25 28.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 120.847 0.356 . . . . 1.43 111.082 -176.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 708' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -137.75 159.59 41.55 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.884 -0.598 . . . . 1.91 111.333 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 709' ' ' TRP . . . . . 0.443 ' C ' HD21 ' A' ' 710' ' ' LEU . 33.0 p-90 -98.92 129.75 45.27 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.384 -0.825 . . . . 0.97 109.363 174.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . 0.443 HD21 ' C ' ' A' ' 709' ' ' TRP . 3.1 mm? -127.4 125.69 41.09 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 110.27 -0.27 . . . . 1.25 110.27 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 54.9 t -73.24 104.17 2.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.188 -0.671 . . . . 1.25 109.188 174.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 712' ' ' ALA . . . . . . . . . . . . . . . -56.81 -31.16 64.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.841 -0.618 . . . . 1.3 111.998 -171.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -58.96 -32.97 70.11 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.245 -0.434 . . . . 1.62 112.032 -178.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 714' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -127.73 19.21 6.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.134 0.492 . . . . 2.77 110.699 -178.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 715' ' ' ALA . . . . . 0.469 ' HB3' ' CD2' ' A' ' 717' ' ' LEU . . . -77.32 -53.82 7.23 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.703 -0.68 . . . . 1.37 111.067 -177.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 716' ' ' ARG . . . . . . . . . . . . . 25.4 tpt85 48.98 65.56 1.34 Allowed 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.864 0.84 . . . . 5.14 110.72 -176.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . 0.469 ' CD2' ' HB3' ' A' ' 715' ' ' ALA . 4.5 mm? -81.34 139.23 35.48 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.207 -0.906 . . . . 1.42 109.472 175.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 718' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -92.79 119.86 32.57 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.137 -0.69 . . . . 2.13 109.137 178.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 719' ' ' SER . . . . . . . . . . . . . 9.7 t -68.99 124.57 24.12 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.859 -0.422 . . . . 2.19 109.859 -178.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 720' ' ' VAL . . . . . . . . . . . . . 4.9 p . . . . . 0 C--O 1.248 0.974 0 CA-C-N 116.095 -0.502 . . . . 2.06 110.664 -177.055 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 . . . . . 0 N--CA 1.478 0.934 0 N-CA-C 110.228 -0.286 . . . . 27.62 110.228 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 646' ' ' LEU . . . . . . . . . . . . . 34.8 tp 64.21 52.55 1.93 Allowed 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.715 0.769 . . . . 26.92 109.674 -177.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 647' ' ' ARG . . . . . . . . . . . . . 29.6 tpt180 -95.19 76.35 3.45 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.26 -0.882 . . . . 24.69 110.027 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 648' ' ' ALA . . . . . . . . . . . . . . . 55.84 77.12 0.25 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.006 -0.543 . . . . 23.98 110.974 -178.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 649' ' ' THR . . . . . . . . . . . . . 8.8 t -82.87 37.83 0.55 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.035 -0.529 . . . . 23.65 111.161 -175.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 650' ' ' VAL . . . . . . . . . . . . . 14.8 t 55.51 58.51 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 121.916 0.865 . . . . 23.57 109.864 -178.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 651' ' ' SER . . . . . . . . . . . . . 25.6 t -161.43 -55.52 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.278 -0.874 . . . . 22.02 110.001 -177.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 652' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -141.7 86.66 10.6 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 116.051 -0.522 . . . . 21.94 110.46 -177.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 653' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -84.1 59.85 6.15 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.593 2.195 . . . . 20.17 111.215 178.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 654' ' ' VAL . . . . . . . . . . . . . 48.3 t 60.69 79.38 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.475 -0.784 . . . . 20.53 110.006 -173.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 655' ' ' SER . . . . . . . . . . . . . 23.9 m -81.47 -20.84 39.37 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.555 -0.748 . . . . 18.62 110.252 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 656' ' ' HIS . . . . . . . . . . . . . 29.5 m170 -77.94 112.47 14.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.831 -0.622 . . . . 16.76 110.276 176.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 657' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -120.25 151.72 38.78 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.159 -0.473 . . . . 18.33 110.281 178.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 658' ' ' ARG . . . . . 0.436 ' NH2' ' HB2' ' A' ' 665' ' ' GLU . 16.8 ttm180 -68.45 -77.1 0.08 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.82 0.343 . . . . 15.71 111.003 -175.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 659' ' ' MET . . . . . . . . . . . . . 27.0 ttt -120.19 -43.2 2.54 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.847 0.356 . . . . 15.12 110.528 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . -143.55 -27.64 0.13 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.8 -0.714 . . . . 12.85 112.169 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 661' ' ' THR . . . . . . . . . . . . . 9.5 p -120.74 141.45 32.42 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-O 120.81 0.338 . . . . 10.68 111.05 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 662' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -79.76 62.17 8.42 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.81 2.34 . . . . 11.11 111.316 174.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 663' ' ' MET . . . . . . . . . . . . . 53.3 ttm -104.09 129.32 51.77 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.841 -0.618 . . . . 9.83 110.421 -177.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 664' ' ' VAL . . . . . . . . . . . . . 59.1 t -80.97 121.05 33.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.956 -0.566 . . . . 7.26 110.217 178.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 665' ' ' GLU . . . . . 0.436 ' HB2' ' NH2' ' A' ' 658' ' ' ARG . 10.5 tp10 -77.77 79.69 4.25 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.216 0.531 . . . . 7.07 109.945 179.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 666' ' ' ASN . . . . . 0.401 HD21 ' C ' ' A' ' 666' ' ' ASN . 0.3 OUTLIER -109.34 147.39 32.79 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.924 -0.58 . . . . 7.24 110.807 -178.916 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 667' ' ' ASP . . . . . . . . . . . . . 12.6 t70 68.16 126.59 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 O-C-N 124.172 0.92 . . . . 5.49 111.32 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 668' ' ' SER . . . . . . . . . . . . . 31.3 t -129.13 36.31 4.19 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.692 -0.686 . . . . 4.8 109.799 -178.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 669' ' ' GLY . . . . . . . . . . . . . . . -147.59 93.73 0.16 Allowed Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.559 -0.829 . . . . 2.2 112.569 -178.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 670' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -68.92 157.27 36.99 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 110.068 -0.345 . . . . 2.3 110.068 176.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -118.12 152.3 35.89 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.275 -0.421 . . . . 3.13 110.983 -176.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . . . . . . . . . 70.0 mt -79.25 133.51 36.66 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.094 -0.503 . . . . 1.6 110.053 176.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 673' ' ' GLY . . . . . . . . . . . . . . . 94.42 1.23 64.45 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.841 -0.695 . . . . 0.66 111.699 -174.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 674' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -81.29 144.63 31.39 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 110.021 -0.362 . . . . 2.74 110.021 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 675' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.47 128.65 50.6 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.086 -0.709 . . . . 4.73 109.086 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 676' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 683' ' ' GLU . 35.8 m -119.7 152.23 22.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 115.814 -0.63 . . . . 1.18 111.465 -173.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 677' ' ' ARG . . . . . 0.429 ' HG3' HG23 ' A' ' 720' ' ' VAL . 32.6 mtp180 -123.06 124.28 42.75 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.28 0.562 . . . . 3.6 110.813 175.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 678' ' ' HIS . . . . . 0.528 ' HB2' ' CD1' ' A' ' 717' ' ' LEU . 43.4 t60 -139.42 104.66 5.02 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.212 -0.904 . . . . 2.48 109.148 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 679' ' ' ALA . . . . . . . . . . . . . . . -40.42 -38.15 0.78 Allowed 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 114.086 1.143 . . . . 1.91 114.086 -170.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 680' ' ' LYS . . . . . . . . . . . . . 18.7 mmtm -75.8 -31.18 59.33 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.646 -0.252 . . . . 3.47 111.542 -172.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 681' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -116.61 -13.08 10.86 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.85 -0.34 . . . . 2.31 111.816 -176.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 682' ' ' GLY . . . . . . . . . . . . . . . 97.82 -155.36 20.42 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.902 -0.666 . . . . 0.82 111.842 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 683' ' ' GLU . . . . . 0.47 ' HA ' ' O ' ' A' ' 676' ' ' VAL . 0.5 OUTLIER -109.53 147.57 32.72 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.003 0.43 . . . . 2.11 110.61 179.075 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 684' ' ' GLY . . . . . . . . . . . . . . . -156.49 179.48 32.31 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 120.594 -0.812 . . . . 0.43 111.999 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 685' ' ' THR . . . . . . . . . . . . . 71.3 m -115.06 127.36 55.58 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.764 0.316 . . . . 1.21 110.201 179.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 33.6 mt -71.63 104.93 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.182 -0.463 . . . . 1.07 109.759 178.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 687' ' ' VAL . . . . . . . . . . . . . 29.3 m -95.54 -26.61 4.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.862 0.363 . . . . 1.13 111.263 -176.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 688' ' ' ASN . . . . . 0.433 ' HB3' ' HB2' ' A' ' 699' ' ' GLN . 21.2 t-20 -146.38 163.47 35.5 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.598 -0.519 . . . . 2.15 109.598 -179.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 689' ' ' MET . . . . . . . . . . . . . 18.0 ptp -158.3 157.39 32.38 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.956 -0.387 . . . . 2.7 109.956 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 690' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -129.15 123.53 32.35 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.435 -0.348 . . . . 2.02 111.405 -177.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . 62.31 -162.83 27.78 Favored Glycine 0 N--CA 1.452 -0.3 0 CA-C-N 115.692 -0.685 . . . . 1.14 113.748 172.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 39.7 m -151.81 170.44 19.78 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.262 -0.644 . . . . 2.41 109.262 177.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 90.38 -139.47 14.96 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.399 -0.905 . . . . 1.46 112.456 177.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 694' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -83.29 -24.7 32.08 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.011 0.434 . . . . 2.85 110.596 -178.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 695' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -102.13 35.52 2.37 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.435 0.636 . . . . 3.85 110.383 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 696' ' ' SER . . . . . 0.476 ' OG ' ' HB1' ' A' ' 712' ' ' ALA . 16.3 p -90.81 135.51 33.68 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.396 -0.82 . . . . 2.05 110.258 179.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 697' ' ' ARG . . . . . . . . . . . . . 34.2 mtp180 -127.69 146.53 50.53 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.595 -0.52 . . . . 3.16 109.595 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 15.5 mt -123.51 130.97 53.47 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.756 -0.461 . . . . 1.25 109.756 178.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 699' ' ' GLN . . . . . 0.464 ' HA ' ' O ' ' A' ' 708' ' ' LYS . 2.1 mp0 -99.14 107.92 20.41 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.468 0.651 . . . . 2.54 109.433 175.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 42.1 t -107.13 125.7 63.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 114.913 -1.04 . . . . 1.08 111.097 -172.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -87.3 94.65 9.73 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.152 -0.476 . . . . 1.14 109.844 176.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 702' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -74.44 135.91 42.33 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.15 0.5 . . . . 2.06 110.345 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -68.62 -31.13 70.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.246 -0.888 . . . . 2.83 111.211 -175.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -81.49 -37.52 17.14 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.729 -0.748 . . . . 0.78 112.795 -178.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 705' ' ' GLN . . . . . 0.409 ' OE1' ' HA ' ' A' ' 705' ' ' GLN . 17.7 mm-40 -113.69 -76.04 0.59 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.041 0.385 . . . . 3.15 112.041 -176.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . . . . . . . . . . . 167.87 -158.1 30.74 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.738 -0.744 . . . . 0.79 112.166 -177.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 64.5 mt -78.46 122.97 34.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.056 0.455 . . . . 1.43 111.13 -176.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 708' ' ' LYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 699' ' ' GLN . 86.2 mttt -129.25 168.66 15.87 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.918 -0.583 . . . . 1.91 110.866 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 709' ' ' TRP . . . . . 0.517 ' C ' HD21 ' A' ' 710' ' ' LEU . 57.0 p-90 -105.24 131.93 52.09 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.434 -0.803 . . . . 0.97 109.782 178.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . 0.517 HD21 ' C ' ' A' ' 709' ' ' TRP . 3.6 mm? -130.29 109.49 10.8 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.742 -0.466 . . . . 1.25 109.742 177.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 59.4 t -64.48 109.41 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.382 -0.599 . . . . 1.25 109.382 177.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 712' ' ' ALA . . . . . 0.476 ' HB1' ' OG ' ' A' ' 696' ' ' SER . . . -55.35 -33.89 63.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.774 -0.648 . . . . 1.3 112.51 -169.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -64.58 -20.26 66.15 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.288 -0.415 . . . . 1.62 111.72 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 714' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -131.49 15.4 4.97 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.965 0.412 . . . . 2.77 110.19 -179.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 715' ' ' ALA . . . . . 0.538 ' HB1' ' CD2' ' A' ' 717' ' ' LEU . . . -85.28 -60.41 2.04 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.016 -0.538 . . . . 1.37 111.454 -173.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 716' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 58.82 77.76 0.29 Allowed 'General case' 0 C--O 1.235 0.341 0 CA-C-O 121.49 0.662 . . . . 5.14 110.945 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . 0.538 ' CD2' ' HB1' ' A' ' 715' ' ' ALA . 3.8 mm? -103.02 129.13 49.68 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.616 -0.72 . . . . 1.42 110.911 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 718' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -86.34 125.42 33.62 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.83 -0.623 . . . . 2.13 109.416 175.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 719' ' ' SER . . . . . . . . . . . . . 34.6 t -70.68 131.18 43.51 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.685 0.279 . . . . 2.19 110.323 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 720' ' ' VAL . . . . . 0.429 HG23 ' HG3' ' A' ' 677' ' ' ARG . 17.5 t . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.671 -0.681 . . . . 2.06 109.988 177.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 21.1 tpt180 . . . . . 0 N--CA 1.479 1.025 0 CA-C-O 120.714 0.292 . . . . 27.62 110.244 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 646' ' ' LEU . . . . . . . . . . . . . 8.8 tt -79.89 118.28 21.51 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.081 -0.508 . . . . 26.92 110.302 -178.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 647' ' ' ARG . . . . . . . . . . . . . 56.6 mtm180 -140.92 132.54 27.15 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.94 -0.573 . . . . 24.69 109.837 177.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 648' ' ' ALA . . . . . . . . . . . . . . . -64.08 120.93 12.98 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.455 -0.339 . . . . 23.98 110.902 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 649' ' ' THR . . . . . . . . . . . . . 1.5 p -80.06 71.23 6.77 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.391 0.615 . . . . 23.65 111.307 -178.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 650' ' ' VAL . . . . . . . . . . . . . 27.5 m -82.5 -10.94 12.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.927 -0.579 . . . . 23.57 110.943 179.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 651' ' ' SER . . . . . . . . . . . . . 14.9 m -80.63 170.14 16.72 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.051 -0.522 . . . . 22.02 109.899 177.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 652' ' ' ARG . . . . . . . . . . . . . 31.7 ttp180 60.27 80.33 0.27 Allowed Pre-proline 0 CA--C 1.531 0.242 0 CA-C-O 121.04 0.448 . . . . 21.94 110.357 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 653' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -77.03 97.53 1.16 Allowed 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.522 2.148 . . . . 20.17 112.707 -176.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 654' ' ' VAL . . . . . 0.445 HG13 ' O ' ' A' ' 654' ' ' VAL . 14.6 t 62.83 34.98 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-O 121.536 0.684 . . . . 20.53 110.131 178.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 655' ' ' SER . . . . . . . . . . . . . 23.6 m 61.59 -83.58 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.261 -0.881 . . . . 18.62 111.671 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 656' ' ' HIS . . . . . . . . . . . . . 35.3 t60 -138.69 102.46 4.59 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.858 -0.793 . . . . 16.76 108.858 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 657' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -109.03 178.68 4.39 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.494 -0.321 . . . . 18.33 110.632 -177.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 658' ' ' ARG . . . . . . . . . . . . . 80.6 mtm180 57.62 73.03 0.48 Allowed 'General case' 0 C--O 1.232 0.181 0 O-C-N 123.742 0.651 . . . . 15.71 110.971 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 659' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -84.31 157.29 21.56 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.032 -0.531 . . . . 15.12 109.911 177.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . -172.67 89.5 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.647 -0.787 . . . . 12.85 112.12 -178.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 661' ' ' THR . . . . . 0.401 ' HA ' ' HD3' ' A' ' 662' ' ' PRO . 0.8 OUTLIER -79.86 119.95 78.37 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-O 120.682 0.277 . . . . 10.68 111.27 179.302 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 662' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 661' ' ' THR . 24.0 Cg_exo -63.95 117.1 4.12 Favored 'Trans proline' 0 C--O 1.235 0.362 0 C-N-CA 122.967 2.445 . . . . 11.11 112.09 178.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 663' ' ' MET . . . . . . . . . . . . . 25.0 mmt 66.21 -176.43 0.19 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.719 -0.673 . . . . 9.83 110.878 -178.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 664' ' ' VAL . . . . . . . . . . . . . 7.2 p -72.87 -36.44 51.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.03 0.443 . . . . 7.26 109.967 177.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 665' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -157.1 -76.37 0.09 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.006 -0.543 . . . . 7.07 110.064 175.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 666' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 54.82 42.66 30.98 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.295 0.569 . . . . 7.24 109.543 -177.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 667' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 66.63 136.98 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 114.934 -1.03 . . . . 5.49 111.104 -173.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 668' ' ' SER . . . . . . . . . . . . . 19.1 m -80.89 37.0 0.41 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.324 0.583 . . . . 4.8 110.526 179.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 669' ' ' GLY . . . . . . . . . . . . . . . 79.24 -113.25 3.62 Favored Glycine 0 N--CA 1.436 -1.316 0 N-CA-C 110.751 -0.939 . . . . 2.2 110.751 -175.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 670' ' ' TYR . . . . . 0.54 ' CD1' HD13 ' A' ' 698' ' ' LEU . 57.1 m-85 -138.28 158.31 44.54 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.603 -0.517 . . . . 2.3 109.603 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 10.4 mtmp? -100.04 143.03 30.72 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.889 0.376 . . . . 3.13 110.553 -177.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . . . . . . . . . 52.4 mt -81.13 137.41 35.95 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.107 -0.497 . . . . 1.6 110.405 -179.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 673' ' ' GLY . . . . . . . . . . . . . . . 88.35 11.82 66.13 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 110.831 -0.907 . . . . 0.66 110.831 -173.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 674' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -94.76 144.07 25.94 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.891 0.376 . . . . 2.74 110.526 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 675' ' ' ARG . . . . . 0.424 ' HD3' ' O ' ' A' ' 684' ' ' GLY . 11.0 tpp85 -97.95 123.82 42.12 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.622 -0.717 . . . . 4.73 109.835 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 676' ' ' VAL . . . . . 0.415 ' HB ' HD11 ' A' ' 717' ' ' LEU . 27.2 m -115.84 161.94 14.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.071 -0.513 . . . . 1.18 110.425 -177.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 677' ' ' ARG . . . . . 0.42 ' HG3' ' HG2' ' A' ' 683' ' ' GLU . 21.5 ttt180 -135.38 131.1 35.91 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.27 -0.423 . . . . 3.6 111.123 178.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 678' ' ' HIS . . . . . 0.467 ' CD2' HD13 ' A' ' 717' ' ' LEU . 0.0 OUTLIER -141.42 147.22 37.6 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.51 -0.768 . . . . 2.48 109.25 175.034 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 679' ' ' ALA . . . . . . . . . . . . . . . -76.85 -26.23 54.05 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.108 0.411 . . . . 1.91 112.108 -169.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 680' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -87.98 -37.81 16.06 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.036 0.384 . . . . 3.47 112.036 -176.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 681' ' ' PHE . . . . . . . . . . . . . 19.2 m-30 -106.71 -11.26 15.86 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 111.814 0.301 . . . . 2.31 111.814 -176.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 682' ' ' GLY . . . . . . . . . . . . . . . 90.53 -156.42 24.81 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.551 -0.833 . . . . 0.82 111.777 -177.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 683' ' ' GLU . . . . . 0.42 ' HG2' ' HG3' ' A' ' 677' ' ' ARG . 27.6 mt-10 -103.6 144.69 31.1 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.9 -0.407 . . . . 2.11 109.9 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 684' ' ' GLY . . . . . 0.424 ' O ' ' HD3' ' A' ' 675' ' ' ARG . . . -148.64 170.88 29.07 Favored Glycine 0 C--N 1.313 -0.742 0 C-N-CA 120.224 -0.989 . . . . 0.43 112.696 -177.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 685' ' ' THR . . . . . . . . . . . . . 32.8 m -113.83 124.67 52.78 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.872 0.368 . . . . 1.21 110.213 178.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 28.3 mt -73.64 104.7 2.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.259 -0.428 . . . . 1.07 109.912 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 687' ' ' VAL . . . . . . . . . . . . . 29.0 m -93.49 -25.63 4.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.732 0.301 . . . . 1.13 111.578 -175.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -152.14 163.93 38.36 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.446 -0.343 . . . . 2.15 110.138 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 689' ' ' MET . . . . . . . . . . . . . 5.1 ppp? -151.91 163.86 38.35 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.496 -0.557 . . . . 2.7 109.496 177.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 690' ' ' GLU . . . . . 0.416 ' CG ' ' HB2' ' A' ' 697' ' ' ARG . 10.7 pt-20 -146.91 155.13 42.05 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.406 -0.361 . . . . 2.02 110.579 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . 78.23 -159.29 46.82 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.963 -0.636 . . . . 1.14 112.485 177.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 29.6 t -161.81 149.43 14.62 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 110.259 -0.275 . . . . 2.41 110.259 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 62.86 -127.52 38.88 Favored Glycine 0 N--CA 1.452 -0.262 0 CA-C-N 116.072 -0.513 . . . . 1.46 113.574 175.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 694' ' ' GLU . . . . . 0.41 ' HA ' ' HB3' ' A' ' 713' ' ' ALA . 42.0 mt-10 -80.58 -15.79 55.77 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.775 0.322 . . . . 2.85 111.417 -175.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 695' ' ' HIS . . . . . . . . . . . . . 18.5 p-80 -109.9 34.71 3.7 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.322 0.582 . . . . 3.85 110.306 178.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 696' ' ' SER . . . . . . . . . . . . . 77.9 p -101.31 145.73 28.49 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.733 -0.667 . . . . 2.05 110.507 178.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 697' ' ' ARG . . . . . 0.416 ' HB2' ' CG ' ' A' ' 690' ' ' GLU . 96.8 mtt180 -125.33 151.05 46.57 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.658 -0.497 . . . . 3.16 109.658 175.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 698' ' ' LEU . . . . . 0.54 HD13 ' CD1' ' A' ' 670' ' ' TYR . 15.5 mt -117.36 146.33 43.47 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.719 -0.474 . . . . 1.25 109.719 178.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 699' ' ' GLN . . . . . 0.507 ' HA ' ' O ' ' A' ' 708' ' ' LYS . 19.0 mt-30 -107.94 99.09 8.57 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.76 0.791 . . . . 2.54 109.27 169.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 700' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 707' ' ' ILE . 20.8 t -100.02 122.72 52.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 114.38 -1.282 . . . . 1.08 110.565 -173.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -85.5 94.31 8.99 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.722 -0.473 . . . . 1.14 109.722 177.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 702' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -74.0 127.02 31.8 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.957 0.408 . . . . 2.06 110.002 178.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -62.43 -26.67 68.62 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.473 -0.785 . . . . 2.83 112.175 -169.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -96.05 -7.25 58.64 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.586 -0.816 . . . . 0.78 113.138 -178.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 705' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -134.59 -79.19 0.45 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 117.184 0.492 . . . . 3.15 111.344 -178.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . . . . . . . . . . . 168.71 -164.26 37.89 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.706 -0.759 . . . . 0.79 112.309 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 707' ' ' ILE . . . . . 0.449 ' HA ' ' O ' ' A' ' 700' ' ' VAL . 61.3 mt -75.89 127.85 37.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.936 0.398 . . . . 1.43 110.883 -178.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 708' ' ' LYS . . . . . 0.507 ' O ' ' HA ' ' A' ' 699' ' ' GLN . 68.1 mttm -127.31 158.97 35.81 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.656 -0.702 . . . . 1.91 110.733 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 709' ' ' TRP . . . . . . . . . . . . . 13.8 p-90 -99.41 111.93 24.2 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.608 0.718 . . . . 0.97 110.222 179.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -117.04 115.22 24.99 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.861 -0.609 . . . . 1.25 110.443 -178.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 46.8 t -63.1 105.48 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.218 -0.66 . . . . 1.25 109.218 174.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 712' ' ' ALA . . . . . . . . . . . . . . . -48.62 -46.92 40.4 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 113.216 0.821 . . . . 1.3 113.216 -167.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 713' ' ' ALA . . . . . 0.41 ' HB3' ' HA ' ' A' ' 694' ' ' GLU . . . -64.11 -28.59 69.88 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.262 -0.427 . . . . 1.62 112.051 -175.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 714' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -111.35 2.47 17.63 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.281 0.563 . . . . 2.77 110.656 -178.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 715' ' ' ALA . . . . . 0.436 ' HB3' ' CD2' ' A' ' 717' ' ' LEU . . . -84.3 -50.82 7.5 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.509 -0.769 . . . . 1.37 109.617 177.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 716' ' ' ARG . . . . . 0.589 ' HA ' ' HE ' ' A' ' 716' ' ' ARG . 1.3 mmp_? 51.41 67.52 0.94 Allowed 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.596 -0.729 . . . . 5.14 110.83 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . 0.467 HD13 ' CD2' ' A' ' 678' ' ' HIS . 4.6 mm? -86.05 152.34 22.97 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.328 -0.851 . . . . 1.42 109.597 177.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 718' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -114.26 128.38 56.33 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.7 -0.481 . . . . 2.13 109.7 178.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 719' ' ' SER . . . . . . . . . . . . . 25.3 m -66.8 123.55 20.45 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.88 -0.415 . . . . 2.19 109.88 176.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 720' ' ' VAL . . . . . . . . . . . . . 3.2 p . . . . . 0 C--O 1.248 1.003 0 CA-C-N 116.463 -0.335 . . . . 2.06 111.038 -177.354 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 . . . . . 0 N--CA 1.484 1.274 0 CA-C-O 120.457 0.17 . . . . 27.62 111.206 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 646' ' ' LEU . . . . . . . . . . . . . 10.0 mp 61.5 27.79 17.24 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 122.617 0.367 . . . . 26.92 111.492 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 647' ' ' ARG . . . . . . . . . . . . . 30.9 tpt180 -76.5 92.36 3.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.409 -0.359 . . . . 24.69 110.573 -178.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 648' ' ' ALA . . . . . . . . . . . . . . . 65.01 -80.71 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.382 -0.826 . . . . 23.98 111.913 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 649' ' ' THR . . . . . . . . . . . . . 6.4 t -77.23 106.32 8.89 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.576 0.703 . . . . 23.65 110.827 -178.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 650' ' ' VAL . . . . . . . . . . . . . 10.3 p -165.63 -37.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.774 -0.648 . . . . 23.57 110.594 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 651' ' ' SER . . . . . . . . . . . . . 22.9 t -79.73 -42.71 24.04 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 109.261 -0.644 . . . . 22.02 109.261 178.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 652' ' ' ARG . . . . . . . . . . . . . 70.6 mtm180 -141.07 107.02 6.22 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.639 -0.71 . . . . 21.94 109.736 172.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 653' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -62.03 91.19 0.12 Allowed 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 122.769 2.313 . . . . 20.17 111.269 174.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 654' ' ' VAL . . . . . . . . . . . . . 97.9 t 72.53 121.44 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.489 -0.778 . . . . 20.53 110.38 -174.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 655' ' ' SER . . . . . . . . . . . . . 32.9 t -74.01 88.36 1.88 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.807 -0.633 . . . . 18.62 110.817 -177.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 656' ' ' HIS . . . . . . . . . . . . . 77.0 m-70 -82.9 117.76 22.98 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.118 -0.492 . . . . 16.76 110.558 177.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 657' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -103.03 113.65 27.3 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.033 0.444 . . . . 18.33 110.182 177.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 658' ' ' ARG . . . . . . . . . . . . . 60.3 mtp180 -88.71 -26.85 21.58 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.148 -0.478 . . . . 15.71 111.423 -176.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 659' ' ' MET . . . . . 0.406 ' O ' ' HG2' ' A' ' 659' ' ' MET . 24.4 ttt 64.52 26.34 13.35 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.454 -0.793 . . . . 15.12 110.924 178.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . -135.4 49.34 0.89 Allowed Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.712 -0.756 . . . . 12.85 112.152 -177.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 661' ' ' THR . . . . . . . . . . . . . 16.1 m -79.22 121.04 82.6 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-O 120.761 0.315 . . . . 10.68 110.247 178.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 662' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -66.97 -39.37 14.17 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.82 2.347 . . . . 11.11 112.503 -178.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 663' ' ' MET . . . . . . . . . . . . . 19.7 ptp -152.67 142.41 21.97 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.187 -0.46 . . . . 9.83 109.922 176.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 664' ' ' VAL . . . . . . . . . . . . . 16.0 m -107.95 156.65 8.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 115.746 -0.661 . . . . 7.26 110.701 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 665' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -124.07 20.71 9.04 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.334 -0.393 . . . . 7.07 111.102 -179.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 666' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -71.28 -26.88 63.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.914 0.387 . . . . 7.24 111.14 -176.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 667' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -122.8 23.64 9.36 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.911 -0.403 . . . . 5.49 109.911 179.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 668' ' ' SER . . . . . . . . . . . . . 11.3 p -53.47 -42.91 67.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.633 -0.712 . . . . 4.8 111.924 -175.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 669' ' ' GLY . . . . . . . . . . . . . . . 108.31 76.87 0.97 Allowed Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.751 -0.738 . . . . 2.2 111.897 178.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 670' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -71.12 143.36 50.62 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.76 0.314 . . . . 2.3 110.41 -178.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -134.77 162.49 32.22 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.95 -0.568 . . . . 3.13 110.297 -174.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . . . . . . . . . 35.5 mt -77.86 134.45 37.95 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.845 0.355 . . . . 1.6 110.293 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 673' ' ' GLY . . . . . . . . . . . . . . . 88.38 -0.27 83.17 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 111.415 -0.674 . . . . 0.66 111.415 -176.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 674' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -82.61 148.45 27.99 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.717 0.294 . . . . 2.74 110.21 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 675' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -103.34 132.4 49.62 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.129 -0.487 . . . . 4.73 110.121 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 676' ' ' VAL . . . . . 0.439 ' HB ' HD11 ' A' ' 717' ' ' LEU . 29.9 m -117.01 153.39 18.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.582 -0.735 . . . . 1.18 110.448 -177.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 677' ' ' ARG . . . . . . . . . . . . . 42.3 ttt180 -126.79 129.31 48.08 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.328 -0.396 . . . . 3.6 110.376 179.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -140.79 121.55 14.37 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.089 -0.708 . . . . 2.48 109.089 177.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 679' ' ' ALA . . . . . . . . . . . . . . . -58.73 -18.5 32.0 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.127 0.417 . . . . 1.91 112.127 -175.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 680' ' ' LYS . . . . . 0.507 ' HD2' ' N ' ' A' ' 680' ' ' LYS . 0.3 OUTLIER -91.07 -35.52 14.56 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.243 -0.435 . . . . 3.47 112.088 -177.515 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 681' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -113.25 -11.46 13.22 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.787 0.327 . . . . 2.31 111.796 -174.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 682' ' ' GLY . . . . . . . . . . . . . . . 92.98 -156.5 22.96 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 111.467 -0.653 . . . . 0.82 111.467 -174.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 683' ' ' GLU . . . . . 0.418 ' HA ' ' O ' ' A' ' 676' ' ' VAL . 12.1 pt-20 -109.13 147.73 31.99 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.777 -0.453 . . . . 2.11 109.777 177.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 684' ' ' GLY . . . . . . . . . . . . . . . -151.15 173.54 30.59 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.428 -0.891 . . . . 0.43 112.286 -177.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 685' ' ' THR . . . . . . . . . . . . . 16.5 m -110.78 125.88 54.02 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.548 0.213 . . . . 1.21 110.687 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 50.6 mt -74.39 107.38 4.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.975 -0.379 . . . . 1.07 109.975 177.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 687' ' ' VAL . . . . . . . . . . . . . 29.9 m -93.63 -31.92 4.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 120.873 0.368 . . . . 1.13 111.073 -177.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -143.0 159.81 41.54 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.112 -0.495 . . . . 2.15 110.243 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 689' ' ' MET . . . . . . . . . . . . . 5.3 ppp? -149.05 142.85 25.63 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.97 0.414 . . . . 2.7 110.262 179.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 690' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -114.72 123.62 49.72 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.814 -0.63 . . . . 2.02 110.63 -175.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . 84.62 -152.16 27.28 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.827 -0.701 . . . . 1.14 113.193 174.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 17.5 p -173.7 126.14 0.39 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 123.168 0.587 . . . . 2.41 109.569 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 111.77 -143.74 17.46 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.765 -0.731 . . . . 1.46 111.703 -175.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 694' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -72.8 -48.6 36.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.083 0.468 . . . . 2.85 111.327 -177.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 695' ' ' HIS . . . . . . . . . . . . . 57.9 m-70 -81.92 37.5 0.48 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.968 -0.56 . . . . 3.85 111.415 -173.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 696' ' ' SER . . . . . . . . . . . . . 4.6 m -98.31 143.97 28.22 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.22 -0.446 . . . . 2.05 110.163 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 697' ' ' ARG . . . . . . . . . . . . . 40.9 mtm180 -117.64 135.79 53.75 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.553 -0.536 . . . . 3.16 109.553 175.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 15.9 mt -107.3 131.25 54.43 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.86 -0.422 . . . . 1.25 109.86 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 699' ' ' GLN . . . . . 0.436 ' HA ' ' O ' ' A' ' 708' ' ' LYS . 5.8 mp0 -93.75 101.52 13.64 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.485 0.659 . . . . 2.54 109.498 174.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 22.0 t -101.98 124.41 55.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-N 115.045 -0.98 . . . . 1.08 110.437 -175.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -88.11 101.44 13.81 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.986 -0.552 . . . . 1.14 110.168 178.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 702' ' ' PHE . . . . . 0.444 ' CD1' ' HD2' ' A' ' 708' ' ' LYS . 91.9 m-85 -87.43 120.25 28.54 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.706 -0.479 . . . . 2.06 109.706 176.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -71.2 -11.3 60.86 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.161 0.505 . . . . 2.83 111.064 -174.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -88.24 -13.12 64.36 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.951 -0.643 . . . . 0.78 113.122 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 705' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -150.78 -55.61 0.15 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 117.568 0.684 . . . . 3.15 111.912 -177.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . . . . . . . . . . . 163.78 -167.79 38.05 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.606 -0.806 . . . . 0.79 112.266 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 61.6 mt -78.02 141.85 14.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.73 0.3 . . . . 1.43 110.383 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 708' ' ' LYS . . . . . 0.444 ' HD2' ' CD1' ' A' ' 702' ' ' PHE . 67.1 mttm -132.66 161.75 33.14 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.033 0.444 . . . . 1.91 111.004 178.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 709' ' ' TRP . . . . . . . . . . . . . 20.5 p-90 -108.68 119.94 41.0 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.288 -0.869 . . . . 0.97 109.124 174.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -120.12 115.13 23.07 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.436 -0.347 . . . . 1.25 110.416 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 48.3 t -66.5 109.42 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.026 -0.731 . . . . 1.25 109.026 175.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 712' ' ' ALA . . . . . . . . . . . . . . . -45.42 -48.63 13.65 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 113.283 0.845 . . . . 1.3 113.283 -168.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -66.24 -31.43 72.24 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.363 0.505 . . . . 1.62 112.363 -175.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 714' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -97.99 -20.79 17.19 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.979 0.419 . . . . 2.77 110.77 -177.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 715' ' ' ALA . . . . . 0.458 ' HB1' ' CD2' ' A' ' 717' ' ' LEU . . . -72.44 -54.55 9.01 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.737 -0.665 . . . . 1.37 110.777 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 716' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 57.17 76.43 0.32 Allowed 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.438 0.637 . . . . 5.14 110.6 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . 0.458 ' CD2' ' HB1' ' A' ' 715' ' ' ALA . 4.4 mm? -97.19 142.4 29.15 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.607 -0.724 . . . . 1.42 110.955 -178.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 718' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -101.89 130.32 48.34 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.678 -0.86 . . . . 2.13 108.678 175.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 719' ' ' SER . . . . . . . . . . . . . 23.2 t -71.05 130.9 42.73 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.878 0.371 . . . . 2.19 110.403 -177.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 720' ' ' VAL . . . . . . . . . . . . . 46.2 t . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.398 -0.81 . . . . 2.06 110.627 -179.118 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 . . . . . 0 N--CA 1.481 1.107 0 N-CA-C 109.746 -0.464 . . . . 27.62 109.746 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 646' ' ' LEU . . . . . . . . . . . . . 84.3 mt -103.62 89.74 3.44 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.481 0.182 . . . . 26.92 110.74 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 647' ' ' ARG . . . . . . . . . . . . . 76.7 mtp180 62.32 98.77 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 O-C-N 123.784 0.677 . . . . 24.69 111.547 177.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 648' ' ' ALA . . . . . . . . . . . . . . . -75.8 -14.83 60.31 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.322 0.582 . . . . 23.98 110.912 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 649' ' ' THR . . . . . . . . . . . . . 24.6 p 52.06 39.51 26.59 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 114.569 -1.196 . . . . 23.65 112.499 177.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 650' ' ' VAL . . . . . . . . . . . . . 42.4 t -77.44 75.8 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-O 121.743 0.782 . . . . 23.57 109.811 178.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 651' ' ' SER . . . . . . . . . . . . . 36.4 t -150.67 -57.93 0.17 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.902 -1.044 . . . . 22.02 108.706 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 652' ' ' ARG . . . . . . . . . . . . . 66.7 mtp180 56.17 76.12 0.52 Allowed Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 115.214 -0.903 . . . . 21.94 111.88 175.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 653' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -74.91 78.22 2.92 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.645 2.23 . . . . 20.17 111.389 176.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 654' ' ' VAL . . . . . . . . . . . . . 12.2 p -64.88 -29.93 48.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.957 -0.565 . . . . 20.53 110.971 -178.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 655' ' ' SER . . . . . . . . . . . . . 24.4 t -102.54 96.62 7.03 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 116.037 -0.529 . . . . 18.62 110.172 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 656' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -88.9 102.31 14.92 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.418 -0.586 . . . . 16.76 109.418 178.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 657' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -130.81 10.2 5.05 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.1 0.407 . . . . 18.33 112.1 -174.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 658' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -82.51 -16.27 49.33 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.656 -0.418 . . . . 15.71 110.621 -177.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 659' ' ' MET . . . . . . . . . . . . . 51.9 tpp -64.0 -56.68 13.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.982 -0.554 . . . . 15.12 110.929 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . -111.55 51.1 0.72 Allowed Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.88 -0.676 . . . . 12.85 112.001 -177.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 661' ' ' THR . . . . . . . . . . . . . 10.8 t -98.74 135.99 20.84 Favored Pre-proline 0 C--N 1.321 -0.673 0 N-CA-C 109.854 -0.425 . . . . 10.68 109.854 178.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 662' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.17 -31.86 96.1 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.096 2.531 . . . . 11.11 112.16 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 663' ' ' MET . . . . . . . . . . . . . 53.8 ttm -147.91 143.7 27.55 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.125 -0.694 . . . . 9.83 109.125 175.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 664' ' ' VAL . . . . . . . . . . . . . 46.8 t -94.23 125.8 46.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.617 -0.265 . . . . 7.26 110.552 -178.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 665' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 61.08 71.88 0.54 Allowed 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.699 -0.682 . . . . 7.07 111.391 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 666' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -74.07 99.65 3.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.014 -0.539 . . . . 7.24 109.936 176.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 667' ' ' ASP . . . . . . . . . . . . . 4.9 t70 63.53 -162.84 0.27 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.803 -0.635 . . . . 5.49 109.43 -175.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 668' ' ' SER . . . . . . . . . . . . . 5.1 p -72.39 -35.31 68.41 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 122.28 -0.263 . . . . 4.8 110.951 -178.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 669' ' ' GLY . . . . . . . . . . . . . . . 60.99 76.78 0.22 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.833 -0.699 . . . . 2.2 112.603 178.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 670' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -73.32 151.34 41.34 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.951 0.405 . . . . 2.3 110.529 -178.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 48.8 mtpt -128.54 155.86 44.21 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.876 -0.602 . . . . 3.13 110.408 -178.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . 0.532 HD23 ' SD ' ' A' ' 689' ' ' MET . 52.0 mt -79.38 134.17 36.58 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.199 -0.455 . . . . 1.6 110.098 177.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 673' ' ' GLY . . . . . . . . . . . . . . . 88.9 15.36 59.54 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.856 -0.687 . . . . 0.66 111.747 -175.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 674' ' ' GLN . . . . . . . . . . . . . 43.9 tp60 -94.49 144.79 25.28 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.286 -0.264 . . . . 2.74 110.286 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 675' ' ' ARG . . . . . . . . . . . . . 19.5 mtm180 -92.0 124.74 36.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.229 -0.441 . . . . 4.73 109.855 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 676' ' ' VAL . . . . . 0.427 ' HB ' HD12 ' A' ' 717' ' ' LEU . 29.0 m -117.91 154.56 19.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-O 120.792 0.33 . . . . 1.18 110.935 -179.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 677' ' ' ARG . . . . . 0.495 ' HB2' HG21 ' A' ' 720' ' ' VAL . 28.3 ttt-85 -130.77 131.61 44.81 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.858 -0.61 . . . . 3.6 109.812 178.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 678' ' ' HIS . . . . . 0.511 ' HB2' ' CD1' ' A' ' 717' ' ' LEU . 20.2 t60 -149.89 113.44 4.99 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.543 -0.54 . . . . 2.48 109.543 176.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 679' ' ' ALA . . . . . . . . . . . . . . . -49.79 -25.68 3.27 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 113.379 0.881 . . . . 1.91 113.379 -173.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 680' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -75.49 -33.19 60.76 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.762 -0.199 . . . . 3.47 111.411 -174.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 681' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -125.75 -13.13 6.48 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.745 0.307 . . . . 2.31 111.821 -174.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 682' ' ' GLY . . . . . . . . . . . . . . . 104.75 -153.59 17.43 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.855 -0.688 . . . . 0.82 111.786 -178.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 683' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -114.51 148.35 38.04 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.854 -0.425 . . . . 2.11 109.854 178.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 684' ' ' GLY . . . . . . . . . . . . . . . -156.66 -178.71 31.03 Favored Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 119.784 -1.198 . . . . 0.43 112.848 -178.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 685' ' ' THR . . . . . . . . . . . . . 12.6 m -113.97 125.62 54.22 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 110.266 -0.272 . . . . 1.21 110.266 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 46.4 mt -70.44 104.92 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.736 -0.468 . . . . 1.07 109.736 177.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 687' ' ' VAL . . . . . . . . . . . . . 27.1 m -93.82 -23.93 5.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 120.978 0.418 . . . . 1.13 111.061 -177.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 688' ' ' ASN . . . . . 0.446 ' HB3' ' HB2' ' A' ' 699' ' ' GLN . 8.5 t30 -151.33 161.3 42.95 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.48 -0.563 . . . . 2.15 109.48 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 689' ' ' MET . . . . . 0.532 ' SD ' HD23 ' A' ' 672' ' ' LEU . 0.0 OUTLIER -157.34 157.89 34.95 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 110.038 -0.356 . . . . 2.7 110.038 178.616 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 690' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -125.2 122.29 36.59 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.631 -0.507 . . . . 2.02 109.631 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . 74.84 -169.34 54.52 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.821 -0.704 . . . . 1.14 112.422 -177.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 49.6 m -155.72 96.37 1.75 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.803 0.335 . . . . 2.41 110.168 177.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 153.12 -130.14 2.92 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.902 -0.666 . . . . 1.46 112.729 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 694' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -84.18 -57.61 3.1 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.579 0.585 . . . . 2.85 112.579 -173.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 695' ' ' HIS . . . . . . . . . . . . . 16.2 p-80 -84.5 21.64 1.44 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.533 0.682 . . . . 3.85 110.855 -174.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 696' ' ' SER . . . . . . . . . . . . . 14.3 m -84.77 152.74 23.46 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.095 -0.957 . . . . 2.05 110.513 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 697' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -116.04 145.28 43.12 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 110.151 -0.314 . . . . 3.16 110.151 176.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 16.6 mt -118.23 135.81 54.04 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.708 -0.479 . . . . 1.25 109.708 178.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 699' ' ' GLN . . . . . 0.51 ' HA ' ' O ' ' A' ' 708' ' ' LYS . 24.6 mp0 -102.97 105.92 16.35 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.708 0.766 . . . . 2.54 109.907 174.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 700' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 707' ' ' ILE . 27.3 t -104.23 125.23 59.02 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 114.545 -1.207 . . . . 1.08 110.69 -174.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -87.76 94.3 9.71 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.155 -0.475 . . . . 1.14 109.742 175.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 702' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -75.94 132.71 40.42 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.014 -0.539 . . . . 2.06 110.203 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -68.59 -25.17 64.74 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.556 -0.747 . . . . 2.83 111.174 -175.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -91.16 1.94 78.02 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.686 -0.768 . . . . 0.78 113.264 -177.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 705' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -157.21 -80.04 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 117.176 0.488 . . . . 3.15 111.421 177.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . . . . . . . . . . . 179.65 -157.44 20.39 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.432 -0.889 . . . . 0.79 112.459 -178.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 707' ' ' ILE . . . . . 0.451 ' HA ' ' O ' ' A' ' 700' ' ' VAL . 60.3 mt -80.88 135.95 24.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.781 0.324 . . . . 1.43 111.039 -177.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 708' ' ' LYS . . . . . 0.51 ' O ' ' HA ' ' A' ' 699' ' ' GLN . 63.8 mttm -135.86 159.4 41.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.87 -0.605 . . . . 1.91 110.561 178.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 709' ' ' TRP . . . . . . . . . . . . . 12.3 p-90 -101.8 121.2 41.63 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.726 -0.67 . . . . 0.97 109.568 177.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -118.1 113.05 21.01 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.311 -0.404 . . . . 1.25 110.141 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 99.3 t -66.24 110.63 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.487 -0.56 . . . . 1.25 109.487 175.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 712' ' ' ALA . . . . . . . . . . . . . . . -41.81 -47.12 4.09 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 113.874 1.065 . . . . 1.3 113.874 -169.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -60.01 -35.75 75.75 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.49 0.552 . . . . 1.62 112.49 -177.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 714' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -100.64 -13.62 18.47 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.28 0.562 . . . . 2.77 110.291 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 715' ' ' ALA . . . . . 0.572 ' HB3' ' CD2' ' A' ' 717' ' ' LEU . . . -70.65 -59.59 2.74 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.298 -0.864 . . . . 1.37 110.397 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 716' ' ' ARG . . . . . . . . . . . . . 19.9 mtp180 50.23 66.65 1.09 Allowed 'General case' 0 N--CA 1.464 0.227 0 O-C-N 123.858 0.724 . . . . 5.14 111.363 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . 0.572 ' CD2' ' HB3' ' A' ' 715' ' ' ALA . 4.1 mm? -87.94 140.28 29.66 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.168 0.509 . . . . 1.42 111.396 -176.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 718' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -101.24 134.99 43.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.523 -0.762 . . . . 2.13 108.988 174.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 719' ' ' SER . . . . . . . . . . . . . 20.6 t -78.04 133.72 37.9 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.691 0.281 . . . . 2.19 110.65 -175.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 720' ' ' VAL . . . . . 0.495 HG21 ' HB2' ' A' ' 677' ' ' ARG . 16.9 t . . . . . 0 C--O 1.251 1.132 0 CA-C-O 118.461 -0.78 . . . . 2.06 110.096 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 16.7 tpp180 . . . . . 0 N--CA 1.479 0.978 0 CA-C-O 120.846 0.355 . . . . 27.62 110.222 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 646' ' ' LEU . . . . . . . . . . . . . 56.5 tp -82.88 131.3 35.2 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.105 -0.498 . . . . 26.92 110.298 179.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 647' ' ' ARG . . . . . . . . . . . . . 25.0 ttm180 -88.65 40.04 0.95 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.488 0.661 . . . . 24.69 110.251 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 648' ' ' ALA . . . . . . . . . . . . . . . -155.32 68.3 0.67 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.927 -0.579 . . . . 23.98 110.193 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 649' ' ' THR . . . . . . . . . . . . . 12.1 t -77.07 -8.24 57.11 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.087 -0.506 . . . . 23.65 111.41 -175.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 650' ' ' VAL . . . . . . . . . . . . . 10.0 p -67.79 -26.55 35.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 121.451 0.643 . . . . 23.57 110.149 176.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 651' ' ' SER . . . . . . . . . . . . . 5.1 p -107.62 142.97 36.74 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 115.629 -0.714 . . . . 22.02 110.485 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 652' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -91.69 110.47 43.6 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 109.648 -0.501 . . . . 21.94 109.648 178.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 653' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -75.62 74.1 4.43 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.729 2.286 . . . . 20.17 112.776 -175.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 654' ' ' VAL . . . . . . . . . . . . . 12.3 p -77.87 52.01 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 122.592 1.187 . . . . 20.53 110.272 177.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 655' ' ' SER . . . . . . . . . . . . . 31.1 t -84.66 117.3 23.69 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.209 -0.905 . . . . 18.62 109.987 -177.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 656' ' ' HIS . . . . . . . . . . . . . 67.8 m-70 -103.07 121.81 43.37 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.942 -0.572 . . . . 16.76 109.578 177.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 657' ' ' GLN . . . . . . . . . . . . . 19.7 mp0 -76.17 -27.98 57.16 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.969 -0.56 . . . . 18.33 110.692 -174.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 658' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 66.5 -80.74 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.162 0 O-C-N 124.005 0.815 . . . . 15.71 110.417 -177.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 659' ' ' MET . . . . . . . . . . . . . 49.4 ttm 54.04 74.63 0.32 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.281 0.562 . . . . 15.12 111.146 175.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . -156.33 -43.77 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.775 -0.726 . . . . 12.85 112.081 -179.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 661' ' ' THR . . . . . . . . . . . . . 15.0 t -82.99 134.93 45.61 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-O 120.963 0.411 . . . . 10.68 110.384 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 662' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -74.46 107.71 2.51 Favored 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 122.506 2.137 . . . . 11.11 111.875 178.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 663' ' ' MET . . . . . . . . . . . . . 88.5 mtp -82.14 128.42 34.12 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.253 -0.431 . . . . 9.83 110.623 -178.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 664' ' ' VAL . . . . . . . . . . . . . 66.3 t -78.66 117.51 24.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.187 -0.461 . . . . 7.26 110.252 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 665' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -111.62 72.31 0.77 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.311 0.577 . . . . 7.07 110.602 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 666' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -117.84 71.4 0.82 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.397 -0.819 . . . . 7.24 108.955 178.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 667' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 59.4 28.8 18.25 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.535 -0.757 . . . . 5.49 109.966 -172.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 668' ' ' SER . . . . . . . . . . . . . 5.0 p -120.94 11.59 11.06 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.975 -1.011 . . . . 4.8 110.62 -177.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 669' ' ' GLY . . . . . . . . . . . . . . . -81.98 -89.93 0.62 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.918 -0.658 . . . . 2.2 112.216 -177.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 670' ' ' TYR . . . . . 0.428 ' CE1' ' HB2' ' A' ' 717' ' ' LEU . 72.7 m-85 -120.84 125.07 46.58 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.069 0.461 . . . . 2.3 110.433 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -119.82 162.8 18.5 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.506 -0.77 . . . . 3.13 110.281 -173.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . . . . . . . . . 30.3 mt -79.22 137.37 37.39 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.332 -0.395 . . . . 1.6 110.053 177.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 673' ' ' GLY . . . . . . . . . . . . . . . 86.82 -3.11 87.24 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.862 -0.685 . . . . 0.66 111.523 -177.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 674' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -80.34 142.62 34.28 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.828 -0.434 . . . . 2.74 109.828 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 675' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -101.95 133.27 47.0 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.016 -0.538 . . . . 4.73 109.958 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 676' ' ' VAL . . . . . 0.445 ' HB ' ' HB3' ' A' ' 717' ' ' LEU . 28.8 m -121.08 152.03 24.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 115.727 -0.669 . . . . 1.18 111.022 -175.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 677' ' ' ARG . . . . . 0.431 ' HB2' HG22 ' A' ' 720' ' ' VAL . 27.9 ttp85 -123.3 123.59 41.08 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.963 -0.755 . . . . 3.6 108.963 176.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 678' ' ' HIS . . . . . 0.53 ' HB2' ' CD1' ' A' ' 717' ' ' LEU . 52.6 t60 -128.89 122.68 30.83 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 110.05 -0.352 . . . . 2.48 110.05 -179.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 679' ' ' ALA . . . . . . . . . . . . . . . -40.92 -45.85 2.64 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.545 0.943 . . . . 1.91 113.545 -172.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 680' ' ' LYS . . . . . . . . . . . . . 31.0 mtpt -92.62 -27.43 17.33 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.659 -0.7 . . . . 3.47 112.819 -168.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 681' ' ' PHE . . . . . . . . . . . . . 20.3 m-30 -106.29 -12.34 15.73 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.02 0.378 . . . . 2.31 112.02 -176.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 682' ' ' GLY . . . . . . . . . . . . . . . 90.08 -155.39 24.43 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.373 -0.918 . . . . 0.82 111.206 -174.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 683' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -111.91 152.67 27.74 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 117.116 0.458 . . . . 2.11 110.844 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 684' ' ' GLY . . . . . . . . . . . . . . . -157.18 -177.32 30.19 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 121.004 -0.617 . . . . 0.43 111.78 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 685' ' ' THR . . . . . . . . . . . . . 41.8 m -118.43 125.8 50.71 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.771 0.32 . . . . 1.21 110.991 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 686' ' ' ILE . . . . . 0.409 HG12 HG22 ' A' ' 700' ' ' VAL . 44.3 mt -71.57 110.23 4.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 120.805 0.336 . . . . 1.07 110.179 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 687' ' ' VAL . . . . . . . . . . . . . 30.1 m -97.07 -27.61 3.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.487 -0.324 . . . . 1.13 111.642 -176.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -149.66 158.2 43.95 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.067 -0.346 . . . . 2.15 110.067 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 689' ' ' MET . . . . . . . . . . . . . 5.2 ppp? -150.8 143.02 24.18 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.021 -0.536 . . . . 2.7 109.666 178.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 690' ' ' GLU . . . . . 0.435 ' O ' ' HA ' ' A' ' 696' ' ' SER . 45.0 mt-10 -121.54 140.94 51.57 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.965 -0.561 . . . . 2.02 110.893 -174.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . 68.13 -157.9 52.28 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 121.053 -0.594 . . . . 1.14 112.73 176.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 52.0 m -155.06 136.66 14.28 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.715 0.293 . . . . 2.41 110.561 178.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 83.51 -138.66 17.96 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 121.082 -0.58 . . . . 1.46 112.873 176.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 694' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -63.36 -37.17 86.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.898 0.38 . . . . 2.85 110.9 -178.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 695' ' ' HIS . . . . . . . . . . . . . 33.6 t-80 -86.79 15.75 5.48 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.267 0.556 . . . . 3.85 110.674 -177.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 696' ' ' SER . . . . . 0.435 ' HA ' ' O ' ' A' ' 690' ' ' GLU . 19.6 t -92.78 142.17 27.64 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.939 0.399 . . . . 2.05 110.417 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 697' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -123.64 134.82 53.7 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.617 -0.512 . . . . 3.16 109.617 174.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 8.6 mt -108.21 133.53 52.33 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 109.649 -0.5 . . . . 1.25 109.649 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 699' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -101.8 106.02 16.95 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.418 0.628 . . . . 2.54 110.017 174.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 700' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 707' ' ' ILE . 40.0 t -99.28 123.33 51.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.097 -0.956 . . . . 1.08 110.598 -176.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -82.86 94.95 7.79 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.767 -0.651 . . . . 1.14 109.823 176.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 702' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -76.11 126.36 30.86 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.622 -0.717 . . . . 2.06 109.966 178.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -64.74 -18.55 65.14 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.716 -0.674 . . . . 2.83 112.041 -173.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -134.92 40.27 1.58 Allowed Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.472 -0.87 . . . . 0.78 112.457 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 705' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -166.78 -23.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.836 0.35 . . . . 3.15 111.029 -178.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . . . . . . . . . . . 101.38 -169.4 20.52 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.546 -0.835 . . . . 0.79 112.038 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 707' ' ' ILE . . . . . 0.512 ' C ' ' HE2' ' A' ' 708' ' ' LYS . 47.0 mt -89.26 117.34 32.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 O-C-N 122.564 -0.374 . . . . 1.43 110.88 -178.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 708' ' ' LYS . . . . . 0.512 ' HE2' ' C ' ' A' ' 707' ' ' ILE . 0.4 OUTLIER -108.74 165.22 11.72 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.299 -0.41 . . . . 1.91 110.265 176.794 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 709' ' ' TRP . . . . . . . . . . . . . 8.1 p-90 -104.91 119.96 40.27 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.706 -0.679 . . . . 0.97 109.858 177.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -115.85 109.84 18.2 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.176 -0.465 . . . . 1.25 110.425 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 57.8 t -61.59 119.24 5.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.395 -0.594 . . . . 1.25 109.395 174.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 712' ' ' ALA . . . . . . . . . . . . . . . -54.99 -25.38 29.48 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.925 0.713 . . . . 1.3 112.925 -172.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -71.02 -25.66 62.77 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.855 0.36 . . . . 1.62 111.6 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 714' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -129.22 16.09 6.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.351 -0.386 . . . . 2.77 110.521 -177.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 715' ' ' ALA . . . . . 0.492 ' HB2' ' CD2' ' A' ' 717' ' ' LEU . . . -70.18 -58.14 4.12 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.078 -0.51 . . . . 1.37 111.101 -175.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 716' ' ' ARG . . . . . . . . . . . . . 74.3 mtt180 57.06 62.14 2.33 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.208 0.528 . . . . 5.14 111.177 175.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . 0.53 ' CD1' ' HB2' ' A' ' 678' ' ' HIS . 3.1 mm? -102.55 129.67 49.17 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.108 -0.496 . . . . 1.42 110.761 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 718' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -93.1 115.16 27.83 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.969 -0.752 . . . . 2.13 108.969 175.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 719' ' ' SER . . . . . . . . . . . . . 1.5 p -62.21 135.01 57.3 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.884 0.373 . . . . 2.19 111.007 -177.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 720' ' ' VAL . . . . . 0.431 HG22 ' HB2' ' A' ' 677' ' ' ARG . 3.4 t . . . . . 0 C--O 1.251 1.167 0 CA-C-O 118.389 -0.815 . . . . 2.06 109.705 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 670' ' ' TYR . . . . . 0.44 ' CD2' HD11 ' A' ' 698' ' ' LEU . 85.8 m-85 . . . . . 0 N--CA 1.454 -0.263 0 CA-C-O 121.081 0.467 . . . . 1.4099999999999999 111.465 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -106.82 151.27 25.42 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.579 -0.737 . . . . 2.7000000000000002 110.234 -175.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 672' ' ' LEU . . . . . . . . . . . . . 41.8 mt -76.0 136.28 39.99 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.025 0.44 . . . . 1.05 111.053 -176.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 673' ' ' GLY . . . . . . . . . . . . . . . 96.9 -3.08 62.27 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.601 -0.727 . . . . 0.64000000000000001 112.167 -178.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 674' ' ' GLN . . . . . . . . . . . . . 59.6 tp60 -79.14 145.52 33.67 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.001 0.429 . . . . 2.2000000000000002 110.385 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 675' ' ' ARG . . . . . . . . . . . . . 23.4 mmt180 -97.38 126.22 42.48 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.54 -0.754 . . . . 4.0700000000000003 109.086 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 676' ' ' VAL . . . . . 0.444 ' HB ' HD12 ' A' ' 717' ' ' LEU . 35.7 m -117.17 162.1 15.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 120.828 0.347 . . . . 0.58999999999999997 111.443 -175.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 677' ' ' ARG . . . . . 0.428 ' HB2' HG22 ' A' ' 720' ' ' VAL . 47.5 ttt180 -138.59 125.86 21.61 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.539 -0.755 . . . . 3.1499999999999999 109.753 -176.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 678' ' ' HIS . . . . . 0.484 ' CD2' HD13 ' A' ' 717' ' ' LEU . 0.0 OUTLIER -147.5 132.65 18.33 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 110.423 -0.214 . . . . 1.53 110.423 178.092 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 679' ' ' ALA . . . . . . . . . . . . . . . -66.45 -14.57 62.39 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.938 0.399 . . . . 1.24 111.95 -176.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 680' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -82.84 -37.78 23.94 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.142 -0.481 . . . . 2.9199999999999999 111.963 -178.265 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 681' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -125.25 -11.8 6.91 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.043 0.386 . . . . 1.5 112.043 -171.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 682' ' ' GLY . . . . . . . . . . . . . . . 98.97 -152.71 19.7 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.294 -0.722 . . . . 0.81999999999999995 111.294 -175.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 683' ' ' GLU . . . . . 0.406 ' H ' ' CD ' ' A' ' 683' ' ' GLU . 0.2 OUTLIER -104.74 147.19 27.96 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.526 -0.546 . . . . 2.1099999999999999 109.526 178.213 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 684' ' ' GLY . . . . . . . . . . . . . . . -151.6 173.67 30.88 Favored Glycine 0 N--CA 1.441 -0.967 0 C-N-CA 119.641 -1.266 . . . . 0.38 112.464 -177.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 685' ' ' THR . . . . . . . . . . . . . 35.2 m -118.44 124.3 47.31 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.941 -0.392 . . . . 0.46999999999999997 109.941 176.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 35.5 mt -72.33 104.88 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.2 -0.455 . . . . 0.46999999999999997 109.837 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 687' ' ' VAL . . . . . . . . . . . . . 28.7 m -94.9 -23.81 5.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.302 -0.408 . . . . 0.5 111.512 -175.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 688' ' ' ASN . . . . . 0.446 ' HB3' ' HB2' ' A' ' 699' ' ' GLN . 63.0 t30 -151.24 165.0 35.31 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.466 -0.334 . . . . 1.6200000000000001 110.196 -178.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 689' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.59 156.59 38.26 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.464 -0.569 . . . . 2.1699999999999999 109.464 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 690' ' ' GLU . . . . . 0.476 ' O ' ' HA ' ' A' ' 696' ' ' SER . 45.9 mt-10 -125.95 123.76 39.26 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.539 -0.3 . . . . 2.02 110.752 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . 69.28 -160.96 52.53 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 121.083 -0.58 . . . . 1.05 112.728 178.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 66.9 m -152.03 157.43 41.66 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.257 -0.275 . . . . 2.1800000000000002 110.257 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 89.67 -142.39 16.61 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.835 -0.698 . . . . 1.3100000000000001 112.313 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 694' ' ' GLU . . . . . 0.401 ' HA ' ' HB2' ' A' ' 713' ' ' ALA . 41.7 mt-10 -74.04 -31.46 62.9 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.042 0.449 . . . . 2.8500000000000001 110.635 -178.125 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 695' ' ' HIS . . . . . . . . . . . . . 35.4 m170 -91.6 16.11 11.19 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.813 -0.631 . . . . 3.0499999999999998 110.661 -176.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 696' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 690' ' ' GLU . 20.8 t -81.97 130.47 35.09 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.437 -0.579 . . . . 1.5 109.437 177.503 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 697' ' ' ARG . . . . . . . . . . . . . 23.9 mtm180 -114.51 133.72 55.56 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.226 -0.657 . . . . 2.54 109.226 177.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 698' ' ' LEU . . . . . 0.44 HD11 ' CD2' ' A' ' 670' ' ' TYR . 9.3 mt -106.14 130.65 53.99 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 120.632 0.253 . . . . 0.46000000000000002 110.449 -177.468 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 699' ' ' GLN . . . . . 0.487 ' HA ' ' O ' ' A' ' 708' ' ' LYS . 3.8 mp0 -95.55 100.63 12.35 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.754 0.788 . . . . 2.2400000000000002 109.264 175.163 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 700' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' A' ' 707' ' ' ILE . 19.5 t -101.71 124.14 55.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 114.729 -1.123 . . . . 0.22 110.815 -172.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -84.83 94.82 8.81 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.233 -0.439 . . . . 0.23000000000000001 110.16 177.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 702' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -78.64 122.56 26.1 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.677 -0.49 . . . . 1.2 109.677 177.043 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -69.15 -13.19 62.28 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.941 -0.572 . . . . 2.79 111.468 -174.049 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -101.06 8.68 57.65 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.749 -0.739 . . . . 0.78000000000000003 112.612 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 705' ' ' GLN . . . . . . . . . . . . . 23.2 tp60 -158.45 -75.64 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.958 0.379 . . . . 2.6200000000000001 111.047 178.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 706' ' ' GLY . . . . . . . . . . . . . . . 170.36 -167.02 40.19 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 121.013 -0.613 . . . . 0.5 112.025 -178.328 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 707' ' ' ILE . . . . . 0.493 ' HA ' ' O ' ' A' ' 700' ' ' VAL . 71.4 mt -79.53 126.22 39.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.158 0.504 . . . . 0.67000000000000004 110.796 -178.701 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 708' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 699' ' ' GLN . 63.6 mttm -125.77 159.4 32.46 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.785 -0.643 . . . . 1.3500000000000001 110.693 -179.397 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 709' ' ' TRP . . . . . . . . . . . . . 14.6 p-90 -100.7 116.28 32.23 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.945 -0.57 . . . . 0.83999999999999997 110.265 178.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -117.76 114.38 23.22 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.016 -0.538 . . . . 0.44 110.206 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 46.5 t -63.86 110.06 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.589 -0.522 . . . . 0.60999999999999999 109.589 177.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 712' ' ' ALA . . . . . . . . . . . . . . . -45.15 -43.24 9.74 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 113.502 0.927 . . . . 0.91000000000000003 113.502 -168.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 713' ' ' ALA . . . . . 0.401 ' HB2' ' HA ' ' A' ' 694' ' ' GLU . . . -64.18 -36.99 85.84 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 111.975 0.361 . . . . 1.1000000000000001 111.975 -177.252 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 714' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -102.5 -9.79 19.91 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.967 0.413 . . . . 1.96 110.815 -177.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 715' ' ' ALA . . . . . 0.474 ' HB1' ' CD2' ' A' ' 717' ' ' LEU . . . -67.74 -62.6 1.33 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.801 -0.636 . . . . 0.77000000000000002 109.941 178.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 716' ' ' ARG . . . . . . . . . . . . . 59.9 mtt180 56.03 66.4 1.21 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.506 0.67 . . . . 4.4100000000000001 110.52 175.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 717' ' ' LEU . . . . . 0.484 HD13 ' CD2' ' A' ' 678' ' ' HIS . 4.6 mm? -89.21 145.15 25.6 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.189 -0.914 . . . . 0.84999999999999998 110.334 -177.601 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 718' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -97.27 134.68 40.24 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.211 -0.663 . . . . 2.1299999999999999 109.211 176.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 719' ' ' SER . . . . . . . . . . . . . 13.5 m -75.81 128.37 34.99 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.58 -0.282 . . . . 1.6799999999999999 110.43 -178.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 720' ' ' VAL . . . . . 0.428 HG22 ' HB2' ' A' ' 677' ' ' ARG . 17.6 t . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.498 -0.763 . . . . 1.6399999999999999 109.77 177.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 670' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 . . . . . 0 N--CA 1.447 -0.58 0 N-CA-C 110.113 -0.329 . . . . 1.4099999999999999 110.113 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 671' ' ' LYS . . . . . 0.437 ' HG2' ' HB2' ' A' ' 674' ' ' GLN . 20.7 pttp -138.86 160.2 40.3 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.313 -0.625 . . . . 2.7000000000000002 109.313 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 672' ' ' LEU . . . . . . . . . . . . . 29.7 mt -72.08 133.08 45.02 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.962 -0.384 . . . . 1.05 109.962 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 673' ' ' GLY . . . . . . . . . . . . . . . 86.94 8.17 76.44 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.791 -0.719 . . . . 0.64000000000000001 111.764 -175.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 674' ' ' GLN . . . . . 0.437 ' HB2' ' HG2' ' A' ' 671' ' ' LYS . 33.2 tt0 -85.87 142.86 28.58 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.949 -0.389 . . . . 2.2000000000000002 109.949 178.661 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 675' ' ' ARG . . . . . 0.473 ' N ' ' HD2' ' A' ' 675' ' ' ARG . 3.7 mpt_? -100.78 127.48 47.19 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.147 0.499 . . . . 4.0700000000000003 110.328 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 676' ' ' VAL . . . . . 0.503 ' HB ' ' HB3' ' A' ' 717' ' ' LEU . 27.1 m -117.23 154.1 18.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.587 -0.733 . . . . 0.58999999999999997 110.917 -177.088 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 677' ' ' ARG . . . . . 0.425 ' CG ' ' HB3' ' A' ' 683' ' ' GLU . 26.9 mtt180 -127.18 136.95 52.77 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.996 -0.547 . . . . 3.1499999999999999 110.957 177.262 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -138.94 142.59 38.43 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.503 -0.772 . . . . 1.53 109.333 172.322 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 679' ' ' ALA . . . . . . . . . . . . . . . -49.46 -52.47 28.87 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.612 0.597 . . . . 1.24 112.612 -172.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 680' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -91.07 -37.05 13.66 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.47 -0.332 . . . . 2.9199999999999999 111.809 -170.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 681' ' ' PHE . . . . . . . . . . . . . 9.3 m-30 -81.2 -11.32 59.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.841 0.353 . . . . 1.5 111.273 -178.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 682' ' ' GLY . . . . . . . . . . . . . . . 86.32 -111.84 3.67 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.508 -0.853 . . . . 0.81999999999999995 111.636 178.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 683' ' ' GLU . . . . . 0.425 ' HB3' ' CG ' ' A' ' 677' ' ' ARG . 10.4 pt-20 -155.66 148.43 24.2 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.725 0.298 . . . . 2.1099999999999999 110.443 178.209 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 684' ' ' GLY . . . . . . . . . . . . . . . -152.41 -177.31 25.94 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.647 -0.787 . . . . 0.38 111.531 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 685' ' ' THR . . . . . . . . . . . . . 58.5 m -119.44 130.14 55.11 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.827 0.346 . . . . 0.46999999999999997 110.414 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 686' ' ' ILE . . . . . 0.438 HG12 HG22 ' A' ' 700' ' ' VAL . 48.8 mt -73.86 104.61 2.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.082 -0.508 . . . . 0.46999999999999997 110.123 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 687' ' ' VAL . . . . . . . . . . . . . 30.3 m -89.63 -26.12 5.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.416 -0.356 . . . . 0.5 111.018 -177.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -152.42 162.41 41.22 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.361 -0.382 . . . . 1.6200000000000001 110.482 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 689' ' ' MET . . . . . . . . . . . . . 22.1 ptp -147.1 146.18 29.86 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.03 -0.532 . . . . 2.1699999999999999 109.905 178.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 690' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -120.81 156.01 32.83 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.882 -0.599 . . . . 2.02 109.832 -176.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . 80.62 -169.42 52.34 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.57 -0.824 . . . . 1.05 111.791 -178.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 21.2 p -157.73 99.86 1.73 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.665 0.269 . . . . 2.1800000000000002 110.368 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 118.74 -136.84 12.39 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.426 -0.892 . . . . 1.3100000000000001 112.555 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 694' ' ' GLU . . . . . 0.459 ' O ' ' HB2' ' A' ' 713' ' ' ALA . 45.2 tt0 -64.38 -53.18 52.56 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.747 0.308 . . . . 2.8500000000000001 111.573 -175.56 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 695' ' ' HIS . . . . . . . . . . . . . 41.9 m-70 -85.24 37.37 0.67 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.862 0.363 . . . . 3.0499999999999998 111.904 -175.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 696' ' ' SER . . . . . . . . . . . . . 16.9 p -81.67 151.32 27.62 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 110.004 -0.369 . . . . 1.5 110.004 177.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 697' ' ' ARG . . . . . . . . . . . . . 32.2 mtm180 -121.47 129.51 53.0 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.646 -0.501 . . . . 2.54 109.646 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 14.3 mt -101.65 138.87 38.06 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 110.275 -0.268 . . . . 0.46000000000000002 110.275 -177.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 699' ' ' GLN . . . . . 0.499 ' HA ' ' O ' ' A' ' 708' ' ' LYS . 12.7 mp0 -103.84 103.93 13.86 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.562 0.696 . . . . 2.2400000000000002 109.278 173.556 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 700' ' ' VAL . . . . . 0.438 HG22 HG12 ' A' ' 686' ' ' ILE . 38.7 t -101.74 123.07 54.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 114.729 -1.123 . . . . 0.22 110.75 -172.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -83.12 94.31 7.8 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.199 -0.455 . . . . 0.23000000000000001 110.569 178.216 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 702' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -81.02 126.67 31.69 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.46 -0.57 . . . . 1.2 109.46 175.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -70.55 -17.27 62.93 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.141 -0.481 . . . . 2.79 110.619 -176.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -82.76 -11.24 81.97 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.895 -0.669 . . . . 0.78000000000000003 113.21 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 705' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -153.55 -68.54 0.15 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 117.294 0.547 . . . . 2.6200000000000001 111.652 -178.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 706' ' ' GLY . . . . . . . . . . . . . . . 173.15 -165.87 38.2 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.519 -0.848 . . . . 0.5 112.437 -178.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 707' ' ' ILE . . . . . 0.408 ' HA ' ' O ' ' A' ' 700' ' ' VAL . 61.5 mt -79.56 120.34 30.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.931 0.396 . . . . 0.67000000000000004 110.758 -178.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 708' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 699' ' ' GLN . 96.1 mttt -114.54 159.47 20.35 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.108 -0.497 . . . . 1.3500000000000001 111.375 -177.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 709' ' ' TRP . . . . . . . . . . . . . 24.3 p-90 -98.37 118.61 35.42 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.253 -0.885 . . . . 0.83999999999999997 110.162 178.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -121.1 109.45 15.03 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.123 -0.49 . . . . 0.44 110.273 178.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 48.4 t -66.82 106.06 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.25 -0.648 . . . . 0.60999999999999999 109.25 176.134 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 712' ' ' ALA . . . . . . . . . . . . . . . -48.13 -47.01 34.95 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.995 0.739 . . . . 0.91000000000000003 112.995 -167.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 713' ' ' ALA . . . . . 0.459 ' HB2' ' O ' ' A' ' 694' ' ' GLU . . . -62.07 -18.11 59.62 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.606 0.595 . . . . 1.1000000000000001 112.606 -176.604 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 714' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -126.57 9.03 7.07 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.145 0.497 . . . . 1.96 110.388 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 715' ' ' ALA . . . . . 0.503 ' HB1' ' CD2' ' A' ' 717' ' ' LEU . . . -93.2 -52.39 4.57 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.851 -0.613 . . . . 0.77000000000000002 110.43 -179.009 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 716' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 53.67 73.99 0.34 Allowed 'General case' 0 C--O 1.232 0.17 0 O-C-N 123.778 0.674 . . . . 4.4100000000000001 110.683 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 717' ' ' LEU . . . . . 0.503 ' CD2' ' HB1' ' A' ' 715' ' ' ALA . 3.9 mm? -97.05 130.4 44.36 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.12 -0.491 . . . . 0.84999999999999998 110.562 -178.459 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 718' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -81.56 144.24 31.43 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.0 -0.545 . . . . 2.1299999999999999 109.948 -178.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 719' ' ' SER . . . . . . . . . . . . . 10.4 p -82.13 119.91 24.64 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.978 -0.555 . . . . 1.6799999999999999 110.774 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 720' ' ' VAL . . . . . 0.419 HG22 ' HG3' ' A' ' 677' ' ' ARG . 56.7 t . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.416 -0.802 . . . . 1.6399999999999999 110.346 176.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 670' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 . . . . . 0 N--CA 1.454 -0.225 0 CA-C-O 120.676 0.275 . . . . 1.4099999999999999 110.906 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -120.81 140.82 51.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.084 -0.507 . . . . 2.7000000000000002 110.139 -176.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 672' ' ' LEU . . . . . 0.409 HD21 ' HG2' ' A' ' 689' ' ' MET . 64.1 mt -69.63 141.91 53.57 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.238 -0.437 . . . . 1.05 110.819 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 673' ' ' GLY . . . . . . . . . . . . . . . 93.29 -11.18 72.21 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.945 -0.645 . . . . 0.64000000000000001 111.849 -178.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 674' ' ' GLN . . . . . . . . . . . . . 21.7 tp60 -79.93 143.09 34.51 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.561 -0.533 . . . . 2.2000000000000002 109.561 178.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 675' ' ' ARG . . . . . 0.71 ' HB2' ' OXT' ' A' ' 720' ' ' VAL . 36.8 mtm180 -96.76 141.51 29.9 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.567 -0.531 . . . . 4.0700000000000003 109.567 177.68 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 676' ' ' VAL . . . . . 0.475 ' HB ' HD12 ' A' ' 717' ' ' LEU . 27.6 m -120.77 155.6 24.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 115.748 -0.66 . . . . 0.58999999999999997 110.558 -177.505 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 677' ' ' ARG . . . . . . . . . . . . . 50.5 ttp180 -130.5 130.28 43.97 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.179 -0.464 . . . . 3.1499999999999999 110.49 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -136.07 131.88 35.44 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.774 -0.824 . . . . 1.53 108.774 177.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 679' ' ' ALA . . . . . . . . . . . . . . . -64.89 -26.71 68.44 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.928 0.394 . . . . 1.24 111.803 -170.3 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 680' ' ' LYS . . . . . 0.444 ' HD2' ' N ' ' A' ' 680' ' ' LYS . 0.6 OUTLIER -93.8 -31.78 14.24 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.011 -0.54 . . . . 2.9199999999999999 112.094 -177.926 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 681' ' ' PHE . . . . . . . . . . . . . 22.6 m-30 -103.43 -11.52 17.79 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.724 0.639 . . . . 1.5 112.724 -174.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 682' ' ' GLY . . . . . . . . . . . . . . . 96.86 -129.12 9.79 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.349 -0.929 . . . . 0.81999999999999995 111.728 -178.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 683' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -145.66 148.97 33.65 Favored 'General case' 0 C--N 1.319 -0.731 0 O-C-N 122.499 -0.412 . . . . 2.1099999999999999 109.93 178.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 684' ' ' GLY . . . . . 0.424 ' CA ' ' HA ' ' A' ' 702' ' ' PHE . . . -153.94 179.42 30.2 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.204 -0.998 . . . . 0.38 112.509 -178.043 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 685' ' ' THR . . . . . . . . . . . . . 42.5 m -116.2 127.96 55.21 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 110.107 -0.331 . . . . 0.46999999999999997 110.107 178.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 38.2 mt -72.02 104.27 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.62 -0.511 . . . . 0.46999999999999997 109.62 178.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 687' ' ' VAL . . . . . . . . . . . . . 27.5 m -95.12 -24.96 4.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 120.892 0.377 . . . . 0.5 111.314 -175.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -151.44 161.98 41.75 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.59 -0.522 . . . . 1.6200000000000001 109.59 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 689' ' ' MET . . . . . 0.409 ' HG2' HD21 ' A' ' 672' ' ' LEU . 24.9 ptt? -151.27 153.51 35.0 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 110.081 -0.34 . . . . 2.1699999999999999 110.081 177.45 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 690' ' ' GLU . . . . . 0.46 ' O ' ' HA ' ' A' ' 696' ' ' SER . 38.7 mt-10 -126.74 126.04 42.79 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.916 -0.584 . . . . 2.02 110.976 -178.594 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . 76.81 176.7 43.72 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.868 -0.682 . . . . 1.05 113.487 173.096 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 9.3 p -141.38 152.93 44.76 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.087 -0.338 . . . . 2.1800000000000002 110.087 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 88.55 -134.8 12.65 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.729 -0.748 . . . . 1.3100000000000001 111.806 -178.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 694' ' ' GLU . . . . . 0.53 ' HA ' ' HB2' ' A' ' 713' ' ' ALA . 37.0 tt0 -80.08 -31.95 39.28 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.287 0.565 . . . . 2.8500000000000001 110.14 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 695' ' ' HIS . . . . . . . . . . . . . 31.4 m-70 -87.18 37.88 0.79 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.739 -0.664 . . . . 3.0499999999999998 110.82 -178.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 696' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' A' ' 690' ' ' GLU . 55.7 p -109.41 134.23 52.1 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.019 0.438 . . . . 1.5 110.667 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 697' ' ' ARG . . . . . . . . . . . . . 21.5 mtm180 -125.68 141.59 51.94 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.515 -0.55 . . . . 2.54 109.515 176.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 17.3 mt -107.71 136.61 47.16 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 109.88 -0.415 . . . . 0.46000000000000002 109.88 178.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 699' ' ' GLN . . . . . 0.499 ' HG2' ' CG2' ' A' ' 707' ' ' ILE . 56.2 tt0 -100.86 100.27 10.89 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 108.573 -0.899 . . . . 2.2400000000000002 108.573 176.274 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 41.2 t -102.6 124.14 56.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.415 -0.811 . . . . 0.22 111.59 -171.226 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 701' ' ' ALA . . . . . 0.402 ' HA ' ' HA ' ' A' ' 707' ' ' ILE . . . -88.37 96.84 10.74 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.077 -0.511 . . . . 0.23000000000000001 109.973 176.164 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 702' ' ' PHE . . . . . 0.424 ' HA ' ' CA ' ' A' ' 684' ' ' GLY . 64.1 m-85 -73.11 149.73 42.82 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.064 -0.516 . . . . 1.2 111.012 -177.426 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 23.6 tp60 -49.22 -50.23 39.39 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.678 0.621 . . . . 2.79 112.678 -170.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -134.03 19.16 4.17 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 119.617 -1.278 . . . . 0.78000000000000003 113.9 -176.178 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 705' ' ' GLN . . . . . 0.48 ' O ' ' HE2' ' A' ' 708' ' ' LYS . 24.6 mp0 -124.98 10.87 8.25 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 117.67 0.735 . . . . 2.6200000000000001 111.801 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 706' ' ' GLY . . . . . . . . . . . . . . . 80.85 -166.62 49.02 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.306 -0.949 . . . . 0.5 112.702 178.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 707' ' ' ILE . . . . . 0.499 ' CG2' ' HG2' ' A' ' 699' ' ' GLN . 29.2 mt -97.87 130.44 46.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 120.638 0.256 . . . . 0.67000000000000004 111.171 -176.285 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 708' ' ' LYS . . . . . 0.48 ' HE2' ' O ' ' A' ' 705' ' ' GLN . 4.6 mptp? -118.09 169.58 9.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.979 0.419 . . . . 1.3500000000000001 111.192 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 709' ' ' TRP . . . . . . . . . . . . . 22.7 p-90 -113.3 119.77 38.84 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.36 -0.836 . . . . 0.83999999999999997 109.859 176.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -120.71 116.18 24.77 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.427 -0.351 . . . . 0.44 110.486 -177.382 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 40.6 t -65.7 108.79 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.444 -0.576 . . . . 0.60999999999999999 109.444 176.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 712' ' ' ALA . . . . . . . . . . . . . . . -57.07 -34.01 67.84 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.894 -0.594 . . . . 0.91000000000000003 112.418 -169.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 713' ' ' ALA . . . . . 0.53 ' HB2' ' HA ' ' A' ' 694' ' ' GLU . . . -65.66 -25.4 67.33 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.776 0.322 . . . . 1.1000000000000001 111.757 -178.454 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 714' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -121.77 8.2 9.98 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.469 -0.332 . . . . 1.96 111.038 -176.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 715' ' ' ALA . . . . . 0.525 ' HB1' ' CD2' ' A' ' 717' ' ' LEU . . . -88.72 -57.97 2.72 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.174 -0.466 . . . . 0.77000000000000002 111.56 -175.134 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 716' ' ' ARG . . . . . . . . . . . . . 26.1 tpt180 55.63 72.37 0.49 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.494 0.664 . . . . 4.4100000000000001 111.038 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 717' ' ' LEU . . . . . 0.525 ' CD2' ' HB1' ' A' ' 715' ' ' ALA . 4.3 mm? -90.88 142.86 27.32 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.633 -0.712 . . . . 0.84999999999999998 111.148 -178.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 718' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -84.32 148.66 26.53 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.542 -0.753 . . . . 2.1299999999999999 109.313 175.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 719' ' ' SER . . . . . . . . . . . . . 19.6 m -92.39 121.91 34.33 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.766 0.317 . . . . 1.6799999999999999 110.79 -178.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 720' ' ' VAL . . . . . 0.71 ' OXT' ' HB2' ' A' ' 675' ' ' ARG . 9.3 p . . . . . 0 C--O 1.247 0.971 0 CA-C-O 118.758 -0.639 . . . . 1.6399999999999999 110.378 178.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 670' ' ' TYR . . . . . 0.544 ' CE2' ' HB2' ' A' ' 717' ' ' LEU . 93.4 m-85 . . . . . 0 C--O 1.234 0.266 0 CA-C-O 120.853 0.359 . . . . 1.4099999999999999 110.863 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -125.42 162.29 25.16 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.966 -0.561 . . . . 2.7000000000000002 110.503 -175.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 672' ' ' LEU . . . . . . . . . . . . . 7.6 mp -79.67 143.48 34.59 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.89 0.376 . . . . 1.05 110.452 177.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 673' ' ' GLY . . . . . . . . . . . . . . . 84.46 3.01 88.81 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.767 -0.652 . . . . 0.64000000000000001 111.542 -177.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 674' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -86.62 145.5 26.7 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.557 -0.321 . . . . 2.2000000000000002 110.228 -178.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 675' ' ' ARG . . . . . . . . . . . . . 30.9 ttm180 -106.48 125.04 50.49 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.219 0.533 . . . . 4.0700000000000003 109.902 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 676' ' ' VAL . . . . . 0.432 ' HB ' ' HB3' ' A' ' 717' ' ' LEU . 34.7 m -117.57 163.32 14.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.456 -0.793 . . . . 0.58999999999999997 111.147 -174.221 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 677' ' ' ARG . . . . . 0.501 ' HB2' HG22 ' A' ' 720' ' ' VAL . 55.8 ttp180 -134.72 121.16 20.37 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.043 -0.526 . . . . 3.1499999999999999 109.98 176.335 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 678' ' ' HIS . . . . . 0.464 ' HB2' ' CD1' ' A' ' 717' ' ' LEU . 51.5 t60 -134.25 122.65 23.04 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.094 -0.706 . . . . 1.53 109.094 179.458 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 679' ' ' ALA . . . . . . . . . . . . . . . -58.41 -20.8 47.39 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.009 0.744 . . . . 1.24 113.009 -169.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 680' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -86.28 -33.46 20.66 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 111.938 0.347 . . . . 2.9199999999999999 111.938 -177.263 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 681' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -116.97 -12.41 10.69 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.438 0.533 . . . . 1.5 112.438 -175.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 682' ' ' GLY . . . . . . . . . . . . . . . 99.03 -156.51 20.06 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.793 -0.717 . . . . 0.81999999999999995 111.548 -178.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 683' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 676' ' ' VAL . 0.8 OUTLIER -105.51 143.24 33.95 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.866 -0.42 . . . . 2.1099999999999999 109.866 176.102 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 684' ' ' GLY . . . . . . . . . . . . . . . -153.79 175.14 32.22 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.218 -0.991 . . . . 0.38 112.486 -177.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 685' ' ' THR . . . . . . . . . . . . . 84.9 m -111.89 123.97 51.37 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.724 0.297 . . . . 0.46999999999999997 110.364 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 44.7 mt -68.76 106.5 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.56 -0.533 . . . . 0.46999999999999997 109.56 178.012 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 687' ' ' VAL . . . . . . . . . . . . . 26.9 m -99.58 -19.05 6.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.326 -0.397 . . . . 0.5 111.454 -174.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 688' ' ' ASN . . . . . 0.472 ' HB3' ' HB2' ' A' ' 699' ' ' GLN . 18.1 t-20 -156.58 162.33 39.9 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.542 -0.54 . . . . 1.6200000000000001 109.542 -178.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 689' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -148.97 146.82 28.0 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.021 -0.733 . . . . 2.1699999999999999 109.021 176.376 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 690' ' ' GLU . . . . . 0.437 ' OE2' ' HD2' ' A' ' 697' ' ' ARG . 36.4 mt-10 -119.93 122.85 42.14 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.635 0.255 . . . . 2.02 111.237 -174.488 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . 68.99 -172.7 36.49 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.144 -0.55 . . . . 1.05 113.235 175.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 8.5 p -139.71 165.67 26.66 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.397 -0.223 . . . . 2.1800000000000002 110.397 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 81.0 -150.65 30.88 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 121.095 -0.574 . . . . 1.3100000000000001 112.615 178.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 694' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -64.47 -40.99 96.73 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.833 0.349 . . . . 2.8500000000000001 111.157 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 695' ' ' HIS . . . . . . . . . . . . . 27.6 p-80 -86.66 21.97 2.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.283 -0.417 . . . . 3.0499999999999998 111.293 -177.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 696' ' ' SER . . . . . . . . . . . . . 19.2 t -82.05 141.36 33.26 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.38 -0.6 . . . . 1.5 109.38 176.182 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 697' ' ' ARG . . . . . 0.437 ' HD2' ' OE2' ' A' ' 690' ' ' GLU . 41.6 mtt180 -122.69 152.77 40.22 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.668 -0.493 . . . . 2.54 109.668 178.488 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 11.2 mt -118.22 130.38 56.04 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.198 -0.668 . . . . 0.46000000000000002 109.198 174.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 699' ' ' GLN . . . . . 0.472 ' HB2' ' HB3' ' A' ' 688' ' ' ASN . 30.5 mt-30 -97.49 101.49 13.03 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.746 0.784 . . . . 2.2400000000000002 109.618 175.617 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 700' ' ' VAL . . . . . 0.447 ' HB ' ' CE1' ' A' ' 702' ' ' PHE . 15.9 t -100.13 123.19 52.83 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 114.674 -1.148 . . . . 0.22 110.35 -174.527 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -86.49 94.3 9.38 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.402 -0.592 . . . . 0.23000000000000001 109.402 176.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 702' ' ' PHE . . . . . 0.447 ' CE1' ' HB ' ' A' ' 700' ' ' VAL . 92.7 m-85 -77.14 117.11 18.36 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.832 -0.622 . . . . 1.2 109.743 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -60.79 -21.51 63.16 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.854 -0.612 . . . . 2.79 112.088 -174.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -83.92 -20.04 60.2 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.67 -0.776 . . . . 0.78000000000000003 112.481 178.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 705' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -135.26 -82.9 0.41 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.864 0.364 . . . . 2.6200000000000001 111.4 -177.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 706' ' ' GLY . . . . . . . . . . . . . . . 179.49 -156.58 18.64 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 121.119 -0.562 . . . . 0.5 111.77 -177.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 707' ' ' ILE . . . . . 0.443 ' HA ' ' O ' ' A' ' 700' ' ' VAL . 61.5 mt -85.17 126.83 40.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 120.982 0.42 . . . . 0.67000000000000004 111.205 -176.439 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 708' ' ' LYS . . . . . 0.443 ' O ' ' HA ' ' A' ' 699' ' ' GLN . 4.5 mptp? -121.47 161.4 22.32 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.891 -0.595 . . . . 1.3500000000000001 109.779 176.13 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 709' ' ' TRP . . . . . . . . . . . . . 17.7 p-90 -105.86 115.29 29.98 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.233 0.539 . . . . 0.83999999999999997 109.657 177.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -112.75 114.62 27.27 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 116.137 -0.483 . . . . 0.44 110.244 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 49.1 t -65.1 115.68 3.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.664 -0.495 . . . . 0.60999999999999999 109.664 178.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 712' ' ' ALA . . . . . . . . . . . . . . . -54.62 -32.57 59.12 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.849 0.685 . . . . 0.91000000000000003 112.849 -170.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -66.34 -25.62 66.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.932 0.396 . . . . 1.1000000000000001 111.545 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 714' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -133.95 29.44 3.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.141 0.496 . . . . 1.96 109.723 -177.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 715' ' ' ALA . . . . . 0.529 ' HB1' ' CD2' ' A' ' 717' ' ' LEU . . . -80.01 -57.49 3.61 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.553 -0.749 . . . . 0.77000000000000002 111.094 -174.185 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 716' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 716' ' ' ARG . 38.3 ttm180 58.3 69.34 0.74 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.63 0.729 . . . . 4.4100000000000001 111.031 178.359 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 717' ' ' LEU . . . . . 0.544 ' HB2' ' CE2' ' A' ' 670' ' ' TYR . 3.6 mm? -105.74 122.92 47.06 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.876 -0.602 . . . . 0.84999999999999998 110.278 177.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 718' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -91.05 130.94 36.91 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.763 -0.653 . . . . 2.1299999999999999 109.787 -179.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 719' ' ' SER . . . . . . . . . . . . . 15.5 p -64.9 125.63 25.47 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.901 -0.407 . . . . 1.6799999999999999 109.901 176.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 720' ' ' VAL . . . . . 0.501 HG22 ' HB2' ' A' ' 677' ' ' ARG . 10.9 t . . . . . 0 C--O 1.246 0.921 0 CA-C-O 118.803 -0.618 . . . . 1.6399999999999999 110.528 -177.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 670' ' ' TYR . . . . . 0.518 ' CD1' HD11 ' A' ' 698' ' ' LEU . 94.1 m-85 . . . . . 0 N--CA 1.448 -0.543 0 N-CA-C 110.163 -0.31 . . . . 1.4099999999999999 110.163 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 671' ' ' LYS . . . . . 0.462 ' HG3' ' HB2' ' A' ' 674' ' ' GLN . 21.2 ptmt -140.33 155.98 46.6 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.392 -0.367 . . . . 2.7000000000000002 110.244 -176.077 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 672' ' ' LEU . . . . . . . . . . . . . 59.6 mt -78.65 140.99 38.32 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.136 -0.484 . . . . 1.05 110.478 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 673' ' ' GLY . . . . . . . . . . . . . . . 84.07 5.74 87.27 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.814 -0.63 . . . . 0.64000000000000001 111.803 -177.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 674' ' ' GLN . . . . . 0.462 ' HB2' ' HG3' ' A' ' 671' ' ' LYS . 35.1 tt0 -83.28 142.89 30.77 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.022 -0.362 . . . . 2.2000000000000002 110.022 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 675' ' ' ARG . . . . . . . . . . . . . 26.8 mmm180 -93.26 120.11 33.17 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.848 -0.614 . . . . 4.0700000000000003 109.841 178.05 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 676' ' ' VAL . . . . . 0.472 ' HB ' ' HB3' ' A' ' 717' ' ' LEU . 34.2 m -117.27 154.74 19.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.883 -0.599 . . . . 0.58999999999999997 110.695 -177.684 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 677' ' ' ARG . . . . . . . . . . . . . 52.1 ttp180 -131.79 137.91 48.34 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.955 -0.566 . . . . 3.1499999999999999 110.014 178.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 678' ' ' HIS . . . . . 0.426 ' CD2' HD13 ' A' ' 717' ' ' LEU . 0.0 OUTLIER -139.99 155.21 47.22 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.129 -0.487 . . . . 1.53 110.464 174.089 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 679' ' ' ALA . . . . . . . . . . . . . . . -56.12 -53.9 51.56 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.673 0.62 . . . . 1.24 112.673 -173.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 680' ' ' LYS . . . . . . . . . . . . . 2.7 mtpm? -92.66 -30.67 15.46 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.957 -0.565 . . . . 2.9199999999999999 111.743 -171.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 681' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -87.42 -11.85 47.93 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.342 -0.39 . . . . 1.5 111.34 -177.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 682' ' ' GLY . . . . . . . . . . . . . . . 84.47 -112.49 3.62 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.582 -0.818 . . . . 0.81999999999999995 111.992 178.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 683' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -151.12 149.14 29.13 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.738 -0.468 . . . . 2.1099999999999999 109.738 177.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 684' ' ' GLY . . . . . . . . . . . . . . . -160.55 -179.46 35.34 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.016 -1.088 . . . . 0.38 113.011 -178.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 685' ' ' THR . . . . . . . . . . . . . 64.6 m -110.83 130.02 55.7 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.738 -0.467 . . . . 0.46999999999999997 109.738 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 686' ' ' ILE . . . . . 0.448 HG12 HG22 ' A' ' 700' ' ' VAL . 31.1 mt -72.74 103.52 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.171 -0.678 . . . . 0.46999999999999997 109.171 175.499 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 687' ' ' VAL . . . . . . . . . . . . . 27.5 m -93.11 -26.28 4.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.18 0.514 . . . . 0.5 111.028 -175.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 688' ' ' ASN . . . . . 0.489 ' HB3' ' HB3' ' A' ' 699' ' ' GLN . 20.1 t-20 -146.07 161.74 39.46 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.916 -0.584 . . . . 1.6200000000000001 109.676 177.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 689' ' ' MET . . . . . . . . . . . . . 26.7 ptm -153.16 143.68 22.6 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.55 -0.537 . . . . 2.1699999999999999 109.55 177.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 690' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -108.73 122.79 47.89 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.756 -0.656 . . . . 2.02 110.456 -176.11 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . 67.64 -168.79 38.83 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.964 -0.636 . . . . 1.05 112.558 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 56.1 m -154.92 131.78 10.77 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.133 -0.321 . . . . 2.1800000000000002 110.133 178.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 109.36 -142.74 16.33 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.713 -0.756 . . . . 1.3100000000000001 112.021 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 694' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -66.54 -34.83 78.78 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.036 0.446 . . . . 2.8500000000000001 111.109 -178.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 695' ' ' HIS . . . . . . . . . . . . . 55.8 m80 -95.36 31.03 2.05 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.253 -0.43 . . . . 3.0499999999999998 110.902 -178.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 696' ' ' SER . . . . . . . . . . . . . 16.7 t -97.56 138.74 34.51 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.252 0.549 . . . . 1.5 110.902 -178.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 697' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -123.02 159.81 27.63 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.967 -0.753 . . . . 2.54 108.967 174.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 698' ' ' LEU . . . . . 0.518 HD11 ' CD1' ' A' ' 670' ' ' TYR . 35.6 mt -122.75 149.39 44.17 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 109.935 -0.394 . . . . 0.46000000000000002 109.935 178.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 699' ' ' GLN . . . . . 0.489 ' HB3' ' HB3' ' A' ' 688' ' ' ASN . 15.1 tt0 -117.63 96.02 5.2 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.229 -1.026 . . . . 2.2400000000000002 108.229 173.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 700' ' ' VAL . . . . . 0.448 HG22 HG12 ' A' ' 686' ' ' ILE . 35.3 t -100.64 134.5 40.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.551 -0.75 . . . . 0.22 111.103 -172.459 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -96.33 94.41 7.44 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.988 -0.551 . . . . 0.23000000000000001 110.09 176.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 702' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -78.78 136.88 37.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.103 0.478 . . . . 1.2 110.691 -177.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -71.43 -21.22 62.01 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.609 -0.723 . . . . 2.79 112.473 -171.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -106.57 2.76 36.67 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.276 -0.964 . . . . 0.78000000000000003 113.336 -175.46 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 705' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -146.64 -54.15 0.24 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 117.017 0.408 . . . . 2.6200000000000001 111.447 -177.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 706' ' ' GLY . . . . . . . . . . . . . . . 139.57 -159.26 25.79 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.282 -0.961 . . . . 0.5 112.433 179.053 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 58.7 mt -79.08 134.25 28.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 120.847 0.356 . . . . 0.67000000000000004 111.082 -176.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 708' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -137.75 159.59 41.55 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.884 -0.598 . . . . 1.3500000000000001 111.333 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 709' ' ' TRP . . . . . 0.447 ' C ' HD22 ' A' ' 710' ' ' LEU . 33.0 p-90 -98.92 129.75 45.27 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.384 -0.825 . . . . 0.83999999999999997 109.363 174.429 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 710' ' ' LEU . . . . . 0.447 HD22 ' C ' ' A' ' 709' ' ' TRP . 3.1 mm? -127.4 125.69 41.09 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 110.27 -0.27 . . . . 0.44 110.27 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 54.9 t -73.24 104.17 2.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.188 -0.671 . . . . 0.60999999999999999 109.188 174.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 712' ' ' ALA . . . . . 0.405 ' HB2' ' HG ' ' A' ' 698' ' ' LEU . . . -56.81 -31.16 64.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.841 -0.618 . . . . 0.91000000000000003 111.998 -171.225 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -58.96 -32.97 70.11 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.245 -0.434 . . . . 1.1000000000000001 112.032 -178.248 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 714' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -127.73 19.21 6.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.134 0.492 . . . . 1.96 110.699 -178.005 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 715' ' ' ALA . . . . . 0.531 ' HB1' ' CD2' ' A' ' 717' ' ' LEU . . . -77.32 -53.82 7.23 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.703 -0.68 . . . . 0.77000000000000002 111.067 -177.264 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 716' ' ' ARG . . . . . . . . . . . . . 25.4 tpt85 48.98 65.56 1.34 Allowed 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.864 0.84 . . . . 4.4100000000000001 110.72 -176.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 717' ' ' LEU . . . . . 0.531 ' CD2' ' HB1' ' A' ' 715' ' ' ALA . 4.5 mm? -81.34 139.23 35.48 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.207 -0.906 . . . . 0.84999999999999998 109.472 175.132 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 718' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -92.79 119.86 32.57 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.137 -0.69 . . . . 2.1299999999999999 109.137 178.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 719' ' ' SER . . . . . . . . . . . . . 9.7 t -68.99 124.57 24.12 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.859 -0.422 . . . . 1.6799999999999999 109.859 -178.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 720' ' ' VAL . . . . . . . . . . . . . 4.9 p . . . . . 0 C--O 1.248 0.974 0 CA-C-N 116.095 -0.502 . . . . 1.6399999999999999 110.664 -177.055 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 670' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 . . . . . 0 C--O 1.232 0.159 0 N-CA-C 110.068 -0.345 . . . . 1.4099999999999999 110.068 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -118.12 152.3 35.89 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.275 -0.421 . . . . 2.7000000000000002 110.983 -176.36 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 672' ' ' LEU . . . . . . . . . . . . . 70.0 mt -79.25 133.51 36.66 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.094 -0.503 . . . . 1.05 110.053 176.278 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 673' ' ' GLY . . . . . . . . . . . . . . . 94.42 1.23 64.45 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.841 -0.695 . . . . 0.64000000000000001 111.699 -174.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 674' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -81.29 144.63 31.39 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 110.021 -0.362 . . . . 2.2000000000000002 110.021 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 675' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.47 128.65 50.6 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.086 -0.709 . . . . 4.0700000000000003 109.086 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 676' ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' A' ' 683' ' ' GLU . 35.8 m -119.7 152.23 22.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 115.814 -0.63 . . . . 0.58999999999999997 111.465 -173.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 677' ' ' ARG . . . . . 0.472 ' HG3' HG22 ' A' ' 720' ' ' VAL . 32.6 mtp180 -123.06 124.28 42.75 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.28 0.562 . . . . 3.1499999999999999 110.813 175.078 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 678' ' ' HIS . . . . . 0.539 ' HB2' ' CD1' ' A' ' 717' ' ' LEU . 43.4 t60 -139.42 104.66 5.02 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.212 -0.904 . . . . 1.53 109.148 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 679' ' ' ALA . . . . . . . . . . . . . . . -40.42 -38.15 0.78 Allowed 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 114.086 1.143 . . . . 1.24 114.086 -170.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 680' ' ' LYS . . . . . . . . . . . . . 18.7 mmtm -75.8 -31.18 59.33 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.646 -0.252 . . . . 2.9199999999999999 111.542 -172.189 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 681' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -116.61 -13.08 10.86 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.85 -0.34 . . . . 1.5 111.816 -176.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 682' ' ' GLY . . . . . . . . . . . . . . . 97.82 -155.36 20.42 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.902 -0.666 . . . . 0.81999999999999995 111.842 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 683' ' ' GLU . . . . . 0.48 ' HA ' ' O ' ' A' ' 676' ' ' VAL . 0.5 OUTLIER -109.53 147.57 32.72 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.003 0.43 . . . . 2.1099999999999999 110.61 179.075 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 684' ' ' GLY . . . . . . . . . . . . . . . -156.49 179.48 32.31 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 120.594 -0.812 . . . . 0.38 111.999 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 685' ' ' THR . . . . . . . . . . . . . 71.3 m -115.06 127.36 55.58 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.764 0.316 . . . . 0.46999999999999997 110.201 179.052 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 686' ' ' ILE . . . . . 0.401 HG12 HG22 ' A' ' 700' ' ' VAL . 33.6 mt -71.63 104.93 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.182 -0.463 . . . . 0.46999999999999997 109.759 178.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 687' ' ' VAL . . . . . . . . . . . . . 29.3 m -95.54 -26.61 4.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.862 0.363 . . . . 0.5 111.263 -176.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 688' ' ' ASN . . . . . 0.462 ' HB3' ' HB2' ' A' ' 699' ' ' GLN . 21.2 t-20 -146.38 163.47 35.5 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.598 -0.519 . . . . 1.6200000000000001 109.598 -179.294 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 689' ' ' MET . . . . . . . . . . . . . 18.0 ptp -158.3 157.39 32.38 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.956 -0.387 . . . . 2.1699999999999999 109.956 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 690' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -129.15 123.53 32.35 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.435 -0.348 . . . . 2.02 111.405 -177.088 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . 62.31 -162.83 27.78 Favored Glycine 0 N--CA 1.452 -0.3 0 CA-C-N 115.692 -0.685 . . . . 1.05 113.748 172.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 692' ' ' SER . . . . . 0.402 ' HA ' ' HB3' ' A' ' 696' ' ' SER . 39.7 m -151.81 170.44 19.78 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.262 -0.644 . . . . 2.1800000000000002 109.262 177.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 90.38 -139.47 14.96 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.399 -0.905 . . . . 1.3100000000000001 112.456 177.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 694' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -83.29 -24.7 32.08 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.011 0.434 . . . . 2.8500000000000001 110.596 -178.126 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 695' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -102.13 35.52 2.37 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.435 0.636 . . . . 3.0499999999999998 110.383 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 696' ' ' SER . . . . . 0.493 ' OG ' ' HB3' ' A' ' 712' ' ' ALA . 16.3 p -90.81 135.51 33.68 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.396 -0.82 . . . . 1.5 110.258 179.161 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 697' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 697' ' ' ARG . 34.2 mtp180 -127.69 146.53 50.53 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.595 -0.52 . . . . 2.54 109.595 178.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 15.5 mt -123.51 130.97 53.47 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.756 -0.461 . . . . 0.46000000000000002 109.756 178.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 699' ' ' GLN . . . . . 0.473 ' HA ' ' O ' ' A' ' 708' ' ' LYS . 2.1 mp0 -99.14 107.92 20.41 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.468 0.651 . . . . 2.2400000000000002 109.433 175.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 700' ' ' VAL . . . . . 0.401 HG22 HG12 ' A' ' 686' ' ' ILE . 42.1 t -107.13 125.7 63.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 114.913 -1.04 . . . . 0.22 111.097 -172.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 701' ' ' ALA . . . . . 0.407 ' HA ' ' HA ' ' A' ' 707' ' ' ILE . . . -87.3 94.65 9.73 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.152 -0.476 . . . . 0.23000000000000001 109.844 176.409 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 702' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -74.44 135.91 42.33 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.15 0.5 . . . . 1.2 110.345 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -68.62 -31.13 70.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.246 -0.888 . . . . 2.79 111.211 -175.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -81.49 -37.52 17.14 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.729 -0.748 . . . . 0.78000000000000003 112.795 -178.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 705' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 -113.69 -76.04 0.59 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.041 0.385 . . . . 2.6200000000000001 112.041 -176.089 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 706' ' ' GLY . . . . . . . . . . . . . . . 167.87 -158.1 30.74 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.738 -0.744 . . . . 0.5 112.166 -177.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 707' ' ' ILE . . . . . 0.407 ' HA ' ' HA ' ' A' ' 701' ' ' ALA . 64.5 mt -78.46 122.97 34.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.056 0.455 . . . . 0.67000000000000004 111.13 -176.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 708' ' ' LYS . . . . . 0.473 ' O ' ' HA ' ' A' ' 699' ' ' GLN . 86.2 mttt -129.25 168.66 15.87 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.918 -0.583 . . . . 1.3500000000000001 110.866 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 709' ' ' TRP . . . . . 0.511 ' C ' HD22 ' A' ' 710' ' ' LEU . 57.0 p-90 -105.24 131.93 52.09 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.434 -0.803 . . . . 0.83999999999999997 109.782 178.594 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 710' ' ' LEU . . . . . 0.511 HD22 ' C ' ' A' ' 709' ' ' TRP . 3.6 mm? -130.29 109.49 10.8 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.742 -0.466 . . . . 0.44 109.742 177.313 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 59.4 t -64.48 109.41 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.382 -0.599 . . . . 0.60999999999999999 109.382 177.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 712' ' ' ALA . . . . . 0.493 ' HB3' ' OG ' ' A' ' 696' ' ' SER . . . -55.35 -33.89 63.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.774 -0.648 . . . . 0.91000000000000003 112.51 -169.535 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -64.58 -20.26 66.15 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.288 -0.415 . . . . 1.1000000000000001 111.72 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 714' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -131.49 15.4 4.97 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.965 0.412 . . . . 1.96 110.19 -179.022 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 715' ' ' ALA . . . . . 0.58 ' HB1' ' CD2' ' A' ' 717' ' ' LEU . . . -85.28 -60.41 2.04 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.016 -0.538 . . . . 0.77000000000000002 111.454 -173.588 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 716' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 58.82 77.76 0.29 Allowed 'General case' 0 C--O 1.235 0.341 0 CA-C-O 121.49 0.662 . . . . 4.4100000000000001 110.945 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 717' ' ' LEU . . . . . 0.58 ' CD2' ' HB1' ' A' ' 715' ' ' ALA . 3.8 mm? -103.02 129.13 49.68 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.616 -0.72 . . . . 0.84999999999999998 110.911 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 718' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -86.34 125.42 33.62 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.83 -0.623 . . . . 2.1299999999999999 109.416 175.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 719' ' ' SER . . . . . . . . . . . . . 34.6 t -70.68 131.18 43.51 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.685 0.279 . . . . 1.6799999999999999 110.323 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 720' ' ' VAL . . . . . 0.472 HG22 ' HG3' ' A' ' 677' ' ' ARG . 17.5 t . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.671 -0.681 . . . . 1.6399999999999999 109.988 177.035 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 670' ' ' TYR . . . . . 0.552 ' CD1' HD11 ' A' ' 698' ' ' LEU . 57.1 m-85 . . . . . 0 N--CA 1.448 -0.56 0 N-CA-C 109.603 -0.517 . . . . 1.4099999999999999 109.603 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 10.4 mtmp? -100.04 143.03 30.72 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.889 0.376 . . . . 2.7000000000000002 110.553 -177.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 672' ' ' LEU . . . . . . . . . . . . . 52.4 mt -81.13 137.41 35.95 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.107 -0.497 . . . . 1.05 110.405 -179.062 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 673' ' ' GLY . . . . . . . . . . . . . . . 88.35 11.82 66.13 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 110.831 -0.907 . . . . 0.64000000000000001 110.831 -173.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 674' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -94.76 144.07 25.94 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.891 0.376 . . . . 2.2000000000000002 110.526 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 675' ' ' ARG . . . . . 0.433 ' HD3' ' O ' ' A' ' 684' ' ' GLY . 11.0 tpp85 -97.95 123.82 42.12 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.622 -0.717 . . . . 4.0700000000000003 109.835 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 676' ' ' VAL . . . . . 0.423 ' HB ' HD12 ' A' ' 717' ' ' LEU . 27.2 m -115.84 161.94 14.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.071 -0.513 . . . . 0.58999999999999997 110.425 -177.487 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 677' ' ' ARG . . . . . 0.431 ' HG3' ' HG2' ' A' ' 683' ' ' GLU . 21.5 ttt180 -135.38 131.1 35.91 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.27 -0.423 . . . . 3.1499999999999999 111.123 178.322 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 678' ' ' HIS . . . . . 0.465 ' CD2' HD13 ' A' ' 717' ' ' LEU . 0.0 OUTLIER -141.42 147.22 37.6 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.51 -0.768 . . . . 1.53 109.25 175.034 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 679' ' ' ALA . . . . . . . . . . . . . . . -76.85 -26.23 54.05 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.108 0.411 . . . . 1.24 112.108 -169.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 680' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -87.98 -37.81 16.06 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.036 0.384 . . . . 2.9199999999999999 112.036 -176.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 681' ' ' PHE . . . . . . . . . . . . . 19.2 m-30 -106.71 -11.26 15.86 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 111.814 0.301 . . . . 1.5 111.814 -176.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 682' ' ' GLY . . . . . . . . . . . . . . . 90.53 -156.42 24.81 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.551 -0.833 . . . . 0.81999999999999995 111.777 -177.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 683' ' ' GLU . . . . . 0.431 ' HG2' ' HG3' ' A' ' 677' ' ' ARG . 27.6 mt-10 -103.6 144.69 31.1 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.9 -0.407 . . . . 2.1099999999999999 109.9 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 684' ' ' GLY . . . . . 0.433 ' O ' ' HD3' ' A' ' 675' ' ' ARG . . . -148.64 170.88 29.07 Favored Glycine 0 C--N 1.313 -0.742 0 C-N-CA 120.224 -0.989 . . . . 0.38 112.696 -177.33 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 685' ' ' THR . . . . . . . . . . . . . 32.8 m -113.83 124.67 52.78 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.872 0.368 . . . . 0.46999999999999997 110.213 178.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 28.3 mt -73.64 104.7 2.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.259 -0.428 . . . . 0.46999999999999997 109.912 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 687' ' ' VAL . . . . . . . . . . . . . 29.0 m -93.49 -25.63 4.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.732 0.301 . . . . 0.5 111.578 -175.353 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -152.14 163.93 38.36 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.446 -0.343 . . . . 1.6200000000000001 110.138 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 689' ' ' MET . . . . . . . . . . . . . 5.1 ppp? -151.91 163.86 38.35 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.496 -0.557 . . . . 2.1699999999999999 109.496 177.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 690' ' ' GLU . . . . . 0.427 ' CG ' ' HB2' ' A' ' 697' ' ' ARG . 10.7 pt-20 -146.91 155.13 42.05 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.406 -0.361 . . . . 2.02 110.579 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . 78.23 -159.29 46.82 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.963 -0.636 . . . . 1.05 112.485 177.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 29.6 t -161.81 149.43 14.62 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 110.259 -0.275 . . . . 2.1800000000000002 110.259 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 62.86 -127.52 38.88 Favored Glycine 0 N--CA 1.452 -0.262 0 CA-C-N 116.072 -0.513 . . . . 1.3100000000000001 113.574 175.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 694' ' ' GLU . . . . . 0.426 ' HA ' ' HB2' ' A' ' 713' ' ' ALA . 42.0 mt-10 -80.58 -15.79 55.77 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.775 0.322 . . . . 2.8500000000000001 111.417 -175.412 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 695' ' ' HIS . . . . . . . . . . . . . 18.5 p-80 -109.9 34.71 3.7 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.322 0.582 . . . . 3.0499999999999998 110.306 178.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 696' ' ' SER . . . . . . . . . . . . . 77.9 p -101.31 145.73 28.49 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.733 -0.667 . . . . 1.5 110.507 178.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 697' ' ' ARG . . . . . 0.427 ' HB2' ' CG ' ' A' ' 690' ' ' GLU . 96.8 mtt180 -125.33 151.05 46.57 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.658 -0.497 . . . . 2.54 109.658 175.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 698' ' ' LEU . . . . . 0.552 HD11 ' CD1' ' A' ' 670' ' ' TYR . 15.5 mt -117.36 146.33 43.47 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.719 -0.474 . . . . 0.46000000000000002 109.719 178.246 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 699' ' ' GLN . . . . . 0.5 ' HA ' ' O ' ' A' ' 708' ' ' LYS . 63.2 mt-30 -107.94 99.09 8.57 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.76 0.791 . . . . 2.2400000000000002 109.27 169.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 700' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 707' ' ' ILE . 20.8 t -100.02 122.72 52.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 114.38 -1.282 . . . . 0.22 110.565 -173.636 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -85.5 94.31 8.99 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.722 -0.473 . . . . 0.23000000000000001 109.722 177.14 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 702' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -74.0 127.02 31.8 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.957 0.408 . . . . 1.2 110.002 178.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -62.43 -26.67 68.62 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.473 -0.785 . . . . 2.79 112.175 -169.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -96.05 -7.25 58.64 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.586 -0.816 . . . . 0.78000000000000003 113.138 -178.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 705' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -134.59 -79.19 0.45 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 117.184 0.492 . . . . 2.6200000000000001 111.344 -178.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 706' ' ' GLY . . . . . . . . . . . . . . . 168.71 -164.26 37.89 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.706 -0.759 . . . . 0.5 112.309 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 707' ' ' ILE . . . . . 0.454 ' HA ' ' O ' ' A' ' 700' ' ' VAL . 61.3 mt -75.89 127.85 37.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.936 0.398 . . . . 0.67000000000000004 110.883 -178.132 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 708' ' ' LYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 699' ' ' GLN . 68.1 mttm -127.31 158.97 35.81 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.656 -0.702 . . . . 1.3500000000000001 110.733 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 709' ' ' TRP . . . . . . . . . . . . . 13.8 p-90 -99.41 111.93 24.2 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.608 0.718 . . . . 0.83999999999999997 110.222 179.079 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -117.04 115.22 24.99 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.861 -0.609 . . . . 0.44 110.443 -178.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 46.8 t -63.1 105.48 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.218 -0.66 . . . . 0.60999999999999999 109.218 174.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 712' ' ' ALA . . . . . . . . . . . . . . . -48.62 -46.92 40.4 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 113.216 0.821 . . . . 0.91000000000000003 113.216 -167.058 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 713' ' ' ALA . . . . . 0.426 ' HB2' ' HA ' ' A' ' 694' ' ' GLU . . . -64.11 -28.59 69.88 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.262 -0.427 . . . . 1.1000000000000001 112.051 -175.703 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 714' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -111.35 2.47 17.63 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.281 0.563 . . . . 1.96 110.656 -178.149 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 715' ' ' ALA . . . . . 0.475 ' HB1' ' CD2' ' A' ' 717' ' ' LEU . . . -84.3 -50.82 7.5 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.509 -0.769 . . . . 0.77000000000000002 109.617 177.225 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 716' ' ' ARG . . . . . 0.637 ' HA ' ' HE ' ' A' ' 716' ' ' ARG . 1.3 mmp_? 51.41 67.52 0.94 Allowed 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.596 -0.729 . . . . 4.4100000000000001 110.83 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 717' ' ' LEU . . . . . 0.475 ' CD2' ' HB1' ' A' ' 715' ' ' ALA . 4.6 mm? -86.05 152.34 22.97 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.328 -0.851 . . . . 0.84999999999999998 109.597 177.558 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 718' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -114.26 128.38 56.33 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.7 -0.481 . . . . 2.1299999999999999 109.7 178.013 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 719' ' ' SER . . . . . . . . . . . . . 25.3 m -66.8 123.55 20.45 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.88 -0.415 . . . . 1.6799999999999999 109.88 176.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 720' ' ' VAL . . . . . . . . . . . . . 3.2 p . . . . . 0 C--O 1.248 1.003 0 CA-C-N 116.463 -0.335 . . . . 1.6399999999999999 111.038 -177.354 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 670' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 . . . . . 0 N--CA 1.452 -0.34 0 CA-C-O 120.76 0.314 . . . . 1.4099999999999999 110.41 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -134.77 162.49 32.22 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.95 -0.568 . . . . 2.7000000000000002 110.297 -174.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 672' ' ' LEU . . . . . . . . . . . . . 35.5 mt -77.86 134.45 37.95 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.845 0.355 . . . . 1.05 110.293 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 673' ' ' GLY . . . . . . . . . . . . . . . 88.38 -0.27 83.17 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 111.415 -0.674 . . . . 0.64000000000000001 111.415 -176.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 674' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -82.61 148.45 27.99 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.717 0.294 . . . . 2.2000000000000002 110.21 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 675' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -103.34 132.4 49.62 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.129 -0.487 . . . . 4.0700000000000003 110.121 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 676' ' ' VAL . . . . . 0.501 ' HB ' HD12 ' A' ' 717' ' ' LEU . 29.9 m -117.01 153.39 18.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.582 -0.735 . . . . 0.58999999999999997 110.448 -177.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 677' ' ' ARG . . . . . 0.435 ' HB2' HG22 ' A' ' 720' ' ' VAL . 42.3 ttt180 -126.79 129.31 48.08 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.328 -0.396 . . . . 3.1499999999999999 110.376 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -140.79 121.55 14.37 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.089 -0.708 . . . . 1.53 109.089 177.425 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 679' ' ' ALA . . . . . . . . . . . . . . . -58.73 -18.5 32.0 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.127 0.417 . . . . 1.24 112.127 -175.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 680' ' ' LYS . . . . . 0.523 ' HD2' ' N ' ' A' ' 680' ' ' LYS . 0.3 OUTLIER -91.07 -35.52 14.56 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.243 -0.435 . . . . 2.9199999999999999 112.088 -177.515 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 681' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -113.25 -11.46 13.22 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.787 0.327 . . . . 1.5 111.796 -174.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 682' ' ' GLY . . . . . . . . . . . . . . . 92.98 -156.5 22.96 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 111.467 -0.653 . . . . 0.81999999999999995 111.467 -174.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 683' ' ' GLU . . . . . 0.441 ' HA ' ' O ' ' A' ' 676' ' ' VAL . 12.1 pt-20 -109.13 147.73 31.99 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.777 -0.453 . . . . 2.1099999999999999 109.777 177.406 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 684' ' ' GLY . . . . . . . . . . . . . . . -151.15 173.54 30.59 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.428 -0.891 . . . . 0.38 112.286 -177.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 685' ' ' THR . . . . . . . . . . . . . 16.5 m -110.78 125.88 54.02 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.548 0.213 . . . . 0.46999999999999997 110.687 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 50.6 mt -74.39 107.38 4.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.975 -0.379 . . . . 0.46999999999999997 109.975 177.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 687' ' ' VAL . . . . . . . . . . . . . 29.9 m -93.63 -31.92 4.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 120.873 0.368 . . . . 0.5 111.073 -177.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -143.0 159.81 41.54 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.112 -0.495 . . . . 1.6200000000000001 110.243 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 689' ' ' MET . . . . . . . . . . . . . 5.3 ppp? -149.05 142.85 25.63 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.97 0.414 . . . . 2.1699999999999999 110.262 179.018 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 690' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -114.72 123.62 49.72 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.814 -0.63 . . . . 2.02 110.63 -175.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . 84.62 -152.16 27.28 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.827 -0.701 . . . . 1.05 113.193 174.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 17.5 p -173.7 126.14 0.39 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 123.168 0.587 . . . . 2.1800000000000002 109.569 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 111.77 -143.74 17.46 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.765 -0.731 . . . . 1.3100000000000001 111.703 -175.451 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 694' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -72.8 -48.6 36.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.083 0.468 . . . . 2.8500000000000001 111.327 -177.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 695' ' ' HIS . . . . . . . . . . . . . 57.9 m-70 -81.92 37.5 0.48 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.968 -0.56 . . . . 3.0499999999999998 111.415 -173.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 696' ' ' SER . . . . . . . . . . . . . 4.6 m -98.31 143.97 28.22 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.22 -0.446 . . . . 1.5 110.163 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 697' ' ' ARG . . . . . . . . . . . . . 40.9 mtm180 -117.64 135.79 53.75 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.553 -0.536 . . . . 2.54 109.553 175.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 15.9 mt -107.3 131.25 54.43 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.86 -0.422 . . . . 0.46000000000000002 109.86 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 699' ' ' GLN . . . . . 0.434 ' HA ' ' O ' ' A' ' 708' ' ' LYS . 5.8 mp0 -93.75 101.52 13.64 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.485 0.659 . . . . 2.2400000000000002 109.498 174.208 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 22.0 t -101.98 124.41 55.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-N 115.045 -0.98 . . . . 0.22 110.437 -175.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 701' ' ' ALA . . . . . 0.411 ' HA ' ' HA ' ' A' ' 707' ' ' ILE . . . -88.11 101.44 13.81 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.986 -0.552 . . . . 0.23000000000000001 110.168 178.263 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 702' ' ' PHE . . . . . 0.444 ' CD1' ' HD2' ' A' ' 708' ' ' LYS . 91.9 m-85 -87.43 120.25 28.54 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.706 -0.479 . . . . 1.2 109.706 176.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -71.2 -11.3 60.86 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.161 0.505 . . . . 2.79 111.064 -174.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -88.24 -13.12 64.36 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.951 -0.643 . . . . 0.78000000000000003 113.122 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 705' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -150.78 -55.61 0.15 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 117.568 0.684 . . . . 2.6200000000000001 111.912 -177.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 706' ' ' GLY . . . . . . . . . . . . . . . 163.78 -167.79 38.05 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.606 -0.806 . . . . 0.5 112.266 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 707' ' ' ILE . . . . . 0.411 ' HA ' ' HA ' ' A' ' 701' ' ' ALA . 61.6 mt -78.02 141.85 14.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.73 0.3 . . . . 0.67000000000000004 110.383 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 708' ' ' LYS . . . . . 0.444 ' HD2' ' CD1' ' A' ' 702' ' ' PHE . 67.1 mttm -132.66 161.75 33.14 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.033 0.444 . . . . 1.3500000000000001 111.004 178.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 709' ' ' TRP . . . . . . . . . . . . . 20.5 p-90 -108.68 119.94 41.0 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.288 -0.869 . . . . 0.83999999999999997 109.124 174.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -120.12 115.13 23.07 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.436 -0.347 . . . . 0.44 110.416 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 48.3 t -66.5 109.42 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.026 -0.731 . . . . 0.60999999999999999 109.026 175.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 712' ' ' ALA . . . . . . . . . . . . . . . -45.42 -48.63 13.65 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 113.283 0.845 . . . . 0.91000000000000003 113.283 -168.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -66.24 -31.43 72.24 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.363 0.505 . . . . 1.1000000000000001 112.363 -175.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 714' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -97.99 -20.79 17.19 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.979 0.419 . . . . 1.96 110.77 -177.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 715' ' ' ALA . . . . . 0.526 ' HB1' ' CD2' ' A' ' 717' ' ' LEU . . . -72.44 -54.55 9.01 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.737 -0.665 . . . . 0.77000000000000002 110.777 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 716' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 57.17 76.43 0.32 Allowed 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.438 0.637 . . . . 4.4100000000000001 110.6 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 717' ' ' LEU . . . . . 0.526 ' CD2' ' HB1' ' A' ' 715' ' ' ALA . 4.4 mm? -97.19 142.4 29.15 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.607 -0.724 . . . . 0.84999999999999998 110.955 -178.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 718' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -101.89 130.32 48.34 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.678 -0.86 . . . . 2.1299999999999999 108.678 175.186 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 719' ' ' SER . . . . . . . . . . . . . 23.2 t -71.05 130.9 42.73 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.878 0.371 . . . . 1.6799999999999999 110.403 -177.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 720' ' ' VAL . . . . . 0.435 HG22 ' HB2' ' A' ' 677' ' ' ARG . 46.2 t . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.398 -0.81 . . . . 1.6399999999999999 110.627 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 670' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 . . . . . 0 N--CA 1.453 -0.287 0 CA-C-O 120.951 0.405 . . . . 1.4099999999999999 110.529 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 48.8 mtpt -128.54 155.86 44.21 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.876 -0.602 . . . . 2.7000000000000002 110.408 -178.372 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 672' ' ' LEU . . . . . 0.56 HD21 ' SD ' ' A' ' 689' ' ' MET . 52.0 mt -79.38 134.17 36.58 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.199 -0.455 . . . . 1.05 110.098 177.242 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 673' ' ' GLY . . . . . . . . . . . . . . . 88.9 15.36 59.54 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.856 -0.687 . . . . 0.64000000000000001 111.747 -175.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 674' ' ' GLN . . . . . . . . . . . . . 43.9 tp60 -94.49 144.79 25.28 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.286 -0.264 . . . . 2.2000000000000002 110.286 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 675' ' ' ARG . . . . . . . . . . . . . 19.5 mtm180 -92.0 124.74 36.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.229 -0.441 . . . . 4.0700000000000003 109.855 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 676' ' ' VAL . . . . . 0.449 ' HB ' HD12 ' A' ' 717' ' ' LEU . 29.0 m -117.91 154.56 19.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-O 120.792 0.33 . . . . 0.58999999999999997 110.935 -179.366 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 677' ' ' ARG . . . . . 0.547 ' HB2' HG22 ' A' ' 720' ' ' VAL . 28.3 ttt-85 -130.77 131.61 44.81 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.858 -0.61 . . . . 3.1499999999999999 109.812 178.521 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 678' ' ' HIS . . . . . 0.517 ' HB2' ' CD1' ' A' ' 717' ' ' LEU . 20.2 t60 -149.89 113.44 4.99 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.543 -0.54 . . . . 1.53 109.543 176.588 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 679' ' ' ALA . . . . . . . . . . . . . . . -49.79 -25.68 3.27 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 113.379 0.881 . . . . 1.24 113.379 -173.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 680' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -75.49 -33.19 60.76 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.762 -0.199 . . . . 2.9199999999999999 111.411 -174.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 681' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -125.75 -13.13 6.48 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.745 0.307 . . . . 1.5 111.821 -174.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 682' ' ' GLY . . . . . . . . . . . . . . . 104.75 -153.59 17.43 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.855 -0.688 . . . . 0.81999999999999995 111.786 -178.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 683' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -114.51 148.35 38.04 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.854 -0.425 . . . . 2.1099999999999999 109.854 178.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 684' ' ' GLY . . . . . . . . . . . . . . . -156.66 -178.71 31.03 Favored Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 119.784 -1.198 . . . . 0.38 112.848 -178.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 685' ' ' THR . . . . . . . . . . . . . 12.6 m -113.97 125.62 54.22 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 110.266 -0.272 . . . . 0.46999999999999997 110.266 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 46.4 mt -70.44 104.92 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.736 -0.468 . . . . 0.46999999999999997 109.736 177.344 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 687' ' ' VAL . . . . . . . . . . . . . 27.1 m -93.82 -23.93 5.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 120.978 0.418 . . . . 0.5 111.061 -177.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 688' ' ' ASN . . . . . 0.471 ' HB3' ' HB2' ' A' ' 699' ' ' GLN . 8.5 t30 -151.33 161.3 42.95 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.48 -0.563 . . . . 1.6200000000000001 109.48 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 689' ' ' MET . . . . . 0.56 ' SD ' HD21 ' A' ' 672' ' ' LEU . 0.0 OUTLIER -157.34 157.89 34.95 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 110.038 -0.356 . . . . 2.1699999999999999 110.038 178.616 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 690' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -125.2 122.29 36.59 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.631 -0.507 . . . . 2.02 109.631 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . 74.84 -169.34 54.52 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.821 -0.704 . . . . 1.05 112.422 -177.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 49.6 m -155.72 96.37 1.75 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.803 0.335 . . . . 2.1800000000000002 110.168 177.18 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 153.12 -130.14 2.92 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.902 -0.666 . . . . 1.3100000000000001 112.729 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 694' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -84.18 -57.61 3.1 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.579 0.585 . . . . 2.8500000000000001 112.579 -173.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 695' ' ' HIS . . . . . . . . . . . . . 16.2 p-80 -84.5 21.64 1.44 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.533 0.682 . . . . 3.0499999999999998 110.855 -174.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 696' ' ' SER . . . . . . . . . . . . . 14.3 m -84.77 152.74 23.46 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.095 -0.957 . . . . 1.5 110.513 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 697' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -116.04 145.28 43.12 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 110.151 -0.314 . . . . 2.54 110.151 176.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 16.6 mt -118.23 135.81 54.04 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.708 -0.479 . . . . 0.46000000000000002 109.708 178.056 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 699' ' ' GLN . . . . . 0.512 ' HA ' ' O ' ' A' ' 708' ' ' LYS . 24.6 mp0 -102.97 105.92 16.35 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.708 0.766 . . . . 2.2400000000000002 109.907 174.267 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 700' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 707' ' ' ILE . 27.3 t -104.23 125.23 59.02 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 114.545 -1.207 . . . . 0.22 110.69 -174.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -87.76 94.3 9.71 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.155 -0.475 . . . . 0.23000000000000001 109.742 175.347 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 702' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -75.94 132.71 40.42 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.014 -0.539 . . . . 1.2 110.203 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 63.1 tp60 -68.59 -25.17 64.74 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.556 -0.747 . . . . 2.79 111.174 -175.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -91.16 1.94 78.02 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.686 -0.768 . . . . 0.78000000000000003 113.264 -177.425 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 705' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -157.21 -80.04 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 117.176 0.488 . . . . 2.6200000000000001 111.421 177.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 706' ' ' GLY . . . . . . . . . . . . . . . 179.65 -157.44 20.39 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.432 -0.889 . . . . 0.5 112.459 -178.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 707' ' ' ILE . . . . . 0.459 ' HA ' ' O ' ' A' ' 700' ' ' VAL . 60.3 mt -80.88 135.95 24.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.781 0.324 . . . . 0.67000000000000004 111.039 -177.552 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 708' ' ' LYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 699' ' ' GLN . 63.8 mttm -135.86 159.4 41.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.87 -0.605 . . . . 1.3500000000000001 110.561 178.338 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 709' ' ' TRP . . . . . . . . . . . . . 12.3 p-90 -101.8 121.2 41.63 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.726 -0.67 . . . . 0.83999999999999997 109.568 177.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 710' ' ' LEU . . . . . 0.443 ' HB3' ' HB2' ' A' ' 715' ' ' ALA . 3.8 mm? -118.1 113.05 21.01 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.311 -0.404 . . . . 0.44 110.141 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 99.3 t -66.24 110.63 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.487 -0.56 . . . . 0.60999999999999999 109.487 175.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 712' ' ' ALA . . . . . . . . . . . . . . . -41.81 -47.12 4.09 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 113.874 1.065 . . . . 0.91000000000000003 113.874 -169.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -60.01 -35.75 75.75 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.49 0.552 . . . . 1.1000000000000001 112.49 -177.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 714' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -100.64 -13.62 18.47 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.28 0.562 . . . . 1.96 110.291 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 715' ' ' ALA . . . . . 0.624 ' HB1' ' CD2' ' A' ' 717' ' ' LEU . . . -70.65 -59.59 2.74 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.298 -0.864 . . . . 0.77000000000000002 110.397 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 716' ' ' ARG . . . . . . . . . . . . . 19.9 mtp180 50.23 66.65 1.09 Allowed 'General case' 0 N--CA 1.464 0.227 0 O-C-N 123.858 0.724 . . . . 4.4100000000000001 111.363 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 717' ' ' LEU . . . . . 0.624 ' CD2' ' HB1' ' A' ' 715' ' ' ALA . 4.1 mm? -87.94 140.28 29.66 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.168 0.509 . . . . 0.84999999999999998 111.396 -176.066 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 718' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -101.24 134.99 43.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.523 -0.762 . . . . 2.1299999999999999 108.988 174.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 719' ' ' SER . . . . . . . . . . . . . 20.6 t -78.04 133.72 37.9 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.691 0.281 . . . . 1.6799999999999999 110.65 -175.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 720' ' ' VAL . . . . . 0.547 HG22 ' HB2' ' A' ' 677' ' ' ARG . 16.9 t . . . . . 0 C--O 1.251 1.132 0 CA-C-O 118.461 -0.78 . . . . 1.6399999999999999 110.096 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 670' ' ' TYR . . . . . 0.441 ' CE1' ' HB2' ' A' ' 717' ' ' LEU . 72.7 m-85 . . . . . 0 N--CA 1.445 -0.678 0 CA-C-O 121.069 0.461 . . . . 1.4099999999999999 110.433 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -119.82 162.8 18.5 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.506 -0.77 . . . . 2.7000000000000002 110.281 -173.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 672' ' ' LEU . . . . . . . . . . . . . 30.3 mt -79.22 137.37 37.39 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.332 -0.395 . . . . 1.05 110.053 177.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 673' ' ' GLY . . . . . . . . . . . . . . . 86.82 -3.11 87.24 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.862 -0.685 . . . . 0.64000000000000001 111.523 -177.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 674' ' ' GLN . . . . . . . . . . . . . 57.8 tp60 -80.34 142.62 34.28 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.828 -0.434 . . . . 2.2000000000000002 109.828 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 675' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -101.95 133.27 47.0 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.016 -0.538 . . . . 4.0700000000000003 109.958 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 676' ' ' VAL . . . . . 0.472 ' HB ' ' HB3' ' A' ' 717' ' ' LEU . 28.8 m -121.08 152.03 24.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 115.727 -0.669 . . . . 0.58999999999999997 111.022 -175.048 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 677' ' ' ARG . . . . . 0.458 ' HB2' HG22 ' A' ' 720' ' ' VAL . 27.9 ttp85 -123.3 123.59 41.08 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.963 -0.755 . . . . 3.1499999999999999 108.963 176.356 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 678' ' ' HIS . . . . . 0.537 ' HB2' ' CD1' ' A' ' 717' ' ' LEU . 52.6 t60 -128.89 122.68 30.83 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 110.05 -0.352 . . . . 1.53 110.05 -179.231 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 679' ' ' ALA . . . . . . . . . . . . . . . -40.92 -45.85 2.64 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.545 0.943 . . . . 1.24 113.545 -172.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 680' ' ' LYS . . . . . . . . . . . . . 31.0 mtpt -92.62 -27.43 17.33 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.659 -0.7 . . . . 2.9199999999999999 112.819 -168.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 681' ' ' PHE . . . . . . . . . . . . . 20.3 m-30 -106.29 -12.34 15.73 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.02 0.378 . . . . 1.5 112.02 -176.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 682' ' ' GLY . . . . . . . . . . . . . . . 90.08 -155.39 24.43 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.373 -0.918 . . . . 0.81999999999999995 111.206 -174.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 683' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -111.91 152.67 27.74 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 117.116 0.458 . . . . 2.1099999999999999 110.844 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 684' ' ' GLY . . . . . . . . . . . . . . . -157.18 -177.32 30.19 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 121.004 -0.617 . . . . 0.38 111.78 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 685' ' ' THR . . . . . . . . . . . . . 41.8 m -118.43 125.8 50.71 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.771 0.32 . . . . 0.46999999999999997 110.991 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 686' ' ' ILE . . . . . 0.438 HG12 HG22 ' A' ' 700' ' ' VAL . 44.3 mt -71.57 110.23 4.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 120.805 0.336 . . . . 0.46999999999999997 110.179 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 687' ' ' VAL . . . . . . . . . . . . . 30.1 m -97.07 -27.61 3.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.487 -0.324 . . . . 0.5 111.642 -176.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -149.66 158.2 43.95 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.067 -0.346 . . . . 1.6200000000000001 110.067 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 689' ' ' MET . . . . . . . . . . . . . 5.2 ppp? -150.8 143.02 24.18 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.021 -0.536 . . . . 2.1699999999999999 109.666 178.293 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 690' ' ' GLU . . . . . 0.45 ' O ' ' HA ' ' A' ' 696' ' ' SER . 45.0 mt-10 -121.54 140.94 51.57 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.965 -0.561 . . . . 2.02 110.893 -174.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . 68.13 -157.9 52.28 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 121.053 -0.594 . . . . 1.05 112.73 176.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 52.0 m -155.06 136.66 14.28 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.715 0.293 . . . . 2.1800000000000002 110.561 178.298 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 83.51 -138.66 17.96 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 121.082 -0.58 . . . . 1.3100000000000001 112.873 176.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 694' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -63.36 -37.17 86.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.898 0.38 . . . . 2.8500000000000001 110.9 -178.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 695' ' ' HIS . . . . . . . . . . . . . 33.6 t-80 -86.79 15.75 5.48 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.267 0.556 . . . . 3.0499999999999998 110.674 -177.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 696' ' ' SER . . . . . 0.45 ' HA ' ' O ' ' A' ' 690' ' ' GLU . 19.6 t -92.78 142.17 27.64 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.939 0.399 . . . . 1.5 110.417 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 697' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -123.64 134.82 53.7 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.617 -0.512 . . . . 2.54 109.617 174.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 8.6 mt -108.21 133.53 52.33 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 109.649 -0.5 . . . . 0.46000000000000002 109.649 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 699' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -101.8 106.02 16.95 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.418 0.628 . . . . 2.2400000000000002 110.017 174.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 700' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 707' ' ' ILE . 40.0 t -99.28 123.33 51.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.097 -0.956 . . . . 0.22 110.598 -176.581 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -82.86 94.95 7.79 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.767 -0.651 . . . . 0.23000000000000001 109.823 176.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 702' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -76.11 126.36 30.86 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.622 -0.717 . . . . 1.2 109.966 178.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -64.74 -18.55 65.14 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.716 -0.674 . . . . 2.79 112.041 -173.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -134.92 40.27 1.58 Allowed Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.472 -0.87 . . . . 0.78000000000000003 112.457 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 705' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -166.78 -23.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.836 0.35 . . . . 2.6200000000000001 111.029 -178.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 706' ' ' GLY . . . . . . . . . . . . . . . 101.38 -169.4 20.52 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.546 -0.835 . . . . 0.5 112.038 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 707' ' ' ILE . . . . . 0.519 ' C ' ' HE2' ' A' ' 708' ' ' LYS . 47.0 mt -89.26 117.34 32.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 O-C-N 122.564 -0.374 . . . . 0.67000000000000004 110.88 -178.305 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 708' ' ' LYS . . . . . 0.519 ' HE2' ' C ' ' A' ' 707' ' ' ILE . 0.4 OUTLIER -108.74 165.22 11.72 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.299 -0.41 . . . . 1.3500000000000001 110.265 176.794 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 709' ' ' TRP . . . . . . . . . . . . . 8.1 p-90 -104.91 119.96 40.27 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.706 -0.679 . . . . 0.83999999999999997 109.858 177.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -115.85 109.84 18.2 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.176 -0.465 . . . . 0.44 110.425 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 57.8 t -61.59 119.24 5.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.395 -0.594 . . . . 0.60999999999999999 109.395 174.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 712' ' ' ALA . . . . . . . . . . . . . . . -54.99 -25.38 29.48 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.925 0.713 . . . . 0.91000000000000003 112.925 -172.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -71.02 -25.66 62.77 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.855 0.36 . . . . 1.1000000000000001 111.6 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 714' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -129.22 16.09 6.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.351 -0.386 . . . . 1.96 110.521 -177.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 715' ' ' ALA . . . . . 0.532 ' HB1' ' CD2' ' A' ' 717' ' ' LEU . . . -70.18 -58.14 4.12 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.078 -0.51 . . . . 0.77000000000000002 111.101 -175.364 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 716' ' ' ARG . . . . . . . . . . . . . 74.3 mtt180 57.06 62.14 2.33 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.208 0.528 . . . . 4.4100000000000001 111.177 175.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 717' ' ' LEU . . . . . 0.537 ' CD1' ' HB2' ' A' ' 678' ' ' HIS . 3.1 mm? -102.55 129.67 49.17 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.108 -0.496 . . . . 0.84999999999999998 110.761 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 718' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -93.1 115.16 27.83 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.969 -0.752 . . . . 2.1299999999999999 108.969 175.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 719' ' ' SER . . . . . . . . . . . . . 1.5 p -62.21 135.01 57.3 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.884 0.373 . . . . 1.6799999999999999 111.007 -177.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 720' ' ' VAL . . . . . 0.458 HG22 ' HB2' ' A' ' 677' ' ' ARG . 3.4 t . . . . . 0 C--O 1.251 1.167 0 CA-C-O 118.389 -0.815 . . . . 1.6399999999999999 109.705 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 3.1 ptp180 . . . . . 0 N--CA 1.484 1.264 0 CA-C-O 120.661 0.267 . . . . 27.27 111.376 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 646' ' ' LEU . . . . . . . . . . . . . 27.5 tp 53.09 52.95 12.75 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.983 -0.553 . . . . 26.57 111.205 178.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 647' ' ' ARG . . . . . . . . . . . . . 26.2 ptt180 -70.28 140.82 52.4 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.319 -0.4 . . . . 24.57 110.458 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 648' ' ' ALA . . . . . . . . . . . . . . . -88.09 76.29 8.55 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.097 0.475 . . . . 23.82 110.925 -178.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 649' ' ' THR . . . . . . . . . . . . . 14.1 t -107.46 -179.75 4.01 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.945 -0.57 . . . . 23.239999999999998 110.013 178.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 650' ' ' VAL . . . . . . . . . . . . . 29.7 m -69.75 136.31 26.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.109 0.481 . . . . 23.34 110.889 -178.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 651' ' ' SER . . . . . . . . . . . . . 49.9 m -85.56 -13.29 49.33 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.078 -0.51 . . . . 21.93 110.203 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 652' ' ' ARG . . . . . 0.403 ' HA ' ' HD3' ' A' ' 653' ' ' PRO . 13.0 tpt180 -79.37 132.4 62.59 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 109.031 -0.729 . . . . 21.539999999999999 109.031 175.556 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 653' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 652' ' ' ARG . 12.8 Cg_exo -70.4 66.32 2.15 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.706 2.27 . . . . 19.800000000000001 112.418 178.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 654' ' ' VAL . . . . . . . . . . . . . 8.5 p -138.72 137.94 42.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.957 -0.565 . . . . 20.260000000000002 110.157 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 655' ' ' SER . . . . . . . . . . . . . 14.9 t -69.03 126.86 31.13 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.275 -0.639 . . . . 18.239999999999998 109.275 176.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 656' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -68.13 101.49 1.17 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.699 0.761 . . . . 16.629999999999999 110.207 -178.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 657' ' ' GLN . . . . . 0.605 ' O ' ' HD3' ' A' ' 716' ' ' ARG . 53.1 mt-30 -106.22 137.34 44.33 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.334 -0.848 . . . . 17.75 109.886 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 658' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -170.3 164.16 8.88 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.439 -0.578 . . . . 15.35 109.439 -178.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 659' ' ' MET . . . . . . . . . . . . . 54.1 ttm -73.91 96.49 2.62 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.702 -0.481 . . . . 14.949999999999999 109.702 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . 134.96 10.77 1.49 Allowed Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.774 -0.648 . . . . 12.49 112.216 -175.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 661' ' ' THR . . . . . . . . . . . . . 6.9 p -72.94 144.7 85.62 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.609 0.243 . . . . 10.68 111.079 177.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 662' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -73.57 49.88 1.89 Allowed 'Trans proline' 0 CA--C 1.531 0.344 0 C-N-CA 123.074 2.516 . . . . 10.300000000000001 112.474 178.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 663' ' ' MET . . . . . . . . . . . . . 25.4 ttt -92.75 127.49 38.27 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.785 -0.643 . . . . 9.4100000000000001 109.994 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 664' ' ' VAL . . . . . . . . . . . . . 43.1 t -65.42 126.86 25.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.127 -0.488 . . . . 7.04 110.098 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 665' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 60.41 46.59 9.69 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.745 -0.661 . . . . 7.0700000000000003 110.712 -175.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 666' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -65.82 145.74 55.59 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.675 -0.693 . . . . 6.7999999999999998 109.938 177.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 667' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -80.67 152.91 28.21 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.069 0.462 . . . . 5.4900000000000002 110.735 -176.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 668' ' ' SER . . . . . . . . . . . . . 47.3 m -112.67 31.42 6.37 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.855 -0.795 . . . . 4.7199999999999998 108.855 173.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 669' ' ' GLY . . . . . . . . . . . . . . . 142.37 126.44 2.1 Favored Glycine 0 N--CA 1.438 -1.17 0 CA-C-N 114.801 -1.09 . . . . 1.8700000000000001 110.854 -173.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 670' ' ' TYR . . . . . 0.44 ' CD2' HD11 ' A' ' 698' ' ' LEU . 85.8 m-85 -67.05 144.51 56.11 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.081 0.467 . . . . 1.4099999999999999 111.465 -176.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -106.82 151.27 25.42 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.579 -0.737 . . . . 2.7000000000000002 110.234 -175.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 672' ' ' LEU . . . . . . . . . . . . . 41.8 mt -76.0 136.28 39.99 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.025 0.44 . . . . 1.05 111.053 -176.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 673' ' ' GLY . . . . . . . . . . . . . . . 96.9 -3.08 62.27 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.601 -0.727 . . . . 0.64000000000000001 112.167 -178.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 674' ' ' GLN . . . . . . . . . . . . . 59.6 tp60 -79.14 145.52 33.67 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.001 0.429 . . . . 2.2000000000000002 110.385 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 675' ' ' ARG . . . . . . . . . . . . . 23.4 mmt180 -97.38 126.22 42.48 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.54 -0.754 . . . . 4.0700000000000003 109.086 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 676' ' ' VAL . . . . . 0.444 ' HB ' HD12 ' A' ' 717' ' ' LEU . 35.7 m -117.17 162.1 15.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 120.828 0.347 . . . . 0.58999999999999997 111.443 -175.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 677' ' ' ARG . . . . . 0.428 ' HB2' HG22 ' A' ' 720' ' ' VAL . 47.5 ttt180 -138.59 125.86 21.61 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.539 -0.755 . . . . 3.1499999999999999 109.753 -176.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 678' ' ' HIS . . . . . 0.484 ' CD2' HD13 ' A' ' 717' ' ' LEU . 0.0 OUTLIER -147.5 132.65 18.33 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 110.423 -0.214 . . . . 1.53 110.423 178.092 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 679' ' ' ALA . . . . . . . . . . . . . . . -66.45 -14.57 62.39 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.938 0.399 . . . . 1.24 111.95 -176.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 680' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -82.84 -37.78 23.94 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.142 -0.481 . . . . 2.9199999999999999 111.963 -178.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 681' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -125.25 -11.8 6.91 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.043 0.386 . . . . 1.5 112.043 -171.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 682' ' ' GLY . . . . . . . . . . . . . . . 98.97 -152.71 19.7 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.294 -0.722 . . . . 0.81999999999999995 111.294 -175.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 683' ' ' GLU . . . . . 0.406 ' H ' ' CD ' ' A' ' 683' ' ' GLU . 0.2 OUTLIER -104.74 147.19 27.96 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.526 -0.546 . . . . 2.1099999999999999 109.526 178.213 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 684' ' ' GLY . . . . . . . . . . . . . . . -151.6 173.67 30.88 Favored Glycine 0 N--CA 1.441 -0.967 0 C-N-CA 119.641 -1.266 . . . . 0.38 112.464 -177.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 685' ' ' THR . . . . . . . . . . . . . 35.2 m -118.44 124.3 47.31 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.941 -0.392 . . . . 0.46999999999999997 109.941 176.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 35.5 mt -72.33 104.88 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.2 -0.455 . . . . 0.46999999999999997 109.837 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 687' ' ' VAL . . . . . . . . . . . . . 28.7 m -94.9 -23.81 5.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.302 -0.408 . . . . 0.5 111.512 -175.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 688' ' ' ASN . . . . . 0.446 ' HB3' ' HB2' ' A' ' 699' ' ' GLN . 63.0 t30 -151.24 165.0 35.31 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.466 -0.334 . . . . 1.6200000000000001 110.196 -178.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 689' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.59 156.59 38.26 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.464 -0.569 . . . . 2.1699999999999999 109.464 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 690' ' ' GLU . . . . . 0.476 ' O ' ' HA ' ' A' ' 696' ' ' SER . 45.9 mt-10 -125.95 123.76 39.26 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.539 -0.3 . . . . 2.02 110.752 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . 69.28 -160.96 52.53 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 121.083 -0.58 . . . . 1.05 112.728 178.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 66.9 m -152.03 157.43 41.66 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.257 -0.275 . . . . 2.1800000000000002 110.257 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 89.67 -142.39 16.61 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.835 -0.698 . . . . 1.3100000000000001 112.313 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 694' ' ' GLU . . . . . 0.401 ' HA ' ' HB2' ' A' ' 713' ' ' ALA . 41.7 mt-10 -74.04 -31.46 62.9 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.042 0.449 . . . . 2.8500000000000001 110.635 -178.125 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 695' ' ' HIS . . . . . . . . . . . . . 35.4 m170 -91.6 16.11 11.19 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.813 -0.631 . . . . 3.0499999999999998 110.661 -176.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 696' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 690' ' ' GLU . 20.8 t -81.97 130.47 35.09 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.437 -0.579 . . . . 1.5 109.437 177.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 697' ' ' ARG . . . . . . . . . . . . . 23.9 mtm180 -114.51 133.72 55.56 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.226 -0.657 . . . . 2.54 109.226 177.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 698' ' ' LEU . . . . . 0.44 HD11 ' CD2' ' A' ' 670' ' ' TYR . 9.3 mt -106.14 130.65 53.99 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 120.632 0.253 . . . . 0.46000000000000002 110.449 -177.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 699' ' ' GLN . . . . . 0.487 ' HA ' ' O ' ' A' ' 708' ' ' LYS . 3.8 mp0 -95.55 100.63 12.35 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.754 0.788 . . . . 2.2400000000000002 109.264 175.163 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 700' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' A' ' 707' ' ' ILE . 19.5 t -101.71 124.14 55.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 114.729 -1.123 . . . . 0.22 110.815 -172.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -84.83 94.82 8.81 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.233 -0.439 . . . . 0.23000000000000001 110.16 177.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 702' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -78.64 122.56 26.1 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.677 -0.49 . . . . 1.2 109.677 177.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -69.15 -13.19 62.28 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.941 -0.572 . . . . 2.79 111.468 -174.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -101.06 8.68 57.65 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.749 -0.739 . . . . 0.78000000000000003 112.612 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 705' ' ' GLN . . . . . . . . . . . . . 23.2 tp60 -158.45 -75.64 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.958 0.379 . . . . 2.6200000000000001 111.047 178.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 706' ' ' GLY . . . . . . . . . . . . . . . 170.36 -167.02 40.19 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 121.013 -0.613 . . . . 0.5 112.025 -178.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 707' ' ' ILE . . . . . 0.493 ' HA ' ' O ' ' A' ' 700' ' ' VAL . 71.4 mt -79.53 126.22 39.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.158 0.504 . . . . 0.67000000000000004 110.796 -178.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 708' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 699' ' ' GLN . 63.6 mttm -125.77 159.4 32.46 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.785 -0.643 . . . . 1.3500000000000001 110.693 -179.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 709' ' ' TRP . . . . . . . . . . . . . 14.6 p-90 -100.7 116.28 32.23 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.945 -0.57 . . . . 0.83999999999999997 110.265 178.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -117.76 114.38 23.22 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.016 -0.538 . . . . 0.44 110.206 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 46.5 t -63.86 110.06 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.589 -0.522 . . . . 0.60999999999999999 109.589 177.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 712' ' ' ALA . . . . . . . . . . . . . . . -45.15 -43.24 9.74 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 113.502 0.927 . . . . 0.91000000000000003 113.502 -168.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 713' ' ' ALA . . . . . 0.401 ' HB2' ' HA ' ' A' ' 694' ' ' GLU . . . -64.18 -36.99 85.84 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 111.975 0.361 . . . . 1.1000000000000001 111.975 -177.252 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 714' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -102.5 -9.79 19.91 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.967 0.413 . . . . 1.96 110.815 -177.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 715' ' ' ALA . . . . . 0.474 ' HB1' ' CD2' ' A' ' 717' ' ' LEU . . . -67.74 -62.6 1.33 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.801 -0.636 . . . . 0.77000000000000002 109.941 178.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 716' ' ' ARG . . . . . 0.605 ' HD3' ' O ' ' A' ' 657' ' ' GLN . 59.9 mtt180 56.03 66.4 1.21 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.506 0.67 . . . . 4.4100000000000001 110.52 175.074 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 717' ' ' LEU . . . . . 0.484 HD13 ' CD2' ' A' ' 678' ' ' HIS . 4.6 mm? -89.21 145.15 25.6 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.189 -0.914 . . . . 0.84999999999999998 110.334 -177.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 718' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -97.27 134.68 40.24 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.211 -0.663 . . . . 2.1299999999999999 109.211 176.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 719' ' ' SER . . . . . . . . . . . . . 13.5 m -75.81 128.37 34.99 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.58 -0.282 . . . . 1.6799999999999999 110.43 -178.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 720' ' ' VAL . . . . . 0.428 HG22 ' HB2' ' A' ' 677' ' ' ARG . 17.6 t . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.498 -0.763 . . . . 1.6399999999999999 109.77 177.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 . . . . . 0 N--CA 1.483 1.193 0 N-CA-C 110.013 -0.366 . . . . 27.27 110.013 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 646' ' ' LEU . . . . . . . . . . . . . 43.4 mt -124.3 105.43 9.46 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.614 0.245 . . . . 26.57 110.853 -174.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 647' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 -83.14 -54.12 5.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.151 0.5 . . . . 24.57 110.332 177.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 648' ' ' ALA . . . . . . . . . . . . . . . -147.97 54.76 1.04 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.658 -0.701 . . . . 23.82 109.139 178.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 649' ' ' THR . . . . . . . . . . . . . 11.8 m -87.97 105.61 17.57 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.358 -0.837 . . . . 23.239999999999998 111.315 -174.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 650' ' ' VAL . . . . . . . . . . . . . 60.9 t 70.75 -73.59 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 115.261 -0.881 . . . . 23.34 112.081 176.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 651' ' ' SER . . . . . . . . . . . . . 32.9 t -155.44 137.96 15.03 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.888 0.375 . . . . 21.93 110.952 -176.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 652' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -162.83 145.52 8.35 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.606 -0.725 . . . . 21.539999999999999 109.07 174.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 653' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_exo -52.09 111.92 0.73 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.046 2.497 . . . . 19.800000000000001 112.363 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 654' ' ' VAL . . . . . . . . . . . . . 26.4 t 57.58 78.14 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 115.362 -0.835 . . . . 20.260000000000002 110.714 -177.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 655' ' ' SER . . . . . . . . . . . . . 18.8 m -75.54 132.03 40.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.955 -0.566 . . . . 18.239999999999998 109.505 177.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 656' ' ' HIS . . . . . . . . . . . . . 42.8 m80 -99.84 101.62 12.81 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.971 0.415 . . . . 16.629999999999999 110.548 -178.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 657' ' ' GLN . . . . . . . . . . . . . 25.6 mp0 -73.59 -39.78 64.35 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.816 -0.629 . . . . 17.75 110.505 -178.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 658' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -115.08 30.66 7.21 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.759 -0.655 . . . . 15.35 110.466 -178.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 659' ' ' MET . . . . . . . . . . . . . 65.3 mtt 62.15 -162.35 0.28 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.383 -0.826 . . . . 14.949999999999999 110.978 178.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . 149.58 -31.59 1.13 Allowed Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.776 -0.726 . . . . 12.49 112.239 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 661' ' ' THR . . . . . . . . . . . . . 12.1 p -88.62 128.58 52.13 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-O 120.586 0.231 . . . . 10.68 110.858 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 662' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -68.78 113.42 3.2 Favored 'Trans proline' 0 C--O 1.233 0.269 0 C-N-CA 122.616 2.211 . . . . 10.300000000000001 111.917 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 663' ' ' MET . . . . . . . . . . . . . 48.3 ttp -83.99 46.64 1.21 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.724 0.773 . . . . 9.4100000000000001 110.03 -178.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 664' ' ' VAL . . . . . . . . . . . . . 4.2 p -81.8 90.49 2.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 122.041 0.924 . . . . 7.04 110.412 -178.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 665' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -156.28 145.73 20.78 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.426 -0.806 . . . . 7.0700000000000003 110.931 -176.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 666' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -101.97 91.38 4.32 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.771 -0.825 . . . . 6.7999999999999998 108.771 173.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 667' ' ' ASP . . . . . 0.405 ' HB3' ' CE1' ' A' ' 670' ' ' TYR . 51.6 m-20 71.92 121.9 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 O-C-N 124.055 0.847 . . . . 5.4900000000000002 110.494 -176.478 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 668' ' ' SER . . . . . . . . . . . . . 16.7 m -62.21 -31.37 71.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.525 -0.762 . . . . 4.7199999999999998 111.611 -175.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 669' ' ' GLY . . . . . . . . . . . . . . . 139.32 111.05 0.94 Allowed Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.463 -0.875 . . . . 1.8700000000000001 112.414 177.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 670' ' ' TYR . . . . . 0.405 ' CE1' ' HB3' ' A' ' 667' ' ' ASP . 77.0 m-85 -95.3 146.21 24.53 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 110.113 -0.329 . . . . 1.4099999999999999 110.113 178.309 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 671' ' ' LYS . . . . . 0.437 ' HG2' ' HB2' ' A' ' 674' ' ' GLN . 20.7 pttp -138.86 160.2 40.3 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.313 -0.625 . . . . 2.7000000000000002 109.313 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 672' ' ' LEU . . . . . . . . . . . . . 29.7 mt -72.08 133.08 45.02 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.962 -0.384 . . . . 1.05 109.962 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 673' ' ' GLY . . . . . . . . . . . . . . . 86.94 8.17 76.44 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.791 -0.719 . . . . 0.64000000000000001 111.764 -175.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 674' ' ' GLN . . . . . 0.437 ' HB2' ' HG2' ' A' ' 671' ' ' LYS . 33.2 tt0 -85.87 142.86 28.58 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.949 -0.389 . . . . 2.2000000000000002 109.949 178.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 675' ' ' ARG . . . . . 0.473 ' N ' ' HD2' ' A' ' 675' ' ' ARG . 3.7 mpt_? -100.78 127.48 47.19 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.147 0.499 . . . . 4.0700000000000003 110.328 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 676' ' ' VAL . . . . . 0.503 ' HB ' ' HB3' ' A' ' 717' ' ' LEU . 27.1 m -117.23 154.1 18.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.587 -0.733 . . . . 0.58999999999999997 110.917 -177.088 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 677' ' ' ARG . . . . . 0.425 ' CG ' ' HB3' ' A' ' 683' ' ' GLU . 26.9 mtt180 -127.18 136.95 52.77 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.996 -0.547 . . . . 3.1499999999999999 110.957 177.262 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -138.94 142.59 38.43 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.503 -0.772 . . . . 1.53 109.333 172.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 679' ' ' ALA . . . . . . . . . . . . . . . -49.46 -52.47 28.87 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.612 0.597 . . . . 1.24 112.612 -172.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 680' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -91.07 -37.05 13.66 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.47 -0.332 . . . . 2.9199999999999999 111.809 -170.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 681' ' ' PHE . . . . . . . . . . . . . 9.3 m-30 -81.2 -11.32 59.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.841 0.353 . . . . 1.5 111.273 -178.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 682' ' ' GLY . . . . . . . . . . . . . . . 86.32 -111.84 3.67 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.508 -0.853 . . . . 0.81999999999999995 111.636 178.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 683' ' ' GLU . . . . . 0.425 ' HB3' ' CG ' ' A' ' 677' ' ' ARG . 10.4 pt-20 -155.66 148.43 24.2 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.725 0.298 . . . . 2.1099999999999999 110.443 178.209 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 684' ' ' GLY . . . . . . . . . . . . . . . -152.41 -177.31 25.94 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.647 -0.787 . . . . 0.38 111.531 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 685' ' ' THR . . . . . . . . . . . . . 58.5 m -119.44 130.14 55.11 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.827 0.346 . . . . 0.46999999999999997 110.414 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 686' ' ' ILE . . . . . 0.438 HG12 HG22 ' A' ' 700' ' ' VAL . 48.8 mt -73.86 104.61 2.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.082 -0.508 . . . . 0.46999999999999997 110.123 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 687' ' ' VAL . . . . . . . . . . . . . 30.3 m -89.63 -26.12 5.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.416 -0.356 . . . . 0.5 111.018 -177.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -152.42 162.41 41.22 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.361 -0.382 . . . . 1.6200000000000001 110.482 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 689' ' ' MET . . . . . . . . . . . . . 22.1 ptp -147.1 146.18 29.86 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.03 -0.532 . . . . 2.1699999999999999 109.905 178.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 690' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -120.81 156.01 32.83 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.882 -0.599 . . . . 2.02 109.832 -176.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . 80.62 -169.42 52.34 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.57 -0.824 . . . . 1.05 111.791 -178.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 21.2 p -157.73 99.86 1.73 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.665 0.269 . . . . 2.1800000000000002 110.368 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 118.74 -136.84 12.39 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.426 -0.892 . . . . 1.3100000000000001 112.555 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 694' ' ' GLU . . . . . 0.459 ' O ' ' HB2' ' A' ' 713' ' ' ALA . 45.2 tt0 -64.38 -53.18 52.56 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.747 0.308 . . . . 2.8500000000000001 111.573 -175.56 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 695' ' ' HIS . . . . . . . . . . . . . 41.9 m-70 -85.24 37.37 0.67 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.862 0.363 . . . . 3.0499999999999998 111.904 -175.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 696' ' ' SER . . . . . . . . . . . . . 16.9 p -81.67 151.32 27.62 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 110.004 -0.369 . . . . 1.5 110.004 177.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 697' ' ' ARG . . . . . . . . . . . . . 32.2 mtm180 -121.47 129.51 53.0 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.646 -0.501 . . . . 2.54 109.646 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 14.3 mt -101.65 138.87 38.06 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 110.275 -0.268 . . . . 0.46000000000000002 110.275 -177.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 699' ' ' GLN . . . . . 0.499 ' HA ' ' O ' ' A' ' 708' ' ' LYS . 12.7 mp0 -103.84 103.93 13.86 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.562 0.696 . . . . 2.2400000000000002 109.278 173.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 700' ' ' VAL . . . . . 0.438 HG22 HG12 ' A' ' 686' ' ' ILE . 38.7 t -101.74 123.07 54.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 114.729 -1.123 . . . . 0.22 110.75 -172.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -83.12 94.31 7.8 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.199 -0.455 . . . . 0.23000000000000001 110.569 178.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 702' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -81.02 126.67 31.69 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.46 -0.57 . . . . 1.2 109.46 175.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -70.55 -17.27 62.93 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.141 -0.481 . . . . 2.79 110.619 -176.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -82.76 -11.24 81.97 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.895 -0.669 . . . . 0.78000000000000003 113.21 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 705' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -153.55 -68.54 0.15 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 117.294 0.547 . . . . 2.6200000000000001 111.652 -178.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 706' ' ' GLY . . . . . . . . . . . . . . . 173.15 -165.87 38.2 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.519 -0.848 . . . . 0.5 112.437 -178.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 707' ' ' ILE . . . . . 0.408 ' HA ' ' O ' ' A' ' 700' ' ' VAL . 61.5 mt -79.56 120.34 30.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.931 0.396 . . . . 0.67000000000000004 110.758 -178.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 708' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 699' ' ' GLN . 96.1 mttt -114.54 159.47 20.35 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.108 -0.497 . . . . 1.3500000000000001 111.375 -177.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 709' ' ' TRP . . . . . . . . . . . . . 24.3 p-90 -98.37 118.61 35.42 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.253 -0.885 . . . . 0.83999999999999997 110.162 178.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -121.1 109.45 15.03 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.123 -0.49 . . . . 0.44 110.273 178.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 48.4 t -66.82 106.06 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.25 -0.648 . . . . 0.60999999999999999 109.25 176.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 712' ' ' ALA . . . . . . . . . . . . . . . -48.13 -47.01 34.95 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.995 0.739 . . . . 0.91000000000000003 112.995 -167.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 713' ' ' ALA . . . . . 0.459 ' HB2' ' O ' ' A' ' 694' ' ' GLU . . . -62.07 -18.11 59.62 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.606 0.595 . . . . 1.1000000000000001 112.606 -176.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 714' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -126.57 9.03 7.07 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.145 0.497 . . . . 1.96 110.388 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 715' ' ' ALA . . . . . 0.503 ' HB1' ' CD2' ' A' ' 717' ' ' LEU . . . -93.2 -52.39 4.57 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.851 -0.613 . . . . 0.77000000000000002 110.43 -179.009 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 716' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 53.67 73.99 0.34 Allowed 'General case' 0 C--O 1.232 0.17 0 O-C-N 123.778 0.674 . . . . 4.4100000000000001 110.683 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 717' ' ' LEU . . . . . 0.503 ' CD2' ' HB1' ' A' ' 715' ' ' ALA . 3.9 mm? -97.05 130.4 44.36 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.12 -0.491 . . . . 0.84999999999999998 110.562 -178.459 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 718' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -81.56 144.24 31.43 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.0 -0.545 . . . . 2.1299999999999999 109.948 -178.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 719' ' ' SER . . . . . . . . . . . . . 10.4 p -82.13 119.91 24.64 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.978 -0.555 . . . . 1.6799999999999999 110.774 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 720' ' ' VAL . . . . . 0.419 HG22 ' HG3' ' A' ' 677' ' ' ARG . 56.7 t . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.416 -0.802 . . . . 1.6399999999999999 110.346 176.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 28.4 tpt180 . . . . . 0 N--CA 1.485 1.281 0 CA-C-O 120.471 0.177 . . . . 27.27 111.101 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 646' ' ' LEU . . . . . . . . . . . . . 64.4 tp -68.17 -62.83 1.22 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.64 0.257 . . . . 26.57 111.289 -175.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 647' ' ' ARG . . . . . . . . . . . . . 33.8 ptt180 -90.23 32.52 0.93 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.326 0.584 . . . . 24.57 110.378 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 648' ' ' ALA . . . . . . . . . . . . . . . -84.45 107.97 17.0 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.9 -0.591 . . . . 23.82 110.276 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 649' ' ' THR . . . . . . . . . . . . . 7.7 m -83.46 61.68 6.34 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.504 0.668 . . . . 23.239999999999998 109.998 178.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 650' ' ' VAL . . . . . . . . . . . . . 46.9 t -85.65 85.95 2.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.733 -0.667 . . . . 23.34 109.824 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 651' ' ' SER . . . . . . . . . . . . . 64.0 m -87.74 31.93 0.75 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.342 0.592 . . . . 21.93 110.651 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 652' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -106.79 114.66 61.5 Favored Pre-proline 0 N--CA 1.448 -0.532 0 CA-C-N 115.429 -0.805 . . . . 21.539999999999999 110.022 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 653' ' ' PRO . . . . . 0.452 ' O ' ' HB ' ' A' ' 654' ' ' VAL . 41.6 Cg_endo -67.81 163.43 35.45 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.564 2.176 . . . . 19.800000000000001 111.508 178.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 654' ' ' VAL . . . . . 0.452 ' HB ' ' O ' ' A' ' 653' ' ' PRO . 95.6 t 76.06 -32.37 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 122.857 0.463 . . . . 20.260000000000002 111.467 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 655' ' ' SER . . . . . 0.4 ' H ' ' C ' ' A' ' 653' ' ' PRO . 9.9 t -79.31 84.53 5.23 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.352 0.596 . . . . 18.239999999999998 110.961 -177.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 656' ' ' HIS . . . . . . . . . . . . . 18.6 p80 -94.97 147.38 23.46 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.195 -0.669 . . . . 16.629999999999999 109.195 175.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 657' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 57.32 62.5 2.16 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 121.512 0.672 . . . . 17.75 109.463 -175.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 658' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -91.38 65.9 5.4 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.885 -0.598 . . . . 15.35 110.25 -176.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 659' ' ' MET . . . . . . . . . . . . . 13.8 tpt -95.78 -30.43 13.71 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.158 0.504 . . . . 14.949999999999999 109.971 176.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . -169.48 -165.62 27.16 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 111.266 -0.734 . . . . 12.49 111.266 177.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 661' ' ' THR . . . . . 0.412 ' HA ' ' HD2' ' A' ' 662' ' ' PRO . 2.1 p -115.12 106.72 50.93 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 116.72 0.26 . . . . 10.68 111.014 177.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 662' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 661' ' ' THR . 38.4 Cg_endo -67.56 -21.8 45.53 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.676 2.251 . . . . 10.300000000000001 112.284 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 663' ' ' MET . . . . . . . . . . . . . 23.8 mmt -127.71 132.67 49.59 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.307 -0.627 . . . . 9.4100000000000001 109.307 177.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 664' ' ' VAL . . . . . 0.504 HG23 ' H ' ' A' ' 665' ' ' GLU . 2.4 m -111.96 -63.85 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 112.018 0.377 . . . . 7.04 112.018 -177.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 665' ' ' GLU . . . . . 0.504 ' H ' HG23 ' A' ' 664' ' ' VAL . 2.7 mp0 50.44 59.54 4.5 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.11 0.481 . . . . 7.0700000000000003 110.744 -177.209 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 666' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -124.41 -167.53 1.67 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.955 -0.566 . . . . 6.7999999999999998 109.734 -176.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 667' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.65 170.95 3.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.033 0.444 . . . . 5.4900000000000002 111.192 178.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 668' ' ' SER . . . . . . . . . . . . . 23.6 t -80.17 -22.77 41.6 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.12 -0.491 . . . . 4.7199999999999998 110.09 178.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 669' ' ' GLY . . . . . . . . . . . . . . . -102.27 -168.37 26.87 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.867 -0.682 . . . . 1.8700000000000001 111.674 177.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 670' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -116.41 165.98 12.59 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 120.676 0.275 . . . . 1.4099999999999999 110.906 -177.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -120.81 140.82 51.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.084 -0.507 . . . . 2.7000000000000002 110.139 -176.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 672' ' ' LEU . . . . . 0.409 HD21 ' HG2' ' A' ' 689' ' ' MET . 64.1 mt -69.63 141.91 53.57 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.238 -0.437 . . . . 1.05 110.819 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 673' ' ' GLY . . . . . . . . . . . . . . . 93.29 -11.18 72.21 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.945 -0.645 . . . . 0.64000000000000001 111.849 -178.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 674' ' ' GLN . . . . . . . . . . . . . 21.7 tp60 -79.93 143.09 34.51 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.561 -0.533 . . . . 2.2000000000000002 109.561 178.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 675' ' ' ARG . . . . . 0.71 ' HB2' ' OXT' ' A' ' 720' ' ' VAL . 36.8 mtm180 -96.76 141.51 29.9 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.567 -0.531 . . . . 4.0700000000000003 109.567 177.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 676' ' ' VAL . . . . . 0.475 ' HB ' HD12 ' A' ' 717' ' ' LEU . 27.6 m -120.77 155.6 24.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 115.748 -0.66 . . . . 0.58999999999999997 110.558 -177.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 677' ' ' ARG . . . . . . . . . . . . . 50.5 ttp180 -130.5 130.28 43.97 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.179 -0.464 . . . . 3.1499999999999999 110.49 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -136.07 131.88 35.44 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.774 -0.824 . . . . 1.53 108.774 177.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 679' ' ' ALA . . . . . . . . . . . . . . . -64.89 -26.71 68.44 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.928 0.394 . . . . 1.24 111.803 -170.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 680' ' ' LYS . . . . . 0.444 ' HD2' ' N ' ' A' ' 680' ' ' LYS . 0.6 OUTLIER -93.8 -31.78 14.24 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.011 -0.54 . . . . 2.9199999999999999 112.094 -177.926 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 681' ' ' PHE . . . . . . . . . . . . . 22.6 m-30 -103.43 -11.52 17.79 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.724 0.639 . . . . 1.5 112.724 -174.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 682' ' ' GLY . . . . . . . . . . . . . . . 96.86 -129.12 9.79 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.349 -0.929 . . . . 0.81999999999999995 111.728 -178.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 683' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -145.66 148.97 33.65 Favored 'General case' 0 C--N 1.319 -0.731 0 O-C-N 122.499 -0.412 . . . . 2.1099999999999999 109.93 178.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 684' ' ' GLY . . . . . 0.424 ' CA ' ' HA ' ' A' ' 702' ' ' PHE . . . -153.94 179.42 30.2 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.204 -0.998 . . . . 0.38 112.509 -178.043 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 685' ' ' THR . . . . . . . . . . . . . 42.5 m -116.2 127.96 55.21 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 110.107 -0.331 . . . . 0.46999999999999997 110.107 178.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 38.2 mt -72.02 104.27 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.62 -0.511 . . . . 0.46999999999999997 109.62 178.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 687' ' ' VAL . . . . . . . . . . . . . 27.5 m -95.12 -24.96 4.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 120.892 0.377 . . . . 0.5 111.314 -175.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -151.44 161.98 41.75 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.59 -0.522 . . . . 1.6200000000000001 109.59 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 689' ' ' MET . . . . . 0.409 ' HG2' HD21 ' A' ' 672' ' ' LEU . 24.9 ptt? -151.27 153.51 35.0 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 110.081 -0.34 . . . . 2.1699999999999999 110.081 177.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 690' ' ' GLU . . . . . 0.46 ' O ' ' HA ' ' A' ' 696' ' ' SER . 38.7 mt-10 -126.74 126.04 42.79 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.916 -0.584 . . . . 2.02 110.976 -178.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . 76.81 176.7 43.72 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.868 -0.682 . . . . 1.05 113.487 173.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 9.3 p -141.38 152.93 44.76 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.087 -0.338 . . . . 2.1800000000000002 110.087 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 88.55 -134.8 12.65 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.729 -0.748 . . . . 1.3100000000000001 111.806 -178.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 694' ' ' GLU . . . . . 0.53 ' HA ' ' HB2' ' A' ' 713' ' ' ALA . 37.0 tt0 -80.08 -31.95 39.28 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.287 0.565 . . . . 2.8500000000000001 110.14 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 695' ' ' HIS . . . . . . . . . . . . . 31.4 m-70 -87.18 37.88 0.79 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.739 -0.664 . . . . 3.0499999999999998 110.82 -178.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 696' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' A' ' 690' ' ' GLU . 55.7 p -109.41 134.23 52.1 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.019 0.438 . . . . 1.5 110.667 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 697' ' ' ARG . . . . . . . . . . . . . 21.5 mtm180 -125.68 141.59 51.94 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.515 -0.55 . . . . 2.54 109.515 176.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 17.3 mt -107.71 136.61 47.16 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 109.88 -0.415 . . . . 0.46000000000000002 109.88 178.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 699' ' ' GLN . . . . . 0.499 ' HG2' ' CG2' ' A' ' 707' ' ' ILE . 56.2 tt0 -100.86 100.27 10.89 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 108.573 -0.899 . . . . 2.2400000000000002 108.573 176.274 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 41.2 t -102.6 124.14 56.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.415 -0.811 . . . . 0.22 111.59 -171.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 701' ' ' ALA . . . . . 0.402 ' HA ' ' HA ' ' A' ' 707' ' ' ILE . . . -88.37 96.84 10.74 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.077 -0.511 . . . . 0.23000000000000001 109.973 176.164 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 702' ' ' PHE . . . . . 0.424 ' HA ' ' CA ' ' A' ' 684' ' ' GLY . 64.1 m-85 -73.11 149.73 42.82 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.064 -0.516 . . . . 1.2 111.012 -177.426 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 23.6 tp60 -49.22 -50.23 39.39 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.678 0.621 . . . . 2.79 112.678 -170.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -134.03 19.16 4.17 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 119.617 -1.278 . . . . 0.78000000000000003 113.9 -176.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 705' ' ' GLN . . . . . 0.48 ' O ' ' HE2' ' A' ' 708' ' ' LYS . 24.6 mp0 -124.98 10.87 8.25 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 117.67 0.735 . . . . 2.6200000000000001 111.801 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 706' ' ' GLY . . . . . . . . . . . . . . . 80.85 -166.62 49.02 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.306 -0.949 . . . . 0.5 112.702 178.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 707' ' ' ILE . . . . . 0.499 ' CG2' ' HG2' ' A' ' 699' ' ' GLN . 29.2 mt -97.87 130.44 46.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 120.638 0.256 . . . . 0.67000000000000004 111.171 -176.285 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 708' ' ' LYS . . . . . 0.48 ' HE2' ' O ' ' A' ' 705' ' ' GLN . 4.6 mptp? -118.09 169.58 9.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.979 0.419 . . . . 1.3500000000000001 111.192 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 709' ' ' TRP . . . . . . . . . . . . . 22.7 p-90 -113.3 119.77 38.84 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.36 -0.836 . . . . 0.83999999999999997 109.859 176.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -120.71 116.18 24.77 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.427 -0.351 . . . . 0.44 110.486 -177.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 40.6 t -65.7 108.79 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.444 -0.576 . . . . 0.60999999999999999 109.444 176.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 712' ' ' ALA . . . . . . . . . . . . . . . -57.07 -34.01 67.84 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.894 -0.594 . . . . 0.91000000000000003 112.418 -169.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 713' ' ' ALA . . . . . 0.53 ' HB2' ' HA ' ' A' ' 694' ' ' GLU . . . -65.66 -25.4 67.33 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.776 0.322 . . . . 1.1000000000000001 111.757 -178.454 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 714' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -121.77 8.2 9.98 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.469 -0.332 . . . . 1.96 111.038 -176.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 715' ' ' ALA . . . . . 0.525 ' HB1' ' CD2' ' A' ' 717' ' ' LEU . . . -88.72 -57.97 2.72 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.174 -0.466 . . . . 0.77000000000000002 111.56 -175.134 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 716' ' ' ARG . . . . . . . . . . . . . 26.1 tpt180 55.63 72.37 0.49 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.494 0.664 . . . . 4.4100000000000001 111.038 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 717' ' ' LEU . . . . . 0.525 ' CD2' ' HB1' ' A' ' 715' ' ' ALA . 4.3 mm? -90.88 142.86 27.32 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.633 -0.712 . . . . 0.84999999999999998 111.148 -178.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 718' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -84.32 148.66 26.53 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.542 -0.753 . . . . 2.1299999999999999 109.313 175.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 719' ' ' SER . . . . . . . . . . . . . 19.6 m -92.39 121.91 34.33 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.766 0.317 . . . . 1.6799999999999999 110.79 -178.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 720' ' ' VAL . . . . . 0.71 ' OXT' ' HB2' ' A' ' 675' ' ' ARG . 9.3 p . . . . . 0 C--O 1.247 0.971 0 CA-C-O 118.758 -0.639 . . . . 1.6399999999999999 110.378 178.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 34.6 ttm180 . . . . . 0 N--CA 1.481 1.098 0 CA-C-O 121.017 0.437 . . . . 27.27 110.199 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 646' ' ' LEU . . . . . . . . . . . . . 96.1 mt -83.8 -20.97 32.32 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.11 -0.496 . . . . 26.57 110.995 -178.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 647' ' ' ARG . . . . . . . . . . . . . 12.0 ptp180 -145.23 138.29 26.38 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.331 -0.395 . . . . 24.57 110.935 -178.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 648' ' ' ALA . . . . . . . . . . . . . . . -117.51 -65.92 1.13 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.0 -0.545 . . . . 23.82 109.725 175.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 649' ' ' THR . . . . . . . . . . . . . 14.9 t 178.46 153.19 0.34 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.979 -0.555 . . . . 23.239999999999998 110.418 176.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 650' ' ' VAL . . . . . . . . . . . . . 9.2 p -131.35 1.05 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.626 0.727 . . . . 23.34 109.167 174.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 651' ' ' SER . . . . . . . . . . . . . 68.1 p -72.11 143.22 49.08 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.249 -0.887 . . . . 21.93 111.452 -174.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 652' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -120.99 129.15 25.43 Favored Pre-proline 0 C--N 1.32 -0.676 0 N-CA-C 109.148 -0.686 . . . . 21.539999999999999 109.148 175.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 653' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.92 51.57 2.0 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.766 2.311 . . . . 19.800000000000001 113.417 -176.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 654' ' ' VAL . . . . . . . . . . . . . 8.4 p -84.96 -27.39 6.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.335 -0.848 . . . . 20.260000000000002 109.098 175.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 655' ' ' SER . . . . . . . . . . . . . 40.9 m -100.39 61.54 1.05 Allowed 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.079 -0.964 . . . . 18.239999999999998 109.105 173.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 656' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -77.12 100.95 5.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.625 -0.716 . . . . 16.629999999999999 110.504 -175.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 657' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -129.53 -50.38 1.17 Allowed 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.889 -0.782 . . . . 17.75 108.889 175.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 658' ' ' ARG . . . . . . . . . . . . . 56.9 mtm180 -107.07 46.77 0.91 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.305 -0.861 . . . . 15.35 109.195 172.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 659' ' ' MET . . . . . . . . . . . . . 1.5 mpt? 73.88 -45.71 0.61 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 114.618 -1.174 . . . . 14.949999999999999 111.986 -178.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . 95.71 28.67 9.3 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 110.719 -0.952 . . . . 12.49 110.719 -178.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 661' ' ' THR . . . . . . . . . . . . . 3.8 t -71.76 136.31 83.01 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.282 -0.459 . . . . 10.68 111.113 -177.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 662' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -74.84 -13.82 21.69 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.611 2.207 . . . . 10.300000000000001 111.436 175.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 663' ' ' MET . . . . . . . . . . . . . 15.5 tpt -115.89 113.82 23.85 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.496 -0.774 . . . . 9.4100000000000001 109.823 178.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 664' ' ' VAL . . . . . . . . . . . . . 47.2 t -69.94 126.49 30.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.05 -0.523 . . . . 7.04 110.198 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 665' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -68.56 -31.78 71.24 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.915 -0.584 . . . . 7.0700000000000003 110.376 -177.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 666' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 -100.9 52.49 0.85 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.065 -0.717 . . . . 6.7999999999999998 109.065 174.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 667' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -60.28 -58.15 9.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.388 -0.824 . . . . 5.4900000000000002 112.444 -172.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 668' ' ' SER . . . . . . . . . . . . . 9.2 t -117.68 -10.49 10.54 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.804 -0.359 . . . . 4.7199999999999998 111.492 -173.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 669' ' ' GLY . . . . . . . . . . . . . . . 105.2 160.4 23.41 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.356 -0.926 . . . . 1.8700000000000001 111.743 -178.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 670' ' ' TYR . . . . . 0.544 ' CE2' ' HB2' ' A' ' 717' ' ' LEU . 93.4 m-85 -93.25 141.8 28.03 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 120.853 0.359 . . . . 1.4099999999999999 110.863 -177.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -125.42 162.29 25.16 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.966 -0.561 . . . . 2.7000000000000002 110.503 -175.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 672' ' ' LEU . . . . . . . . . . . . . 7.6 mp -79.67 143.48 34.59 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.89 0.376 . . . . 1.05 110.452 177.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 673' ' ' GLY . . . . . . . . . . . . . . . 84.46 3.01 88.81 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.767 -0.652 . . . . 0.64000000000000001 111.542 -177.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 674' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -86.62 145.5 26.7 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.557 -0.321 . . . . 2.2000000000000002 110.228 -178.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 675' ' ' ARG . . . . . . . . . . . . . 30.9 ttm180 -106.48 125.04 50.49 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.219 0.533 . . . . 4.0700000000000003 109.902 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 676' ' ' VAL . . . . . 0.432 ' HB ' ' HB3' ' A' ' 717' ' ' LEU . 34.7 m -117.57 163.32 14.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.456 -0.793 . . . . 0.58999999999999997 111.147 -174.221 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 677' ' ' ARG . . . . . 0.501 ' HB2' HG22 ' A' ' 720' ' ' VAL . 55.8 ttp180 -134.72 121.16 20.37 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.043 -0.526 . . . . 3.1499999999999999 109.98 176.335 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 678' ' ' HIS . . . . . 0.464 ' HB2' ' CD1' ' A' ' 717' ' ' LEU . 51.5 t60 -134.25 122.65 23.04 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.094 -0.706 . . . . 1.53 109.094 179.458 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 679' ' ' ALA . . . . . . . . . . . . . . . -58.41 -20.8 47.39 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.009 0.744 . . . . 1.24 113.009 -169.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 680' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -86.28 -33.46 20.66 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 111.938 0.347 . . . . 2.9199999999999999 111.938 -177.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 681' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -116.97 -12.41 10.69 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.438 0.533 . . . . 1.5 112.438 -175.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 682' ' ' GLY . . . . . . . . . . . . . . . 99.03 -156.51 20.06 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.793 -0.717 . . . . 0.81999999999999995 111.548 -178.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 683' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 676' ' ' VAL . 0.8 OUTLIER -105.51 143.24 33.95 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.866 -0.42 . . . . 2.1099999999999999 109.866 176.102 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 684' ' ' GLY . . . . . . . . . . . . . . . -153.79 175.14 32.22 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.218 -0.991 . . . . 0.38 112.486 -177.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 685' ' ' THR . . . . . . . . . . . . . 84.9 m -111.89 123.97 51.37 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.724 0.297 . . . . 0.46999999999999997 110.364 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 44.7 mt -68.76 106.5 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.56 -0.533 . . . . 0.46999999999999997 109.56 178.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 687' ' ' VAL . . . . . . . . . . . . . 26.9 m -99.58 -19.05 6.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.326 -0.397 . . . . 0.5 111.454 -174.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 688' ' ' ASN . . . . . 0.472 ' HB3' ' HB2' ' A' ' 699' ' ' GLN . 18.1 t-20 -156.58 162.33 39.9 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.542 -0.54 . . . . 1.6200000000000001 109.542 -178.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 689' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -148.97 146.82 28.0 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.021 -0.733 . . . . 2.1699999999999999 109.021 176.376 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 690' ' ' GLU . . . . . 0.437 ' OE2' ' HD2' ' A' ' 697' ' ' ARG . 36.4 mt-10 -119.93 122.85 42.14 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.635 0.255 . . . . 2.02 111.237 -174.488 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . 68.99 -172.7 36.49 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.144 -0.55 . . . . 1.05 113.235 175.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 8.5 p -139.71 165.67 26.66 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.397 -0.223 . . . . 2.1800000000000002 110.397 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 81.0 -150.65 30.88 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 121.095 -0.574 . . . . 1.3100000000000001 112.615 178.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 694' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -64.47 -40.99 96.73 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.833 0.349 . . . . 2.8500000000000001 111.157 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 695' ' ' HIS . . . . . . . . . . . . . 27.6 p-80 -86.66 21.97 2.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.283 -0.417 . . . . 3.0499999999999998 111.293 -177.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 696' ' ' SER . . . . . . . . . . . . . 19.2 t -82.05 141.36 33.26 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.38 -0.6 . . . . 1.5 109.38 176.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 697' ' ' ARG . . . . . 0.437 ' HD2' ' OE2' ' A' ' 690' ' ' GLU . 41.6 mtt180 -122.69 152.77 40.22 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.668 -0.493 . . . . 2.54 109.668 178.488 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 11.2 mt -118.22 130.38 56.04 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.198 -0.668 . . . . 0.46000000000000002 109.198 174.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 699' ' ' GLN . . . . . 0.472 ' HB2' ' HB3' ' A' ' 688' ' ' ASN . 30.5 mt-30 -97.49 101.49 13.03 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.746 0.784 . . . . 2.2400000000000002 109.618 175.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 700' ' ' VAL . . . . . 0.447 ' HB ' ' CE1' ' A' ' 702' ' ' PHE . 15.9 t -100.13 123.19 52.83 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 114.674 -1.148 . . . . 0.22 110.35 -174.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -86.49 94.3 9.38 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.402 -0.592 . . . . 0.23000000000000001 109.402 176.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 702' ' ' PHE . . . . . 0.447 ' CE1' ' HB ' ' A' ' 700' ' ' VAL . 92.7 m-85 -77.14 117.11 18.36 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.832 -0.622 . . . . 1.2 109.743 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -60.79 -21.51 63.16 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.854 -0.612 . . . . 2.79 112.088 -174.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -83.92 -20.04 60.2 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.67 -0.776 . . . . 0.78000000000000003 112.481 178.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 705' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -135.26 -82.9 0.41 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.864 0.364 . . . . 2.6200000000000001 111.4 -177.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 706' ' ' GLY . . . . . . . . . . . . . . . 179.49 -156.58 18.64 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 121.119 -0.562 . . . . 0.5 111.77 -177.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 707' ' ' ILE . . . . . 0.443 ' HA ' ' O ' ' A' ' 700' ' ' VAL . 61.5 mt -85.17 126.83 40.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 120.982 0.42 . . . . 0.67000000000000004 111.205 -176.439 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 708' ' ' LYS . . . . . 0.443 ' O ' ' HA ' ' A' ' 699' ' ' GLN . 4.5 mptp? -121.47 161.4 22.32 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.891 -0.595 . . . . 1.3500000000000001 109.779 176.13 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 709' ' ' TRP . . . . . . . . . . . . . 17.7 p-90 -105.86 115.29 29.98 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.233 0.539 . . . . 0.83999999999999997 109.657 177.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -112.75 114.62 27.27 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 116.137 -0.483 . . . . 0.44 110.244 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 49.1 t -65.1 115.68 3.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.664 -0.495 . . . . 0.60999999999999999 109.664 178.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 712' ' ' ALA . . . . . . . . . . . . . . . -54.62 -32.57 59.12 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.849 0.685 . . . . 0.91000000000000003 112.849 -170.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -66.34 -25.62 66.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.932 0.396 . . . . 1.1000000000000001 111.545 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 714' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -133.95 29.44 3.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.141 0.496 . . . . 1.96 109.723 -177.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 715' ' ' ALA . . . . . 0.529 ' HB1' ' CD2' ' A' ' 717' ' ' LEU . . . -80.01 -57.49 3.61 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.553 -0.749 . . . . 0.77000000000000002 111.094 -174.185 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 716' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 716' ' ' ARG . 38.3 ttm180 58.3 69.34 0.74 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.63 0.729 . . . . 4.4100000000000001 111.031 178.359 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 717' ' ' LEU . . . . . 0.544 ' HB2' ' CE2' ' A' ' 670' ' ' TYR . 3.6 mm? -105.74 122.92 47.06 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.876 -0.602 . . . . 0.84999999999999998 110.278 177.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 718' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -91.05 130.94 36.91 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.763 -0.653 . . . . 2.1299999999999999 109.787 -179.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 719' ' ' SER . . . . . . . . . . . . . 15.5 p -64.9 125.63 25.47 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.901 -0.407 . . . . 1.6799999999999999 109.901 176.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 720' ' ' VAL . . . . . 0.501 HG22 ' HB2' ' A' ' 677' ' ' ARG . 10.9 t . . . . . 0 C--O 1.246 0.921 0 CA-C-O 118.803 -0.618 . . . . 1.6399999999999999 110.528 -177.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.144 0 N-CA-C 111.463 0.171 . . . . 27.27 111.463 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 646' ' ' LEU . . . . . . . . . . . . . 68.6 tp -137.51 -71.47 0.43 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.682 0.277 . . . . 26.57 110.988 -177.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 647' ' ' ARG . . . . . . . . . . . . . 58.1 mtm180 -103.16 102.56 12.55 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.796 -0.446 . . . . 24.57 109.796 178.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 648' ' ' ALA . . . . . . . . . . . . . . . -67.72 129.11 38.91 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.013 -0.54 . . . . 23.82 111.167 -177.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 649' ' ' THR . . . . . . . . . . . . . 9.0 t -145.1 132.02 20.21 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.889 -0.596 . . . . 23.239999999999998 109.437 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 650' ' ' VAL . . . . . . . . . . . . . 46.3 t -80.3 -52.97 13.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.912 -0.585 . . . . 23.34 110.711 -176.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 651' ' ' SER . . . . . . . . . . . . . 16.8 p -160.06 -71.53 0.07 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.053 0.454 . . . . 21.93 110.79 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 652' ' ' ARG . . . . . . . . . . . . . 31.9 mmt180 -118.01 114.51 37.11 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.077 -0.511 . . . . 21.539999999999999 110.313 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 653' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -57.67 162.47 10.55 Favored 'Trans proline' 0 C--O 1.235 0.349 0 C-N-CA 123.06 2.507 . . . . 19.800000000000001 112.17 177.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 654' ' ' VAL . . . . . . . . . . . . . 37.0 t -76.98 79.64 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.356 0.598 . . . . 20.260000000000002 110.484 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 655' ' ' SER . . . . . . . . . . . . . 15.2 m -93.98 41.63 1.09 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.467 -0.788 . . . . 18.239999999999998 110.032 178.01 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 656' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -107.28 101.83 11.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.768 -0.651 . . . . 16.629999999999999 109.897 -178.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 657' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -109.69 152.86 25.06 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.123 -0.489 . . . . 17.75 110.457 -179.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 658' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -109.55 99.3 8.52 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.323 -0.399 . . . . 15.35 110.536 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 659' ' ' MET . . . . . . . . . . . . . 24.6 ttt -79.31 -24.15 43.03 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.293 0.568 . . . . 14.949999999999999 110.353 178.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . -94.94 25.18 25.04 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.89 -0.671 . . . . 12.49 111.753 -178.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 661' ' ' THR . . . . . . . . . . . . . 8.8 t -76.77 127.61 83.66 Favored Pre-proline 0 N--CA 1.449 -0.494 0 N-CA-C 110.147 -0.316 . . . . 10.68 110.147 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 662' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -71.16 150.67 60.07 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.348 2.032 . . . . 10.300000000000001 110.778 173.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 663' ' ' MET . . . . . . . . . . . . . 26.4 mmt 63.55 100.12 0.03 OUTLIER 'General case' 0 C--O 1.235 0.32 0 O-C-N 123.708 0.63 . . . . 9.4100000000000001 110.754 -177.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 664' ' ' VAL . . . . . . . . . . . . . 59.4 t -66.24 100.7 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.546 -0.752 . . . . 7.04 110.784 -178.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 665' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -87.28 -12.48 46.48 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.047 -0.524 . . . . 7.0700000000000003 111.0 -179.018 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 666' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -148.88 -62.84 0.24 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.222 -0.444 . . . . 6.7999999999999998 110.219 177.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 667' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -150.59 169.66 21.01 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.978 -0.556 . . . . 5.4900000000000002 110.087 178.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 668' ' ' SER . . . . . . . . . . . . . 11.9 m -92.9 25.75 3.05 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.246 -0.433 . . . . 4.7199999999999998 111.777 -173.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 669' ' ' GLY . . . . . . . . . . . . . . . 137.78 -56.88 0.66 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.632 -0.794 . . . . 1.8700000000000001 112.215 177.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 670' ' ' TYR . . . . . 0.518 ' CD1' HD11 ' A' ' 698' ' ' LEU . 94.1 m-85 -134.19 172.76 12.41 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 110.163 -0.31 . . . . 1.4099999999999999 110.163 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 671' ' ' LYS . . . . . 0.462 ' HG3' ' HB2' ' A' ' 674' ' ' GLN . 21.2 ptmt -140.33 155.98 46.6 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.392 -0.367 . . . . 2.7000000000000002 110.244 -176.077 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 672' ' ' LEU . . . . . . . . . . . . . 59.6 mt -78.65 140.99 38.32 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.136 -0.484 . . . . 1.05 110.478 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 673' ' ' GLY . . . . . . . . . . . . . . . 84.07 5.74 87.27 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.814 -0.63 . . . . 0.64000000000000001 111.803 -177.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 674' ' ' GLN . . . . . 0.462 ' HB2' ' HG3' ' A' ' 671' ' ' LYS . 35.1 tt0 -83.28 142.89 30.77 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.022 -0.362 . . . . 2.2000000000000002 110.022 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 675' ' ' ARG . . . . . . . . . . . . . 26.8 mmm180 -93.26 120.11 33.17 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.848 -0.614 . . . . 4.0700000000000003 109.841 178.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 676' ' ' VAL . . . . . 0.472 ' HB ' ' HB3' ' A' ' 717' ' ' LEU . 34.2 m -117.27 154.74 19.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.883 -0.599 . . . . 0.58999999999999997 110.695 -177.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 677' ' ' ARG . . . . . . . . . . . . . 52.1 ttp180 -131.79 137.91 48.34 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.955 -0.566 . . . . 3.1499999999999999 110.014 178.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 678' ' ' HIS . . . . . 0.426 ' CD2' HD13 ' A' ' 717' ' ' LEU . 0.0 OUTLIER -139.99 155.21 47.22 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.129 -0.487 . . . . 1.53 110.464 174.089 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 679' ' ' ALA . . . . . . . . . . . . . . . -56.12 -53.9 51.56 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.673 0.62 . . . . 1.24 112.673 -173.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 680' ' ' LYS . . . . . . . . . . . . . 2.7 mtpm? -92.66 -30.67 15.46 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.957 -0.565 . . . . 2.9199999999999999 111.743 -171.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 681' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -87.42 -11.85 47.93 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.342 -0.39 . . . . 1.5 111.34 -177.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 682' ' ' GLY . . . . . . . . . . . . . . . 84.47 -112.49 3.62 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.582 -0.818 . . . . 0.81999999999999995 111.992 178.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 683' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -151.12 149.14 29.13 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.738 -0.468 . . . . 2.1099999999999999 109.738 177.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 684' ' ' GLY . . . . . . . . . . . . . . . -160.55 -179.46 35.34 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.016 -1.088 . . . . 0.38 113.011 -178.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 685' ' ' THR . . . . . . . . . . . . . 64.6 m -110.83 130.02 55.7 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.738 -0.467 . . . . 0.46999999999999997 109.738 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 686' ' ' ILE . . . . . 0.448 HG12 HG22 ' A' ' 700' ' ' VAL . 31.1 mt -72.74 103.52 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.171 -0.678 . . . . 0.46999999999999997 109.171 175.499 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 687' ' ' VAL . . . . . . . . . . . . . 27.5 m -93.11 -26.28 4.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.18 0.514 . . . . 0.5 111.028 -175.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 688' ' ' ASN . . . . . 0.489 ' HB3' ' HB3' ' A' ' 699' ' ' GLN . 20.1 t-20 -146.07 161.74 39.46 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.916 -0.584 . . . . 1.6200000000000001 109.676 177.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 689' ' ' MET . . . . . . . . . . . . . 26.7 ptm -153.16 143.68 22.6 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.55 -0.537 . . . . 2.1699999999999999 109.55 177.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 690' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -108.73 122.79 47.89 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.756 -0.656 . . . . 2.02 110.456 -176.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . 67.64 -168.79 38.83 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.964 -0.636 . . . . 1.05 112.558 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 56.1 m -154.92 131.78 10.77 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.133 -0.321 . . . . 2.1800000000000002 110.133 178.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 109.36 -142.74 16.33 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.713 -0.756 . . . . 1.3100000000000001 112.021 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 694' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -66.54 -34.83 78.78 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.036 0.446 . . . . 2.8500000000000001 111.109 -178.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 695' ' ' HIS . . . . . . . . . . . . . 55.8 m80 -95.36 31.03 2.05 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.253 -0.43 . . . . 3.0499999999999998 110.902 -178.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 696' ' ' SER . . . . . . . . . . . . . 16.7 t -97.56 138.74 34.51 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.252 0.549 . . . . 1.5 110.902 -178.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 697' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -123.02 159.81 27.63 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.967 -0.753 . . . . 2.54 108.967 174.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 698' ' ' LEU . . . . . 0.518 HD11 ' CD1' ' A' ' 670' ' ' TYR . 35.6 mt -122.75 149.39 44.17 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 109.935 -0.394 . . . . 0.46000000000000002 109.935 178.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 699' ' ' GLN . . . . . 0.489 ' HB3' ' HB3' ' A' ' 688' ' ' ASN . 15.1 tt0 -117.63 96.02 5.2 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.229 -1.026 . . . . 2.2400000000000002 108.229 173.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 700' ' ' VAL . . . . . 0.448 HG22 HG12 ' A' ' 686' ' ' ILE . 35.3 t -100.64 134.5 40.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.551 -0.75 . . . . 0.22 111.103 -172.459 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -96.33 94.41 7.44 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.988 -0.551 . . . . 0.23000000000000001 110.09 176.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 702' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -78.78 136.88 37.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.103 0.478 . . . . 1.2 110.691 -177.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -71.43 -21.22 62.01 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.609 -0.723 . . . . 2.79 112.473 -171.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -106.57 2.76 36.67 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.276 -0.964 . . . . 0.78000000000000003 113.336 -175.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 705' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -146.64 -54.15 0.24 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 117.017 0.408 . . . . 2.6200000000000001 111.447 -177.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 706' ' ' GLY . . . . . . . . . . . . . . . 139.57 -159.26 25.79 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.282 -0.961 . . . . 0.5 112.433 179.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 58.7 mt -79.08 134.25 28.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 120.847 0.356 . . . . 0.67000000000000004 111.082 -176.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 708' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -137.75 159.59 41.55 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.884 -0.598 . . . . 1.3500000000000001 111.333 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 709' ' ' TRP . . . . . 0.447 ' C ' HD22 ' A' ' 710' ' ' LEU . 33.0 p-90 -98.92 129.75 45.27 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.384 -0.825 . . . . 0.83999999999999997 109.363 174.429 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 710' ' ' LEU . . . . . 0.447 HD22 ' C ' ' A' ' 709' ' ' TRP . 3.1 mm? -127.4 125.69 41.09 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 110.27 -0.27 . . . . 0.44 110.27 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 54.9 t -73.24 104.17 2.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.188 -0.671 . . . . 0.60999999999999999 109.188 174.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 712' ' ' ALA . . . . . 0.405 ' HB2' ' HG ' ' A' ' 698' ' ' LEU . . . -56.81 -31.16 64.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.841 -0.618 . . . . 0.91000000000000003 111.998 -171.225 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -58.96 -32.97 70.11 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.245 -0.434 . . . . 1.1000000000000001 112.032 -178.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 714' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -127.73 19.21 6.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.134 0.492 . . . . 1.96 110.699 -178.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 715' ' ' ALA . . . . . 0.531 ' HB1' ' CD2' ' A' ' 717' ' ' LEU . . . -77.32 -53.82 7.23 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.703 -0.68 . . . . 0.77000000000000002 111.067 -177.264 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 716' ' ' ARG . . . . . . . . . . . . . 25.4 tpt85 48.98 65.56 1.34 Allowed 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.864 0.84 . . . . 4.4100000000000001 110.72 -176.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 717' ' ' LEU . . . . . 0.531 ' CD2' ' HB1' ' A' ' 715' ' ' ALA . 4.5 mm? -81.34 139.23 35.48 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.207 -0.906 . . . . 0.84999999999999998 109.472 175.132 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 718' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -92.79 119.86 32.57 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.137 -0.69 . . . . 2.1299999999999999 109.137 178.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 719' ' ' SER . . . . . . . . . . . . . 9.7 t -68.99 124.57 24.12 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.859 -0.422 . . . . 1.6799999999999999 109.859 -178.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 720' ' ' VAL . . . . . . . . . . . . . 4.9 p . . . . . 0 C--O 1.248 0.974 0 CA-C-N 116.095 -0.502 . . . . 1.6399999999999999 110.664 -177.055 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 . . . . . 0 N--CA 1.478 0.934 0 N-CA-C 110.228 -0.286 . . . . 27.27 110.228 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 646' ' ' LEU . . . . . . . . . . . . . 34.8 tp 64.21 52.55 1.93 Allowed 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.715 0.769 . . . . 26.57 109.674 -177.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 647' ' ' ARG . . . . . . . . . . . . . 29.6 tpt180 -95.19 76.35 3.45 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.26 -0.882 . . . . 24.57 110.027 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 648' ' ' ALA . . . . . . . . . . . . . . . 55.84 77.12 0.25 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.006 -0.543 . . . . 23.82 110.974 -178.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 649' ' ' THR . . . . . . . . . . . . . 8.8 t -82.87 37.83 0.55 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.035 -0.529 . . . . 23.239999999999998 111.161 -175.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 650' ' ' VAL . . . . . . . . . . . . . 14.8 t 55.51 58.51 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 121.916 0.865 . . . . 23.34 109.864 -178.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 651' ' ' SER . . . . . . . . . . . . . 25.6 t -161.43 -55.52 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.278 -0.874 . . . . 21.93 110.001 -177.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 652' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -141.7 86.66 10.6 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 116.051 -0.522 . . . . 21.539999999999999 110.46 -177.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 653' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -84.1 59.85 6.15 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.593 2.195 . . . . 19.800000000000001 111.215 178.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 654' ' ' VAL . . . . . . . . . . . . . 48.3 t 60.69 79.38 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.475 -0.784 . . . . 20.260000000000002 110.006 -173.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 655' ' ' SER . . . . . . . . . . . . . 23.9 m -81.47 -20.84 39.37 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.555 -0.748 . . . . 18.239999999999998 110.252 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 656' ' ' HIS . . . . . . . . . . . . . 29.5 m170 -77.94 112.47 14.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.831 -0.622 . . . . 16.629999999999999 110.276 176.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 657' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -120.25 151.72 38.78 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.159 -0.473 . . . . 17.75 110.281 178.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 658' ' ' ARG . . . . . 0.439 ' NH2' ' HB2' ' A' ' 665' ' ' GLU . 16.8 ttm180 -68.45 -77.1 0.08 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.82 0.343 . . . . 15.35 111.003 -175.545 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 659' ' ' MET . . . . . . . . . . . . . 27.0 ttt -120.19 -43.2 2.54 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.847 0.356 . . . . 14.949999999999999 110.528 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . -143.55 -27.64 0.13 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.8 -0.714 . . . . 12.49 112.169 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 661' ' ' THR . . . . . . . . . . . . . 9.5 p -120.74 141.45 32.42 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-O 120.81 0.338 . . . . 10.68 111.05 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 662' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -79.76 62.17 8.42 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.81 2.34 . . . . 10.300000000000001 111.316 174.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 663' ' ' MET . . . . . . . . . . . . . 53.3 ttm -104.09 129.32 51.77 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.841 -0.618 . . . . 9.4100000000000001 110.421 -177.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 664' ' ' VAL . . . . . . . . . . . . . 59.1 t -80.97 121.05 33.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.956 -0.566 . . . . 7.04 110.217 178.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 665' ' ' GLU . . . . . 0.439 ' HB2' ' NH2' ' A' ' 658' ' ' ARG . 10.5 tp10 -77.77 79.69 4.25 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.216 0.531 . . . . 7.0700000000000003 109.945 179.46 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 666' ' ' ASN . . . . . 0.408 HD22 ' C ' ' A' ' 666' ' ' ASN . 0.3 OUTLIER -109.34 147.39 32.79 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.924 -0.58 . . . . 6.7999999999999998 110.807 -178.916 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 667' ' ' ASP . . . . . . . . . . . . . 12.6 t70 68.16 126.59 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 O-C-N 124.172 0.92 . . . . 5.4900000000000002 111.32 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 668' ' ' SER . . . . . . . . . . . . . 31.3 t -129.13 36.31 4.19 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.692 -0.686 . . . . 4.7199999999999998 109.799 -178.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 669' ' ' GLY . . . . . . . . . . . . . . . -147.59 93.73 0.16 Allowed Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.559 -0.829 . . . . 1.8700000000000001 112.569 -178.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 670' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -68.92 157.27 36.99 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 110.068 -0.345 . . . . 1.4099999999999999 110.068 176.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -118.12 152.3 35.89 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.275 -0.421 . . . . 2.7000000000000002 110.983 -176.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 672' ' ' LEU . . . . . . . . . . . . . 70.0 mt -79.25 133.51 36.66 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.094 -0.503 . . . . 1.05 110.053 176.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 673' ' ' GLY . . . . . . . . . . . . . . . 94.42 1.23 64.45 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.841 -0.695 . . . . 0.64000000000000001 111.699 -174.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 674' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -81.29 144.63 31.39 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 110.021 -0.362 . . . . 2.2000000000000002 110.021 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 675' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.47 128.65 50.6 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.086 -0.709 . . . . 4.0700000000000003 109.086 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 676' ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' A' ' 683' ' ' GLU . 35.8 m -119.7 152.23 22.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 115.814 -0.63 . . . . 0.58999999999999997 111.465 -173.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 677' ' ' ARG . . . . . 0.472 ' HG3' HG22 ' A' ' 720' ' ' VAL . 32.6 mtp180 -123.06 124.28 42.75 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.28 0.562 . . . . 3.1499999999999999 110.813 175.078 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 678' ' ' HIS . . . . . 0.539 ' HB2' ' CD1' ' A' ' 717' ' ' LEU . 43.4 t60 -139.42 104.66 5.02 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.212 -0.904 . . . . 1.53 109.148 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 679' ' ' ALA . . . . . . . . . . . . . . . -40.42 -38.15 0.78 Allowed 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 114.086 1.143 . . . . 1.24 114.086 -170.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 680' ' ' LYS . . . . . . . . . . . . . 18.7 mmtm -75.8 -31.18 59.33 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.646 -0.252 . . . . 2.9199999999999999 111.542 -172.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 681' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -116.61 -13.08 10.86 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.85 -0.34 . . . . 1.5 111.816 -176.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 682' ' ' GLY . . . . . . . . . . . . . . . 97.82 -155.36 20.42 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.902 -0.666 . . . . 0.81999999999999995 111.842 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 683' ' ' GLU . . . . . 0.48 ' HA ' ' O ' ' A' ' 676' ' ' VAL . 0.5 OUTLIER -109.53 147.57 32.72 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.003 0.43 . . . . 2.1099999999999999 110.61 179.075 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 684' ' ' GLY . . . . . . . . . . . . . . . -156.49 179.48 32.31 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 120.594 -0.812 . . . . 0.38 111.999 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 685' ' ' THR . . . . . . . . . . . . . 71.3 m -115.06 127.36 55.58 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.764 0.316 . . . . 0.46999999999999997 110.201 179.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 686' ' ' ILE . . . . . 0.401 HG12 HG22 ' A' ' 700' ' ' VAL . 33.6 mt -71.63 104.93 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.182 -0.463 . . . . 0.46999999999999997 109.759 178.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 687' ' ' VAL . . . . . . . . . . . . . 29.3 m -95.54 -26.61 4.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.862 0.363 . . . . 0.5 111.263 -176.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 688' ' ' ASN . . . . . 0.462 ' HB3' ' HB2' ' A' ' 699' ' ' GLN . 21.2 t-20 -146.38 163.47 35.5 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.598 -0.519 . . . . 1.6200000000000001 109.598 -179.294 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 689' ' ' MET . . . . . . . . . . . . . 18.0 ptp -158.3 157.39 32.38 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.956 -0.387 . . . . 2.1699999999999999 109.956 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 690' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -129.15 123.53 32.35 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.435 -0.348 . . . . 2.02 111.405 -177.088 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . 62.31 -162.83 27.78 Favored Glycine 0 N--CA 1.452 -0.3 0 CA-C-N 115.692 -0.685 . . . . 1.05 113.748 172.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 692' ' ' SER . . . . . 0.402 ' HA ' ' HB3' ' A' ' 696' ' ' SER . 39.7 m -151.81 170.44 19.78 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.262 -0.644 . . . . 2.1800000000000002 109.262 177.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 90.38 -139.47 14.96 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.399 -0.905 . . . . 1.3100000000000001 112.456 177.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 694' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -83.29 -24.7 32.08 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.011 0.434 . . . . 2.8500000000000001 110.596 -178.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 695' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -102.13 35.52 2.37 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.435 0.636 . . . . 3.0499999999999998 110.383 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 696' ' ' SER . . . . . 0.493 ' OG ' ' HB3' ' A' ' 712' ' ' ALA . 16.3 p -90.81 135.51 33.68 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.396 -0.82 . . . . 1.5 110.258 179.161 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 697' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 697' ' ' ARG . 34.2 mtp180 -127.69 146.53 50.53 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.595 -0.52 . . . . 2.54 109.595 178.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 15.5 mt -123.51 130.97 53.47 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.756 -0.461 . . . . 0.46000000000000002 109.756 178.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 699' ' ' GLN . . . . . 0.473 ' HA ' ' O ' ' A' ' 708' ' ' LYS . 2.1 mp0 -99.14 107.92 20.41 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.468 0.651 . . . . 2.2400000000000002 109.433 175.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 700' ' ' VAL . . . . . 0.401 HG22 HG12 ' A' ' 686' ' ' ILE . 42.1 t -107.13 125.7 63.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 114.913 -1.04 . . . . 0.22 111.097 -172.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 701' ' ' ALA . . . . . 0.407 ' HA ' ' HA ' ' A' ' 707' ' ' ILE . . . -87.3 94.65 9.73 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.152 -0.476 . . . . 0.23000000000000001 109.844 176.409 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 702' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -74.44 135.91 42.33 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.15 0.5 . . . . 1.2 110.345 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -68.62 -31.13 70.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.246 -0.888 . . . . 2.79 111.211 -175.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -81.49 -37.52 17.14 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.729 -0.748 . . . . 0.78000000000000003 112.795 -178.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 705' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 -113.69 -76.04 0.59 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.041 0.385 . . . . 2.6200000000000001 112.041 -176.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 706' ' ' GLY . . . . . . . . . . . . . . . 167.87 -158.1 30.74 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.738 -0.744 . . . . 0.5 112.166 -177.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 707' ' ' ILE . . . . . 0.407 ' HA ' ' HA ' ' A' ' 701' ' ' ALA . 64.5 mt -78.46 122.97 34.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.056 0.455 . . . . 0.67000000000000004 111.13 -176.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 708' ' ' LYS . . . . . 0.473 ' O ' ' HA ' ' A' ' 699' ' ' GLN . 86.2 mttt -129.25 168.66 15.87 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.918 -0.583 . . . . 1.3500000000000001 110.866 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 709' ' ' TRP . . . . . 0.511 ' C ' HD22 ' A' ' 710' ' ' LEU . 57.0 p-90 -105.24 131.93 52.09 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.434 -0.803 . . . . 0.83999999999999997 109.782 178.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 710' ' ' LEU . . . . . 0.511 HD22 ' C ' ' A' ' 709' ' ' TRP . 3.6 mm? -130.29 109.49 10.8 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.742 -0.466 . . . . 0.44 109.742 177.313 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 59.4 t -64.48 109.41 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.382 -0.599 . . . . 0.60999999999999999 109.382 177.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 712' ' ' ALA . . . . . 0.493 ' HB3' ' OG ' ' A' ' 696' ' ' SER . . . -55.35 -33.89 63.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.774 -0.648 . . . . 0.91000000000000003 112.51 -169.535 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -64.58 -20.26 66.15 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.288 -0.415 . . . . 1.1000000000000001 111.72 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 714' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -131.49 15.4 4.97 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.965 0.412 . . . . 1.96 110.19 -179.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 715' ' ' ALA . . . . . 0.58 ' HB1' ' CD2' ' A' ' 717' ' ' LEU . . . -85.28 -60.41 2.04 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.016 -0.538 . . . . 0.77000000000000002 111.454 -173.588 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 716' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 58.82 77.76 0.29 Allowed 'General case' 0 C--O 1.235 0.341 0 CA-C-O 121.49 0.662 . . . . 4.4100000000000001 110.945 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 717' ' ' LEU . . . . . 0.58 ' CD2' ' HB1' ' A' ' 715' ' ' ALA . 3.8 mm? -103.02 129.13 49.68 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.616 -0.72 . . . . 0.84999999999999998 110.911 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 718' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -86.34 125.42 33.62 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.83 -0.623 . . . . 2.1299999999999999 109.416 175.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 719' ' ' SER . . . . . . . . . . . . . 34.6 t -70.68 131.18 43.51 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.685 0.279 . . . . 1.6799999999999999 110.323 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 720' ' ' VAL . . . . . 0.472 HG22 ' HG3' ' A' ' 677' ' ' ARG . 17.5 t . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.671 -0.681 . . . . 1.6399999999999999 109.988 177.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 21.1 tpt180 . . . . . 0 N--CA 1.479 1.025 0 CA-C-O 120.714 0.292 . . . . 27.27 110.244 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 646' ' ' LEU . . . . . . . . . . . . . 8.8 tt -79.89 118.28 21.51 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.081 -0.508 . . . . 26.57 110.302 -178.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 647' ' ' ARG . . . . . . . . . . . . . 56.6 mtm180 -140.92 132.54 27.15 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.94 -0.573 . . . . 24.57 109.837 177.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 648' ' ' ALA . . . . . . . . . . . . . . . -64.08 120.93 12.98 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.455 -0.339 . . . . 23.82 110.902 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 649' ' ' THR . . . . . . . . . . . . . 1.5 p -80.06 71.23 6.77 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.391 0.615 . . . . 23.239999999999998 111.307 -178.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 650' ' ' VAL . . . . . . . . . . . . . 27.5 m -82.5 -10.94 12.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.927 -0.579 . . . . 23.34 110.943 179.023 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 651' ' ' SER . . . . . . . . . . . . . 14.9 m -80.63 170.14 16.72 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.051 -0.522 . . . . 21.93 109.899 177.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 652' ' ' ARG . . . . . . . . . . . . . 31.7 ttp180 60.27 80.33 0.27 Allowed Pre-proline 0 CA--C 1.531 0.242 0 CA-C-O 121.04 0.448 . . . . 21.539999999999999 110.357 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 653' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -77.03 97.53 1.16 Allowed 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.522 2.148 . . . . 19.800000000000001 112.707 -176.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 654' ' ' VAL . . . . . 0.448 ' O ' HG12 ' A' ' 654' ' ' VAL . 14.6 t 62.83 34.98 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-O 121.536 0.684 . . . . 20.260000000000002 110.131 178.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 655' ' ' SER . . . . . . . . . . . . . 23.6 m 61.59 -83.58 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.261 -0.881 . . . . 18.239999999999998 111.671 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 656' ' ' HIS . . . . . . . . . . . . . 35.3 t60 -138.69 102.46 4.59 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.858 -0.793 . . . . 16.629999999999999 108.858 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 657' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -109.03 178.68 4.39 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.494 -0.321 . . . . 17.75 110.632 -177.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 658' ' ' ARG . . . . . . . . . . . . . 80.6 mtm180 57.62 73.03 0.48 Allowed 'General case' 0 C--O 1.232 0.181 0 O-C-N 123.742 0.651 . . . . 15.35 110.971 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 659' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -84.31 157.29 21.56 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.032 -0.531 . . . . 14.949999999999999 109.911 177.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . -172.67 89.5 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.647 -0.787 . . . . 12.49 112.12 -178.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 661' ' ' THR . . . . . 0.431 ' HA ' ' HD3' ' A' ' 662' ' ' PRO . 0.8 OUTLIER -79.86 119.95 78.37 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-O 120.682 0.277 . . . . 10.68 111.27 179.302 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 662' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 661' ' ' THR . 24.0 Cg_exo -63.95 117.1 4.12 Favored 'Trans proline' 0 C--O 1.235 0.362 0 C-N-CA 122.967 2.445 . . . . 10.300000000000001 112.09 178.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 663' ' ' MET . . . . . . . . . . . . . 25.0 mmt 66.21 -176.43 0.19 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.719 -0.673 . . . . 9.4100000000000001 110.878 -178.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 664' ' ' VAL . . . . . . . . . . . . . 7.2 p -72.87 -36.44 51.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.03 0.443 . . . . 7.04 109.967 177.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 665' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -157.1 -76.37 0.09 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.006 -0.543 . . . . 7.0700000000000003 110.064 175.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 666' ' ' ASN . . . . . . . . . . . . . 64.8 t30 54.82 42.66 30.98 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.295 0.569 . . . . 6.7999999999999998 109.543 -177.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 667' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 66.63 136.98 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 114.934 -1.03 . . . . 5.4900000000000002 111.104 -173.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 668' ' ' SER . . . . . . . . . . . . . 19.1 m -80.89 37.0 0.41 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.324 0.583 . . . . 4.7199999999999998 110.526 179.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 669' ' ' GLY . . . . . . . . . . . . . . . 79.24 -113.25 3.62 Favored Glycine 0 N--CA 1.436 -1.316 0 N-CA-C 110.751 -0.939 . . . . 1.8700000000000001 110.751 -175.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 670' ' ' TYR . . . . . 0.552 ' CD1' HD11 ' A' ' 698' ' ' LEU . 57.1 m-85 -138.28 158.31 44.54 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.603 -0.517 . . . . 1.4099999999999999 109.603 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 10.4 mtmp? -100.04 143.03 30.72 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.889 0.376 . . . . 2.7000000000000002 110.553 -177.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 672' ' ' LEU . . . . . . . . . . . . . 52.4 mt -81.13 137.41 35.95 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.107 -0.497 . . . . 1.05 110.405 -179.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 673' ' ' GLY . . . . . . . . . . . . . . . 88.35 11.82 66.13 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 110.831 -0.907 . . . . 0.64000000000000001 110.831 -173.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 674' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -94.76 144.07 25.94 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.891 0.376 . . . . 2.2000000000000002 110.526 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 675' ' ' ARG . . . . . 0.433 ' HD3' ' O ' ' A' ' 684' ' ' GLY . 11.0 tpp85 -97.95 123.82 42.12 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.622 -0.717 . . . . 4.0700000000000003 109.835 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 676' ' ' VAL . . . . . 0.423 ' HB ' HD12 ' A' ' 717' ' ' LEU . 27.2 m -115.84 161.94 14.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.071 -0.513 . . . . 0.58999999999999997 110.425 -177.487 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 677' ' ' ARG . . . . . 0.431 ' HG3' ' HG2' ' A' ' 683' ' ' GLU . 21.5 ttt180 -135.38 131.1 35.91 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.27 -0.423 . . . . 3.1499999999999999 111.123 178.322 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 678' ' ' HIS . . . . . 0.465 ' CD2' HD13 ' A' ' 717' ' ' LEU . 0.0 OUTLIER -141.42 147.22 37.6 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.51 -0.768 . . . . 1.53 109.25 175.034 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 679' ' ' ALA . . . . . . . . . . . . . . . -76.85 -26.23 54.05 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.108 0.411 . . . . 1.24 112.108 -169.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 680' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -87.98 -37.81 16.06 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.036 0.384 . . . . 2.9199999999999999 112.036 -176.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 681' ' ' PHE . . . . . . . . . . . . . 19.2 m-30 -106.71 -11.26 15.86 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 111.814 0.301 . . . . 1.5 111.814 -176.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 682' ' ' GLY . . . . . . . . . . . . . . . 90.53 -156.42 24.81 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.551 -0.833 . . . . 0.81999999999999995 111.777 -177.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 683' ' ' GLU . . . . . 0.431 ' HG2' ' HG3' ' A' ' 677' ' ' ARG . 27.6 mt-10 -103.6 144.69 31.1 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.9 -0.407 . . . . 2.1099999999999999 109.9 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 684' ' ' GLY . . . . . 0.433 ' O ' ' HD3' ' A' ' 675' ' ' ARG . . . -148.64 170.88 29.07 Favored Glycine 0 C--N 1.313 -0.742 0 C-N-CA 120.224 -0.989 . . . . 0.38 112.696 -177.33 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 685' ' ' THR . . . . . . . . . . . . . 32.8 m -113.83 124.67 52.78 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.872 0.368 . . . . 0.46999999999999997 110.213 178.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 28.3 mt -73.64 104.7 2.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.259 -0.428 . . . . 0.46999999999999997 109.912 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 687' ' ' VAL . . . . . . . . . . . . . 29.0 m -93.49 -25.63 4.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.732 0.301 . . . . 0.5 111.578 -175.353 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -152.14 163.93 38.36 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.446 -0.343 . . . . 1.6200000000000001 110.138 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 689' ' ' MET . . . . . . . . . . . . . 5.1 ppp? -151.91 163.86 38.35 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.496 -0.557 . . . . 2.1699999999999999 109.496 177.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 690' ' ' GLU . . . . . 0.427 ' CG ' ' HB2' ' A' ' 697' ' ' ARG . 10.7 pt-20 -146.91 155.13 42.05 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.406 -0.361 . . . . 2.02 110.579 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . 78.23 -159.29 46.82 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.963 -0.636 . . . . 1.05 112.485 177.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 29.6 t -161.81 149.43 14.62 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 110.259 -0.275 . . . . 2.1800000000000002 110.259 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 62.86 -127.52 38.88 Favored Glycine 0 N--CA 1.452 -0.262 0 CA-C-N 116.072 -0.513 . . . . 1.3100000000000001 113.574 175.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 694' ' ' GLU . . . . . 0.426 ' HA ' ' HB2' ' A' ' 713' ' ' ALA . 42.0 mt-10 -80.58 -15.79 55.77 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.775 0.322 . . . . 2.8500000000000001 111.417 -175.412 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 695' ' ' HIS . . . . . . . . . . . . . 18.5 p-80 -109.9 34.71 3.7 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.322 0.582 . . . . 3.0499999999999998 110.306 178.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 696' ' ' SER . . . . . . . . . . . . . 77.9 p -101.31 145.73 28.49 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.733 -0.667 . . . . 1.5 110.507 178.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 697' ' ' ARG . . . . . 0.427 ' HB2' ' CG ' ' A' ' 690' ' ' GLU . 96.8 mtt180 -125.33 151.05 46.57 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.658 -0.497 . . . . 2.54 109.658 175.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 698' ' ' LEU . . . . . 0.552 HD11 ' CD1' ' A' ' 670' ' ' TYR . 15.5 mt -117.36 146.33 43.47 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.719 -0.474 . . . . 0.46000000000000002 109.719 178.246 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 699' ' ' GLN . . . . . 0.5 ' HA ' ' O ' ' A' ' 708' ' ' LYS . 63.2 mt-30 -107.94 99.09 8.57 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.76 0.791 . . . . 2.2400000000000002 109.27 169.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 700' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 707' ' ' ILE . 20.8 t -100.02 122.72 52.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 114.38 -1.282 . . . . 0.22 110.565 -173.636 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -85.5 94.31 8.99 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.722 -0.473 . . . . 0.23000000000000001 109.722 177.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 702' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -74.0 127.02 31.8 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.957 0.408 . . . . 1.2 110.002 178.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -62.43 -26.67 68.62 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.473 -0.785 . . . . 2.79 112.175 -169.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -96.05 -7.25 58.64 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.586 -0.816 . . . . 0.78000000000000003 113.138 -178.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 705' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -134.59 -79.19 0.45 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 117.184 0.492 . . . . 2.6200000000000001 111.344 -178.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 706' ' ' GLY . . . . . . . . . . . . . . . 168.71 -164.26 37.89 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.706 -0.759 . . . . 0.5 112.309 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 707' ' ' ILE . . . . . 0.454 ' HA ' ' O ' ' A' ' 700' ' ' VAL . 61.3 mt -75.89 127.85 37.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.936 0.398 . . . . 0.67000000000000004 110.883 -178.132 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 708' ' ' LYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 699' ' ' GLN . 68.1 mttm -127.31 158.97 35.81 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.656 -0.702 . . . . 1.3500000000000001 110.733 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 709' ' ' TRP . . . . . . . . . . . . . 13.8 p-90 -99.41 111.93 24.2 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.608 0.718 . . . . 0.83999999999999997 110.222 179.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -117.04 115.22 24.99 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.861 -0.609 . . . . 0.44 110.443 -178.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 46.8 t -63.1 105.48 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.218 -0.66 . . . . 0.60999999999999999 109.218 174.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 712' ' ' ALA . . . . . . . . . . . . . . . -48.62 -46.92 40.4 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 113.216 0.821 . . . . 0.91000000000000003 113.216 -167.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 713' ' ' ALA . . . . . 0.426 ' HB2' ' HA ' ' A' ' 694' ' ' GLU . . . -64.11 -28.59 69.88 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.262 -0.427 . . . . 1.1000000000000001 112.051 -175.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 714' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -111.35 2.47 17.63 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.281 0.563 . . . . 1.96 110.656 -178.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 715' ' ' ALA . . . . . 0.475 ' HB1' ' CD2' ' A' ' 717' ' ' LEU . . . -84.3 -50.82 7.5 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.509 -0.769 . . . . 0.77000000000000002 109.617 177.225 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 716' ' ' ARG . . . . . 0.637 ' HA ' ' HE ' ' A' ' 716' ' ' ARG . 1.3 mmp_? 51.41 67.52 0.94 Allowed 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.596 -0.729 . . . . 4.4100000000000001 110.83 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 717' ' ' LEU . . . . . 0.475 ' CD2' ' HB1' ' A' ' 715' ' ' ALA . 4.6 mm? -86.05 152.34 22.97 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.328 -0.851 . . . . 0.84999999999999998 109.597 177.558 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 718' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -114.26 128.38 56.33 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.7 -0.481 . . . . 2.1299999999999999 109.7 178.013 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 719' ' ' SER . . . . . . . . . . . . . 25.3 m -66.8 123.55 20.45 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.88 -0.415 . . . . 1.6799999999999999 109.88 176.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 720' ' ' VAL . . . . . . . . . . . . . 3.2 p . . . . . 0 C--O 1.248 1.003 0 CA-C-N 116.463 -0.335 . . . . 1.6399999999999999 111.038 -177.354 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 . . . . . 0 N--CA 1.484 1.274 0 CA-C-O 120.457 0.17 . . . . 27.27 111.206 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 646' ' ' LEU . . . . . 0.438 ' HG ' HG21 ' A' ' 650' ' ' VAL . 10.0 mp 61.5 27.79 17.24 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 122.617 0.367 . . . . 26.57 111.492 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 647' ' ' ARG . . . . . . . . . . . . . 30.9 tpt180 -76.5 92.36 3.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.409 -0.359 . . . . 24.57 110.573 -178.037 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 648' ' ' ALA . . . . . . . . . . . . . . . 65.01 -80.71 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.382 -0.826 . . . . 23.82 111.913 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 649' ' ' THR . . . . . . . . . . . . . 6.4 t -77.23 106.32 8.89 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.576 0.703 . . . . 23.239999999999998 110.827 -178.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 650' ' ' VAL . . . . . 0.438 HG21 ' HG ' ' A' ' 646' ' ' LEU . 10.3 p -165.63 -37.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.774 -0.648 . . . . 23.34 110.594 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 651' ' ' SER . . . . . . . . . . . . . 22.9 t -79.73 -42.71 24.04 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 109.261 -0.644 . . . . 21.93 109.261 178.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 652' ' ' ARG . . . . . . . . . . . . . 70.6 mtm180 -141.07 107.02 6.22 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.639 -0.71 . . . . 21.539999999999999 109.736 172.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 653' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -62.03 91.19 0.12 Allowed 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 122.769 2.313 . . . . 19.800000000000001 111.269 174.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 654' ' ' VAL . . . . . . . . . . . . . 97.9 t 72.53 121.44 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.489 -0.778 . . . . 20.260000000000002 110.38 -174.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 655' ' ' SER . . . . . . . . . . . . . 32.9 t -74.01 88.36 1.88 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.807 -0.633 . . . . 18.239999999999998 110.817 -177.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 656' ' ' HIS . . . . . . . . . . . . . 77.0 m-70 -82.9 117.76 22.98 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.118 -0.492 . . . . 16.629999999999999 110.558 177.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 657' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -103.03 113.65 27.3 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.033 0.444 . . . . 17.75 110.182 177.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 658' ' ' ARG . . . . . . . . . . . . . 60.3 mtp180 -88.71 -26.85 21.58 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.148 -0.478 . . . . 15.35 111.423 -176.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 659' ' ' MET . . . . . 0.41 ' O ' ' HG2' ' A' ' 659' ' ' MET . 24.4 ttt 64.52 26.34 13.35 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.454 -0.793 . . . . 14.949999999999999 110.924 178.462 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . -135.4 49.34 0.89 Allowed Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.712 -0.756 . . . . 12.49 112.152 -177.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 661' ' ' THR . . . . . . . . . . . . . 16.1 m -79.22 121.04 82.6 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-O 120.761 0.315 . . . . 10.68 110.247 178.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 662' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -66.97 -39.37 14.17 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.82 2.347 . . . . 10.300000000000001 112.503 -178.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 663' ' ' MET . . . . . . . . . . . . . 19.7 ptp -152.67 142.41 21.97 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.187 -0.46 . . . . 9.4100000000000001 109.922 176.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 664' ' ' VAL . . . . . . . . . . . . . 16.0 m -107.95 156.65 8.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 115.746 -0.661 . . . . 7.04 110.701 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 665' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -124.07 20.71 9.04 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.334 -0.393 . . . . 7.0700000000000003 111.102 -179.298 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 666' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -71.28 -26.88 63.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.914 0.387 . . . . 6.7999999999999998 111.14 -176.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 667' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -122.8 23.64 9.36 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.911 -0.403 . . . . 5.4900000000000002 109.911 179.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 668' ' ' SER . . . . . . . . . . . . . 11.3 p -53.47 -42.91 67.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.633 -0.712 . . . . 4.7199999999999998 111.924 -175.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 669' ' ' GLY . . . . . . . . . . . . . . . 108.31 76.87 0.97 Allowed Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.751 -0.738 . . . . 1.8700000000000001 111.897 178.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 670' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -71.12 143.36 50.62 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.76 0.314 . . . . 1.4099999999999999 110.41 -178.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -134.77 162.49 32.22 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.95 -0.568 . . . . 2.7000000000000002 110.297 -174.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 672' ' ' LEU . . . . . . . . . . . . . 35.5 mt -77.86 134.45 37.95 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.845 0.355 . . . . 1.05 110.293 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 673' ' ' GLY . . . . . . . . . . . . . . . 88.38 -0.27 83.17 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 111.415 -0.674 . . . . 0.64000000000000001 111.415 -176.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 674' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -82.61 148.45 27.99 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.717 0.294 . . . . 2.2000000000000002 110.21 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 675' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -103.34 132.4 49.62 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.129 -0.487 . . . . 4.0700000000000003 110.121 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 676' ' ' VAL . . . . . 0.501 ' HB ' HD12 ' A' ' 717' ' ' LEU . 29.9 m -117.01 153.39 18.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.582 -0.735 . . . . 0.58999999999999997 110.448 -177.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 677' ' ' ARG . . . . . 0.435 ' HB2' HG22 ' A' ' 720' ' ' VAL . 42.3 ttt180 -126.79 129.31 48.08 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.328 -0.396 . . . . 3.1499999999999999 110.376 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -140.79 121.55 14.37 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.089 -0.708 . . . . 1.53 109.089 177.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 679' ' ' ALA . . . . . . . . . . . . . . . -58.73 -18.5 32.0 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.127 0.417 . . . . 1.24 112.127 -175.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 680' ' ' LYS . . . . . 0.523 ' HD2' ' N ' ' A' ' 680' ' ' LYS . 0.3 OUTLIER -91.07 -35.52 14.56 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.243 -0.435 . . . . 2.9199999999999999 112.088 -177.515 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 681' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -113.25 -11.46 13.22 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.787 0.327 . . . . 1.5 111.796 -174.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 682' ' ' GLY . . . . . . . . . . . . . . . 92.98 -156.5 22.96 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 111.467 -0.653 . . . . 0.81999999999999995 111.467 -174.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 683' ' ' GLU . . . . . 0.441 ' HA ' ' O ' ' A' ' 676' ' ' VAL . 12.1 pt-20 -109.13 147.73 31.99 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.777 -0.453 . . . . 2.1099999999999999 109.777 177.406 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 684' ' ' GLY . . . . . . . . . . . . . . . -151.15 173.54 30.59 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.428 -0.891 . . . . 0.38 112.286 -177.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 685' ' ' THR . . . . . . . . . . . . . 16.5 m -110.78 125.88 54.02 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.548 0.213 . . . . 0.46999999999999997 110.687 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 50.6 mt -74.39 107.38 4.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.975 -0.379 . . . . 0.46999999999999997 109.975 177.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 687' ' ' VAL . . . . . . . . . . . . . 29.9 m -93.63 -31.92 4.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 120.873 0.368 . . . . 0.5 111.073 -177.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -143.0 159.81 41.54 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.112 -0.495 . . . . 1.6200000000000001 110.243 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 689' ' ' MET . . . . . . . . . . . . . 5.3 ppp? -149.05 142.85 25.63 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.97 0.414 . . . . 2.1699999999999999 110.262 179.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 690' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -114.72 123.62 49.72 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.814 -0.63 . . . . 2.02 110.63 -175.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . 84.62 -152.16 27.28 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.827 -0.701 . . . . 1.05 113.193 174.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 17.5 p -173.7 126.14 0.39 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 123.168 0.587 . . . . 2.1800000000000002 109.569 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 111.77 -143.74 17.46 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.765 -0.731 . . . . 1.3100000000000001 111.703 -175.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 694' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -72.8 -48.6 36.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.083 0.468 . . . . 2.8500000000000001 111.327 -177.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 695' ' ' HIS . . . . . . . . . . . . . 57.9 m-70 -81.92 37.5 0.48 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.968 -0.56 . . . . 3.0499999999999998 111.415 -173.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 696' ' ' SER . . . . . . . . . . . . . 4.6 m -98.31 143.97 28.22 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.22 -0.446 . . . . 1.5 110.163 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 697' ' ' ARG . . . . . . . . . . . . . 40.9 mtm180 -117.64 135.79 53.75 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.553 -0.536 . . . . 2.54 109.553 175.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 15.9 mt -107.3 131.25 54.43 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.86 -0.422 . . . . 0.46000000000000002 109.86 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 699' ' ' GLN . . . . . 0.434 ' HA ' ' O ' ' A' ' 708' ' ' LYS . 5.8 mp0 -93.75 101.52 13.64 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.485 0.659 . . . . 2.2400000000000002 109.498 174.208 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 22.0 t -101.98 124.41 55.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-N 115.045 -0.98 . . . . 0.22 110.437 -175.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 701' ' ' ALA . . . . . 0.411 ' HA ' ' HA ' ' A' ' 707' ' ' ILE . . . -88.11 101.44 13.81 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.986 -0.552 . . . . 0.23000000000000001 110.168 178.263 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 702' ' ' PHE . . . . . 0.444 ' CD1' ' HD2' ' A' ' 708' ' ' LYS . 91.9 m-85 -87.43 120.25 28.54 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.706 -0.479 . . . . 1.2 109.706 176.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -71.2 -11.3 60.86 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.161 0.505 . . . . 2.79 111.064 -174.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -88.24 -13.12 64.36 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.951 -0.643 . . . . 0.78000000000000003 113.122 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 705' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -150.78 -55.61 0.15 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 117.568 0.684 . . . . 2.6200000000000001 111.912 -177.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 706' ' ' GLY . . . . . . . . . . . . . . . 163.78 -167.79 38.05 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.606 -0.806 . . . . 0.5 112.266 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 707' ' ' ILE . . . . . 0.411 ' HA ' ' HA ' ' A' ' 701' ' ' ALA . 61.6 mt -78.02 141.85 14.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.73 0.3 . . . . 0.67000000000000004 110.383 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 708' ' ' LYS . . . . . 0.444 ' HD2' ' CD1' ' A' ' 702' ' ' PHE . 67.1 mttm -132.66 161.75 33.14 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.033 0.444 . . . . 1.3500000000000001 111.004 178.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 709' ' ' TRP . . . . . . . . . . . . . 20.5 p-90 -108.68 119.94 41.0 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.288 -0.869 . . . . 0.83999999999999997 109.124 174.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -120.12 115.13 23.07 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.436 -0.347 . . . . 0.44 110.416 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 48.3 t -66.5 109.42 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.026 -0.731 . . . . 0.60999999999999999 109.026 175.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 712' ' ' ALA . . . . . . . . . . . . . . . -45.42 -48.63 13.65 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 113.283 0.845 . . . . 0.91000000000000003 113.283 -168.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -66.24 -31.43 72.24 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.363 0.505 . . . . 1.1000000000000001 112.363 -175.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 714' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -97.99 -20.79 17.19 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.979 0.419 . . . . 1.96 110.77 -177.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 715' ' ' ALA . . . . . 0.526 ' HB1' ' CD2' ' A' ' 717' ' ' LEU . . . -72.44 -54.55 9.01 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.737 -0.665 . . . . 0.77000000000000002 110.777 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 716' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 57.17 76.43 0.32 Allowed 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.438 0.637 . . . . 4.4100000000000001 110.6 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 717' ' ' LEU . . . . . 0.526 ' CD2' ' HB1' ' A' ' 715' ' ' ALA . 4.4 mm? -97.19 142.4 29.15 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.607 -0.724 . . . . 0.84999999999999998 110.955 -178.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 718' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -101.89 130.32 48.34 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.678 -0.86 . . . . 2.1299999999999999 108.678 175.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 719' ' ' SER . . . . . . . . . . . . . 23.2 t -71.05 130.9 42.73 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.878 0.371 . . . . 1.6799999999999999 110.403 -177.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 720' ' ' VAL . . . . . 0.435 HG22 ' HB2' ' A' ' 677' ' ' ARG . 46.2 t . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.398 -0.81 . . . . 1.6399999999999999 110.627 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 . . . . . 0 N--CA 1.481 1.107 0 N-CA-C 109.746 -0.464 . . . . 27.27 109.746 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 646' ' ' LEU . . . . . . . . . . . . . 84.3 mt -103.62 89.74 3.44 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.481 0.182 . . . . 26.57 110.74 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 647' ' ' ARG . . . . . . . . . . . . . 76.7 mtp180 62.32 98.77 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 O-C-N 123.784 0.677 . . . . 24.57 111.547 177.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 648' ' ' ALA . . . . . . . . . . . . . . . -75.8 -14.83 60.31 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.322 0.582 . . . . 23.82 110.912 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 649' ' ' THR . . . . . . . . . . . . . 24.6 p 52.06 39.51 26.59 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 114.569 -1.196 . . . . 23.239999999999998 112.499 177.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 650' ' ' VAL . . . . . . . . . . . . . 42.4 t -77.44 75.8 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-O 121.743 0.782 . . . . 23.34 109.811 178.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 651' ' ' SER . . . . . . . . . . . . . 36.4 t -150.67 -57.93 0.17 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.902 -1.044 . . . . 21.93 108.706 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 652' ' ' ARG . . . . . . . . . . . . . 66.7 mtp180 56.17 76.12 0.52 Allowed Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 115.214 -0.903 . . . . 21.539999999999999 111.88 175.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 653' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -74.91 78.22 2.92 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.645 2.23 . . . . 19.800000000000001 111.389 176.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 654' ' ' VAL . . . . . . . . . . . . . 12.2 p -64.88 -29.93 48.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.957 -0.565 . . . . 20.260000000000002 110.971 -178.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 655' ' ' SER . . . . . . . . . . . . . 24.4 t -102.54 96.62 7.03 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 116.037 -0.529 . . . . 18.239999999999998 110.172 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 656' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -88.9 102.31 14.92 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.418 -0.586 . . . . 16.629999999999999 109.418 178.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 657' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -130.81 10.2 5.05 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.1 0.407 . . . . 17.75 112.1 -174.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 658' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -82.51 -16.27 49.33 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.656 -0.418 . . . . 15.35 110.621 -177.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 659' ' ' MET . . . . . . . . . . . . . 51.9 tpp -64.0 -56.68 13.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.982 -0.554 . . . . 14.949999999999999 110.929 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . -111.55 51.1 0.72 Allowed Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.88 -0.676 . . . . 12.49 112.001 -177.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 661' ' ' THR . . . . . 0.403 ' HA ' ' HD3' ' A' ' 662' ' ' PRO . 10.8 t -98.74 135.99 20.84 Favored Pre-proline 0 C--N 1.321 -0.673 0 N-CA-C 109.854 -0.425 . . . . 10.68 109.854 178.539 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 662' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 661' ' ' THR . 31.6 Cg_exo -59.17 -31.86 96.1 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.096 2.531 . . . . 10.300000000000001 112.16 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 663' ' ' MET . . . . . . . . . . . . . 53.8 ttm -147.91 143.7 27.55 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.125 -0.694 . . . . 9.4100000000000001 109.125 175.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 664' ' ' VAL . . . . . 0.425 HG12 ' HG3' ' A' ' 665' ' ' GLU . 46.8 t -94.23 125.8 46.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.617 -0.265 . . . . 7.04 110.552 -178.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 665' ' ' GLU . . . . . 0.425 ' HG3' HG12 ' A' ' 664' ' ' VAL . 50.6 mt-10 61.08 71.88 0.54 Allowed 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.699 -0.682 . . . . 7.0700000000000003 111.391 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 666' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -74.07 99.65 3.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.014 -0.539 . . . . 6.7999999999999998 109.936 176.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 667' ' ' ASP . . . . . . . . . . . . . 4.9 t70 63.53 -162.84 0.27 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.803 -0.635 . . . . 5.4900000000000002 109.43 -175.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 668' ' ' SER . . . . . . . . . . . . . 5.1 p -72.39 -35.31 68.41 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 122.28 -0.263 . . . . 4.7199999999999998 110.951 -178.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 669' ' ' GLY . . . . . . . . . . . . . . . 60.99 76.78 0.22 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.833 -0.699 . . . . 1.8700000000000001 112.603 178.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 670' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -73.32 151.34 41.34 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.951 0.405 . . . . 1.4099999999999999 110.529 -178.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 48.8 mtpt -128.54 155.86 44.21 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.876 -0.602 . . . . 2.7000000000000002 110.408 -178.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 672' ' ' LEU . . . . . 0.56 HD21 ' SD ' ' A' ' 689' ' ' MET . 52.0 mt -79.38 134.17 36.58 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.199 -0.455 . . . . 1.05 110.098 177.242 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 673' ' ' GLY . . . . . . . . . . . . . . . 88.9 15.36 59.54 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.856 -0.687 . . . . 0.64000000000000001 111.747 -175.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 674' ' ' GLN . . . . . . . . . . . . . 43.9 tp60 -94.49 144.79 25.28 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.286 -0.264 . . . . 2.2000000000000002 110.286 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 675' ' ' ARG . . . . . . . . . . . . . 19.5 mtm180 -92.0 124.74 36.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.229 -0.441 . . . . 4.0700000000000003 109.855 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 676' ' ' VAL . . . . . 0.449 ' HB ' HD12 ' A' ' 717' ' ' LEU . 29.0 m -117.91 154.56 19.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-O 120.792 0.33 . . . . 0.58999999999999997 110.935 -179.366 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 677' ' ' ARG . . . . . 0.547 ' HB2' HG22 ' A' ' 720' ' ' VAL . 28.3 ttt-85 -130.77 131.61 44.81 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.858 -0.61 . . . . 3.1499999999999999 109.812 178.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 678' ' ' HIS . . . . . 0.517 ' HB2' ' CD1' ' A' ' 717' ' ' LEU . 20.2 t60 -149.89 113.44 4.99 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.543 -0.54 . . . . 1.53 109.543 176.588 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 679' ' ' ALA . . . . . . . . . . . . . . . -49.79 -25.68 3.27 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 113.379 0.881 . . . . 1.24 113.379 -173.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 680' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -75.49 -33.19 60.76 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.762 -0.199 . . . . 2.9199999999999999 111.411 -174.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 681' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -125.75 -13.13 6.48 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.745 0.307 . . . . 1.5 111.821 -174.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 682' ' ' GLY . . . . . . . . . . . . . . . 104.75 -153.59 17.43 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.855 -0.688 . . . . 0.81999999999999995 111.786 -178.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 683' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -114.51 148.35 38.04 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.854 -0.425 . . . . 2.1099999999999999 109.854 178.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 684' ' ' GLY . . . . . . . . . . . . . . . -156.66 -178.71 31.03 Favored Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 119.784 -1.198 . . . . 0.38 112.848 -178.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 685' ' ' THR . . . . . . . . . . . . . 12.6 m -113.97 125.62 54.22 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 110.266 -0.272 . . . . 0.46999999999999997 110.266 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 46.4 mt -70.44 104.92 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.736 -0.468 . . . . 0.46999999999999997 109.736 177.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 687' ' ' VAL . . . . . . . . . . . . . 27.1 m -93.82 -23.93 5.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 120.978 0.418 . . . . 0.5 111.061 -177.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 688' ' ' ASN . . . . . 0.471 ' HB3' ' HB2' ' A' ' 699' ' ' GLN . 8.5 t30 -151.33 161.3 42.95 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.48 -0.563 . . . . 1.6200000000000001 109.48 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 689' ' ' MET . . . . . 0.56 ' SD ' HD21 ' A' ' 672' ' ' LEU . 0.0 OUTLIER -157.34 157.89 34.95 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 110.038 -0.356 . . . . 2.1699999999999999 110.038 178.616 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 690' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -125.2 122.29 36.59 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.631 -0.507 . . . . 2.02 109.631 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . 74.84 -169.34 54.52 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.821 -0.704 . . . . 1.05 112.422 -177.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 49.6 m -155.72 96.37 1.75 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.803 0.335 . . . . 2.1800000000000002 110.168 177.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 153.12 -130.14 2.92 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.902 -0.666 . . . . 1.3100000000000001 112.729 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 694' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -84.18 -57.61 3.1 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.579 0.585 . . . . 2.8500000000000001 112.579 -173.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 695' ' ' HIS . . . . . . . . . . . . . 16.2 p-80 -84.5 21.64 1.44 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.533 0.682 . . . . 3.0499999999999998 110.855 -174.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 696' ' ' SER . . . . . . . . . . . . . 14.3 m -84.77 152.74 23.46 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.095 -0.957 . . . . 1.5 110.513 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 697' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -116.04 145.28 43.12 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 110.151 -0.314 . . . . 2.54 110.151 176.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 16.6 mt -118.23 135.81 54.04 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.708 -0.479 . . . . 0.46000000000000002 109.708 178.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 699' ' ' GLN . . . . . 0.512 ' HA ' ' O ' ' A' ' 708' ' ' LYS . 24.6 mp0 -102.97 105.92 16.35 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.708 0.766 . . . . 2.2400000000000002 109.907 174.267 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 700' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 707' ' ' ILE . 27.3 t -104.23 125.23 59.02 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 114.545 -1.207 . . . . 0.22 110.69 -174.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -87.76 94.3 9.71 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.155 -0.475 . . . . 0.23000000000000001 109.742 175.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 702' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -75.94 132.71 40.42 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.014 -0.539 . . . . 1.2 110.203 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 63.1 tp60 -68.59 -25.17 64.74 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.556 -0.747 . . . . 2.79 111.174 -175.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -91.16 1.94 78.02 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.686 -0.768 . . . . 0.78000000000000003 113.264 -177.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 705' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -157.21 -80.04 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 117.176 0.488 . . . . 2.6200000000000001 111.421 177.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 706' ' ' GLY . . . . . . . . . . . . . . . 179.65 -157.44 20.39 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.432 -0.889 . . . . 0.5 112.459 -178.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 707' ' ' ILE . . . . . 0.459 ' HA ' ' O ' ' A' ' 700' ' ' VAL . 60.3 mt -80.88 135.95 24.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.781 0.324 . . . . 0.67000000000000004 111.039 -177.552 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 708' ' ' LYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 699' ' ' GLN . 63.8 mttm -135.86 159.4 41.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.87 -0.605 . . . . 1.3500000000000001 110.561 178.338 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 709' ' ' TRP . . . . . . . . . . . . . 12.3 p-90 -101.8 121.2 41.63 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.726 -0.67 . . . . 0.83999999999999997 109.568 177.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 710' ' ' LEU . . . . . 0.443 ' HB3' ' HB2' ' A' ' 715' ' ' ALA . 3.8 mm? -118.1 113.05 21.01 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.311 -0.404 . . . . 0.44 110.141 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 99.3 t -66.24 110.63 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.487 -0.56 . . . . 0.60999999999999999 109.487 175.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 712' ' ' ALA . . . . . . . . . . . . . . . -41.81 -47.12 4.09 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 113.874 1.065 . . . . 0.91000000000000003 113.874 -169.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -60.01 -35.75 75.75 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.49 0.552 . . . . 1.1000000000000001 112.49 -177.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 714' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -100.64 -13.62 18.47 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.28 0.562 . . . . 1.96 110.291 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 715' ' ' ALA . . . . . 0.624 ' HB1' ' CD2' ' A' ' 717' ' ' LEU . . . -70.65 -59.59 2.74 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.298 -0.864 . . . . 0.77000000000000002 110.397 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 716' ' ' ARG . . . . . . . . . . . . . 19.9 mtp180 50.23 66.65 1.09 Allowed 'General case' 0 N--CA 1.464 0.227 0 O-C-N 123.858 0.724 . . . . 4.4100000000000001 111.363 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 717' ' ' LEU . . . . . 0.624 ' CD2' ' HB1' ' A' ' 715' ' ' ALA . 4.1 mm? -87.94 140.28 29.66 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.168 0.509 . . . . 0.84999999999999998 111.396 -176.066 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 718' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -101.24 134.99 43.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.523 -0.762 . . . . 2.1299999999999999 108.988 174.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 719' ' ' SER . . . . . . . . . . . . . 20.6 t -78.04 133.72 37.9 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.691 0.281 . . . . 1.6799999999999999 110.65 -175.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 720' ' ' VAL . . . . . 0.547 HG22 ' HB2' ' A' ' 677' ' ' ARG . 16.9 t . . . . . 0 C--O 1.251 1.132 0 CA-C-O 118.461 -0.78 . . . . 1.6399999999999999 110.096 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 16.7 tpp180 . . . . . 0 N--CA 1.479 0.978 0 CA-C-O 120.846 0.355 . . . . 27.27 110.222 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 646' ' ' LEU . . . . . . . . . . . . . 56.5 tp -82.88 131.3 35.2 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.105 -0.498 . . . . 26.57 110.298 179.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 647' ' ' ARG . . . . . . . . . . . . . 25.0 ttm180 -88.65 40.04 0.95 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.488 0.661 . . . . 24.57 110.251 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 648' ' ' ALA . . . . . . . . . . . . . . . -155.32 68.3 0.67 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.927 -0.579 . . . . 23.82 110.193 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 649' ' ' THR . . . . . . . . . . . . . 12.1 t -77.07 -8.24 57.11 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.087 -0.506 . . . . 23.239999999999998 111.41 -175.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 650' ' ' VAL . . . . . . . . . . . . . 10.0 p -67.79 -26.55 35.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 121.451 0.643 . . . . 23.34 110.149 176.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 651' ' ' SER . . . . . . . . . . . . . 5.1 p -107.62 142.97 36.74 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 115.629 -0.714 . . . . 21.93 110.485 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 652' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -91.69 110.47 43.6 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 109.648 -0.501 . . . . 21.539999999999999 109.648 178.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 653' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -75.62 74.1 4.43 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.729 2.286 . . . . 19.800000000000001 112.776 -175.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 654' ' ' VAL . . . . . . . . . . . . . 12.3 p -77.87 52.01 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 122.592 1.187 . . . . 20.260000000000002 110.272 177.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 655' ' ' SER . . . . . . . . . . . . . 31.1 t -84.66 117.3 23.69 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.209 -0.905 . . . . 18.239999999999998 109.987 -177.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 656' ' ' HIS . . . . . . . . . . . . . 67.8 m-70 -103.07 121.81 43.37 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.942 -0.572 . . . . 16.629999999999999 109.578 177.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 657' ' ' GLN . . . . . . . . . . . . . 19.7 mp0 -76.17 -27.98 57.16 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.969 -0.56 . . . . 17.75 110.692 -174.07 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 658' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 66.5 -80.74 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.162 0 O-C-N 124.005 0.815 . . . . 15.35 110.417 -177.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 659' ' ' MET . . . . . . . . . . . . . 49.4 ttm 54.04 74.63 0.32 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.281 0.562 . . . . 14.949999999999999 111.146 175.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . -156.33 -43.77 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.775 -0.726 . . . . 12.49 112.081 -179.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 661' ' ' THR . . . . . . . . . . . . . 15.0 t -82.99 134.93 45.61 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-O 120.963 0.411 . . . . 10.68 110.384 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 662' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -74.46 107.71 2.51 Favored 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 122.506 2.137 . . . . 10.300000000000001 111.875 178.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 663' ' ' MET . . . . . . . . . . . . . 88.5 mtp -82.14 128.42 34.12 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.253 -0.431 . . . . 9.4100000000000001 110.623 -178.11 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 664' ' ' VAL . . . . . . . . . . . . . 66.3 t -78.66 117.51 24.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.187 -0.461 . . . . 7.04 110.252 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 665' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -111.62 72.31 0.77 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.311 0.577 . . . . 7.0700000000000003 110.602 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 666' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -117.84 71.4 0.82 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.397 -0.819 . . . . 6.7999999999999998 108.955 178.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 667' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 59.4 28.8 18.25 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.535 -0.757 . . . . 5.4900000000000002 109.966 -172.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 668' ' ' SER . . . . . . . . . . . . . 5.0 p -120.94 11.59 11.06 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.975 -1.011 . . . . 4.7199999999999998 110.62 -177.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 669' ' ' GLY . . . . . . . . . . . . . . . -81.98 -89.93 0.62 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.918 -0.658 . . . . 1.8700000000000001 112.216 -177.236 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 670' ' ' TYR . . . . . 0.441 ' CE1' ' HB2' ' A' ' 717' ' ' LEU . 72.7 m-85 -120.84 125.07 46.58 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.069 0.461 . . . . 1.4099999999999999 110.433 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -119.82 162.8 18.5 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.506 -0.77 . . . . 2.7000000000000002 110.281 -173.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 672' ' ' LEU . . . . . . . . . . . . . 30.3 mt -79.22 137.37 37.39 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.332 -0.395 . . . . 1.05 110.053 177.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 673' ' ' GLY . . . . . . . . . . . . . . . 86.82 -3.11 87.24 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.862 -0.685 . . . . 0.64000000000000001 111.523 -177.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 674' ' ' GLN . . . . . . . . . . . . . 57.8 tp60 -80.34 142.62 34.28 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.828 -0.434 . . . . 2.2000000000000002 109.828 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 675' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -101.95 133.27 47.0 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.016 -0.538 . . . . 4.0700000000000003 109.958 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 676' ' ' VAL . . . . . 0.472 ' HB ' ' HB3' ' A' ' 717' ' ' LEU . 28.8 m -121.08 152.03 24.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 115.727 -0.669 . . . . 0.58999999999999997 111.022 -175.048 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 677' ' ' ARG . . . . . 0.458 ' HB2' HG22 ' A' ' 720' ' ' VAL . 27.9 ttp85 -123.3 123.59 41.08 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.963 -0.755 . . . . 3.1499999999999999 108.963 176.356 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 678' ' ' HIS . . . . . 0.537 ' HB2' ' CD1' ' A' ' 717' ' ' LEU . 52.6 t60 -128.89 122.68 30.83 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 110.05 -0.352 . . . . 1.53 110.05 -179.231 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 679' ' ' ALA . . . . . . . . . . . . . . . -40.92 -45.85 2.64 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.545 0.943 . . . . 1.24 113.545 -172.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 680' ' ' LYS . . . . . . . . . . . . . 31.0 mtpt -92.62 -27.43 17.33 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.659 -0.7 . . . . 2.9199999999999999 112.819 -168.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 681' ' ' PHE . . . . . . . . . . . . . 20.3 m-30 -106.29 -12.34 15.73 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.02 0.378 . . . . 1.5 112.02 -176.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 682' ' ' GLY . . . . . . . . . . . . . . . 90.08 -155.39 24.43 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.373 -0.918 . . . . 0.81999999999999995 111.206 -174.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 683' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -111.91 152.67 27.74 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 117.116 0.458 . . . . 2.1099999999999999 110.844 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 684' ' ' GLY . . . . . . . . . . . . . . . -157.18 -177.32 30.19 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 121.004 -0.617 . . . . 0.38 111.78 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 685' ' ' THR . . . . . . . . . . . . . 41.8 m -118.43 125.8 50.71 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.771 0.32 . . . . 0.46999999999999997 110.991 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 686' ' ' ILE . . . . . 0.438 HG12 HG22 ' A' ' 700' ' ' VAL . 44.3 mt -71.57 110.23 4.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 120.805 0.336 . . . . 0.46999999999999997 110.179 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 687' ' ' VAL . . . . . . . . . . . . . 30.1 m -97.07 -27.61 3.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.487 -0.324 . . . . 0.5 111.642 -176.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -149.66 158.2 43.95 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.067 -0.346 . . . . 1.6200000000000001 110.067 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 689' ' ' MET . . . . . . . . . . . . . 5.2 ppp? -150.8 143.02 24.18 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.021 -0.536 . . . . 2.1699999999999999 109.666 178.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 690' ' ' GLU . . . . . 0.45 ' O ' ' HA ' ' A' ' 696' ' ' SER . 45.0 mt-10 -121.54 140.94 51.57 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.965 -0.561 . . . . 2.02 110.893 -174.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . 68.13 -157.9 52.28 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 121.053 -0.594 . . . . 1.05 112.73 176.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 52.0 m -155.06 136.66 14.28 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.715 0.293 . . . . 2.1800000000000002 110.561 178.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 83.51 -138.66 17.96 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 121.082 -0.58 . . . . 1.3100000000000001 112.873 176.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 694' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -63.36 -37.17 86.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.898 0.38 . . . . 2.8500000000000001 110.9 -178.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 695' ' ' HIS . . . . . . . . . . . . . 33.6 t-80 -86.79 15.75 5.48 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.267 0.556 . . . . 3.0499999999999998 110.674 -177.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 696' ' ' SER . . . . . 0.45 ' HA ' ' O ' ' A' ' 690' ' ' GLU . 19.6 t -92.78 142.17 27.64 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.939 0.399 . . . . 1.5 110.417 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 697' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -123.64 134.82 53.7 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.617 -0.512 . . . . 2.54 109.617 174.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 8.6 mt -108.21 133.53 52.33 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 109.649 -0.5 . . . . 0.46000000000000002 109.649 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 699' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -101.8 106.02 16.95 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.418 0.628 . . . . 2.2400000000000002 110.017 174.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 700' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 707' ' ' ILE . 40.0 t -99.28 123.33 51.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.097 -0.956 . . . . 0.22 110.598 -176.581 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -82.86 94.95 7.79 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.767 -0.651 . . . . 0.23000000000000001 109.823 176.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 702' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -76.11 126.36 30.86 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.622 -0.717 . . . . 1.2 109.966 178.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -64.74 -18.55 65.14 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.716 -0.674 . . . . 2.79 112.041 -173.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -134.92 40.27 1.58 Allowed Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.472 -0.87 . . . . 0.78000000000000003 112.457 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 705' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -166.78 -23.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.836 0.35 . . . . 2.6200000000000001 111.029 -178.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 706' ' ' GLY . . . . . . . . . . . . . . . 101.38 -169.4 20.52 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.546 -0.835 . . . . 0.5 112.038 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 707' ' ' ILE . . . . . 0.519 ' C ' ' HE2' ' A' ' 708' ' ' LYS . 47.0 mt -89.26 117.34 32.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 O-C-N 122.564 -0.374 . . . . 0.67000000000000004 110.88 -178.305 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 708' ' ' LYS . . . . . 0.519 ' HE2' ' C ' ' A' ' 707' ' ' ILE . 0.4 OUTLIER -108.74 165.22 11.72 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.299 -0.41 . . . . 1.3500000000000001 110.265 176.794 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 709' ' ' TRP . . . . . . . . . . . . . 8.1 p-90 -104.91 119.96 40.27 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.706 -0.679 . . . . 0.83999999999999997 109.858 177.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -115.85 109.84 18.2 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.176 -0.465 . . . . 0.44 110.425 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 57.8 t -61.59 119.24 5.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.395 -0.594 . . . . 0.60999999999999999 109.395 174.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 712' ' ' ALA . . . . . . . . . . . . . . . -54.99 -25.38 29.48 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.925 0.713 . . . . 0.91000000000000003 112.925 -172.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -71.02 -25.66 62.77 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.855 0.36 . . . . 1.1000000000000001 111.6 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 714' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -129.22 16.09 6.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.351 -0.386 . . . . 1.96 110.521 -177.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 715' ' ' ALA . . . . . 0.532 ' HB1' ' CD2' ' A' ' 717' ' ' LEU . . . -70.18 -58.14 4.12 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.078 -0.51 . . . . 0.77000000000000002 111.101 -175.364 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 716' ' ' ARG . . . . . . . . . . . . . 74.3 mtt180 57.06 62.14 2.33 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.208 0.528 . . . . 4.4100000000000001 111.177 175.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 717' ' ' LEU . . . . . 0.537 ' CD1' ' HB2' ' A' ' 678' ' ' HIS . 3.1 mm? -102.55 129.67 49.17 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.108 -0.496 . . . . 0.84999999999999998 110.761 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 718' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -93.1 115.16 27.83 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.969 -0.752 . . . . 2.1299999999999999 108.969 175.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 719' ' ' SER . . . . . . . . . . . . . 1.5 p -62.21 135.01 57.3 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.884 0.373 . . . . 1.6799999999999999 111.007 -177.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 720' ' ' VAL . . . . . 0.458 HG22 ' HB2' ' A' ' 677' ' ' ARG . 3.4 t . . . . . 0 C--O 1.251 1.167 0 CA-C-O 118.389 -0.815 . . . . 1.6399999999999999 109.705 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 670' ' ' TYR . . . . . 0.44 ' CD2' HD11 ' A' ' 698' ' ' LEU . 85.8 m-85 . . . . . 0 N--CA 1.454 -0.263 0 CA-C-O 121.081 0.467 . . . . 1.41 111.465 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -106.82 151.27 25.42 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.579 -0.737 . . . . 2.7 110.234 -175.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . . . . . . . . . 41.8 mt -76.0 136.28 39.99 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.025 0.44 . . . . 1.05 111.053 -176.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 673' ' ' GLY . . . . . . . . . . . . . . . 96.9 -3.08 62.27 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.601 -0.727 . . . . 0.64 112.167 -178.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 674' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -79.14 145.52 33.67 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.001 0.429 . . . . 2.2 110.385 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 675' ' ' ARG . . . . . . . . . . . . . 23.4 mmt180 -97.38 126.22 42.48 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.54 -0.754 . . . . 4.07 109.086 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 676' ' ' VAL . . . . . 0.444 ' HB ' HD12 ' A' ' 717' ' ' LEU . 35.7 m -117.17 162.1 15.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 120.828 0.347 . . . . 0.59 111.443 -175.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 677' ' ' ARG . . . . . 0.428 ' HB2' HG22 ' A' ' 720' ' ' VAL . 47.5 ttt180 -138.59 125.86 21.61 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.539 -0.755 . . . . 3.15 109.753 -176.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 678' ' ' HIS . . . . . 0.484 ' CD2' HD13 ' A' ' 717' ' ' LEU . 0.0 OUTLIER -147.5 132.65 18.33 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 110.423 -0.214 . . . . 1.53 110.423 178.092 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 679' ' ' ALA . . . . . . . . . . . . . . . -66.45 -14.57 62.39 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.938 0.399 . . . . 1.24 111.95 -176.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 680' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -82.84 -37.78 23.94 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.142 -0.481 . . . . 2.92 111.963 -178.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 681' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -125.25 -11.8 6.91 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.043 0.386 . . . . 1.5 112.043 -171.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 682' ' ' GLY . . . . . . . . . . . . . . . 98.97 -152.71 19.7 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.294 -0.722 . . . . 0.82 111.294 -175.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 683' ' ' GLU . . . . . 0.406 ' H ' ' CD ' ' A' ' 683' ' ' GLU . 0.2 OUTLIER -104.74 147.19 27.96 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.526 -0.546 . . . . 2.11 109.526 178.213 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 684' ' ' GLY . . . . . . . . . . . . . . . -151.6 173.67 30.88 Favored Glycine 0 N--CA 1.441 -0.967 0 C-N-CA 119.641 -1.266 . . . . 0.38 112.464 -177.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 685' ' ' THR . . . . . . . . . . . . . 35.2 m -118.44 124.3 47.31 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.941 -0.392 . . . . 0.47 109.941 176.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 35.5 mt -72.33 104.88 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.2 -0.455 . . . . 0.47 109.837 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 687' ' ' VAL . . . . . . . . . . . . . 28.7 m -94.9 -23.81 5.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.302 -0.408 . . . . 0.5 111.512 -175.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 688' ' ' ASN . . . . . 0.446 ' HB3' ' HB2' ' A' ' 699' ' ' GLN . 63.0 t30 -151.24 165.0 35.31 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.466 -0.334 . . . . 1.62 110.196 -178.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 689' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.59 156.59 38.26 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.464 -0.569 . . . . 2.17 109.464 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 690' ' ' GLU . . . . . 0.476 ' O ' ' HA ' ' A' ' 696' ' ' SER . 45.9 mt-10 -125.95 123.76 39.26 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.539 -0.3 . . . . 2.02 110.752 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . 69.28 -160.96 52.53 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 121.083 -0.58 . . . . 1.05 112.728 178.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 66.9 m -152.03 157.43 41.66 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.257 -0.275 . . . . 2.18 110.257 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 89.67 -142.39 16.61 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.835 -0.698 . . . . 1.31 112.313 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 694' ' ' GLU . . . . . 0.401 ' HA ' ' HB2' ' A' ' 713' ' ' ALA . 41.7 mt-10 -74.04 -31.46 62.9 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.042 0.449 . . . . 2.85 110.635 -178.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 695' ' ' HIS . . . . . . . . . . . . . 35.4 m170 -91.6 16.11 11.19 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.813 -0.631 . . . . 3.05 110.661 -176.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 696' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 690' ' ' GLU . 20.8 t -81.97 130.47 35.09 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.437 -0.579 . . . . 1.5 109.437 177.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 697' ' ' ARG . . . . . . . . . . . . . 23.9 mtm180 -114.51 133.72 55.56 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.226 -0.657 . . . . 2.54 109.226 177.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 698' ' ' LEU . . . . . 0.44 HD11 ' CD2' ' A' ' 670' ' ' TYR . 9.3 mt -106.14 130.65 53.99 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 120.632 0.253 . . . . 0.46 110.449 -177.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 699' ' ' GLN . . . . . 0.487 ' HA ' ' O ' ' A' ' 708' ' ' LYS . 3.8 mp0 -95.55 100.63 12.35 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.754 0.788 . . . . 2.24 109.264 175.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 700' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' A' ' 707' ' ' ILE . 19.5 t -101.71 124.14 55.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 114.729 -1.123 . . . . 0.22 110.815 -172.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -84.83 94.82 8.81 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.233 -0.439 . . . . 0.23 110.16 177.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 702' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -78.64 122.56 26.1 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.677 -0.49 . . . . 1.2 109.677 177.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -69.15 -13.19 62.28 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.941 -0.572 . . . . 2.79 111.468 -174.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -101.06 8.68 57.65 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.749 -0.739 . . . . 0.78 112.612 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 705' ' ' GLN . . . . . . . . . . . . . 23.2 tp60 -158.45 -75.64 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.958 0.379 . . . . 2.62 111.047 178.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 706' ' ' GLY . . . . . . . . . . . . . . . 170.36 -167.02 40.19 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 121.013 -0.613 . . . . 0.5 112.025 -178.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 707' ' ' ILE . . . . . 0.493 ' HA ' ' O ' ' A' ' 700' ' ' VAL . 71.4 mt -79.53 126.22 39.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.158 0.504 . . . . 0.67 110.796 -178.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 708' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 699' ' ' GLN . 63.6 mttm -125.77 159.4 32.46 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.785 -0.643 . . . . 1.35 110.693 -179.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 709' ' ' TRP . . . . . . . . . . . . . 14.6 p-90 -100.7 116.28 32.23 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.945 -0.57 . . . . 0.84 110.265 178.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -117.76 114.38 23.22 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.016 -0.538 . . . . 0.44 110.206 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 46.5 t -63.86 110.06 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.589 -0.522 . . . . 0.61 109.589 177.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 712' ' ' ALA . . . . . . . . . . . . . . . -45.15 -43.24 9.74 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 113.502 0.927 . . . . 0.91 113.502 -168.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 713' ' ' ALA . . . . . 0.401 ' HB2' ' HA ' ' A' ' 694' ' ' GLU . . . -64.18 -36.99 85.84 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 111.975 0.361 . . . . 1.1 111.975 -177.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 714' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -102.5 -9.79 19.91 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.967 0.413 . . . . 1.96 110.815 -177.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 715' ' ' ALA . . . . . 0.474 ' HB1' ' CD2' ' A' ' 717' ' ' LEU . . . -67.74 -62.6 1.33 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.801 -0.636 . . . . 0.77 109.941 178.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 716' ' ' ARG . . . . . . . . . . . . . 59.9 mtt180 56.03 66.4 1.21 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.506 0.67 . . . . 4.41 110.52 175.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . 0.484 HD13 ' CD2' ' A' ' 678' ' ' HIS . 4.6 mm? -89.21 145.15 25.6 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.189 -0.914 . . . . 0.85 110.334 -177.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 718' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -97.27 134.68 40.24 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.211 -0.663 . . . . 2.13 109.211 176.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 719' ' ' SER . . . . . . . . . . . . . 13.5 m -75.81 128.37 34.99 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.58 -0.282 . . . . 1.68 110.43 -178.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 720' ' ' VAL . . . . . 0.428 HG22 ' HB2' ' A' ' 677' ' ' ARG . 17.6 t . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.498 -0.763 . . . . 1.64 109.77 177.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 670' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 . . . . . 0 N--CA 1.447 -0.58 0 N-CA-C 110.113 -0.329 . . . . 1.41 110.113 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 671' ' ' LYS . . . . . 0.437 ' HG2' ' HB2' ' A' ' 674' ' ' GLN . 20.7 pttp -138.86 160.2 40.3 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.313 -0.625 . . . . 2.7 109.313 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . . . . . . . . . 29.7 mt -72.08 133.08 45.02 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.962 -0.384 . . . . 1.05 109.962 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 673' ' ' GLY . . . . . . . . . . . . . . . 86.94 8.17 76.44 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.791 -0.719 . . . . 0.64 111.764 -175.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 674' ' ' GLN . . . . . 0.437 ' HB2' ' HG2' ' A' ' 671' ' ' LYS . 33.2 tt0 -85.87 142.86 28.58 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.949 -0.389 . . . . 2.2 109.949 178.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 675' ' ' ARG . . . . . 0.473 ' HD2' ' N ' ' A' ' 675' ' ' ARG . 3.7 mpt_? -100.78 127.48 47.19 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.147 0.499 . . . . 4.07 110.328 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 676' ' ' VAL . . . . . 0.503 ' HB ' ' HB3' ' A' ' 717' ' ' LEU . 27.1 m -117.23 154.1 18.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.587 -0.733 . . . . 0.59 110.917 -177.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 677' ' ' ARG . . . . . 0.425 ' CG ' ' HB3' ' A' ' 683' ' ' GLU . 26.9 mtt180 -127.18 136.95 52.77 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.996 -0.547 . . . . 3.15 110.957 177.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -138.94 142.59 38.43 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.503 -0.772 . . . . 1.53 109.333 172.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 679' ' ' ALA . . . . . . . . . . . . . . . -49.46 -52.47 28.87 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.612 0.597 . . . . 1.24 112.612 -172.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 680' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -91.07 -37.05 13.66 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.47 -0.332 . . . . 2.92 111.809 -170.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 681' ' ' PHE . . . . . . . . . . . . . 9.3 m-30 -81.2 -11.32 59.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.841 0.353 . . . . 1.5 111.273 -178.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 682' ' ' GLY . . . . . . . . . . . . . . . 86.32 -111.84 3.67 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.508 -0.853 . . . . 0.82 111.636 178.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 683' ' ' GLU . . . . . 0.425 ' HB3' ' CG ' ' A' ' 677' ' ' ARG . 10.4 pt-20 -155.66 148.43 24.2 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.725 0.298 . . . . 2.11 110.443 178.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 684' ' ' GLY . . . . . . . . . . . . . . . -152.41 -177.31 25.94 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.647 -0.787 . . . . 0.38 111.531 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 685' ' ' THR . . . . . . . . . . . . . 58.5 m -119.44 130.14 55.11 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.827 0.346 . . . . 0.47 110.414 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 686' ' ' ILE . . . . . 0.438 HG12 HG22 ' A' ' 700' ' ' VAL . 48.8 mt -73.86 104.61 2.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.082 -0.508 . . . . 0.47 110.123 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 687' ' ' VAL . . . . . . . . . . . . . 30.3 m -89.63 -26.12 5.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.416 -0.356 . . . . 0.5 111.018 -177.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -152.42 162.41 41.22 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.361 -0.382 . . . . 1.62 110.482 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 689' ' ' MET . . . . . . . . . . . . . 22.1 ptp -147.1 146.18 29.86 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.03 -0.532 . . . . 2.17 109.905 178.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 690' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -120.81 156.01 32.83 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.882 -0.599 . . . . 2.02 109.832 -176.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . 80.62 -169.42 52.34 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.57 -0.824 . . . . 1.05 111.791 -178.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 21.2 p -157.73 99.86 1.73 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.665 0.269 . . . . 2.18 110.368 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 118.74 -136.84 12.39 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.426 -0.892 . . . . 1.31 112.555 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 694' ' ' GLU . . . . . 0.459 ' O ' ' HB2' ' A' ' 713' ' ' ALA . 45.2 tt0 -64.38 -53.18 52.56 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.747 0.308 . . . . 2.85 111.573 -175.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 695' ' ' HIS . . . . . . . . . . . . . 41.9 m-70 -85.24 37.37 0.67 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.862 0.363 . . . . 3.05 111.904 -175.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 696' ' ' SER . . . . . . . . . . . . . 16.9 p -81.67 151.32 27.62 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 110.004 -0.369 . . . . 1.5 110.004 177.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 697' ' ' ARG . . . . . . . . . . . . . 32.2 mtm180 -121.47 129.51 53.0 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.646 -0.501 . . . . 2.54 109.646 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 14.3 mt -101.65 138.87 38.06 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 110.275 -0.268 . . . . 0.46 110.275 -177.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 699' ' ' GLN . . . . . 0.499 ' HA ' ' O ' ' A' ' 708' ' ' LYS . 1.3 mp0 -103.84 103.93 13.86 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.562 0.696 . . . . 2.24 109.278 173.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 700' ' ' VAL . . . . . 0.438 HG22 HG12 ' A' ' 686' ' ' ILE . 38.7 t -101.74 123.07 54.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 114.729 -1.123 . . . . 0.22 110.75 -172.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -83.12 94.31 7.8 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.199 -0.455 . . . . 0.23 110.569 178.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 702' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -81.02 126.67 31.69 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.46 -0.57 . . . . 1.2 109.46 175.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -70.55 -17.27 62.93 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.141 -0.481 . . . . 2.79 110.619 -176.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -82.76 -11.24 81.97 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.895 -0.669 . . . . 0.78 113.21 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 705' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -153.55 -68.54 0.15 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 117.294 0.547 . . . . 2.62 111.652 -178.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 706' ' ' GLY . . . . . . . . . . . . . . . 173.15 -165.87 38.2 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.519 -0.848 . . . . 0.5 112.437 -178.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 707' ' ' ILE . . . . . 0.408 ' HA ' ' O ' ' A' ' 700' ' ' VAL . 61.5 mt -79.56 120.34 30.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.931 0.396 . . . . 0.67 110.758 -178.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 708' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 699' ' ' GLN . 96.1 mttt -114.54 159.47 20.35 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.108 -0.497 . . . . 1.35 111.375 -177.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 709' ' ' TRP . . . . . . . . . . . . . 24.3 p-90 -98.37 118.61 35.42 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.253 -0.885 . . . . 0.84 110.162 178.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -121.1 109.45 15.03 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.123 -0.49 . . . . 0.44 110.273 178.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 48.4 t -66.82 106.06 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.25 -0.648 . . . . 0.61 109.25 176.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 712' ' ' ALA . . . . . . . . . . . . . . . -48.13 -47.01 34.95 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.995 0.739 . . . . 0.91 112.995 -167.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 713' ' ' ALA . . . . . 0.459 ' HB2' ' O ' ' A' ' 694' ' ' GLU . . . -62.07 -18.11 59.62 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.606 0.595 . . . . 1.1 112.606 -176.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 714' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -126.57 9.03 7.07 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.145 0.497 . . . . 1.96 110.388 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 715' ' ' ALA . . . . . 0.503 ' HB1' ' CD2' ' A' ' 717' ' ' LEU . . . -93.2 -52.39 4.57 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.851 -0.613 . . . . 0.77 110.43 -179.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 716' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 53.67 73.99 0.34 Allowed 'General case' 0 C--O 1.232 0.17 0 O-C-N 123.778 0.674 . . . . 4.41 110.683 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . 0.503 ' CD2' ' HB1' ' A' ' 715' ' ' ALA . 3.9 mm? -97.05 130.4 44.36 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.12 -0.491 . . . . 0.85 110.562 -178.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 718' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -81.56 144.24 31.43 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.0 -0.545 . . . . 2.13 109.948 -178.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 719' ' ' SER . . . . . . . . . . . . . 10.4 p -82.13 119.91 24.64 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.978 -0.555 . . . . 1.68 110.774 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 720' ' ' VAL . . . . . 0.419 HG22 ' HG3' ' A' ' 677' ' ' ARG . 56.7 t . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.416 -0.802 . . . . 1.64 110.346 176.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 670' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 . . . . . 0 N--CA 1.454 -0.225 0 CA-C-O 120.676 0.275 . . . . 1.41 110.906 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -120.81 140.82 51.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.084 -0.507 . . . . 2.7 110.139 -176.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . 0.409 HD21 ' HG2' ' A' ' 689' ' ' MET . 64.1 mt -69.63 141.91 53.57 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.238 -0.437 . . . . 1.05 110.819 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 673' ' ' GLY . . . . . . . . . . . . . . . 93.29 -11.18 72.21 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.945 -0.645 . . . . 0.64 111.849 -178.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 674' ' ' GLN . . . . . . . . . . . . . 21.7 tp60 -79.93 143.09 34.51 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.561 -0.533 . . . . 2.2 109.561 178.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 675' ' ' ARG . . . . . 0.71 ' HB2' ' OXT' ' A' ' 720' ' ' VAL . 36.8 mtm180 -96.76 141.51 29.9 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.567 -0.531 . . . . 4.07 109.567 177.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 676' ' ' VAL . . . . . 0.475 ' HB ' HD12 ' A' ' 717' ' ' LEU . 27.6 m -120.77 155.6 24.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 115.748 -0.66 . . . . 0.59 110.558 -177.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 677' ' ' ARG . . . . . . . . . . . . . 50.5 ttp180 -130.5 130.28 43.97 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.179 -0.464 . . . . 3.15 110.49 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -136.07 131.88 35.44 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.774 -0.824 . . . . 1.53 108.774 177.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 679' ' ' ALA . . . . . . . . . . . . . . . -64.89 -26.71 68.44 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.928 0.394 . . . . 1.24 111.803 -170.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 680' ' ' LYS . . . . . 0.444 ' HD2' ' N ' ' A' ' 680' ' ' LYS . 0.6 OUTLIER -93.8 -31.78 14.24 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.011 -0.54 . . . . 2.92 112.094 -177.926 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 681' ' ' PHE . . . . . . . . . . . . . 22.6 m-30 -103.43 -11.52 17.79 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.724 0.639 . . . . 1.5 112.724 -174.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 682' ' ' GLY . . . . . . . . . . . . . . . 96.86 -129.12 9.79 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.349 -0.929 . . . . 0.82 111.728 -178.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 683' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -145.66 148.97 33.65 Favored 'General case' 0 C--N 1.319 -0.731 0 O-C-N 122.499 -0.412 . . . . 2.11 109.93 178.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 684' ' ' GLY . . . . . 0.424 ' CA ' ' HA ' ' A' ' 702' ' ' PHE . . . -153.94 179.42 30.2 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.204 -0.998 . . . . 0.38 112.509 -178.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 685' ' ' THR . . . . . . . . . . . . . 42.5 m -116.2 127.96 55.21 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 110.107 -0.331 . . . . 0.47 110.107 178.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 38.2 mt -72.02 104.27 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.62 -0.511 . . . . 0.47 109.62 178.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 687' ' ' VAL . . . . . . . . . . . . . 27.5 m -95.12 -24.96 4.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 120.892 0.377 . . . . 0.5 111.314 -175.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -151.44 161.98 41.75 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.59 -0.522 . . . . 1.62 109.59 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 689' ' ' MET . . . . . 0.409 ' HG2' HD21 ' A' ' 672' ' ' LEU . 24.9 ptt? -151.27 153.51 35.0 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 110.081 -0.34 . . . . 2.17 110.081 177.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 690' ' ' GLU . . . . . 0.46 ' O ' ' HA ' ' A' ' 696' ' ' SER . 38.7 mt-10 -126.74 126.04 42.79 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.916 -0.584 . . . . 2.02 110.976 -178.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . 76.81 176.7 43.72 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.868 -0.682 . . . . 1.05 113.487 173.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 9.3 p -141.38 152.93 44.76 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.087 -0.338 . . . . 2.18 110.087 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 88.55 -134.8 12.65 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.729 -0.748 . . . . 1.31 111.806 -178.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 694' ' ' GLU . . . . . 0.53 ' HA ' ' HB2' ' A' ' 713' ' ' ALA . 37.0 tt0 -80.08 -31.95 39.28 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.287 0.565 . . . . 2.85 110.14 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 695' ' ' HIS . . . . . . . . . . . . . 31.4 m-70 -87.18 37.88 0.79 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.739 -0.664 . . . . 3.05 110.82 -178.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 696' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' A' ' 690' ' ' GLU . 55.7 p -109.41 134.23 52.1 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.019 0.438 . . . . 1.5 110.667 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 697' ' ' ARG . . . . . . . . . . . . . 21.5 mtm180 -125.68 141.59 51.94 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.515 -0.55 . . . . 2.54 109.515 176.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 17.3 mt -107.71 136.61 47.16 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 109.88 -0.415 . . . . 0.46 109.88 178.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 699' ' ' GLN . . . . . 0.499 ' HG2' ' CG2' ' A' ' 707' ' ' ILE . 56.2 tt0 -100.86 100.27 10.89 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 108.573 -0.899 . . . . 2.24 108.573 176.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 41.2 t -102.6 124.14 56.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.415 -0.811 . . . . 0.22 111.59 -171.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 701' ' ' ALA . . . . . 0.402 ' HA ' ' HA ' ' A' ' 707' ' ' ILE . . . -88.37 96.84 10.74 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.077 -0.511 . . . . 0.23 109.973 176.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 702' ' ' PHE . . . . . 0.424 ' HA ' ' CA ' ' A' ' 684' ' ' GLY . 64.1 m-85 -73.11 149.73 42.82 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.064 -0.516 . . . . 1.2 111.012 -177.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 23.6 tp60 -49.22 -50.23 39.39 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.678 0.621 . . . . 2.79 112.678 -170.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -134.03 19.16 4.17 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 119.617 -1.278 . . . . 0.78 113.9 -176.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 705' ' ' GLN . . . . . 0.48 ' O ' ' HE2' ' A' ' 708' ' ' LYS . 1.5 mp0 -124.98 10.87 8.25 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 117.67 0.735 . . . . 2.62 111.801 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 706' ' ' GLY . . . . . . . . . . . . . . . 80.85 -166.62 49.02 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.306 -0.949 . . . . 0.5 112.702 178.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 707' ' ' ILE . . . . . 0.499 ' CG2' ' HG2' ' A' ' 699' ' ' GLN . 29.2 mt -97.87 130.44 46.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 120.638 0.256 . . . . 0.67 111.171 -176.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 708' ' ' LYS . . . . . 0.48 ' HE2' ' O ' ' A' ' 705' ' ' GLN . 4.6 mptp? -118.09 169.58 9.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.979 0.419 . . . . 1.35 111.192 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 709' ' ' TRP . . . . . . . . . . . . . 22.7 p-90 -113.3 119.77 38.84 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.36 -0.836 . . . . 0.84 109.859 176.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -120.71 116.18 24.77 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.427 -0.351 . . . . 0.44 110.486 -177.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 40.6 t -65.7 108.79 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.444 -0.576 . . . . 0.61 109.444 176.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 712' ' ' ALA . . . . . . . . . . . . . . . -57.07 -34.01 67.84 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.894 -0.594 . . . . 0.91 112.418 -169.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 713' ' ' ALA . . . . . 0.53 ' HB2' ' HA ' ' A' ' 694' ' ' GLU . . . -65.66 -25.4 67.33 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.776 0.322 . . . . 1.1 111.757 -178.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 714' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -121.77 8.2 9.98 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.469 -0.332 . . . . 1.96 111.038 -176.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 715' ' ' ALA . . . . . 0.525 ' HB1' ' CD2' ' A' ' 717' ' ' LEU . . . -88.72 -57.97 2.72 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.174 -0.466 . . . . 0.77 111.56 -175.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 716' ' ' ARG . . . . . . . . . . . . . 26.1 tpt180 55.63 72.37 0.49 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.494 0.664 . . . . 4.41 111.038 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . 0.525 ' CD2' ' HB1' ' A' ' 715' ' ' ALA . 4.3 mm? -90.88 142.86 27.32 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.633 -0.712 . . . . 0.85 111.148 -178.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 718' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -84.32 148.66 26.53 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.542 -0.753 . . . . 2.13 109.313 175.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 719' ' ' SER . . . . . . . . . . . . . 19.6 m -92.39 121.91 34.33 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.766 0.317 . . . . 1.68 110.79 -178.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 720' ' ' VAL . . . . . 0.71 ' OXT' ' HB2' ' A' ' 675' ' ' ARG . 9.3 p . . . . . 0 C--O 1.247 0.971 0 CA-C-O 118.758 -0.639 . . . . 1.64 110.378 178.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 670' ' ' TYR . . . . . 0.544 ' CE2' ' HB2' ' A' ' 717' ' ' LEU . 93.4 m-85 . . . . . 0 C--O 1.234 0.266 0 CA-C-O 120.853 0.359 . . . . 1.41 110.863 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -125.42 162.29 25.16 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.966 -0.561 . . . . 2.7 110.503 -175.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . . . . . . . . . 7.6 mp -79.67 143.48 34.59 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.89 0.376 . . . . 1.05 110.452 177.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 673' ' ' GLY . . . . . . . . . . . . . . . 84.46 3.01 88.81 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.767 -0.652 . . . . 0.64 111.542 -177.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 674' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -86.62 145.5 26.7 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.557 -0.321 . . . . 2.2 110.228 -178.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 675' ' ' ARG . . . . . . . . . . . . . 30.9 ttm180 -106.48 125.04 50.49 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.219 0.533 . . . . 4.07 109.902 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 676' ' ' VAL . . . . . 0.432 ' HB ' ' HB3' ' A' ' 717' ' ' LEU . 34.7 m -117.57 163.32 14.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.456 -0.793 . . . . 0.59 111.147 -174.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 677' ' ' ARG . . . . . 0.501 ' HB2' HG22 ' A' ' 720' ' ' VAL . 55.8 ttp180 -134.72 121.16 20.37 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.043 -0.526 . . . . 3.15 109.98 176.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 678' ' ' HIS . . . . . 0.464 ' HB2' ' CD1' ' A' ' 717' ' ' LEU . 51.5 t60 -134.25 122.65 23.04 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.094 -0.706 . . . . 1.53 109.094 179.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 679' ' ' ALA . . . . . . . . . . . . . . . -58.41 -20.8 47.39 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.009 0.744 . . . . 1.24 113.009 -169.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 680' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -86.28 -33.46 20.66 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 111.938 0.347 . . . . 2.92 111.938 -177.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 681' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -116.97 -12.41 10.69 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.438 0.533 . . . . 1.5 112.438 -175.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 682' ' ' GLY . . . . . . . . . . . . . . . 99.03 -156.51 20.06 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.793 -0.717 . . . . 0.82 111.548 -178.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 683' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 676' ' ' VAL . 0.8 OUTLIER -105.51 143.24 33.95 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.866 -0.42 . . . . 2.11 109.866 176.102 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 684' ' ' GLY . . . . . . . . . . . . . . . -153.79 175.14 32.22 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.218 -0.991 . . . . 0.38 112.486 -177.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 685' ' ' THR . . . . . . . . . . . . . 84.9 m -111.89 123.97 51.37 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.724 0.297 . . . . 0.47 110.364 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 44.7 mt -68.76 106.5 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.56 -0.533 . . . . 0.47 109.56 178.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 687' ' ' VAL . . . . . . . . . . . . . 26.9 m -99.58 -19.05 6.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.326 -0.397 . . . . 0.5 111.454 -174.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 688' ' ' ASN . . . . . 0.472 ' HB3' ' HB2' ' A' ' 699' ' ' GLN . 18.1 t-20 -156.58 162.33 39.9 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.542 -0.54 . . . . 1.62 109.542 -178.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 689' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -148.97 146.82 28.0 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.021 -0.733 . . . . 2.17 109.021 176.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 690' ' ' GLU . . . . . 0.437 ' OE2' ' HD2' ' A' ' 697' ' ' ARG . 36.4 mt-10 -119.93 122.85 42.14 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.635 0.255 . . . . 2.02 111.237 -174.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . 68.99 -172.7 36.49 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.144 -0.55 . . . . 1.05 113.235 175.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 8.5 p -139.71 165.67 26.66 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.397 -0.223 . . . . 2.18 110.397 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 81.0 -150.65 30.88 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 121.095 -0.574 . . . . 1.31 112.615 178.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 694' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -64.47 -40.99 96.73 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.833 0.349 . . . . 2.85 111.157 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 695' ' ' HIS . . . . . . . . . . . . . 27.6 p-80 -86.66 21.97 2.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.283 -0.417 . . . . 3.05 111.293 -177.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 696' ' ' SER . . . . . . . . . . . . . 19.2 t -82.05 141.36 33.26 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.38 -0.6 . . . . 1.5 109.38 176.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 697' ' ' ARG . . . . . 0.437 ' HD2' ' OE2' ' A' ' 690' ' ' GLU . 41.6 mtt180 -122.69 152.77 40.22 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.668 -0.493 . . . . 2.54 109.668 178.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 11.2 mt -118.22 130.38 56.04 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.198 -0.668 . . . . 0.46 109.198 174.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 699' ' ' GLN . . . . . 0.472 ' HB2' ' HB3' ' A' ' 688' ' ' ASN . 30.5 mt-30 -97.49 101.49 13.03 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.746 0.784 . . . . 2.24 109.618 175.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 700' ' ' VAL . . . . . 0.447 ' HB ' ' CE1' ' A' ' 702' ' ' PHE . 15.9 t -100.13 123.19 52.83 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 114.674 -1.148 . . . . 0.22 110.35 -174.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -86.49 94.3 9.38 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.402 -0.592 . . . . 0.23 109.402 176.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 702' ' ' PHE . . . . . 0.447 ' CE1' ' HB ' ' A' ' 700' ' ' VAL . 92.7 m-85 -77.14 117.11 18.36 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.832 -0.622 . . . . 1.2 109.743 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -60.79 -21.51 63.16 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.854 -0.612 . . . . 2.79 112.088 -174.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -83.92 -20.04 60.2 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.67 -0.776 . . . . 0.78 112.481 178.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 705' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -135.26 -82.9 0.41 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.864 0.364 . . . . 2.62 111.4 -177.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 706' ' ' GLY . . . . . . . . . . . . . . . 179.49 -156.58 18.64 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 121.119 -0.562 . . . . 0.5 111.77 -177.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 707' ' ' ILE . . . . . 0.443 ' HA ' ' O ' ' A' ' 700' ' ' VAL . 61.5 mt -85.17 126.83 40.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 120.982 0.42 . . . . 0.67 111.205 -176.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 708' ' ' LYS . . . . . 0.443 ' O ' ' HA ' ' A' ' 699' ' ' GLN . 4.5 mptp? -121.47 161.4 22.32 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.891 -0.595 . . . . 1.35 109.779 176.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 709' ' ' TRP . . . . . . . . . . . . . 17.7 p-90 -105.86 115.29 29.98 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.233 0.539 . . . . 0.84 109.657 177.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -112.75 114.62 27.27 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 116.137 -0.483 . . . . 0.44 110.244 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 49.1 t -65.1 115.68 3.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.664 -0.495 . . . . 0.61 109.664 178.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 712' ' ' ALA . . . . . . . . . . . . . . . -54.62 -32.57 59.12 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.849 0.685 . . . . 0.91 112.849 -170.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -66.34 -25.62 66.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.932 0.396 . . . . 1.1 111.545 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 714' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -133.95 29.44 3.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.141 0.496 . . . . 1.96 109.723 -177.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 715' ' ' ALA . . . . . 0.529 ' HB1' ' CD2' ' A' ' 717' ' ' LEU . . . -80.01 -57.49 3.61 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.553 -0.749 . . . . 0.77 111.094 -174.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 716' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 716' ' ' ARG . 38.3 ttm180 58.3 69.34 0.74 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.63 0.729 . . . . 4.41 111.031 178.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . 0.544 ' HB2' ' CE2' ' A' ' 670' ' ' TYR . 3.6 mm? -105.74 122.92 47.06 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.876 -0.602 . . . . 0.85 110.278 177.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 718' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -91.05 130.94 36.91 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.763 -0.653 . . . . 2.13 109.787 -179.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 719' ' ' SER . . . . . . . . . . . . . 15.5 p -64.9 125.63 25.47 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.901 -0.407 . . . . 1.68 109.901 176.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 720' ' ' VAL . . . . . 0.501 HG22 ' HB2' ' A' ' 677' ' ' ARG . 10.9 t . . . . . 0 C--O 1.246 0.921 0 CA-C-O 118.803 -0.618 . . . . 1.64 110.528 -177.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 670' ' ' TYR . . . . . 0.518 ' CD1' HD11 ' A' ' 698' ' ' LEU . 94.1 m-85 . . . . . 0 N--CA 1.448 -0.543 0 N-CA-C 110.163 -0.31 . . . . 1.41 110.163 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 671' ' ' LYS . . . . . 0.494 ' HG2' HE21 ' A' ' 674' ' ' GLN . 21.2 ptmt -140.33 155.98 46.6 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.392 -0.367 . . . . 2.7 110.244 -176.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . . . . . . . . . 59.6 mt -78.65 140.99 38.32 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.136 -0.484 . . . . 1.05 110.478 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 673' ' ' GLY . . . . . . . . . . . . . . . 84.07 5.74 87.27 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.814 -0.63 . . . . 0.64 111.803 -177.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 674' ' ' GLN . . . . . 0.494 HE21 ' HG2' ' A' ' 671' ' ' LYS . 6.7 tt0 -83.28 142.89 30.77 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.022 -0.362 . . . . 2.2 110.022 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 675' ' ' ARG . . . . . . . . . . . . . 26.8 mmm180 -93.26 120.11 33.17 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.848 -0.614 . . . . 4.07 109.841 178.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 676' ' ' VAL . . . . . 0.472 ' HB ' ' HB3' ' A' ' 717' ' ' LEU . 34.2 m -117.27 154.74 19.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.883 -0.599 . . . . 0.59 110.695 -177.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 677' ' ' ARG . . . . . . . . . . . . . 52.1 ttp180 -131.79 137.91 48.34 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.955 -0.566 . . . . 3.15 110.014 178.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 678' ' ' HIS . . . . . 0.426 ' CD2' HD13 ' A' ' 717' ' ' LEU . 0.0 OUTLIER -139.99 155.21 47.22 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.129 -0.487 . . . . 1.53 110.464 174.089 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 679' ' ' ALA . . . . . . . . . . . . . . . -56.12 -53.9 51.56 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.673 0.62 . . . . 1.24 112.673 -173.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 680' ' ' LYS . . . . . . . . . . . . . 2.7 mtpm? -92.66 -30.67 15.46 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.957 -0.565 . . . . 2.92 111.743 -171.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 681' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -87.42 -11.85 47.93 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.342 -0.39 . . . . 1.5 111.34 -177.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 682' ' ' GLY . . . . . . . . . . . . . . . 84.47 -112.49 3.62 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.582 -0.818 . . . . 0.82 111.992 178.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 683' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -151.12 149.14 29.13 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.738 -0.468 . . . . 2.11 109.738 177.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 684' ' ' GLY . . . . . . . . . . . . . . . -160.55 -179.46 35.34 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.016 -1.088 . . . . 0.38 113.011 -178.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 685' ' ' THR . . . . . . . . . . . . . 64.6 m -110.83 130.02 55.7 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.738 -0.467 . . . . 0.47 109.738 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 686' ' ' ILE . . . . . 0.448 HG12 HG22 ' A' ' 700' ' ' VAL . 31.1 mt -72.74 103.52 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.171 -0.678 . . . . 0.47 109.171 175.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 687' ' ' VAL . . . . . . . . . . . . . 27.5 m -93.11 -26.28 4.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.18 0.514 . . . . 0.5 111.028 -175.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 688' ' ' ASN . . . . . 0.489 ' HB3' ' HB3' ' A' ' 699' ' ' GLN . 20.1 t-20 -146.07 161.74 39.46 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.916 -0.584 . . . . 1.62 109.676 177.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 689' ' ' MET . . . . . . . . . . . . . 26.7 ptm -153.16 143.68 22.6 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.55 -0.537 . . . . 2.17 109.55 177.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 690' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -108.73 122.79 47.89 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.756 -0.656 . . . . 2.02 110.456 -176.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . 67.64 -168.79 38.83 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.964 -0.636 . . . . 1.05 112.558 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 56.1 m -154.92 131.78 10.77 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.133 -0.321 . . . . 2.18 110.133 178.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 109.36 -142.74 16.33 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.713 -0.756 . . . . 1.31 112.021 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 694' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -66.54 -34.83 78.78 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.036 0.446 . . . . 2.85 111.109 -178.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 695' ' ' HIS . . . . . . . . . . . . . 55.8 m80 -95.36 31.03 2.05 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.253 -0.43 . . . . 3.05 110.902 -178.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 696' ' ' SER . . . . . . . . . . . . . 16.7 t -97.56 138.74 34.51 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.252 0.549 . . . . 1.5 110.902 -178.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 697' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -123.02 159.81 27.63 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.967 -0.753 . . . . 2.54 108.967 174.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 698' ' ' LEU . . . . . 0.518 HD11 ' CD1' ' A' ' 670' ' ' TYR . 35.6 mt -122.75 149.39 44.17 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 109.935 -0.394 . . . . 0.46 109.935 178.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 699' ' ' GLN . . . . . 0.489 ' HB3' ' HB3' ' A' ' 688' ' ' ASN . 15.1 tt0 -117.63 96.02 5.2 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.229 -1.026 . . . . 2.24 108.229 173.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 700' ' ' VAL . . . . . 0.448 HG22 HG12 ' A' ' 686' ' ' ILE . 35.3 t -100.64 134.5 40.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.551 -0.75 . . . . 0.22 111.103 -172.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -96.33 94.41 7.44 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.988 -0.551 . . . . 0.23 110.09 176.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 702' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -78.78 136.88 37.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.103 0.478 . . . . 1.2 110.691 -177.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -71.43 -21.22 62.01 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.609 -0.723 . . . . 2.79 112.473 -171.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -106.57 2.76 36.67 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.276 -0.964 . . . . 0.78 113.336 -175.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 705' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -146.64 -54.15 0.24 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 117.017 0.408 . . . . 2.62 111.447 -177.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 706' ' ' GLY . . . . . . . . . . . . . . . 139.57 -159.26 25.79 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.282 -0.961 . . . . 0.5 112.433 179.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 58.7 mt -79.08 134.25 28.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 120.847 0.356 . . . . 0.67 111.082 -176.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 708' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -137.75 159.59 41.55 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.884 -0.598 . . . . 1.35 111.333 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 709' ' ' TRP . . . . . 0.447 ' C ' HD22 ' A' ' 710' ' ' LEU . 33.0 p-90 -98.92 129.75 45.27 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.384 -0.825 . . . . 0.84 109.363 174.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 710' ' ' LEU . . . . . 0.447 HD22 ' C ' ' A' ' 709' ' ' TRP . 3.1 mm? -127.4 125.69 41.09 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 110.27 -0.27 . . . . 0.44 110.27 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 54.9 t -73.24 104.17 2.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.188 -0.671 . . . . 0.61 109.188 174.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 712' ' ' ALA . . . . . 0.405 ' HB2' ' HG ' ' A' ' 698' ' ' LEU . . . -56.81 -31.16 64.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.841 -0.618 . . . . 0.91 111.998 -171.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -58.96 -32.97 70.11 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.245 -0.434 . . . . 1.1 112.032 -178.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 714' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -127.73 19.21 6.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.134 0.492 . . . . 1.96 110.699 -178.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 715' ' ' ALA . . . . . 0.531 ' HB1' ' CD2' ' A' ' 717' ' ' LEU . . . -77.32 -53.82 7.23 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.703 -0.68 . . . . 0.77 111.067 -177.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 716' ' ' ARG . . . . . . . . . . . . . 25.4 tpt85 48.98 65.56 1.34 Allowed 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.864 0.84 . . . . 4.41 110.72 -176.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . 0.531 ' CD2' ' HB1' ' A' ' 715' ' ' ALA . 4.5 mm? -81.34 139.23 35.48 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.207 -0.906 . . . . 0.85 109.472 175.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 718' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -92.79 119.86 32.57 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.137 -0.69 . . . . 2.13 109.137 178.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 719' ' ' SER . . . . . . . . . . . . . 9.7 t -68.99 124.57 24.12 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.859 -0.422 . . . . 1.68 109.859 -178.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 720' ' ' VAL . . . . . . . . . . . . . 4.9 p . . . . . 0 C--O 1.248 0.974 0 CA-C-N 116.095 -0.502 . . . . 1.64 110.664 -177.055 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 670' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 . . . . . 0 C--O 1.232 0.159 0 N-CA-C 110.068 -0.345 . . . . 1.41 110.068 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -118.12 152.3 35.89 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.275 -0.421 . . . . 2.7 110.983 -176.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . . . . . . . . . 70.0 mt -79.25 133.51 36.66 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.094 -0.503 . . . . 1.05 110.053 176.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 673' ' ' GLY . . . . . . . . . . . . . . . 94.42 1.23 64.45 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.841 -0.695 . . . . 0.64 111.699 -174.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 674' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -81.29 144.63 31.39 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 110.021 -0.362 . . . . 2.2 110.021 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 675' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.47 128.65 50.6 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.086 -0.709 . . . . 4.07 109.086 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 676' ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' A' ' 683' ' ' GLU . 35.8 m -119.7 152.23 22.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 115.814 -0.63 . . . . 0.59 111.465 -173.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 677' ' ' ARG . . . . . 0.472 ' HG3' HG22 ' A' ' 720' ' ' VAL . 32.6 mtp180 -123.06 124.28 42.75 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.28 0.562 . . . . 3.15 110.813 175.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 678' ' ' HIS . . . . . 0.539 ' HB2' ' CD1' ' A' ' 717' ' ' LEU . 43.4 t60 -139.42 104.66 5.02 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.212 -0.904 . . . . 1.53 109.148 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 679' ' ' ALA . . . . . . . . . . . . . . . -40.42 -38.15 0.78 Allowed 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 114.086 1.143 . . . . 1.24 114.086 -170.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 680' ' ' LYS . . . . . . . . . . . . . 18.7 mmtm -75.8 -31.18 59.33 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.646 -0.252 . . . . 2.92 111.542 -172.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 681' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -116.61 -13.08 10.86 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.85 -0.34 . . . . 1.5 111.816 -176.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 682' ' ' GLY . . . . . . . . . . . . . . . 97.82 -155.36 20.42 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.902 -0.666 . . . . 0.82 111.842 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 683' ' ' GLU . . . . . 0.48 ' HA ' ' O ' ' A' ' 676' ' ' VAL . 0.5 OUTLIER -109.53 147.57 32.72 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.003 0.43 . . . . 2.11 110.61 179.075 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 684' ' ' GLY . . . . . . . . . . . . . . . -156.49 179.48 32.31 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 120.594 -0.812 . . . . 0.38 111.999 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 685' ' ' THR . . . . . . . . . . . . . 71.3 m -115.06 127.36 55.58 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.764 0.316 . . . . 0.47 110.201 179.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 686' ' ' ILE . . . . . 0.401 HG12 HG22 ' A' ' 700' ' ' VAL . 33.6 mt -71.63 104.93 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.182 -0.463 . . . . 0.47 109.759 178.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 687' ' ' VAL . . . . . . . . . . . . . 29.3 m -95.54 -26.61 4.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.862 0.363 . . . . 0.5 111.263 -176.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 688' ' ' ASN . . . . . 0.462 ' HB3' ' HB2' ' A' ' 699' ' ' GLN . 21.2 t-20 -146.38 163.47 35.5 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.598 -0.519 . . . . 1.62 109.598 -179.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 689' ' ' MET . . . . . . . . . . . . . 18.0 ptp -158.3 157.39 32.38 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.956 -0.387 . . . . 2.17 109.956 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 690' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -129.15 123.53 32.35 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.435 -0.348 . . . . 2.02 111.405 -177.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . 62.31 -162.83 27.78 Favored Glycine 0 N--CA 1.452 -0.3 0 CA-C-N 115.692 -0.685 . . . . 1.05 113.748 172.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 692' ' ' SER . . . . . 0.402 ' HA ' ' HB3' ' A' ' 696' ' ' SER . 39.7 m -151.81 170.44 19.78 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.262 -0.644 . . . . 2.18 109.262 177.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 90.38 -139.47 14.96 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.399 -0.905 . . . . 1.31 112.456 177.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 694' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -83.29 -24.7 32.08 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.011 0.434 . . . . 2.85 110.596 -178.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 695' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -102.13 35.52 2.37 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.435 0.636 . . . . 3.05 110.383 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 696' ' ' SER . . . . . 0.493 ' OG ' ' HB3' ' A' ' 712' ' ' ALA . 16.3 p -90.81 135.51 33.68 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.396 -0.82 . . . . 1.5 110.258 179.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 697' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 697' ' ' ARG . 34.2 mtp180 -127.69 146.53 50.53 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.595 -0.52 . . . . 2.54 109.595 178.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 15.5 mt -123.51 130.97 53.47 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.756 -0.461 . . . . 0.46 109.756 178.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 699' ' ' GLN . . . . . 0.473 ' HA ' ' O ' ' A' ' 708' ' ' LYS . 2.1 mp0 -99.14 107.92 20.41 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.468 0.651 . . . . 2.24 109.433 175.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 700' ' ' VAL . . . . . 0.401 HG22 HG12 ' A' ' 686' ' ' ILE . 42.1 t -107.13 125.7 63.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 114.913 -1.04 . . . . 0.22 111.097 -172.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 701' ' ' ALA . . . . . 0.407 ' HA ' ' HA ' ' A' ' 707' ' ' ILE . . . -87.3 94.65 9.73 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.152 -0.476 . . . . 0.23 109.844 176.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 702' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -74.44 135.91 42.33 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.15 0.5 . . . . 1.2 110.345 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -68.62 -31.13 70.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.246 -0.888 . . . . 2.79 111.211 -175.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -81.49 -37.52 17.14 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.729 -0.748 . . . . 0.78 112.795 -178.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 705' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 -113.69 -76.04 0.59 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.041 0.385 . . . . 2.62 112.041 -176.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 706' ' ' GLY . . . . . . . . . . . . . . . 167.87 -158.1 30.74 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.738 -0.744 . . . . 0.5 112.166 -177.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 707' ' ' ILE . . . . . 0.407 ' HA ' ' HA ' ' A' ' 701' ' ' ALA . 64.5 mt -78.46 122.97 34.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.056 0.455 . . . . 0.67 111.13 -176.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 708' ' ' LYS . . . . . 0.473 ' O ' ' HA ' ' A' ' 699' ' ' GLN . 86.2 mttt -129.25 168.66 15.87 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.918 -0.583 . . . . 1.35 110.866 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 709' ' ' TRP . . . . . 0.511 ' C ' HD22 ' A' ' 710' ' ' LEU . 57.0 p-90 -105.24 131.93 52.09 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.434 -0.803 . . . . 0.84 109.782 178.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 710' ' ' LEU . . . . . 0.511 HD22 ' C ' ' A' ' 709' ' ' TRP . 3.6 mm? -130.29 109.49 10.8 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.742 -0.466 . . . . 0.44 109.742 177.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 59.4 t -64.48 109.41 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.382 -0.599 . . . . 0.61 109.382 177.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 712' ' ' ALA . . . . . 0.493 ' HB3' ' OG ' ' A' ' 696' ' ' SER . . . -55.35 -33.89 63.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.774 -0.648 . . . . 0.91 112.51 -169.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -64.58 -20.26 66.15 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.288 -0.415 . . . . 1.1 111.72 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 714' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -131.49 15.4 4.97 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.965 0.412 . . . . 1.96 110.19 -179.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 715' ' ' ALA . . . . . 0.58 ' HB1' ' CD2' ' A' ' 717' ' ' LEU . . . -85.28 -60.41 2.04 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.016 -0.538 . . . . 0.77 111.454 -173.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 716' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 58.82 77.76 0.29 Allowed 'General case' 0 C--O 1.235 0.341 0 CA-C-O 121.49 0.662 . . . . 4.41 110.945 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . 0.58 ' CD2' ' HB1' ' A' ' 715' ' ' ALA . 3.8 mm? -103.02 129.13 49.68 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.616 -0.72 . . . . 0.85 110.911 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 718' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -86.34 125.42 33.62 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.83 -0.623 . . . . 2.13 109.416 175.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 719' ' ' SER . . . . . . . . . . . . . 34.6 t -70.68 131.18 43.51 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.685 0.279 . . . . 1.68 110.323 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 720' ' ' VAL . . . . . 0.472 HG22 ' HG3' ' A' ' 677' ' ' ARG . 17.5 t . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.671 -0.681 . . . . 1.64 109.988 177.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 670' ' ' TYR . . . . . 0.552 ' CD1' HD11 ' A' ' 698' ' ' LEU . 57.1 m-85 . . . . . 0 N--CA 1.448 -0.56 0 N-CA-C 109.603 -0.517 . . . . 1.41 109.603 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 10.4 mtmp? -100.04 143.03 30.72 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.889 0.376 . . . . 2.7 110.553 -177.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . . . . . . . . . 52.4 mt -81.13 137.41 35.95 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.107 -0.497 . . . . 1.05 110.405 -179.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 673' ' ' GLY . . . . . . . . . . . . . . . 88.35 11.82 66.13 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 110.831 -0.907 . . . . 0.64 110.831 -173.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 674' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -94.76 144.07 25.94 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.891 0.376 . . . . 2.2 110.526 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 675' ' ' ARG . . . . . 0.433 ' HD3' ' O ' ' A' ' 684' ' ' GLY . 11.0 tpp85 -97.95 123.82 42.12 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.622 -0.717 . . . . 4.07 109.835 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 676' ' ' VAL . . . . . 0.423 ' HB ' HD12 ' A' ' 717' ' ' LEU . 27.2 m -115.84 161.94 14.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.071 -0.513 . . . . 0.59 110.425 -177.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 677' ' ' ARG . . . . . 0.431 ' HG3' ' HG2' ' A' ' 683' ' ' GLU . 21.5 ttt180 -135.38 131.1 35.91 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.27 -0.423 . . . . 3.15 111.123 178.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 678' ' ' HIS . . . . . 0.465 ' CD2' HD13 ' A' ' 717' ' ' LEU . 0.0 OUTLIER -141.42 147.22 37.6 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.51 -0.768 . . . . 1.53 109.25 175.034 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 679' ' ' ALA . . . . . . . . . . . . . . . -76.85 -26.23 54.05 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.108 0.411 . . . . 1.24 112.108 -169.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 680' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -87.98 -37.81 16.06 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.036 0.384 . . . . 2.92 112.036 -176.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 681' ' ' PHE . . . . . . . . . . . . . 19.2 m-30 -106.71 -11.26 15.86 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 111.814 0.301 . . . . 1.5 111.814 -176.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 682' ' ' GLY . . . . . . . . . . . . . . . 90.53 -156.42 24.81 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.551 -0.833 . . . . 0.82 111.777 -177.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 683' ' ' GLU . . . . . 0.431 ' HG2' ' HG3' ' A' ' 677' ' ' ARG . 27.6 mt-10 -103.6 144.69 31.1 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.9 -0.407 . . . . 2.11 109.9 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 684' ' ' GLY . . . . . 0.433 ' O ' ' HD3' ' A' ' 675' ' ' ARG . . . -148.64 170.88 29.07 Favored Glycine 0 C--N 1.313 -0.742 0 C-N-CA 120.224 -0.989 . . . . 0.38 112.696 -177.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 685' ' ' THR . . . . . . . . . . . . . 32.8 m -113.83 124.67 52.78 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.872 0.368 . . . . 0.47 110.213 178.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 28.3 mt -73.64 104.7 2.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.259 -0.428 . . . . 0.47 109.912 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 687' ' ' VAL . . . . . . . . . . . . . 29.0 m -93.49 -25.63 4.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.732 0.301 . . . . 0.5 111.578 -175.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -152.14 163.93 38.36 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.446 -0.343 . . . . 1.62 110.138 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 689' ' ' MET . . . . . . . . . . . . . 5.1 ppp? -151.91 163.86 38.35 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.496 -0.557 . . . . 2.17 109.496 177.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 690' ' ' GLU . . . . . 0.427 ' CG ' ' HB2' ' A' ' 697' ' ' ARG . 10.7 pt-20 -146.91 155.13 42.05 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.406 -0.361 . . . . 2.02 110.579 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . 78.23 -159.29 46.82 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.963 -0.636 . . . . 1.05 112.485 177.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 29.6 t -161.81 149.43 14.62 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 110.259 -0.275 . . . . 2.18 110.259 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 62.86 -127.52 38.88 Favored Glycine 0 N--CA 1.452 -0.262 0 CA-C-N 116.072 -0.513 . . . . 1.31 113.574 175.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 694' ' ' GLU . . . . . 0.426 ' HA ' ' HB2' ' A' ' 713' ' ' ALA . 42.0 mt-10 -80.58 -15.79 55.77 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.775 0.322 . . . . 2.85 111.417 -175.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 695' ' ' HIS . . . . . . . . . . . . . 18.5 p-80 -109.9 34.71 3.7 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.322 0.582 . . . . 3.05 110.306 178.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 696' ' ' SER . . . . . . . . . . . . . 77.9 p -101.31 145.73 28.49 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.733 -0.667 . . . . 1.5 110.507 178.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 697' ' ' ARG . . . . . 0.427 ' HB2' ' CG ' ' A' ' 690' ' ' GLU . 96.8 mtt180 -125.33 151.05 46.57 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.658 -0.497 . . . . 2.54 109.658 175.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 698' ' ' LEU . . . . . 0.552 HD11 ' CD1' ' A' ' 670' ' ' TYR . 15.5 mt -117.36 146.33 43.47 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.719 -0.474 . . . . 0.46 109.719 178.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 699' ' ' GLN . . . . . 0.5 ' HA ' ' O ' ' A' ' 708' ' ' LYS . 19.0 mt-30 -107.94 99.09 8.57 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.76 0.791 . . . . 2.24 109.27 169.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 700' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 707' ' ' ILE . 20.8 t -100.02 122.72 52.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 114.38 -1.282 . . . . 0.22 110.565 -173.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -85.5 94.31 8.99 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.722 -0.473 . . . . 0.23 109.722 177.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 702' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -74.0 127.02 31.8 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.957 0.408 . . . . 1.2 110.002 178.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -62.43 -26.67 68.62 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.473 -0.785 . . . . 2.79 112.175 -169.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -96.05 -7.25 58.64 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.586 -0.816 . . . . 0.78 113.138 -178.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 705' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -134.59 -79.19 0.45 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 117.184 0.492 . . . . 2.62 111.344 -178.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 706' ' ' GLY . . . . . . . . . . . . . . . 168.71 -164.26 37.89 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.706 -0.759 . . . . 0.5 112.309 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 707' ' ' ILE . . . . . 0.454 ' HA ' ' O ' ' A' ' 700' ' ' VAL . 61.3 mt -75.89 127.85 37.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.936 0.398 . . . . 0.67 110.883 -178.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 708' ' ' LYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 699' ' ' GLN . 68.1 mttm -127.31 158.97 35.81 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.656 -0.702 . . . . 1.35 110.733 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 709' ' ' TRP . . . . . . . . . . . . . 13.8 p-90 -99.41 111.93 24.2 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.608 0.718 . . . . 0.84 110.222 179.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -117.04 115.22 24.99 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.861 -0.609 . . . . 0.44 110.443 -178.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 46.8 t -63.1 105.48 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.218 -0.66 . . . . 0.61 109.218 174.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 712' ' ' ALA . . . . . . . . . . . . . . . -48.62 -46.92 40.4 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 113.216 0.821 . . . . 0.91 113.216 -167.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 713' ' ' ALA . . . . . 0.426 ' HB2' ' HA ' ' A' ' 694' ' ' GLU . . . -64.11 -28.59 69.88 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.262 -0.427 . . . . 1.1 112.051 -175.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 714' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -111.35 2.47 17.63 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.281 0.563 . . . . 1.96 110.656 -178.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 715' ' ' ALA . . . . . 0.475 ' HB1' ' CD2' ' A' ' 717' ' ' LEU . . . -84.3 -50.82 7.5 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.509 -0.769 . . . . 0.77 109.617 177.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 716' ' ' ARG . . . . . 0.637 ' HA ' ' HE ' ' A' ' 716' ' ' ARG . 1.3 mmp_? 51.41 67.52 0.94 Allowed 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.596 -0.729 . . . . 4.41 110.83 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . 0.475 ' CD2' ' HB1' ' A' ' 715' ' ' ALA . 4.6 mm? -86.05 152.34 22.97 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.328 -0.851 . . . . 0.85 109.597 177.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 718' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -114.26 128.38 56.33 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.7 -0.481 . . . . 2.13 109.7 178.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 719' ' ' SER . . . . . . . . . . . . . 25.3 m -66.8 123.55 20.45 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.88 -0.415 . . . . 1.68 109.88 176.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 720' ' ' VAL . . . . . . . . . . . . . 3.2 p . . . . . 0 C--O 1.248 1.003 0 CA-C-N 116.463 -0.335 . . . . 1.64 111.038 -177.354 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 670' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 . . . . . 0 N--CA 1.452 -0.34 0 CA-C-O 120.76 0.314 . . . . 1.41 110.41 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -134.77 162.49 32.22 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.95 -0.568 . . . . 2.7 110.297 -174.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . . . . . . . . . 35.5 mt -77.86 134.45 37.95 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.845 0.355 . . . . 1.05 110.293 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 673' ' ' GLY . . . . . . . . . . . . . . . 88.38 -0.27 83.17 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 111.415 -0.674 . . . . 0.64 111.415 -176.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 674' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -82.61 148.45 27.99 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.717 0.294 . . . . 2.2 110.21 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 675' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -103.34 132.4 49.62 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.129 -0.487 . . . . 4.07 110.121 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 676' ' ' VAL . . . . . 0.501 ' HB ' HD12 ' A' ' 717' ' ' LEU . 29.9 m -117.01 153.39 18.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.582 -0.735 . . . . 0.59 110.448 -177.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 677' ' ' ARG . . . . . 0.435 ' HB2' HG22 ' A' ' 720' ' ' VAL . 42.3 ttt180 -126.79 129.31 48.08 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.328 -0.396 . . . . 3.15 110.376 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -140.79 121.55 14.37 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.089 -0.708 . . . . 1.53 109.089 177.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 679' ' ' ALA . . . . . . . . . . . . . . . -58.73 -18.5 32.0 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.127 0.417 . . . . 1.24 112.127 -175.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 680' ' ' LYS . . . . . 0.523 ' HD2' ' N ' ' A' ' 680' ' ' LYS . 0.3 OUTLIER -91.07 -35.52 14.56 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.243 -0.435 . . . . 2.92 112.088 -177.515 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 681' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -113.25 -11.46 13.22 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.787 0.327 . . . . 1.5 111.796 -174.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 682' ' ' GLY . . . . . . . . . . . . . . . 92.98 -156.5 22.96 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 111.467 -0.653 . . . . 0.82 111.467 -174.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 683' ' ' GLU . . . . . 0.441 ' HA ' ' O ' ' A' ' 676' ' ' VAL . 12.1 pt-20 -109.13 147.73 31.99 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.777 -0.453 . . . . 2.11 109.777 177.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 684' ' ' GLY . . . . . . . . . . . . . . . -151.15 173.54 30.59 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.428 -0.891 . . . . 0.38 112.286 -177.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 685' ' ' THR . . . . . . . . . . . . . 16.5 m -110.78 125.88 54.02 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.548 0.213 . . . . 0.47 110.687 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 50.6 mt -74.39 107.38 4.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.975 -0.379 . . . . 0.47 109.975 177.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 687' ' ' VAL . . . . . . . . . . . . . 29.9 m -93.63 -31.92 4.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 120.873 0.368 . . . . 0.5 111.073 -177.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -143.0 159.81 41.54 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.112 -0.495 . . . . 1.62 110.243 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 689' ' ' MET . . . . . . . . . . . . . 5.3 ppp? -149.05 142.85 25.63 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.97 0.414 . . . . 2.17 110.262 179.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 690' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -114.72 123.62 49.72 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.814 -0.63 . . . . 2.02 110.63 -175.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . 84.62 -152.16 27.28 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.827 -0.701 . . . . 1.05 113.193 174.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 17.5 p -173.7 126.14 0.39 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 123.168 0.587 . . . . 2.18 109.569 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 111.77 -143.74 17.46 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.765 -0.731 . . . . 1.31 111.703 -175.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 694' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -72.8 -48.6 36.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.083 0.468 . . . . 2.85 111.327 -177.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 695' ' ' HIS . . . . . . . . . . . . . 57.9 m-70 -81.92 37.5 0.48 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.968 -0.56 . . . . 3.05 111.415 -173.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 696' ' ' SER . . . . . . . . . . . . . 4.6 m -98.31 143.97 28.22 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.22 -0.446 . . . . 1.5 110.163 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 697' ' ' ARG . . . . . . . . . . . . . 40.9 mtm180 -117.64 135.79 53.75 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.553 -0.536 . . . . 2.54 109.553 175.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 15.9 mt -107.3 131.25 54.43 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.86 -0.422 . . . . 0.46 109.86 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 699' ' ' GLN . . . . . 0.434 ' HA ' ' O ' ' A' ' 708' ' ' LYS . 5.8 mp0 -93.75 101.52 13.64 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.485 0.659 . . . . 2.24 109.498 174.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 22.0 t -101.98 124.41 55.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-N 115.045 -0.98 . . . . 0.22 110.437 -175.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 701' ' ' ALA . . . . . 0.411 ' HA ' ' HA ' ' A' ' 707' ' ' ILE . . . -88.11 101.44 13.81 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.986 -0.552 . . . . 0.23 110.168 178.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 702' ' ' PHE . . . . . 0.444 ' CD1' ' HD2' ' A' ' 708' ' ' LYS . 91.9 m-85 -87.43 120.25 28.54 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.706 -0.479 . . . . 1.2 109.706 176.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -71.2 -11.3 60.86 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.161 0.505 . . . . 2.79 111.064 -174.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -88.24 -13.12 64.36 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.951 -0.643 . . . . 0.78 113.122 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 705' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -150.78 -55.61 0.15 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 117.568 0.684 . . . . 2.62 111.912 -177.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 706' ' ' GLY . . . . . . . . . . . . . . . 163.78 -167.79 38.05 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.606 -0.806 . . . . 0.5 112.266 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 707' ' ' ILE . . . . . 0.411 ' HA ' ' HA ' ' A' ' 701' ' ' ALA . 61.6 mt -78.02 141.85 14.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.73 0.3 . . . . 0.67 110.383 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 708' ' ' LYS . . . . . 0.444 ' HD2' ' CD1' ' A' ' 702' ' ' PHE . 67.1 mttm -132.66 161.75 33.14 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.033 0.444 . . . . 1.35 111.004 178.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 709' ' ' TRP . . . . . . . . . . . . . 20.5 p-90 -108.68 119.94 41.0 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.288 -0.869 . . . . 0.84 109.124 174.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -120.12 115.13 23.07 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.436 -0.347 . . . . 0.44 110.416 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 48.3 t -66.5 109.42 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.026 -0.731 . . . . 0.61 109.026 175.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 712' ' ' ALA . . . . . . . . . . . . . . . -45.42 -48.63 13.65 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 113.283 0.845 . . . . 0.91 113.283 -168.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -66.24 -31.43 72.24 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.363 0.505 . . . . 1.1 112.363 -175.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 714' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -97.99 -20.79 17.19 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.979 0.419 . . . . 1.96 110.77 -177.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 715' ' ' ALA . . . . . 0.526 ' HB1' ' CD2' ' A' ' 717' ' ' LEU . . . -72.44 -54.55 9.01 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.737 -0.665 . . . . 0.77 110.777 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 716' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 57.17 76.43 0.32 Allowed 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.438 0.637 . . . . 4.41 110.6 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . 0.526 ' CD2' ' HB1' ' A' ' 715' ' ' ALA . 4.4 mm? -97.19 142.4 29.15 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.607 -0.724 . . . . 0.85 110.955 -178.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 718' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -101.89 130.32 48.34 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.678 -0.86 . . . . 2.13 108.678 175.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 719' ' ' SER . . . . . . . . . . . . . 23.2 t -71.05 130.9 42.73 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.878 0.371 . . . . 1.68 110.403 -177.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 720' ' ' VAL . . . . . 0.435 HG22 ' HB2' ' A' ' 677' ' ' ARG . 46.2 t . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.398 -0.81 . . . . 1.64 110.627 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 670' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 . . . . . 0 N--CA 1.453 -0.287 0 CA-C-O 120.951 0.405 . . . . 1.41 110.529 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 48.8 mtpt -128.54 155.86 44.21 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.876 -0.602 . . . . 2.7 110.408 -178.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . 0.56 HD21 ' SD ' ' A' ' 689' ' ' MET . 52.0 mt -79.38 134.17 36.58 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.199 -0.455 . . . . 1.05 110.098 177.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 673' ' ' GLY . . . . . . . . . . . . . . . 88.9 15.36 59.54 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.856 -0.687 . . . . 0.64 111.747 -175.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 674' ' ' GLN . . . . . . . . . . . . . 43.9 tp60 -94.49 144.79 25.28 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.286 -0.264 . . . . 2.2 110.286 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 675' ' ' ARG . . . . . . . . . . . . . 19.5 mtm180 -92.0 124.74 36.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.229 -0.441 . . . . 4.07 109.855 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 676' ' ' VAL . . . . . 0.449 ' HB ' HD12 ' A' ' 717' ' ' LEU . 29.0 m -117.91 154.56 19.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-O 120.792 0.33 . . . . 0.59 110.935 -179.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 677' ' ' ARG . . . . . 0.547 ' HB2' HG22 ' A' ' 720' ' ' VAL . 28.3 ttt-85 -130.77 131.61 44.81 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.858 -0.61 . . . . 3.15 109.812 178.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 678' ' ' HIS . . . . . 0.517 ' HB2' ' CD1' ' A' ' 717' ' ' LEU . 20.2 t60 -149.89 113.44 4.99 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.543 -0.54 . . . . 1.53 109.543 176.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 679' ' ' ALA . . . . . . . . . . . . . . . -49.79 -25.68 3.27 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 113.379 0.881 . . . . 1.24 113.379 -173.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 680' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -75.49 -33.19 60.76 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.762 -0.199 . . . . 2.92 111.411 -174.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 681' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -125.75 -13.13 6.48 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.745 0.307 . . . . 1.5 111.821 -174.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 682' ' ' GLY . . . . . . . . . . . . . . . 104.75 -153.59 17.43 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.855 -0.688 . . . . 0.82 111.786 -178.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 683' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -114.51 148.35 38.04 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.854 -0.425 . . . . 2.11 109.854 178.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 684' ' ' GLY . . . . . . . . . . . . . . . -156.66 -178.71 31.03 Favored Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 119.784 -1.198 . . . . 0.38 112.848 -178.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 685' ' ' THR . . . . . . . . . . . . . 12.6 m -113.97 125.62 54.22 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 110.266 -0.272 . . . . 0.47 110.266 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 46.4 mt -70.44 104.92 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.736 -0.468 . . . . 0.47 109.736 177.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 687' ' ' VAL . . . . . . . . . . . . . 27.1 m -93.82 -23.93 5.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 120.978 0.418 . . . . 0.5 111.061 -177.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 688' ' ' ASN . . . . . 0.471 ' HB3' ' HB2' ' A' ' 699' ' ' GLN . 8.5 t30 -151.33 161.3 42.95 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.48 -0.563 . . . . 1.62 109.48 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 689' ' ' MET . . . . . 0.56 ' SD ' HD21 ' A' ' 672' ' ' LEU . 0.0 OUTLIER -157.34 157.89 34.95 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 110.038 -0.356 . . . . 2.17 110.038 178.616 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 690' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -125.2 122.29 36.59 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.631 -0.507 . . . . 2.02 109.631 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . 74.84 -169.34 54.52 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.821 -0.704 . . . . 1.05 112.422 -177.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 49.6 m -155.72 96.37 1.75 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.803 0.335 . . . . 2.18 110.168 177.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 153.12 -130.14 2.92 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.902 -0.666 . . . . 1.31 112.729 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 694' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -84.18 -57.61 3.1 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.579 0.585 . . . . 2.85 112.579 -173.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 695' ' ' HIS . . . . . . . . . . . . . 16.2 p-80 -84.5 21.64 1.44 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.533 0.682 . . . . 3.05 110.855 -174.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 696' ' ' SER . . . . . . . . . . . . . 14.3 m -84.77 152.74 23.46 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.095 -0.957 . . . . 1.5 110.513 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 697' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -116.04 145.28 43.12 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 110.151 -0.314 . . . . 2.54 110.151 176.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 16.6 mt -118.23 135.81 54.04 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.708 -0.479 . . . . 0.46 109.708 178.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 699' ' ' GLN . . . . . 0.512 ' HA ' ' O ' ' A' ' 708' ' ' LYS . 24.6 mp0 -102.97 105.92 16.35 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.708 0.766 . . . . 2.24 109.907 174.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 700' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 707' ' ' ILE . 27.3 t -104.23 125.23 59.02 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 114.545 -1.207 . . . . 0.22 110.69 -174.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -87.76 94.3 9.71 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.155 -0.475 . . . . 0.23 109.742 175.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 702' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -75.94 132.71 40.42 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.014 -0.539 . . . . 1.2 110.203 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -68.59 -25.17 64.74 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.556 -0.747 . . . . 2.79 111.174 -175.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -91.16 1.94 78.02 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.686 -0.768 . . . . 0.78 113.264 -177.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 705' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -157.21 -80.04 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 117.176 0.488 . . . . 2.62 111.421 177.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 706' ' ' GLY . . . . . . . . . . . . . . . 179.65 -157.44 20.39 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.432 -0.889 . . . . 0.5 112.459 -178.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 707' ' ' ILE . . . . . 0.459 ' HA ' ' O ' ' A' ' 700' ' ' VAL . 60.3 mt -80.88 135.95 24.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.781 0.324 . . . . 0.67 111.039 -177.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 708' ' ' LYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 699' ' ' GLN . 63.8 mttm -135.86 159.4 41.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.87 -0.605 . . . . 1.35 110.561 178.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 709' ' ' TRP . . . . . . . . . . . . . 12.3 p-90 -101.8 121.2 41.63 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.726 -0.67 . . . . 0.84 109.568 177.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 710' ' ' LEU . . . . . 0.443 ' HB3' ' HB2' ' A' ' 715' ' ' ALA . 3.8 mm? -118.1 113.05 21.01 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.311 -0.404 . . . . 0.44 110.141 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 99.3 t -66.24 110.63 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.487 -0.56 . . . . 0.61 109.487 175.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 712' ' ' ALA . . . . . . . . . . . . . . . -41.81 -47.12 4.09 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 113.874 1.065 . . . . 0.91 113.874 -169.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -60.01 -35.75 75.75 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.49 0.552 . . . . 1.1 112.49 -177.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 714' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -100.64 -13.62 18.47 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.28 0.562 . . . . 1.96 110.291 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 715' ' ' ALA . . . . . 0.624 ' HB1' ' CD2' ' A' ' 717' ' ' LEU . . . -70.65 -59.59 2.74 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.298 -0.864 . . . . 0.77 110.397 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 716' ' ' ARG . . . . . . . . . . . . . 19.9 mtp180 50.23 66.65 1.09 Allowed 'General case' 0 N--CA 1.464 0.227 0 O-C-N 123.858 0.724 . . . . 4.41 111.363 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . 0.624 ' CD2' ' HB1' ' A' ' 715' ' ' ALA . 4.1 mm? -87.94 140.28 29.66 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.168 0.509 . . . . 0.85 111.396 -176.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 718' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -101.24 134.99 43.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.523 -0.762 . . . . 2.13 108.988 174.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 719' ' ' SER . . . . . . . . . . . . . 20.6 t -78.04 133.72 37.9 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.691 0.281 . . . . 1.68 110.65 -175.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 720' ' ' VAL . . . . . 0.547 HG22 ' HB2' ' A' ' 677' ' ' ARG . 16.9 t . . . . . 0 C--O 1.251 1.132 0 CA-C-O 118.461 -0.78 . . . . 1.64 110.096 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 670' ' ' TYR . . . . . 0.441 ' CE1' ' HB2' ' A' ' 717' ' ' LEU . 72.7 m-85 . . . . . 0 N--CA 1.445 -0.678 0 CA-C-O 121.069 0.461 . . . . 1.41 110.433 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -119.82 162.8 18.5 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.506 -0.77 . . . . 2.7 110.281 -173.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . . . . . . . . . 30.3 mt -79.22 137.37 37.39 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.332 -0.395 . . . . 1.05 110.053 177.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 673' ' ' GLY . . . . . . . . . . . . . . . 86.82 -3.11 87.24 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.862 -0.685 . . . . 0.64 111.523 -177.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 674' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -80.34 142.62 34.28 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.828 -0.434 . . . . 2.2 109.828 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 675' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -101.95 133.27 47.0 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.016 -0.538 . . . . 4.07 109.958 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 676' ' ' VAL . . . . . 0.472 ' HB ' ' HB3' ' A' ' 717' ' ' LEU . 28.8 m -121.08 152.03 24.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 115.727 -0.669 . . . . 0.59 111.022 -175.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 677' ' ' ARG . . . . . 0.458 ' HB2' HG22 ' A' ' 720' ' ' VAL . 27.9 ttp85 -123.3 123.59 41.08 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.963 -0.755 . . . . 3.15 108.963 176.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 678' ' ' HIS . . . . . 0.537 ' HB2' ' CD1' ' A' ' 717' ' ' LEU . 52.6 t60 -128.89 122.68 30.83 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 110.05 -0.352 . . . . 1.53 110.05 -179.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 679' ' ' ALA . . . . . . . . . . . . . . . -40.92 -45.85 2.64 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.545 0.943 . . . . 1.24 113.545 -172.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 680' ' ' LYS . . . . . . . . . . . . . 31.0 mtpt -92.62 -27.43 17.33 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.659 -0.7 . . . . 2.92 112.819 -168.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 681' ' ' PHE . . . . . . . . . . . . . 20.3 m-30 -106.29 -12.34 15.73 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.02 0.378 . . . . 1.5 112.02 -176.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 682' ' ' GLY . . . . . . . . . . . . . . . 90.08 -155.39 24.43 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.373 -0.918 . . . . 0.82 111.206 -174.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 683' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -111.91 152.67 27.74 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 117.116 0.458 . . . . 2.11 110.844 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 684' ' ' GLY . . . . . . . . . . . . . . . -157.18 -177.32 30.19 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 121.004 -0.617 . . . . 0.38 111.78 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 685' ' ' THR . . . . . . . . . . . . . 41.8 m -118.43 125.8 50.71 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.771 0.32 . . . . 0.47 110.991 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 686' ' ' ILE . . . . . 0.438 HG12 HG22 ' A' ' 700' ' ' VAL . 44.3 mt -71.57 110.23 4.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 120.805 0.336 . . . . 0.47 110.179 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 687' ' ' VAL . . . . . . . . . . . . . 30.1 m -97.07 -27.61 3.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.487 -0.324 . . . . 0.5 111.642 -176.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -149.66 158.2 43.95 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.067 -0.346 . . . . 1.62 110.067 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 689' ' ' MET . . . . . . . . . . . . . 5.2 ppp? -150.8 143.02 24.18 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.021 -0.536 . . . . 2.17 109.666 178.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 690' ' ' GLU . . . . . 0.45 ' O ' ' HA ' ' A' ' 696' ' ' SER . 45.0 mt-10 -121.54 140.94 51.57 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.965 -0.561 . . . . 2.02 110.893 -174.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . 68.13 -157.9 52.28 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 121.053 -0.594 . . . . 1.05 112.73 176.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 52.0 m -155.06 136.66 14.28 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.715 0.293 . . . . 2.18 110.561 178.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 83.51 -138.66 17.96 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 121.082 -0.58 . . . . 1.31 112.873 176.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 694' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -63.36 -37.17 86.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.898 0.38 . . . . 2.85 110.9 -178.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 695' ' ' HIS . . . . . . . . . . . . . 33.6 t-80 -86.79 15.75 5.48 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.267 0.556 . . . . 3.05 110.674 -177.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 696' ' ' SER . . . . . 0.45 ' HA ' ' O ' ' A' ' 690' ' ' GLU . 19.6 t -92.78 142.17 27.64 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.939 0.399 . . . . 1.5 110.417 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 697' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -123.64 134.82 53.7 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.617 -0.512 . . . . 2.54 109.617 174.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 8.6 mt -108.21 133.53 52.33 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 109.649 -0.5 . . . . 0.46 109.649 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 699' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -101.8 106.02 16.95 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.418 0.628 . . . . 2.24 110.017 174.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 700' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 707' ' ' ILE . 40.0 t -99.28 123.33 51.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.097 -0.956 . . . . 0.22 110.598 -176.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -82.86 94.95 7.79 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.767 -0.651 . . . . 0.23 109.823 176.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 702' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -76.11 126.36 30.86 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.622 -0.717 . . . . 1.2 109.966 178.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -64.74 -18.55 65.14 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.716 -0.674 . . . . 2.79 112.041 -173.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -134.92 40.27 1.58 Allowed Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.472 -0.87 . . . . 0.78 112.457 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 705' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -166.78 -23.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.836 0.35 . . . . 2.62 111.029 -178.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 706' ' ' GLY . . . . . . . . . . . . . . . 101.38 -169.4 20.52 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.546 -0.835 . . . . 0.5 112.038 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 707' ' ' ILE . . . . . 0.519 ' C ' ' HE2' ' A' ' 708' ' ' LYS . 47.0 mt -89.26 117.34 32.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 O-C-N 122.564 -0.374 . . . . 0.67 110.88 -178.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 708' ' ' LYS . . . . . 0.519 ' HE2' ' C ' ' A' ' 707' ' ' ILE . 0.4 OUTLIER -108.74 165.22 11.72 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.299 -0.41 . . . . 1.35 110.265 176.794 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 709' ' ' TRP . . . . . . . . . . . . . 8.1 p-90 -104.91 119.96 40.27 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.706 -0.679 . . . . 0.84 109.858 177.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -115.85 109.84 18.2 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.176 -0.465 . . . . 0.44 110.425 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 57.8 t -61.59 119.24 5.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.395 -0.594 . . . . 0.61 109.395 174.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 712' ' ' ALA . . . . . . . . . . . . . . . -54.99 -25.38 29.48 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.925 0.713 . . . . 0.91 112.925 -172.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -71.02 -25.66 62.77 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.855 0.36 . . . . 1.1 111.6 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 714' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -129.22 16.09 6.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.351 -0.386 . . . . 1.96 110.521 -177.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 715' ' ' ALA . . . . . 0.532 ' HB1' ' CD2' ' A' ' 717' ' ' LEU . . . -70.18 -58.14 4.12 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.078 -0.51 . . . . 0.77 111.101 -175.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 716' ' ' ARG . . . . . . . . . . . . . 74.3 mtt180 57.06 62.14 2.33 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.208 0.528 . . . . 4.41 111.177 175.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . 0.537 ' CD1' ' HB2' ' A' ' 678' ' ' HIS . 3.1 mm? -102.55 129.67 49.17 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.108 -0.496 . . . . 0.85 110.761 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 718' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -93.1 115.16 27.83 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.969 -0.752 . . . . 2.13 108.969 175.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 719' ' ' SER . . . . . . . . . . . . . 1.5 p -62.21 135.01 57.3 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.884 0.373 . . . . 1.68 111.007 -177.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 720' ' ' VAL . . . . . 0.458 HG22 ' HB2' ' A' ' 677' ' ' ARG . 3.4 t . . . . . 0 C--O 1.251 1.167 0 CA-C-O 118.389 -0.815 . . . . 1.64 109.705 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 3.1 ptp180 . . . . . 0 N--CA 1.484 1.264 0 CA-C-O 120.661 0.267 . . . . 27.27 111.376 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 646' ' ' LEU . . . . . . . . . . . . . 27.5 tp 53.09 52.95 12.75 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.983 -0.553 . . . . 26.57 111.205 178.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 647' ' ' ARG . . . . . . . . . . . . . 26.2 ptt180 -70.28 140.82 52.4 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.319 -0.4 . . . . 24.57 110.458 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 648' ' ' ALA . . . . . . . . . . . . . . . -88.09 76.29 8.55 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.097 0.475 . . . . 23.82 110.925 -178.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 649' ' ' THR . . . . . . . . . . . . . 14.1 t -107.46 -179.75 4.01 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.945 -0.57 . . . . 23.24 110.013 178.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 650' ' ' VAL . . . . . . . . . . . . . 29.7 m -69.75 136.31 26.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.109 0.481 . . . . 23.34 110.889 -178.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 651' ' ' SER . . . . . . . . . . . . . 49.9 m -85.56 -13.29 49.33 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.078 -0.51 . . . . 21.93 110.203 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 652' ' ' ARG . . . . . 0.403 ' HA ' ' HD3' ' A' ' 653' ' ' PRO . 13.0 tpt180 -79.37 132.4 62.59 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 109.031 -0.729 . . . . 21.54 109.031 175.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 653' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 652' ' ' ARG . 12.8 Cg_exo -70.4 66.32 2.15 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.706 2.27 . . . . 19.8 112.418 178.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 654' ' ' VAL . . . . . . . . . . . . . 8.5 p -138.72 137.94 42.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.957 -0.565 . . . . 20.26 110.157 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 655' ' ' SER . . . . . . . . . . . . . 14.9 t -69.03 126.86 31.13 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.275 -0.639 . . . . 18.24 109.275 176.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 656' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -68.13 101.49 1.17 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.699 0.761 . . . . 16.63 110.207 -178.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 657' ' ' GLN . . . . . 0.605 ' O ' ' HD3' ' A' ' 716' ' ' ARG . 53.1 mt-30 -106.22 137.34 44.33 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.334 -0.848 . . . . 17.75 109.886 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 658' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -170.3 164.16 8.88 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.439 -0.578 . . . . 15.35 109.439 -178.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 659' ' ' MET . . . . . . . . . . . . . 54.1 ttm -73.91 96.49 2.62 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.702 -0.481 . . . . 14.95 109.702 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . 134.96 10.77 1.49 Allowed Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.774 -0.648 . . . . 12.49 112.216 -175.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 661' ' ' THR . . . . . . . . . . . . . 6.9 p -72.94 144.7 85.62 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.609 0.243 . . . . 10.68 111.079 177.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 662' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -73.57 49.88 1.89 Allowed 'Trans proline' 0 CA--C 1.531 0.344 0 C-N-CA 123.074 2.516 . . . . 10.3 112.474 178.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 663' ' ' MET . . . . . . . . . . . . . 25.4 ttt -92.75 127.49 38.27 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.785 -0.643 . . . . 9.41 109.994 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 664' ' ' VAL . . . . . . . . . . . . . 43.1 t -65.42 126.86 25.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.127 -0.488 . . . . 7.04 110.098 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 665' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 60.41 46.59 9.69 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.745 -0.661 . . . . 7.07 110.712 -175.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 666' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -65.82 145.74 55.59 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.675 -0.693 . . . . 6.8 109.938 177.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 667' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -80.67 152.91 28.21 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.069 0.462 . . . . 5.49 110.735 -176.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 668' ' ' SER . . . . . . . . . . . . . 47.3 m -112.67 31.42 6.37 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.855 -0.795 . . . . 4.72 108.855 173.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 669' ' ' GLY . . . . . . . . . . . . . . . 142.37 126.44 2.1 Favored Glycine 0 N--CA 1.438 -1.17 0 CA-C-N 114.801 -1.09 . . . . 1.87 110.854 -173.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 670' ' ' TYR . . . . . 0.44 ' CD2' HD11 ' A' ' 698' ' ' LEU . 85.8 m-85 -67.05 144.51 56.11 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.081 0.467 . . . . 1.41 111.465 -176.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -106.82 151.27 25.42 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.579 -0.737 . . . . 2.7 110.234 -175.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . . . . . . . . . 41.8 mt -76.0 136.28 39.99 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.025 0.44 . . . . 1.05 111.053 -176.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 673' ' ' GLY . . . . . . . . . . . . . . . 96.9 -3.08 62.27 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.601 -0.727 . . . . 0.64 112.167 -178.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 674' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -79.14 145.52 33.67 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.001 0.429 . . . . 2.2 110.385 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 675' ' ' ARG . . . . . . . . . . . . . 23.4 mmt180 -97.38 126.22 42.48 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.54 -0.754 . . . . 4.07 109.086 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 676' ' ' VAL . . . . . 0.444 ' HB ' HD12 ' A' ' 717' ' ' LEU . 35.7 m -117.17 162.1 15.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 120.828 0.347 . . . . 0.59 111.443 -175.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 677' ' ' ARG . . . . . 0.428 ' HB2' HG22 ' A' ' 720' ' ' VAL . 47.5 ttt180 -138.59 125.86 21.61 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.539 -0.755 . . . . 3.15 109.753 -176.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 678' ' ' HIS . . . . . 0.484 ' CD2' HD13 ' A' ' 717' ' ' LEU . 0.0 OUTLIER -147.5 132.65 18.33 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 110.423 -0.214 . . . . 1.53 110.423 178.092 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 679' ' ' ALA . . . . . . . . . . . . . . . -66.45 -14.57 62.39 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.938 0.399 . . . . 1.24 111.95 -176.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 680' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -82.84 -37.78 23.94 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.142 -0.481 . . . . 2.92 111.963 -178.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 681' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -125.25 -11.8 6.91 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.043 0.386 . . . . 1.5 112.043 -171.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 682' ' ' GLY . . . . . . . . . . . . . . . 98.97 -152.71 19.7 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.294 -0.722 . . . . 0.82 111.294 -175.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 683' ' ' GLU . . . . . 0.406 ' H ' ' CD ' ' A' ' 683' ' ' GLU . 0.2 OUTLIER -104.74 147.19 27.96 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.526 -0.546 . . . . 2.11 109.526 178.213 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 684' ' ' GLY . . . . . . . . . . . . . . . -151.6 173.67 30.88 Favored Glycine 0 N--CA 1.441 -0.967 0 C-N-CA 119.641 -1.266 . . . . 0.38 112.464 -177.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 685' ' ' THR . . . . . . . . . . . . . 35.2 m -118.44 124.3 47.31 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.941 -0.392 . . . . 0.47 109.941 176.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 35.5 mt -72.33 104.88 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.2 -0.455 . . . . 0.47 109.837 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 687' ' ' VAL . . . . . . . . . . . . . 28.7 m -94.9 -23.81 5.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.302 -0.408 . . . . 0.5 111.512 -175.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 688' ' ' ASN . . . . . 0.446 ' HB3' ' HB2' ' A' ' 699' ' ' GLN . 63.0 t30 -151.24 165.0 35.31 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.466 -0.334 . . . . 1.62 110.196 -178.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 689' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.59 156.59 38.26 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.464 -0.569 . . . . 2.17 109.464 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 690' ' ' GLU . . . . . 0.476 ' O ' ' HA ' ' A' ' 696' ' ' SER . 45.9 mt-10 -125.95 123.76 39.26 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.539 -0.3 . . . . 2.02 110.752 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . 69.28 -160.96 52.53 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 121.083 -0.58 . . . . 1.05 112.728 178.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 66.9 m -152.03 157.43 41.66 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.257 -0.275 . . . . 2.18 110.257 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 89.67 -142.39 16.61 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.835 -0.698 . . . . 1.31 112.313 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 694' ' ' GLU . . . . . 0.401 ' HA ' ' HB2' ' A' ' 713' ' ' ALA . 41.7 mt-10 -74.04 -31.46 62.9 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.042 0.449 . . . . 2.85 110.635 -178.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 695' ' ' HIS . . . . . . . . . . . . . 35.4 m170 -91.6 16.11 11.19 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.813 -0.631 . . . . 3.05 110.661 -176.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 696' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 690' ' ' GLU . 20.8 t -81.97 130.47 35.09 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.437 -0.579 . . . . 1.5 109.437 177.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 697' ' ' ARG . . . . . . . . . . . . . 23.9 mtm180 -114.51 133.72 55.56 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.226 -0.657 . . . . 2.54 109.226 177.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 698' ' ' LEU . . . . . 0.44 HD11 ' CD2' ' A' ' 670' ' ' TYR . 9.3 mt -106.14 130.65 53.99 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 120.632 0.253 . . . . 0.46 110.449 -177.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 699' ' ' GLN . . . . . 0.487 ' HA ' ' O ' ' A' ' 708' ' ' LYS . 3.8 mp0 -95.55 100.63 12.35 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.754 0.788 . . . . 2.24 109.264 175.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 700' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' A' ' 707' ' ' ILE . 19.5 t -101.71 124.14 55.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 114.729 -1.123 . . . . 0.22 110.815 -172.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -84.83 94.82 8.81 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.233 -0.439 . . . . 0.23 110.16 177.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 702' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -78.64 122.56 26.1 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.677 -0.49 . . . . 1.2 109.677 177.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -69.15 -13.19 62.28 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.941 -0.572 . . . . 2.79 111.468 -174.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -101.06 8.68 57.65 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.749 -0.739 . . . . 0.78 112.612 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 705' ' ' GLN . . . . . . . . . . . . . 23.2 tp60 -158.45 -75.64 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.958 0.379 . . . . 2.62 111.047 178.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . . . . . . . . . . . 170.36 -167.02 40.19 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 121.013 -0.613 . . . . 0.5 112.025 -178.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 707' ' ' ILE . . . . . 0.493 ' HA ' ' O ' ' A' ' 700' ' ' VAL . 71.4 mt -79.53 126.22 39.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.158 0.504 . . . . 0.67 110.796 -178.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 708' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 699' ' ' GLN . 63.6 mttm -125.77 159.4 32.46 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.785 -0.643 . . . . 1.35 110.693 -179.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 709' ' ' TRP . . . . . . . . . . . . . 14.6 p-90 -100.7 116.28 32.23 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.945 -0.57 . . . . 0.84 110.265 178.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -117.76 114.38 23.22 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.016 -0.538 . . . . 0.44 110.206 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 46.5 t -63.86 110.06 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.589 -0.522 . . . . 0.61 109.589 177.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 712' ' ' ALA . . . . . . . . . . . . . . . -45.15 -43.24 9.74 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 113.502 0.927 . . . . 0.91 113.502 -168.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 713' ' ' ALA . . . . . 0.401 ' HB2' ' HA ' ' A' ' 694' ' ' GLU . . . -64.18 -36.99 85.84 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 111.975 0.361 . . . . 1.1 111.975 -177.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 714' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -102.5 -9.79 19.91 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.967 0.413 . . . . 1.96 110.815 -177.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 715' ' ' ALA . . . . . 0.474 ' HB1' ' CD2' ' A' ' 717' ' ' LEU . . . -67.74 -62.6 1.33 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.801 -0.636 . . . . 0.77 109.941 178.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 716' ' ' ARG . . . . . 0.605 ' HD3' ' O ' ' A' ' 657' ' ' GLN . 59.9 mtt180 56.03 66.4 1.21 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.506 0.67 . . . . 4.41 110.52 175.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . 0.484 HD13 ' CD2' ' A' ' 678' ' ' HIS . 4.6 mm? -89.21 145.15 25.6 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.189 -0.914 . . . . 0.85 110.334 -177.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 718' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -97.27 134.68 40.24 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.211 -0.663 . . . . 2.13 109.211 176.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 719' ' ' SER . . . . . . . . . . . . . 13.5 m -75.81 128.37 34.99 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.58 -0.282 . . . . 1.68 110.43 -178.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 720' ' ' VAL . . . . . 0.428 HG22 ' HB2' ' A' ' 677' ' ' ARG . 17.6 t . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.498 -0.763 . . . . 1.64 109.77 177.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 . . . . . 0 N--CA 1.483 1.193 0 N-CA-C 110.013 -0.366 . . . . 27.27 110.013 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 646' ' ' LEU . . . . . . . . . . . . . 43.4 mt -124.3 105.43 9.46 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.614 0.245 . . . . 26.57 110.853 -174.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 647' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 -83.14 -54.12 5.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.151 0.5 . . . . 24.57 110.332 177.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 648' ' ' ALA . . . . . . . . . . . . . . . -147.97 54.76 1.04 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.658 -0.701 . . . . 23.82 109.139 178.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 649' ' ' THR . . . . . . . . . . . . . 11.8 m -87.97 105.61 17.57 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.358 -0.837 . . . . 23.24 111.315 -174.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 650' ' ' VAL . . . . . . . . . . . . . 60.9 t 70.75 -73.59 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 115.261 -0.881 . . . . 23.34 112.081 176.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 651' ' ' SER . . . . . . . . . . . . . 32.9 t -155.44 137.96 15.03 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.888 0.375 . . . . 21.93 110.952 -176.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 652' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -162.83 145.52 8.35 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.606 -0.725 . . . . 21.54 109.07 174.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 653' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_exo -52.09 111.92 0.73 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.046 2.497 . . . . 19.8 112.363 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 654' ' ' VAL . . . . . . . . . . . . . 26.4 t 57.58 78.14 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 115.362 -0.835 . . . . 20.26 110.714 -177.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 655' ' ' SER . . . . . . . . . . . . . 18.8 m -75.54 132.03 40.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.955 -0.566 . . . . 18.24 109.505 177.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 656' ' ' HIS . . . . . . . . . . . . . 42.8 m80 -99.84 101.62 12.81 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.971 0.415 . . . . 16.63 110.548 -178.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 657' ' ' GLN . . . . . . . . . . . . . 25.6 mp0 -73.59 -39.78 64.35 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.816 -0.629 . . . . 17.75 110.505 -178.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 658' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -115.08 30.66 7.21 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.759 -0.655 . . . . 15.35 110.466 -178.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 659' ' ' MET . . . . . . . . . . . . . 65.3 mtt 62.15 -162.35 0.28 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.383 -0.826 . . . . 14.95 110.978 178.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . 149.58 -31.59 1.13 Allowed Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.776 -0.726 . . . . 12.49 112.239 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 661' ' ' THR . . . . . . . . . . . . . 12.1 p -88.62 128.58 52.13 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-O 120.586 0.231 . . . . 10.68 110.858 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 662' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -68.78 113.42 3.2 Favored 'Trans proline' 0 C--O 1.233 0.269 0 C-N-CA 122.616 2.211 . . . . 10.3 111.917 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 663' ' ' MET . . . . . . . . . . . . . 48.3 ttp -83.99 46.64 1.21 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.724 0.773 . . . . 9.41 110.03 -178.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 664' ' ' VAL . . . . . . . . . . . . . 4.2 p -81.8 90.49 2.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 122.041 0.924 . . . . 7.04 110.412 -178.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 665' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -156.28 145.73 20.78 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.426 -0.806 . . . . 7.07 110.931 -176.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 666' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -101.97 91.38 4.32 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.771 -0.825 . . . . 6.8 108.771 173.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 667' ' ' ASP . . . . . 0.405 ' HB3' ' CE1' ' A' ' 670' ' ' TYR . 51.6 m-20 71.92 121.9 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 O-C-N 124.055 0.847 . . . . 5.49 110.494 -176.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 668' ' ' SER . . . . . . . . . . . . . 16.7 m -62.21 -31.37 71.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.525 -0.762 . . . . 4.72 111.611 -175.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 669' ' ' GLY . . . . . . . . . . . . . . . 139.32 111.05 0.94 Allowed Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.463 -0.875 . . . . 1.87 112.414 177.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 670' ' ' TYR . . . . . 0.405 ' CE1' ' HB3' ' A' ' 667' ' ' ASP . 77.0 m-85 -95.3 146.21 24.53 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 110.113 -0.329 . . . . 1.41 110.113 178.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 671' ' ' LYS . . . . . 0.437 ' HG2' ' HB2' ' A' ' 674' ' ' GLN . 20.7 pttp -138.86 160.2 40.3 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.313 -0.625 . . . . 2.7 109.313 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . . . . . . . . . 29.7 mt -72.08 133.08 45.02 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.962 -0.384 . . . . 1.05 109.962 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 673' ' ' GLY . . . . . . . . . . . . . . . 86.94 8.17 76.44 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.791 -0.719 . . . . 0.64 111.764 -175.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 674' ' ' GLN . . . . . 0.437 ' HB2' ' HG2' ' A' ' 671' ' ' LYS . 33.2 tt0 -85.87 142.86 28.58 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.949 -0.389 . . . . 2.2 109.949 178.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 675' ' ' ARG . . . . . 0.473 ' HD2' ' N ' ' A' ' 675' ' ' ARG . 3.7 mpt_? -100.78 127.48 47.19 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.147 0.499 . . . . 4.07 110.328 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 676' ' ' VAL . . . . . 0.503 ' HB ' ' HB3' ' A' ' 717' ' ' LEU . 27.1 m -117.23 154.1 18.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.587 -0.733 . . . . 0.59 110.917 -177.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 677' ' ' ARG . . . . . 0.425 ' CG ' ' HB3' ' A' ' 683' ' ' GLU . 26.9 mtt180 -127.18 136.95 52.77 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.996 -0.547 . . . . 3.15 110.957 177.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -138.94 142.59 38.43 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.503 -0.772 . . . . 1.53 109.333 172.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 679' ' ' ALA . . . . . . . . . . . . . . . -49.46 -52.47 28.87 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.612 0.597 . . . . 1.24 112.612 -172.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 680' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -91.07 -37.05 13.66 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.47 -0.332 . . . . 2.92 111.809 -170.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 681' ' ' PHE . . . . . . . . . . . . . 9.3 m-30 -81.2 -11.32 59.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.841 0.353 . . . . 1.5 111.273 -178.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 682' ' ' GLY . . . . . . . . . . . . . . . 86.32 -111.84 3.67 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.508 -0.853 . . . . 0.82 111.636 178.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 683' ' ' GLU . . . . . 0.425 ' HB3' ' CG ' ' A' ' 677' ' ' ARG . 10.4 pt-20 -155.66 148.43 24.2 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.725 0.298 . . . . 2.11 110.443 178.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 684' ' ' GLY . . . . . . . . . . . . . . . -152.41 -177.31 25.94 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.647 -0.787 . . . . 0.38 111.531 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 685' ' ' THR . . . . . . . . . . . . . 58.5 m -119.44 130.14 55.11 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.827 0.346 . . . . 0.47 110.414 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 686' ' ' ILE . . . . . 0.438 HG12 HG22 ' A' ' 700' ' ' VAL . 48.8 mt -73.86 104.61 2.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.082 -0.508 . . . . 0.47 110.123 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 687' ' ' VAL . . . . . . . . . . . . . 30.3 m -89.63 -26.12 5.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.416 -0.356 . . . . 0.5 111.018 -177.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -152.42 162.41 41.22 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.361 -0.382 . . . . 1.62 110.482 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 689' ' ' MET . . . . . . . . . . . . . 22.1 ptp -147.1 146.18 29.86 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.03 -0.532 . . . . 2.17 109.905 178.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 690' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -120.81 156.01 32.83 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.882 -0.599 . . . . 2.02 109.832 -176.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . 80.62 -169.42 52.34 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.57 -0.824 . . . . 1.05 111.791 -178.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 21.2 p -157.73 99.86 1.73 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.665 0.269 . . . . 2.18 110.368 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 118.74 -136.84 12.39 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.426 -0.892 . . . . 1.31 112.555 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 694' ' ' GLU . . . . . 0.459 ' O ' ' HB2' ' A' ' 713' ' ' ALA . 45.2 tt0 -64.38 -53.18 52.56 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.747 0.308 . . . . 2.85 111.573 -175.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 695' ' ' HIS . . . . . . . . . . . . . 41.9 m-70 -85.24 37.37 0.67 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.862 0.363 . . . . 3.05 111.904 -175.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 696' ' ' SER . . . . . . . . . . . . . 16.9 p -81.67 151.32 27.62 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 110.004 -0.369 . . . . 1.5 110.004 177.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 697' ' ' ARG . . . . . . . . . . . . . 32.2 mtm180 -121.47 129.51 53.0 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.646 -0.501 . . . . 2.54 109.646 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 14.3 mt -101.65 138.87 38.06 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 110.275 -0.268 . . . . 0.46 110.275 -177.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 699' ' ' GLN . . . . . 0.499 ' HA ' ' O ' ' A' ' 708' ' ' LYS . 1.3 mp0 -103.84 103.93 13.86 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.562 0.696 . . . . 2.24 109.278 173.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 700' ' ' VAL . . . . . 0.438 HG22 HG12 ' A' ' 686' ' ' ILE . 38.7 t -101.74 123.07 54.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 114.729 -1.123 . . . . 0.22 110.75 -172.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -83.12 94.31 7.8 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.199 -0.455 . . . . 0.23 110.569 178.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 702' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -81.02 126.67 31.69 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.46 -0.57 . . . . 1.2 109.46 175.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -70.55 -17.27 62.93 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.141 -0.481 . . . . 2.79 110.619 -176.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -82.76 -11.24 81.97 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.895 -0.669 . . . . 0.78 113.21 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 705' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -153.55 -68.54 0.15 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 117.294 0.547 . . . . 2.62 111.652 -178.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . . . . . . . . . . . 173.15 -165.87 38.2 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.519 -0.848 . . . . 0.5 112.437 -178.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 707' ' ' ILE . . . . . 0.408 ' HA ' ' O ' ' A' ' 700' ' ' VAL . 61.5 mt -79.56 120.34 30.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.931 0.396 . . . . 0.67 110.758 -178.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 708' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 699' ' ' GLN . 96.1 mttt -114.54 159.47 20.35 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.108 -0.497 . . . . 1.35 111.375 -177.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 709' ' ' TRP . . . . . . . . . . . . . 24.3 p-90 -98.37 118.61 35.42 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.253 -0.885 . . . . 0.84 110.162 178.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -121.1 109.45 15.03 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.123 -0.49 . . . . 0.44 110.273 178.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 48.4 t -66.82 106.06 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.25 -0.648 . . . . 0.61 109.25 176.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 712' ' ' ALA . . . . . . . . . . . . . . . -48.13 -47.01 34.95 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.995 0.739 . . . . 0.91 112.995 -167.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 713' ' ' ALA . . . . . 0.459 ' HB2' ' O ' ' A' ' 694' ' ' GLU . . . -62.07 -18.11 59.62 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.606 0.595 . . . . 1.1 112.606 -176.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 714' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -126.57 9.03 7.07 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.145 0.497 . . . . 1.96 110.388 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 715' ' ' ALA . . . . . 0.503 ' HB1' ' CD2' ' A' ' 717' ' ' LEU . . . -93.2 -52.39 4.57 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.851 -0.613 . . . . 0.77 110.43 -179.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 716' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 53.67 73.99 0.34 Allowed 'General case' 0 C--O 1.232 0.17 0 O-C-N 123.778 0.674 . . . . 4.41 110.683 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . 0.503 ' CD2' ' HB1' ' A' ' 715' ' ' ALA . 3.9 mm? -97.05 130.4 44.36 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.12 -0.491 . . . . 0.85 110.562 -178.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 718' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -81.56 144.24 31.43 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.0 -0.545 . . . . 2.13 109.948 -178.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 719' ' ' SER . . . . . . . . . . . . . 10.4 p -82.13 119.91 24.64 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.978 -0.555 . . . . 1.68 110.774 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 720' ' ' VAL . . . . . 0.419 HG22 ' HG3' ' A' ' 677' ' ' ARG . 56.7 t . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.416 -0.802 . . . . 1.64 110.346 176.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 28.4 tpt180 . . . . . 0 N--CA 1.485 1.281 0 CA-C-O 120.471 0.177 . . . . 27.27 111.101 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 646' ' ' LEU . . . . . . . . . . . . . 64.4 tp -68.17 -62.83 1.22 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.64 0.257 . . . . 26.57 111.289 -175.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 647' ' ' ARG . . . . . . . . . . . . . 33.8 ptt180 -90.23 32.52 0.93 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.326 0.584 . . . . 24.57 110.378 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 648' ' ' ALA . . . . . . . . . . . . . . . -84.45 107.97 17.0 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.9 -0.591 . . . . 23.82 110.276 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 649' ' ' THR . . . . . . . . . . . . . 7.7 m -83.46 61.68 6.34 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.504 0.668 . . . . 23.24 109.998 178.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 650' ' ' VAL . . . . . . . . . . . . . 46.9 t -85.65 85.95 2.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.733 -0.667 . . . . 23.34 109.824 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 651' ' ' SER . . . . . . . . . . . . . 64.0 m -87.74 31.93 0.75 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.342 0.592 . . . . 21.93 110.651 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 652' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -106.79 114.66 61.5 Favored Pre-proline 0 N--CA 1.448 -0.532 0 CA-C-N 115.429 -0.805 . . . . 21.54 110.022 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 653' ' ' PRO . . . . . 0.452 ' O ' ' HB ' ' A' ' 654' ' ' VAL . 41.6 Cg_endo -67.81 163.43 35.45 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.564 2.176 . . . . 19.8 111.508 178.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 654' ' ' VAL . . . . . 0.452 ' HB ' ' O ' ' A' ' 653' ' ' PRO . 95.6 t 76.06 -32.37 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 122.857 0.463 . . . . 20.26 111.467 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 655' ' ' SER . . . . . 0.4 ' H ' ' C ' ' A' ' 653' ' ' PRO . 9.9 t -79.31 84.53 5.23 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.352 0.596 . . . . 18.24 110.961 -177.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 656' ' ' HIS . . . . . . . . . . . . . 18.6 p80 -94.97 147.38 23.46 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.195 -0.669 . . . . 16.63 109.195 175.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 657' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 57.32 62.5 2.16 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 121.512 0.672 . . . . 17.75 109.463 -175.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 658' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -91.38 65.9 5.4 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.885 -0.598 . . . . 15.35 110.25 -176.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 659' ' ' MET . . . . . . . . . . . . . 13.8 tpt -95.78 -30.43 13.71 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.158 0.504 . . . . 14.95 109.971 176.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . -169.48 -165.62 27.16 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 111.266 -0.734 . . . . 12.49 111.266 177.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 661' ' ' THR . . . . . 0.412 ' HA ' ' HD2' ' A' ' 662' ' ' PRO . 2.1 p -115.12 106.72 50.93 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 116.72 0.26 . . . . 10.68 111.014 177.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 662' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 661' ' ' THR . 38.4 Cg_endo -67.56 -21.8 45.53 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.676 2.251 . . . . 10.3 112.284 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 663' ' ' MET . . . . . . . . . . . . . 23.8 mmt -127.71 132.67 49.59 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.307 -0.627 . . . . 9.41 109.307 177.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 664' ' ' VAL . . . . . 0.504 HG23 ' H ' ' A' ' 665' ' ' GLU . 2.4 m -111.96 -63.85 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 112.018 0.377 . . . . 7.04 112.018 -177.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 665' ' ' GLU . . . . . 0.504 ' H ' HG23 ' A' ' 664' ' ' VAL . 2.7 mp0 50.44 59.54 4.5 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.11 0.481 . . . . 7.07 110.744 -177.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 666' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -124.41 -167.53 1.67 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.955 -0.566 . . . . 6.8 109.734 -176.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 667' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.65 170.95 3.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.033 0.444 . . . . 5.49 111.192 178.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 668' ' ' SER . . . . . . . . . . . . . 23.6 t -80.17 -22.77 41.6 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.12 -0.491 . . . . 4.72 110.09 178.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 669' ' ' GLY . . . . . . . . . . . . . . . -102.27 -168.37 26.87 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.867 -0.682 . . . . 1.87 111.674 177.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 670' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -116.41 165.98 12.59 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 120.676 0.275 . . . . 1.41 110.906 -177.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -120.81 140.82 51.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.084 -0.507 . . . . 2.7 110.139 -176.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . 0.409 HD21 ' HG2' ' A' ' 689' ' ' MET . 64.1 mt -69.63 141.91 53.57 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.238 -0.437 . . . . 1.05 110.819 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 673' ' ' GLY . . . . . . . . . . . . . . . 93.29 -11.18 72.21 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.945 -0.645 . . . . 0.64 111.849 -178.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 674' ' ' GLN . . . . . . . . . . . . . 21.7 tp60 -79.93 143.09 34.51 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.561 -0.533 . . . . 2.2 109.561 178.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 675' ' ' ARG . . . . . 0.71 ' HB2' ' OXT' ' A' ' 720' ' ' VAL . 36.8 mtm180 -96.76 141.51 29.9 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.567 -0.531 . . . . 4.07 109.567 177.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 676' ' ' VAL . . . . . 0.475 ' HB ' HD12 ' A' ' 717' ' ' LEU . 27.6 m -120.77 155.6 24.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 115.748 -0.66 . . . . 0.59 110.558 -177.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 677' ' ' ARG . . . . . . . . . . . . . 50.5 ttp180 -130.5 130.28 43.97 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.179 -0.464 . . . . 3.15 110.49 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -136.07 131.88 35.44 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.774 -0.824 . . . . 1.53 108.774 177.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 679' ' ' ALA . . . . . . . . . . . . . . . -64.89 -26.71 68.44 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.928 0.394 . . . . 1.24 111.803 -170.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 680' ' ' LYS . . . . . 0.444 ' HD2' ' N ' ' A' ' 680' ' ' LYS . 0.6 OUTLIER -93.8 -31.78 14.24 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.011 -0.54 . . . . 2.92 112.094 -177.926 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 681' ' ' PHE . . . . . . . . . . . . . 22.6 m-30 -103.43 -11.52 17.79 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.724 0.639 . . . . 1.5 112.724 -174.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 682' ' ' GLY . . . . . . . . . . . . . . . 96.86 -129.12 9.79 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.349 -0.929 . . . . 0.82 111.728 -178.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 683' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -145.66 148.97 33.65 Favored 'General case' 0 C--N 1.319 -0.731 0 O-C-N 122.499 -0.412 . . . . 2.11 109.93 178.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 684' ' ' GLY . . . . . 0.424 ' CA ' ' HA ' ' A' ' 702' ' ' PHE . . . -153.94 179.42 30.2 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.204 -0.998 . . . . 0.38 112.509 -178.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 685' ' ' THR . . . . . . . . . . . . . 42.5 m -116.2 127.96 55.21 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 110.107 -0.331 . . . . 0.47 110.107 178.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 38.2 mt -72.02 104.27 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.62 -0.511 . . . . 0.47 109.62 178.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 687' ' ' VAL . . . . . . . . . . . . . 27.5 m -95.12 -24.96 4.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 120.892 0.377 . . . . 0.5 111.314 -175.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -151.44 161.98 41.75 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.59 -0.522 . . . . 1.62 109.59 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 689' ' ' MET . . . . . 0.409 ' HG2' HD21 ' A' ' 672' ' ' LEU . 24.9 ptt? -151.27 153.51 35.0 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 110.081 -0.34 . . . . 2.17 110.081 177.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 690' ' ' GLU . . . . . 0.46 ' O ' ' HA ' ' A' ' 696' ' ' SER . 38.7 mt-10 -126.74 126.04 42.79 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.916 -0.584 . . . . 2.02 110.976 -178.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . 76.81 176.7 43.72 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.868 -0.682 . . . . 1.05 113.487 173.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 9.3 p -141.38 152.93 44.76 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.087 -0.338 . . . . 2.18 110.087 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 88.55 -134.8 12.65 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.729 -0.748 . . . . 1.31 111.806 -178.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 694' ' ' GLU . . . . . 0.53 ' HA ' ' HB2' ' A' ' 713' ' ' ALA . 37.0 tt0 -80.08 -31.95 39.28 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.287 0.565 . . . . 2.85 110.14 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 695' ' ' HIS . . . . . . . . . . . . . 31.4 m-70 -87.18 37.88 0.79 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.739 -0.664 . . . . 3.05 110.82 -178.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 696' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' A' ' 690' ' ' GLU . 55.7 p -109.41 134.23 52.1 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.019 0.438 . . . . 1.5 110.667 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 697' ' ' ARG . . . . . . . . . . . . . 21.5 mtm180 -125.68 141.59 51.94 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.515 -0.55 . . . . 2.54 109.515 176.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 17.3 mt -107.71 136.61 47.16 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 109.88 -0.415 . . . . 0.46 109.88 178.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 699' ' ' GLN . . . . . 0.499 ' HG2' ' CG2' ' A' ' 707' ' ' ILE . 56.2 tt0 -100.86 100.27 10.89 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 108.573 -0.899 . . . . 2.24 108.573 176.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 41.2 t -102.6 124.14 56.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.415 -0.811 . . . . 0.22 111.59 -171.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 701' ' ' ALA . . . . . 0.402 ' HA ' ' HA ' ' A' ' 707' ' ' ILE . . . -88.37 96.84 10.74 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.077 -0.511 . . . . 0.23 109.973 176.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 702' ' ' PHE . . . . . 0.424 ' HA ' ' CA ' ' A' ' 684' ' ' GLY . 64.1 m-85 -73.11 149.73 42.82 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.064 -0.516 . . . . 1.2 111.012 -177.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 23.6 tp60 -49.22 -50.23 39.39 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.678 0.621 . . . . 2.79 112.678 -170.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -134.03 19.16 4.17 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 119.617 -1.278 . . . . 0.78 113.9 -176.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 705' ' ' GLN . . . . . 0.48 ' O ' ' HE2' ' A' ' 708' ' ' LYS . 1.5 mp0 -124.98 10.87 8.25 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 117.67 0.735 . . . . 2.62 111.801 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . . . . . . . . . . . 80.85 -166.62 49.02 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.306 -0.949 . . . . 0.5 112.702 178.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 707' ' ' ILE . . . . . 0.499 ' CG2' ' HG2' ' A' ' 699' ' ' GLN . 29.2 mt -97.87 130.44 46.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 120.638 0.256 . . . . 0.67 111.171 -176.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 708' ' ' LYS . . . . . 0.48 ' HE2' ' O ' ' A' ' 705' ' ' GLN . 4.6 mptp? -118.09 169.58 9.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.979 0.419 . . . . 1.35 111.192 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 709' ' ' TRP . . . . . . . . . . . . . 22.7 p-90 -113.3 119.77 38.84 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.36 -0.836 . . . . 0.84 109.859 176.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -120.71 116.18 24.77 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.427 -0.351 . . . . 0.44 110.486 -177.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 40.6 t -65.7 108.79 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.444 -0.576 . . . . 0.61 109.444 176.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 712' ' ' ALA . . . . . . . . . . . . . . . -57.07 -34.01 67.84 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.894 -0.594 . . . . 0.91 112.418 -169.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 713' ' ' ALA . . . . . 0.53 ' HB2' ' HA ' ' A' ' 694' ' ' GLU . . . -65.66 -25.4 67.33 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.776 0.322 . . . . 1.1 111.757 -178.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 714' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -121.77 8.2 9.98 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.469 -0.332 . . . . 1.96 111.038 -176.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 715' ' ' ALA . . . . . 0.525 ' HB1' ' CD2' ' A' ' 717' ' ' LEU . . . -88.72 -57.97 2.72 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.174 -0.466 . . . . 0.77 111.56 -175.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 716' ' ' ARG . . . . . . . . . . . . . 26.1 tpt180 55.63 72.37 0.49 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.494 0.664 . . . . 4.41 111.038 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . 0.525 ' CD2' ' HB1' ' A' ' 715' ' ' ALA . 4.3 mm? -90.88 142.86 27.32 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.633 -0.712 . . . . 0.85 111.148 -178.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 718' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -84.32 148.66 26.53 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.542 -0.753 . . . . 2.13 109.313 175.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 719' ' ' SER . . . . . . . . . . . . . 19.6 m -92.39 121.91 34.33 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.766 0.317 . . . . 1.68 110.79 -178.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 720' ' ' VAL . . . . . 0.71 ' OXT' ' HB2' ' A' ' 675' ' ' ARG . 9.3 p . . . . . 0 C--O 1.247 0.971 0 CA-C-O 118.758 -0.639 . . . . 1.64 110.378 178.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 34.6 ttm180 . . . . . 0 N--CA 1.481 1.098 0 CA-C-O 121.017 0.437 . . . . 27.27 110.199 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 646' ' ' LEU . . . . . . . . . . . . . 96.1 mt -83.8 -20.97 32.32 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.11 -0.496 . . . . 26.57 110.995 -178.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 647' ' ' ARG . . . . . . . . . . . . . 12.0 ptp180 -145.23 138.29 26.38 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.331 -0.395 . . . . 24.57 110.935 -178.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 648' ' ' ALA . . . . . . . . . . . . . . . -117.51 -65.92 1.13 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.0 -0.545 . . . . 23.82 109.725 175.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 649' ' ' THR . . . . . . . . . . . . . 14.9 t 178.46 153.19 0.34 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.979 -0.555 . . . . 23.24 110.418 176.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 650' ' ' VAL . . . . . . . . . . . . . 9.2 p -131.35 1.05 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.626 0.727 . . . . 23.34 109.167 174.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 651' ' ' SER . . . . . . . . . . . . . 68.1 p -72.11 143.22 49.08 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.249 -0.887 . . . . 21.93 111.452 -174.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 652' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -120.99 129.15 25.43 Favored Pre-proline 0 C--N 1.32 -0.676 0 N-CA-C 109.148 -0.686 . . . . 21.54 109.148 175.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 653' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.92 51.57 2.0 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.766 2.311 . . . . 19.8 113.417 -176.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 654' ' ' VAL . . . . . . . . . . . . . 8.4 p -84.96 -27.39 6.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.335 -0.848 . . . . 20.26 109.098 175.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 655' ' ' SER . . . . . . . . . . . . . 40.9 m -100.39 61.54 1.05 Allowed 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.079 -0.964 . . . . 18.24 109.105 173.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 656' ' ' HIS . . . . . 0.504 ' CE1' ' HA ' ' A' ' 659' ' ' MET . 20.5 t60 -77.12 100.95 5.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.625 -0.716 . . . . 16.63 110.504 -175.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 657' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -129.53 -50.38 1.17 Allowed 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.889 -0.782 . . . . 17.75 108.889 175.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 658' ' ' ARG . . . . . . . . . . . . . 56.9 mtm180 -107.07 46.77 0.91 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.305 -0.861 . . . . 15.35 109.195 172.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 659' ' ' MET . . . . . 0.504 ' HA ' ' CE1' ' A' ' 656' ' ' HIS . 1.5 mpt? 73.88 -45.71 0.61 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 114.618 -1.174 . . . . 14.95 111.986 -178.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . 95.71 28.67 9.3 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 110.719 -0.952 . . . . 12.49 110.719 -178.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 661' ' ' THR . . . . . . . . . . . . . 3.8 t -71.76 136.31 83.01 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.282 -0.459 . . . . 10.68 111.113 -177.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 662' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -74.84 -13.82 21.69 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.611 2.207 . . . . 10.3 111.436 175.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 663' ' ' MET . . . . . . . . . . . . . 15.5 tpt -115.89 113.82 23.85 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.496 -0.774 . . . . 9.41 109.823 178.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 664' ' ' VAL . . . . . . . . . . . . . 47.2 t -69.94 126.49 30.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.05 -0.523 . . . . 7.04 110.198 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 665' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -68.56 -31.78 71.24 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.915 -0.584 . . . . 7.07 110.376 -177.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 666' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 -100.9 52.49 0.85 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.065 -0.717 . . . . 6.8 109.065 174.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 667' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -60.28 -58.15 9.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.388 -0.824 . . . . 5.49 112.444 -172.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 668' ' ' SER . . . . . . . . . . . . . 9.2 t -117.68 -10.49 10.54 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.804 -0.359 . . . . 4.72 111.492 -173.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 669' ' ' GLY . . . . . . . . . . . . . . . 105.2 160.4 23.41 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.356 -0.926 . . . . 1.87 111.743 -178.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 670' ' ' TYR . . . . . 0.544 ' CE2' ' HB2' ' A' ' 717' ' ' LEU . 93.4 m-85 -93.25 141.8 28.03 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 120.853 0.359 . . . . 1.41 110.863 -177.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -125.42 162.29 25.16 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.966 -0.561 . . . . 2.7 110.503 -175.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . . . . . . . . . 7.6 mp -79.67 143.48 34.59 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.89 0.376 . . . . 1.05 110.452 177.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 673' ' ' GLY . . . . . . . . . . . . . . . 84.46 3.01 88.81 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.767 -0.652 . . . . 0.64 111.542 -177.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 674' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -86.62 145.5 26.7 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.557 -0.321 . . . . 2.2 110.228 -178.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 675' ' ' ARG . . . . . . . . . . . . . 30.9 ttm180 -106.48 125.04 50.49 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.219 0.533 . . . . 4.07 109.902 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 676' ' ' VAL . . . . . 0.432 ' HB ' ' HB3' ' A' ' 717' ' ' LEU . 34.7 m -117.57 163.32 14.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.456 -0.793 . . . . 0.59 111.147 -174.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 677' ' ' ARG . . . . . 0.501 ' HB2' HG22 ' A' ' 720' ' ' VAL . 55.8 ttp180 -134.72 121.16 20.37 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.043 -0.526 . . . . 3.15 109.98 176.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 678' ' ' HIS . . . . . 0.464 ' HB2' ' CD1' ' A' ' 717' ' ' LEU . 51.5 t60 -134.25 122.65 23.04 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.094 -0.706 . . . . 1.53 109.094 179.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 679' ' ' ALA . . . . . . . . . . . . . . . -58.41 -20.8 47.39 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.009 0.744 . . . . 1.24 113.009 -169.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 680' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -86.28 -33.46 20.66 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 111.938 0.347 . . . . 2.92 111.938 -177.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 681' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -116.97 -12.41 10.69 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.438 0.533 . . . . 1.5 112.438 -175.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 682' ' ' GLY . . . . . . . . . . . . . . . 99.03 -156.51 20.06 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.793 -0.717 . . . . 0.82 111.548 -178.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 683' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 676' ' ' VAL . 0.8 OUTLIER -105.51 143.24 33.95 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.866 -0.42 . . . . 2.11 109.866 176.102 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 684' ' ' GLY . . . . . . . . . . . . . . . -153.79 175.14 32.22 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.218 -0.991 . . . . 0.38 112.486 -177.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 685' ' ' THR . . . . . . . . . . . . . 84.9 m -111.89 123.97 51.37 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.724 0.297 . . . . 0.47 110.364 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 44.7 mt -68.76 106.5 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.56 -0.533 . . . . 0.47 109.56 178.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 687' ' ' VAL . . . . . . . . . . . . . 26.9 m -99.58 -19.05 6.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.326 -0.397 . . . . 0.5 111.454 -174.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 688' ' ' ASN . . . . . 0.472 ' HB3' ' HB2' ' A' ' 699' ' ' GLN . 18.1 t-20 -156.58 162.33 39.9 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.542 -0.54 . . . . 1.62 109.542 -178.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 689' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -148.97 146.82 28.0 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.021 -0.733 . . . . 2.17 109.021 176.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 690' ' ' GLU . . . . . 0.437 ' OE2' ' HD2' ' A' ' 697' ' ' ARG . 36.4 mt-10 -119.93 122.85 42.14 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.635 0.255 . . . . 2.02 111.237 -174.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . 68.99 -172.7 36.49 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.144 -0.55 . . . . 1.05 113.235 175.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 8.5 p -139.71 165.67 26.66 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.397 -0.223 . . . . 2.18 110.397 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 81.0 -150.65 30.88 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 121.095 -0.574 . . . . 1.31 112.615 178.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 694' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -64.47 -40.99 96.73 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.833 0.349 . . . . 2.85 111.157 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 695' ' ' HIS . . . . . . . . . . . . . 27.6 p-80 -86.66 21.97 2.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.283 -0.417 . . . . 3.05 111.293 -177.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 696' ' ' SER . . . . . . . . . . . . . 19.2 t -82.05 141.36 33.26 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.38 -0.6 . . . . 1.5 109.38 176.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 697' ' ' ARG . . . . . 0.437 ' HD2' ' OE2' ' A' ' 690' ' ' GLU . 41.6 mtt180 -122.69 152.77 40.22 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.668 -0.493 . . . . 2.54 109.668 178.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 11.2 mt -118.22 130.38 56.04 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.198 -0.668 . . . . 0.46 109.198 174.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 699' ' ' GLN . . . . . 0.472 ' HB2' ' HB3' ' A' ' 688' ' ' ASN . 30.5 mt-30 -97.49 101.49 13.03 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.746 0.784 . . . . 2.24 109.618 175.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 700' ' ' VAL . . . . . 0.447 ' HB ' ' CE1' ' A' ' 702' ' ' PHE . 15.9 t -100.13 123.19 52.83 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 114.674 -1.148 . . . . 0.22 110.35 -174.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -86.49 94.3 9.38 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.402 -0.592 . . . . 0.23 109.402 176.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 702' ' ' PHE . . . . . 0.447 ' CE1' ' HB ' ' A' ' 700' ' ' VAL . 92.7 m-85 -77.14 117.11 18.36 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.832 -0.622 . . . . 1.2 109.743 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -60.79 -21.51 63.16 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.854 -0.612 . . . . 2.79 112.088 -174.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -83.92 -20.04 60.2 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.67 -0.776 . . . . 0.78 112.481 178.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 705' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -135.26 -82.9 0.41 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.864 0.364 . . . . 2.62 111.4 -177.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . . . . . . . . . . . 179.49 -156.58 18.64 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 121.119 -0.562 . . . . 0.5 111.77 -177.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 707' ' ' ILE . . . . . 0.443 ' HA ' ' O ' ' A' ' 700' ' ' VAL . 61.5 mt -85.17 126.83 40.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 120.982 0.42 . . . . 0.67 111.205 -176.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 708' ' ' LYS . . . . . 0.443 ' O ' ' HA ' ' A' ' 699' ' ' GLN . 4.5 mptp? -121.47 161.4 22.32 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.891 -0.595 . . . . 1.35 109.779 176.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 709' ' ' TRP . . . . . . . . . . . . . 17.7 p-90 -105.86 115.29 29.98 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.233 0.539 . . . . 0.84 109.657 177.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -112.75 114.62 27.27 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 116.137 -0.483 . . . . 0.44 110.244 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 49.1 t -65.1 115.68 3.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.664 -0.495 . . . . 0.61 109.664 178.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 712' ' ' ALA . . . . . . . . . . . . . . . -54.62 -32.57 59.12 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.849 0.685 . . . . 0.91 112.849 -170.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -66.34 -25.62 66.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.932 0.396 . . . . 1.1 111.545 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 714' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -133.95 29.44 3.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.141 0.496 . . . . 1.96 109.723 -177.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 715' ' ' ALA . . . . . 0.529 ' HB1' ' CD2' ' A' ' 717' ' ' LEU . . . -80.01 -57.49 3.61 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.553 -0.749 . . . . 0.77 111.094 -174.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 716' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 716' ' ' ARG . 38.3 ttm180 58.3 69.34 0.74 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.63 0.729 . . . . 4.41 111.031 178.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . 0.544 ' HB2' ' CE2' ' A' ' 670' ' ' TYR . 3.6 mm? -105.74 122.92 47.06 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.876 -0.602 . . . . 0.85 110.278 177.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 718' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -91.05 130.94 36.91 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.763 -0.653 . . . . 2.13 109.787 -179.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 719' ' ' SER . . . . . . . . . . . . . 15.5 p -64.9 125.63 25.47 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.901 -0.407 . . . . 1.68 109.901 176.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 720' ' ' VAL . . . . . 0.501 HG22 ' HB2' ' A' ' 677' ' ' ARG . 10.9 t . . . . . 0 C--O 1.246 0.921 0 CA-C-O 118.803 -0.618 . . . . 1.64 110.528 -177.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.144 0 N-CA-C 111.463 0.171 . . . . 27.27 111.463 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 646' ' ' LEU . . . . . . . . . . . . . 68.6 tp -137.51 -71.47 0.43 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.682 0.277 . . . . 26.57 110.988 -177.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 647' ' ' ARG . . . . . . . . . . . . . 58.1 mtm180 -103.16 102.56 12.55 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.796 -0.446 . . . . 24.57 109.796 178.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 648' ' ' ALA . . . . . . . . . . . . . . . -67.72 129.11 38.91 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.013 -0.54 . . . . 23.82 111.167 -177.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 649' ' ' THR . . . . . . . . . . . . . 9.0 t -145.1 132.02 20.21 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.889 -0.596 . . . . 23.24 109.437 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 650' ' ' VAL . . . . . . . . . . . . . 46.3 t -80.3 -52.97 13.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.912 -0.585 . . . . 23.34 110.711 -176.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 651' ' ' SER . . . . . . . . . . . . . 16.8 p -160.06 -71.53 0.07 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.053 0.454 . . . . 21.93 110.79 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 652' ' ' ARG . . . . . . . . . . . . . 31.9 mmt180 -118.01 114.51 37.11 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.077 -0.511 . . . . 21.54 110.313 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 653' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -57.67 162.47 10.55 Favored 'Trans proline' 0 C--O 1.235 0.349 0 C-N-CA 123.06 2.507 . . . . 19.8 112.17 177.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 654' ' ' VAL . . . . . . . . . . . . . 37.0 t -76.98 79.64 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.356 0.598 . . . . 20.26 110.484 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 655' ' ' SER . . . . . . . . . . . . . 15.2 m -93.98 41.63 1.09 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.467 -0.788 . . . . 18.24 110.032 178.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 656' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -107.28 101.83 11.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.768 -0.651 . . . . 16.63 109.897 -178.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 657' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -109.69 152.86 25.06 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.123 -0.489 . . . . 17.75 110.457 -179.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 658' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -109.55 99.3 8.52 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.323 -0.399 . . . . 15.35 110.536 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 659' ' ' MET . . . . . . . . . . . . . 24.6 ttt -79.31 -24.15 43.03 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.293 0.568 . . . . 14.95 110.353 178.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . -94.94 25.18 25.04 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.89 -0.671 . . . . 12.49 111.753 -178.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 661' ' ' THR . . . . . . . . . . . . . 8.8 t -76.77 127.61 83.66 Favored Pre-proline 0 N--CA 1.449 -0.494 0 N-CA-C 110.147 -0.316 . . . . 10.68 110.147 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 662' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -71.16 150.67 60.07 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.348 2.032 . . . . 10.3 110.778 173.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 663' ' ' MET . . . . . . . . . . . . . 26.4 mmt 63.55 100.12 0.03 OUTLIER 'General case' 0 C--O 1.235 0.32 0 O-C-N 123.708 0.63 . . . . 9.41 110.754 -177.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 664' ' ' VAL . . . . . . . . . . . . . 59.4 t -66.24 100.7 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.546 -0.752 . . . . 7.04 110.784 -178.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 665' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -87.28 -12.48 46.48 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.047 -0.524 . . . . 7.07 111.0 -179.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 666' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -148.88 -62.84 0.24 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.222 -0.444 . . . . 6.8 110.219 177.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 667' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -150.59 169.66 21.01 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.978 -0.556 . . . . 5.49 110.087 178.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 668' ' ' SER . . . . . . . . . . . . . 11.9 m -92.9 25.75 3.05 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.246 -0.433 . . . . 4.72 111.777 -173.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 669' ' ' GLY . . . . . . . . . . . . . . . 137.78 -56.88 0.66 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.632 -0.794 . . . . 1.87 112.215 177.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 670' ' ' TYR . . . . . 0.518 ' CD1' HD11 ' A' ' 698' ' ' LEU . 94.1 m-85 -134.19 172.76 12.41 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 110.163 -0.31 . . . . 1.41 110.163 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 671' ' ' LYS . . . . . 0.494 ' HG2' HE21 ' A' ' 674' ' ' GLN . 21.2 ptmt -140.33 155.98 46.6 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.392 -0.367 . . . . 2.7 110.244 -176.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . . . . . . . . . 59.6 mt -78.65 140.99 38.32 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.136 -0.484 . . . . 1.05 110.478 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 673' ' ' GLY . . . . . . . . . . . . . . . 84.07 5.74 87.27 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.814 -0.63 . . . . 0.64 111.803 -177.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 674' ' ' GLN . . . . . 0.494 HE21 ' HG2' ' A' ' 671' ' ' LYS . 6.7 tt0 -83.28 142.89 30.77 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.022 -0.362 . . . . 2.2 110.022 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 675' ' ' ARG . . . . . . . . . . . . . 26.8 mmm180 -93.26 120.11 33.17 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.848 -0.614 . . . . 4.07 109.841 178.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 676' ' ' VAL . . . . . 0.472 ' HB ' ' HB3' ' A' ' 717' ' ' LEU . 34.2 m -117.27 154.74 19.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.883 -0.599 . . . . 0.59 110.695 -177.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 677' ' ' ARG . . . . . . . . . . . . . 52.1 ttp180 -131.79 137.91 48.34 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.955 -0.566 . . . . 3.15 110.014 178.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 678' ' ' HIS . . . . . 0.426 ' CD2' HD13 ' A' ' 717' ' ' LEU . 0.0 OUTLIER -139.99 155.21 47.22 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.129 -0.487 . . . . 1.53 110.464 174.089 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 679' ' ' ALA . . . . . . . . . . . . . . . -56.12 -53.9 51.56 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.673 0.62 . . . . 1.24 112.673 -173.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 680' ' ' LYS . . . . . . . . . . . . . 2.7 mtpm? -92.66 -30.67 15.46 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.957 -0.565 . . . . 2.92 111.743 -171.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 681' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -87.42 -11.85 47.93 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.342 -0.39 . . . . 1.5 111.34 -177.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 682' ' ' GLY . . . . . . . . . . . . . . . 84.47 -112.49 3.62 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.582 -0.818 . . . . 0.82 111.992 178.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 683' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -151.12 149.14 29.13 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.738 -0.468 . . . . 2.11 109.738 177.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 684' ' ' GLY . . . . . . . . . . . . . . . -160.55 -179.46 35.34 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.016 -1.088 . . . . 0.38 113.011 -178.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 685' ' ' THR . . . . . . . . . . . . . 64.6 m -110.83 130.02 55.7 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.738 -0.467 . . . . 0.47 109.738 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 686' ' ' ILE . . . . . 0.448 HG12 HG22 ' A' ' 700' ' ' VAL . 31.1 mt -72.74 103.52 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.171 -0.678 . . . . 0.47 109.171 175.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 687' ' ' VAL . . . . . . . . . . . . . 27.5 m -93.11 -26.28 4.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.18 0.514 . . . . 0.5 111.028 -175.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 688' ' ' ASN . . . . . 0.489 ' HB3' ' HB3' ' A' ' 699' ' ' GLN . 20.1 t-20 -146.07 161.74 39.46 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.916 -0.584 . . . . 1.62 109.676 177.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 689' ' ' MET . . . . . . . . . . . . . 26.7 ptm -153.16 143.68 22.6 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.55 -0.537 . . . . 2.17 109.55 177.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 690' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -108.73 122.79 47.89 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.756 -0.656 . . . . 2.02 110.456 -176.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . 67.64 -168.79 38.83 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.964 -0.636 . . . . 1.05 112.558 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 56.1 m -154.92 131.78 10.77 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.133 -0.321 . . . . 2.18 110.133 178.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 109.36 -142.74 16.33 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.713 -0.756 . . . . 1.31 112.021 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 694' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -66.54 -34.83 78.78 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.036 0.446 . . . . 2.85 111.109 -178.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 695' ' ' HIS . . . . . . . . . . . . . 55.8 m80 -95.36 31.03 2.05 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.253 -0.43 . . . . 3.05 110.902 -178.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 696' ' ' SER . . . . . . . . . . . . . 16.7 t -97.56 138.74 34.51 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.252 0.549 . . . . 1.5 110.902 -178.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 697' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -123.02 159.81 27.63 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.967 -0.753 . . . . 2.54 108.967 174.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 698' ' ' LEU . . . . . 0.518 HD11 ' CD1' ' A' ' 670' ' ' TYR . 35.6 mt -122.75 149.39 44.17 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 109.935 -0.394 . . . . 0.46 109.935 178.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 699' ' ' GLN . . . . . 0.489 ' HB3' ' HB3' ' A' ' 688' ' ' ASN . 15.1 tt0 -117.63 96.02 5.2 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.229 -1.026 . . . . 2.24 108.229 173.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 700' ' ' VAL . . . . . 0.448 HG22 HG12 ' A' ' 686' ' ' ILE . 35.3 t -100.64 134.5 40.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.551 -0.75 . . . . 0.22 111.103 -172.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -96.33 94.41 7.44 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.988 -0.551 . . . . 0.23 110.09 176.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 702' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -78.78 136.88 37.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.103 0.478 . . . . 1.2 110.691 -177.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -71.43 -21.22 62.01 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.609 -0.723 . . . . 2.79 112.473 -171.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -106.57 2.76 36.67 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.276 -0.964 . . . . 0.78 113.336 -175.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 705' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -146.64 -54.15 0.24 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 117.017 0.408 . . . . 2.62 111.447 -177.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . . . . . . . . . . . 139.57 -159.26 25.79 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.282 -0.961 . . . . 0.5 112.433 179.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 58.7 mt -79.08 134.25 28.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 120.847 0.356 . . . . 0.67 111.082 -176.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 708' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -137.75 159.59 41.55 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.884 -0.598 . . . . 1.35 111.333 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 709' ' ' TRP . . . . . 0.447 ' C ' HD22 ' A' ' 710' ' ' LEU . 33.0 p-90 -98.92 129.75 45.27 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.384 -0.825 . . . . 0.84 109.363 174.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . 0.447 HD22 ' C ' ' A' ' 709' ' ' TRP . 3.1 mm? -127.4 125.69 41.09 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 110.27 -0.27 . . . . 0.44 110.27 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 54.9 t -73.24 104.17 2.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.188 -0.671 . . . . 0.61 109.188 174.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 712' ' ' ALA . . . . . 0.405 ' HB2' ' HG ' ' A' ' 698' ' ' LEU . . . -56.81 -31.16 64.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.841 -0.618 . . . . 0.91 111.998 -171.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -58.96 -32.97 70.11 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.245 -0.434 . . . . 1.1 112.032 -178.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 714' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -127.73 19.21 6.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.134 0.492 . . . . 1.96 110.699 -178.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 715' ' ' ALA . . . . . 0.531 ' HB1' ' CD2' ' A' ' 717' ' ' LEU . . . -77.32 -53.82 7.23 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.703 -0.68 . . . . 0.77 111.067 -177.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 716' ' ' ARG . . . . . . . . . . . . . 25.4 tpt85 48.98 65.56 1.34 Allowed 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.864 0.84 . . . . 4.41 110.72 -176.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . 0.531 ' CD2' ' HB1' ' A' ' 715' ' ' ALA . 4.5 mm? -81.34 139.23 35.48 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.207 -0.906 . . . . 0.85 109.472 175.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 718' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -92.79 119.86 32.57 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.137 -0.69 . . . . 2.13 109.137 178.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 719' ' ' SER . . . . . . . . . . . . . 9.7 t -68.99 124.57 24.12 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.859 -0.422 . . . . 1.68 109.859 -178.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 720' ' ' VAL . . . . . . . . . . . . . 4.9 p . . . . . 0 C--O 1.248 0.974 0 CA-C-N 116.095 -0.502 . . . . 1.64 110.664 -177.055 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 . . . . . 0 N--CA 1.478 0.934 0 N-CA-C 110.228 -0.286 . . . . 27.27 110.228 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 646' ' ' LEU . . . . . . . . . . . . . 34.8 tp 64.21 52.55 1.93 Allowed 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.715 0.769 . . . . 26.57 109.674 -177.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 647' ' ' ARG . . . . . . . . . . . . . 29.6 tpt180 -95.19 76.35 3.45 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.26 -0.882 . . . . 24.57 110.027 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 648' ' ' ALA . . . . . . . . . . . . . . . 55.84 77.12 0.25 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.006 -0.543 . . . . 23.82 110.974 -178.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 649' ' ' THR . . . . . . . . . . . . . 8.8 t -82.87 37.83 0.55 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.035 -0.529 . . . . 23.24 111.161 -175.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 650' ' ' VAL . . . . . . . . . . . . . 14.8 t 55.51 58.51 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 121.916 0.865 . . . . 23.34 109.864 -178.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 651' ' ' SER . . . . . . . . . . . . . 25.6 t -161.43 -55.52 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.278 -0.874 . . . . 21.93 110.001 -177.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 652' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -141.7 86.66 10.6 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 116.051 -0.522 . . . . 21.54 110.46 -177.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 653' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -84.1 59.85 6.15 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.593 2.195 . . . . 19.8 111.215 178.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 654' ' ' VAL . . . . . . . . . . . . . 48.3 t 60.69 79.38 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.475 -0.784 . . . . 20.26 110.006 -173.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 655' ' ' SER . . . . . . . . . . . . . 23.9 m -81.47 -20.84 39.37 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.555 -0.748 . . . . 18.24 110.252 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 656' ' ' HIS . . . . . . . . . . . . . 29.5 m170 -77.94 112.47 14.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.831 -0.622 . . . . 16.63 110.276 176.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 657' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -120.25 151.72 38.78 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.159 -0.473 . . . . 17.75 110.281 178.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 658' ' ' ARG . . . . . 0.439 ' NH2' ' HB2' ' A' ' 665' ' ' GLU . 16.8 ttm180 -68.45 -77.1 0.08 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.82 0.343 . . . . 15.35 111.003 -175.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 659' ' ' MET . . . . . . . . . . . . . 27.0 ttt -120.19 -43.2 2.54 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.847 0.356 . . . . 14.95 110.528 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . -143.55 -27.64 0.13 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.8 -0.714 . . . . 12.49 112.169 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 661' ' ' THR . . . . . . . . . . . . . 9.5 p -120.74 141.45 32.42 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-O 120.81 0.338 . . . . 10.68 111.05 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 662' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -79.76 62.17 8.42 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.81 2.34 . . . . 10.3 111.316 174.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 663' ' ' MET . . . . . . . . . . . . . 53.3 ttm -104.09 129.32 51.77 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.841 -0.618 . . . . 9.41 110.421 -177.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 664' ' ' VAL . . . . . . . . . . . . . 59.1 t -80.97 121.05 33.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.956 -0.566 . . . . 7.04 110.217 178.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 665' ' ' GLU . . . . . 0.439 ' HB2' ' NH2' ' A' ' 658' ' ' ARG . 10.5 tp10 -77.77 79.69 4.25 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.216 0.531 . . . . 7.07 109.945 179.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 666' ' ' ASN . . . . . 0.408 HD22 ' C ' ' A' ' 666' ' ' ASN . 0.3 OUTLIER -109.34 147.39 32.79 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.924 -0.58 . . . . 6.8 110.807 -178.916 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 667' ' ' ASP . . . . . . . . . . . . . 12.6 t70 68.16 126.59 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 O-C-N 124.172 0.92 . . . . 5.49 111.32 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 668' ' ' SER . . . . . . . . . . . . . 31.3 t -129.13 36.31 4.19 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.692 -0.686 . . . . 4.72 109.799 -178.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 669' ' ' GLY . . . . . . . . . . . . . . . -147.59 93.73 0.16 Allowed Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.559 -0.829 . . . . 1.87 112.569 -178.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 670' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -68.92 157.27 36.99 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 110.068 -0.345 . . . . 1.41 110.068 176.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -118.12 152.3 35.89 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.275 -0.421 . . . . 2.7 110.983 -176.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . . . . . . . . . 70.0 mt -79.25 133.51 36.66 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.094 -0.503 . . . . 1.05 110.053 176.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 673' ' ' GLY . . . . . . . . . . . . . . . 94.42 1.23 64.45 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.841 -0.695 . . . . 0.64 111.699 -174.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 674' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -81.29 144.63 31.39 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 110.021 -0.362 . . . . 2.2 110.021 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 675' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.47 128.65 50.6 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.086 -0.709 . . . . 4.07 109.086 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 676' ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' A' ' 683' ' ' GLU . 35.8 m -119.7 152.23 22.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 115.814 -0.63 . . . . 0.59 111.465 -173.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 677' ' ' ARG . . . . . 0.472 ' HG3' HG22 ' A' ' 720' ' ' VAL . 32.6 mtp180 -123.06 124.28 42.75 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.28 0.562 . . . . 3.15 110.813 175.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 678' ' ' HIS . . . . . 0.539 ' HB2' ' CD1' ' A' ' 717' ' ' LEU . 43.4 t60 -139.42 104.66 5.02 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.212 -0.904 . . . . 1.53 109.148 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 679' ' ' ALA . . . . . . . . . . . . . . . -40.42 -38.15 0.78 Allowed 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 114.086 1.143 . . . . 1.24 114.086 -170.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 680' ' ' LYS . . . . . . . . . . . . . 18.7 mmtm -75.8 -31.18 59.33 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.646 -0.252 . . . . 2.92 111.542 -172.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 681' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -116.61 -13.08 10.86 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.85 -0.34 . . . . 1.5 111.816 -176.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 682' ' ' GLY . . . . . . . . . . . . . . . 97.82 -155.36 20.42 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.902 -0.666 . . . . 0.82 111.842 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 683' ' ' GLU . . . . . 0.48 ' HA ' ' O ' ' A' ' 676' ' ' VAL . 0.5 OUTLIER -109.53 147.57 32.72 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.003 0.43 . . . . 2.11 110.61 179.075 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 684' ' ' GLY . . . . . . . . . . . . . . . -156.49 179.48 32.31 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 120.594 -0.812 . . . . 0.38 111.999 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 685' ' ' THR . . . . . . . . . . . . . 71.3 m -115.06 127.36 55.58 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.764 0.316 . . . . 0.47 110.201 179.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 686' ' ' ILE . . . . . 0.401 HG12 HG22 ' A' ' 700' ' ' VAL . 33.6 mt -71.63 104.93 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.182 -0.463 . . . . 0.47 109.759 178.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 687' ' ' VAL . . . . . . . . . . . . . 29.3 m -95.54 -26.61 4.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.862 0.363 . . . . 0.5 111.263 -176.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 688' ' ' ASN . . . . . 0.462 ' HB3' ' HB2' ' A' ' 699' ' ' GLN . 21.2 t-20 -146.38 163.47 35.5 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.598 -0.519 . . . . 1.62 109.598 -179.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 689' ' ' MET . . . . . . . . . . . . . 18.0 ptp -158.3 157.39 32.38 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.956 -0.387 . . . . 2.17 109.956 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 690' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -129.15 123.53 32.35 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.435 -0.348 . . . . 2.02 111.405 -177.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . 62.31 -162.83 27.78 Favored Glycine 0 N--CA 1.452 -0.3 0 CA-C-N 115.692 -0.685 . . . . 1.05 113.748 172.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 692' ' ' SER . . . . . 0.402 ' HA ' ' HB3' ' A' ' 696' ' ' SER . 39.7 m -151.81 170.44 19.78 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.262 -0.644 . . . . 2.18 109.262 177.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 90.38 -139.47 14.96 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.399 -0.905 . . . . 1.31 112.456 177.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 694' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -83.29 -24.7 32.08 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.011 0.434 . . . . 2.85 110.596 -178.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 695' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -102.13 35.52 2.37 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.435 0.636 . . . . 3.05 110.383 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 696' ' ' SER . . . . . 0.493 ' OG ' ' HB3' ' A' ' 712' ' ' ALA . 16.3 p -90.81 135.51 33.68 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.396 -0.82 . . . . 1.5 110.258 179.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 697' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 697' ' ' ARG . 34.2 mtp180 -127.69 146.53 50.53 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.595 -0.52 . . . . 2.54 109.595 178.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 15.5 mt -123.51 130.97 53.47 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.756 -0.461 . . . . 0.46 109.756 178.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 699' ' ' GLN . . . . . 0.473 ' HA ' ' O ' ' A' ' 708' ' ' LYS . 2.1 mp0 -99.14 107.92 20.41 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.468 0.651 . . . . 2.24 109.433 175.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 700' ' ' VAL . . . . . 0.401 HG22 HG12 ' A' ' 686' ' ' ILE . 42.1 t -107.13 125.7 63.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 114.913 -1.04 . . . . 0.22 111.097 -172.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 701' ' ' ALA . . . . . 0.407 ' HA ' ' HA ' ' A' ' 707' ' ' ILE . . . -87.3 94.65 9.73 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.152 -0.476 . . . . 0.23 109.844 176.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 702' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -74.44 135.91 42.33 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.15 0.5 . . . . 1.2 110.345 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -68.62 -31.13 70.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.246 -0.888 . . . . 2.79 111.211 -175.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -81.49 -37.52 17.14 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.729 -0.748 . . . . 0.78 112.795 -178.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 705' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 -113.69 -76.04 0.59 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.041 0.385 . . . . 2.62 112.041 -176.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . . . . . . . . . . . 167.87 -158.1 30.74 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.738 -0.744 . . . . 0.5 112.166 -177.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 707' ' ' ILE . . . . . 0.407 ' HA ' ' HA ' ' A' ' 701' ' ' ALA . 64.5 mt -78.46 122.97 34.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.056 0.455 . . . . 0.67 111.13 -176.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 708' ' ' LYS . . . . . 0.473 ' O ' ' HA ' ' A' ' 699' ' ' GLN . 86.2 mttt -129.25 168.66 15.87 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.918 -0.583 . . . . 1.35 110.866 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 709' ' ' TRP . . . . . 0.511 ' C ' HD22 ' A' ' 710' ' ' LEU . 57.0 p-90 -105.24 131.93 52.09 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.434 -0.803 . . . . 0.84 109.782 178.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . 0.511 HD22 ' C ' ' A' ' 709' ' ' TRP . 3.6 mm? -130.29 109.49 10.8 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.742 -0.466 . . . . 0.44 109.742 177.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 59.4 t -64.48 109.41 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.382 -0.599 . . . . 0.61 109.382 177.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 712' ' ' ALA . . . . . 0.493 ' HB3' ' OG ' ' A' ' 696' ' ' SER . . . -55.35 -33.89 63.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.774 -0.648 . . . . 0.91 112.51 -169.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -64.58 -20.26 66.15 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.288 -0.415 . . . . 1.1 111.72 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 714' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -131.49 15.4 4.97 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.965 0.412 . . . . 1.96 110.19 -179.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 715' ' ' ALA . . . . . 0.58 ' HB1' ' CD2' ' A' ' 717' ' ' LEU . . . -85.28 -60.41 2.04 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.016 -0.538 . . . . 0.77 111.454 -173.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 716' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 58.82 77.76 0.29 Allowed 'General case' 0 C--O 1.235 0.341 0 CA-C-O 121.49 0.662 . . . . 4.41 110.945 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . 0.58 ' CD2' ' HB1' ' A' ' 715' ' ' ALA . 3.8 mm? -103.02 129.13 49.68 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.616 -0.72 . . . . 0.85 110.911 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 718' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -86.34 125.42 33.62 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.83 -0.623 . . . . 2.13 109.416 175.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 719' ' ' SER . . . . . . . . . . . . . 34.6 t -70.68 131.18 43.51 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.685 0.279 . . . . 1.68 110.323 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 720' ' ' VAL . . . . . 0.472 HG22 ' HG3' ' A' ' 677' ' ' ARG . 17.5 t . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.671 -0.681 . . . . 1.64 109.988 177.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 21.1 tpt180 . . . . . 0 N--CA 1.479 1.025 0 CA-C-O 120.714 0.292 . . . . 27.27 110.244 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 646' ' ' LEU . . . . . . . . . . . . . 8.8 tt -79.89 118.28 21.51 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.081 -0.508 . . . . 26.57 110.302 -178.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 647' ' ' ARG . . . . . . . . . . . . . 56.6 mtm180 -140.92 132.54 27.15 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.94 -0.573 . . . . 24.57 109.837 177.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 648' ' ' ALA . . . . . . . . . . . . . . . -64.08 120.93 12.98 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.455 -0.339 . . . . 23.82 110.902 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 649' ' ' THR . . . . . . . . . . . . . 1.5 p -80.06 71.23 6.77 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.391 0.615 . . . . 23.24 111.307 -178.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 650' ' ' VAL . . . . . . . . . . . . . 27.5 m -82.5 -10.94 12.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.927 -0.579 . . . . 23.34 110.943 179.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 651' ' ' SER . . . . . . . . . . . . . 14.9 m -80.63 170.14 16.72 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.051 -0.522 . . . . 21.93 109.899 177.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 652' ' ' ARG . . . . . . . . . . . . . 31.7 ttp180 60.27 80.33 0.27 Allowed Pre-proline 0 CA--C 1.531 0.242 0 CA-C-O 121.04 0.448 . . . . 21.54 110.357 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 653' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -77.03 97.53 1.16 Allowed 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.522 2.148 . . . . 19.8 112.707 -176.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 654' ' ' VAL . . . . . 0.448 HG12 ' O ' ' A' ' 654' ' ' VAL . 14.6 t 62.83 34.98 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-O 121.536 0.684 . . . . 20.26 110.131 178.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 655' ' ' SER . . . . . . . . . . . . . 23.6 m 61.59 -83.58 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.261 -0.881 . . . . 18.24 111.671 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 656' ' ' HIS . . . . . . . . . . . . . 35.3 t60 -138.69 102.46 4.59 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.858 -0.793 . . . . 16.63 108.858 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 657' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -109.03 178.68 4.39 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.494 -0.321 . . . . 17.75 110.632 -177.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 658' ' ' ARG . . . . . . . . . . . . . 80.6 mtm180 57.62 73.03 0.48 Allowed 'General case' 0 C--O 1.232 0.181 0 O-C-N 123.742 0.651 . . . . 15.35 110.971 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 659' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -84.31 157.29 21.56 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.032 -0.531 . . . . 14.95 109.911 177.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . -172.67 89.5 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.647 -0.787 . . . . 12.49 112.12 -178.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 661' ' ' THR . . . . . 0.431 ' HA ' ' HD3' ' A' ' 662' ' ' PRO . 0.8 OUTLIER -79.86 119.95 78.37 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-O 120.682 0.277 . . . . 10.68 111.27 179.302 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 662' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 661' ' ' THR . 24.0 Cg_exo -63.95 117.1 4.12 Favored 'Trans proline' 0 C--O 1.235 0.362 0 C-N-CA 122.967 2.445 . . . . 10.3 112.09 178.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 663' ' ' MET . . . . . . . . . . . . . 25.0 mmt 66.21 -176.43 0.19 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.719 -0.673 . . . . 9.41 110.878 -178.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 664' ' ' VAL . . . . . . . . . . . . . 7.2 p -72.87 -36.44 51.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.03 0.443 . . . . 7.04 109.967 177.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 665' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -157.1 -76.37 0.09 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.006 -0.543 . . . . 7.07 110.064 175.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 666' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 54.82 42.66 30.98 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.295 0.569 . . . . 6.8 109.543 -177.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 667' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 66.63 136.98 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 114.934 -1.03 . . . . 5.49 111.104 -173.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 668' ' ' SER . . . . . . . . . . . . . 19.1 m -80.89 37.0 0.41 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.324 0.583 . . . . 4.72 110.526 179.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 669' ' ' GLY . . . . . . . . . . . . . . . 79.24 -113.25 3.62 Favored Glycine 0 N--CA 1.436 -1.316 0 N-CA-C 110.751 -0.939 . . . . 1.87 110.751 -175.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 670' ' ' TYR . . . . . 0.552 ' CD1' HD11 ' A' ' 698' ' ' LEU . 57.1 m-85 -138.28 158.31 44.54 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.603 -0.517 . . . . 1.41 109.603 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 10.4 mtmp? -100.04 143.03 30.72 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.889 0.376 . . . . 2.7 110.553 -177.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . . . . . . . . . 52.4 mt -81.13 137.41 35.95 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.107 -0.497 . . . . 1.05 110.405 -179.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 673' ' ' GLY . . . . . . . . . . . . . . . 88.35 11.82 66.13 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 110.831 -0.907 . . . . 0.64 110.831 -173.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 674' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -94.76 144.07 25.94 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.891 0.376 . . . . 2.2 110.526 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 675' ' ' ARG . . . . . 0.433 ' HD3' ' O ' ' A' ' 684' ' ' GLY . 11.0 tpp85 -97.95 123.82 42.12 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.622 -0.717 . . . . 4.07 109.835 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 676' ' ' VAL . . . . . 0.423 ' HB ' HD12 ' A' ' 717' ' ' LEU . 27.2 m -115.84 161.94 14.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.071 -0.513 . . . . 0.59 110.425 -177.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 677' ' ' ARG . . . . . 0.431 ' HG3' ' HG2' ' A' ' 683' ' ' GLU . 21.5 ttt180 -135.38 131.1 35.91 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.27 -0.423 . . . . 3.15 111.123 178.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 678' ' ' HIS . . . . . 0.465 ' CD2' HD13 ' A' ' 717' ' ' LEU . 0.0 OUTLIER -141.42 147.22 37.6 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.51 -0.768 . . . . 1.53 109.25 175.034 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 679' ' ' ALA . . . . . . . . . . . . . . . -76.85 -26.23 54.05 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.108 0.411 . . . . 1.24 112.108 -169.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 680' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -87.98 -37.81 16.06 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.036 0.384 . . . . 2.92 112.036 -176.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 681' ' ' PHE . . . . . . . . . . . . . 19.2 m-30 -106.71 -11.26 15.86 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 111.814 0.301 . . . . 1.5 111.814 -176.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 682' ' ' GLY . . . . . . . . . . . . . . . 90.53 -156.42 24.81 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.551 -0.833 . . . . 0.82 111.777 -177.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 683' ' ' GLU . . . . . 0.431 ' HG2' ' HG3' ' A' ' 677' ' ' ARG . 27.6 mt-10 -103.6 144.69 31.1 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.9 -0.407 . . . . 2.11 109.9 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 684' ' ' GLY . . . . . 0.433 ' O ' ' HD3' ' A' ' 675' ' ' ARG . . . -148.64 170.88 29.07 Favored Glycine 0 C--N 1.313 -0.742 0 C-N-CA 120.224 -0.989 . . . . 0.38 112.696 -177.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 685' ' ' THR . . . . . . . . . . . . . 32.8 m -113.83 124.67 52.78 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.872 0.368 . . . . 0.47 110.213 178.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 28.3 mt -73.64 104.7 2.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.259 -0.428 . . . . 0.47 109.912 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 687' ' ' VAL . . . . . . . . . . . . . 29.0 m -93.49 -25.63 4.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.732 0.301 . . . . 0.5 111.578 -175.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -152.14 163.93 38.36 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.446 -0.343 . . . . 1.62 110.138 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 689' ' ' MET . . . . . . . . . . . . . 5.1 ppp? -151.91 163.86 38.35 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.496 -0.557 . . . . 2.17 109.496 177.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 690' ' ' GLU . . . . . 0.427 ' CG ' ' HB2' ' A' ' 697' ' ' ARG . 10.7 pt-20 -146.91 155.13 42.05 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.406 -0.361 . . . . 2.02 110.579 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . 78.23 -159.29 46.82 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.963 -0.636 . . . . 1.05 112.485 177.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 29.6 t -161.81 149.43 14.62 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 110.259 -0.275 . . . . 2.18 110.259 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 62.86 -127.52 38.88 Favored Glycine 0 N--CA 1.452 -0.262 0 CA-C-N 116.072 -0.513 . . . . 1.31 113.574 175.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 694' ' ' GLU . . . . . 0.426 ' HA ' ' HB2' ' A' ' 713' ' ' ALA . 42.0 mt-10 -80.58 -15.79 55.77 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.775 0.322 . . . . 2.85 111.417 -175.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 695' ' ' HIS . . . . . . . . . . . . . 18.5 p-80 -109.9 34.71 3.7 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.322 0.582 . . . . 3.05 110.306 178.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 696' ' ' SER . . . . . . . . . . . . . 77.9 p -101.31 145.73 28.49 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.733 -0.667 . . . . 1.5 110.507 178.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 697' ' ' ARG . . . . . 0.427 ' HB2' ' CG ' ' A' ' 690' ' ' GLU . 96.8 mtt180 -125.33 151.05 46.57 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.658 -0.497 . . . . 2.54 109.658 175.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 698' ' ' LEU . . . . . 0.552 HD11 ' CD1' ' A' ' 670' ' ' TYR . 15.5 mt -117.36 146.33 43.47 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.719 -0.474 . . . . 0.46 109.719 178.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 699' ' ' GLN . . . . . 0.5 ' HA ' ' O ' ' A' ' 708' ' ' LYS . 19.0 mt-30 -107.94 99.09 8.57 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.76 0.791 . . . . 2.24 109.27 169.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 700' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 707' ' ' ILE . 20.8 t -100.02 122.72 52.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 114.38 -1.282 . . . . 0.22 110.565 -173.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -85.5 94.31 8.99 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.722 -0.473 . . . . 0.23 109.722 177.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 702' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -74.0 127.02 31.8 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.957 0.408 . . . . 1.2 110.002 178.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -62.43 -26.67 68.62 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.473 -0.785 . . . . 2.79 112.175 -169.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -96.05 -7.25 58.64 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.586 -0.816 . . . . 0.78 113.138 -178.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 705' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -134.59 -79.19 0.45 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 117.184 0.492 . . . . 2.62 111.344 -178.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . . . . . . . . . . . 168.71 -164.26 37.89 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.706 -0.759 . . . . 0.5 112.309 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 707' ' ' ILE . . . . . 0.454 ' HA ' ' O ' ' A' ' 700' ' ' VAL . 61.3 mt -75.89 127.85 37.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.936 0.398 . . . . 0.67 110.883 -178.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 708' ' ' LYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 699' ' ' GLN . 68.1 mttm -127.31 158.97 35.81 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.656 -0.702 . . . . 1.35 110.733 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 709' ' ' TRP . . . . . . . . . . . . . 13.8 p-90 -99.41 111.93 24.2 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.608 0.718 . . . . 0.84 110.222 179.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -117.04 115.22 24.99 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.861 -0.609 . . . . 0.44 110.443 -178.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 46.8 t -63.1 105.48 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.218 -0.66 . . . . 0.61 109.218 174.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 712' ' ' ALA . . . . . . . . . . . . . . . -48.62 -46.92 40.4 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 113.216 0.821 . . . . 0.91 113.216 -167.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 713' ' ' ALA . . . . . 0.426 ' HB2' ' HA ' ' A' ' 694' ' ' GLU . . . -64.11 -28.59 69.88 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.262 -0.427 . . . . 1.1 112.051 -175.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 714' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -111.35 2.47 17.63 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.281 0.563 . . . . 1.96 110.656 -178.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 715' ' ' ALA . . . . . 0.475 ' HB1' ' CD2' ' A' ' 717' ' ' LEU . . . -84.3 -50.82 7.5 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.509 -0.769 . . . . 0.77 109.617 177.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 716' ' ' ARG . . . . . 0.637 ' HA ' ' HE ' ' A' ' 716' ' ' ARG . 1.3 mmp_? 51.41 67.52 0.94 Allowed 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.596 -0.729 . . . . 4.41 110.83 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . 0.475 ' CD2' ' HB1' ' A' ' 715' ' ' ALA . 4.6 mm? -86.05 152.34 22.97 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.328 -0.851 . . . . 0.85 109.597 177.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 718' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -114.26 128.38 56.33 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.7 -0.481 . . . . 2.13 109.7 178.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 719' ' ' SER . . . . . . . . . . . . . 25.3 m -66.8 123.55 20.45 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.88 -0.415 . . . . 1.68 109.88 176.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 720' ' ' VAL . . . . . . . . . . . . . 3.2 p . . . . . 0 C--O 1.248 1.003 0 CA-C-N 116.463 -0.335 . . . . 1.64 111.038 -177.354 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 . . . . . 0 N--CA 1.484 1.274 0 CA-C-O 120.457 0.17 . . . . 27.27 111.206 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 646' ' ' LEU . . . . . 0.438 ' HG ' HG21 ' A' ' 650' ' ' VAL . 10.0 mp 61.5 27.79 17.24 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 122.617 0.367 . . . . 26.57 111.492 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 647' ' ' ARG . . . . . . . . . . . . . 30.9 tpt180 -76.5 92.36 3.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.409 -0.359 . . . . 24.57 110.573 -178.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 648' ' ' ALA . . . . . . . . . . . . . . . 65.01 -80.71 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.382 -0.826 . . . . 23.82 111.913 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 649' ' ' THR . . . . . . . . . . . . . 6.4 t -77.23 106.32 8.89 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.576 0.703 . . . . 23.24 110.827 -178.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 650' ' ' VAL . . . . . 0.438 HG21 ' HG ' ' A' ' 646' ' ' LEU . 10.3 p -165.63 -37.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.774 -0.648 . . . . 23.34 110.594 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 651' ' ' SER . . . . . . . . . . . . . 22.9 t -79.73 -42.71 24.04 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 109.261 -0.644 . . . . 21.93 109.261 178.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 652' ' ' ARG . . . . . . . . . . . . . 70.6 mtm180 -141.07 107.02 6.22 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.639 -0.71 . . . . 21.54 109.736 172.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 653' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -62.03 91.19 0.12 Allowed 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 122.769 2.313 . . . . 19.8 111.269 174.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 654' ' ' VAL . . . . . . . . . . . . . 97.9 t 72.53 121.44 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.489 -0.778 . . . . 20.26 110.38 -174.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 655' ' ' SER . . . . . . . . . . . . . 32.9 t -74.01 88.36 1.88 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.807 -0.633 . . . . 18.24 110.817 -177.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 656' ' ' HIS . . . . . . . . . . . . . 77.0 m-70 -82.9 117.76 22.98 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.118 -0.492 . . . . 16.63 110.558 177.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 657' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -103.03 113.65 27.3 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.033 0.444 . . . . 17.75 110.182 177.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 658' ' ' ARG . . . . . . . . . . . . . 60.3 mtp180 -88.71 -26.85 21.58 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.148 -0.478 . . . . 15.35 111.423 -176.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 659' ' ' MET . . . . . 0.41 ' O ' ' HG2' ' A' ' 659' ' ' MET . 24.4 ttt 64.52 26.34 13.35 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.454 -0.793 . . . . 14.95 110.924 178.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . -135.4 49.34 0.89 Allowed Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.712 -0.756 . . . . 12.49 112.152 -177.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 661' ' ' THR . . . . . . . . . . . . . 16.1 m -79.22 121.04 82.6 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-O 120.761 0.315 . . . . 10.68 110.247 178.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 662' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -66.97 -39.37 14.17 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.82 2.347 . . . . 10.3 112.503 -178.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 663' ' ' MET . . . . . . . . . . . . . 19.7 ptp -152.67 142.41 21.97 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.187 -0.46 . . . . 9.41 109.922 176.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 664' ' ' VAL . . . . . . . . . . . . . 16.0 m -107.95 156.65 8.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 115.746 -0.661 . . . . 7.04 110.701 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 665' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -124.07 20.71 9.04 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.334 -0.393 . . . . 7.07 111.102 -179.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 666' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -71.28 -26.88 63.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.914 0.387 . . . . 6.8 111.14 -176.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 667' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -122.8 23.64 9.36 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.911 -0.403 . . . . 5.49 109.911 179.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 668' ' ' SER . . . . . . . . . . . . . 11.3 p -53.47 -42.91 67.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.633 -0.712 . . . . 4.72 111.924 -175.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 669' ' ' GLY . . . . . . . . . . . . . . . 108.31 76.87 0.97 Allowed Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.751 -0.738 . . . . 1.87 111.897 178.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 670' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -71.12 143.36 50.62 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.76 0.314 . . . . 1.41 110.41 -178.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -134.77 162.49 32.22 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.95 -0.568 . . . . 2.7 110.297 -174.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . . . . . . . . . 35.5 mt -77.86 134.45 37.95 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.845 0.355 . . . . 1.05 110.293 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 673' ' ' GLY . . . . . . . . . . . . . . . 88.38 -0.27 83.17 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 111.415 -0.674 . . . . 0.64 111.415 -176.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 674' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -82.61 148.45 27.99 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.717 0.294 . . . . 2.2 110.21 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 675' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -103.34 132.4 49.62 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.129 -0.487 . . . . 4.07 110.121 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 676' ' ' VAL . . . . . 0.501 ' HB ' HD12 ' A' ' 717' ' ' LEU . 29.9 m -117.01 153.39 18.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.582 -0.735 . . . . 0.59 110.448 -177.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 677' ' ' ARG . . . . . 0.435 ' HB2' HG22 ' A' ' 720' ' ' VAL . 42.3 ttt180 -126.79 129.31 48.08 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.328 -0.396 . . . . 3.15 110.376 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -140.79 121.55 14.37 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.089 -0.708 . . . . 1.53 109.089 177.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 679' ' ' ALA . . . . . . . . . . . . . . . -58.73 -18.5 32.0 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.127 0.417 . . . . 1.24 112.127 -175.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 680' ' ' LYS . . . . . 0.523 ' HD2' ' N ' ' A' ' 680' ' ' LYS . 0.3 OUTLIER -91.07 -35.52 14.56 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.243 -0.435 . . . . 2.92 112.088 -177.515 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 681' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -113.25 -11.46 13.22 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.787 0.327 . . . . 1.5 111.796 -174.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 682' ' ' GLY . . . . . . . . . . . . . . . 92.98 -156.5 22.96 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 111.467 -0.653 . . . . 0.82 111.467 -174.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 683' ' ' GLU . . . . . 0.441 ' HA ' ' O ' ' A' ' 676' ' ' VAL . 12.1 pt-20 -109.13 147.73 31.99 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.777 -0.453 . . . . 2.11 109.777 177.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 684' ' ' GLY . . . . . . . . . . . . . . . -151.15 173.54 30.59 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.428 -0.891 . . . . 0.38 112.286 -177.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 685' ' ' THR . . . . . . . . . . . . . 16.5 m -110.78 125.88 54.02 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.548 0.213 . . . . 0.47 110.687 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 50.6 mt -74.39 107.38 4.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.975 -0.379 . . . . 0.47 109.975 177.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 687' ' ' VAL . . . . . . . . . . . . . 29.9 m -93.63 -31.92 4.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 120.873 0.368 . . . . 0.5 111.073 -177.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -143.0 159.81 41.54 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.112 -0.495 . . . . 1.62 110.243 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 689' ' ' MET . . . . . . . . . . . . . 5.3 ppp? -149.05 142.85 25.63 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.97 0.414 . . . . 2.17 110.262 179.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 690' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -114.72 123.62 49.72 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.814 -0.63 . . . . 2.02 110.63 -175.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . 84.62 -152.16 27.28 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.827 -0.701 . . . . 1.05 113.193 174.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 17.5 p -173.7 126.14 0.39 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 123.168 0.587 . . . . 2.18 109.569 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 111.77 -143.74 17.46 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.765 -0.731 . . . . 1.31 111.703 -175.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 694' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -72.8 -48.6 36.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.083 0.468 . . . . 2.85 111.327 -177.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 695' ' ' HIS . . . . . . . . . . . . . 57.9 m-70 -81.92 37.5 0.48 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.968 -0.56 . . . . 3.05 111.415 -173.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 696' ' ' SER . . . . . . . . . . . . . 4.6 m -98.31 143.97 28.22 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.22 -0.446 . . . . 1.5 110.163 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 697' ' ' ARG . . . . . . . . . . . . . 40.9 mtm180 -117.64 135.79 53.75 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.553 -0.536 . . . . 2.54 109.553 175.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 15.9 mt -107.3 131.25 54.43 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.86 -0.422 . . . . 0.46 109.86 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 699' ' ' GLN . . . . . 0.434 ' HA ' ' O ' ' A' ' 708' ' ' LYS . 5.8 mp0 -93.75 101.52 13.64 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.485 0.659 . . . . 2.24 109.498 174.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 22.0 t -101.98 124.41 55.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-N 115.045 -0.98 . . . . 0.22 110.437 -175.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 701' ' ' ALA . . . . . 0.411 ' HA ' ' HA ' ' A' ' 707' ' ' ILE . . . -88.11 101.44 13.81 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.986 -0.552 . . . . 0.23 110.168 178.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 702' ' ' PHE . . . . . 0.444 ' CD1' ' HD2' ' A' ' 708' ' ' LYS . 91.9 m-85 -87.43 120.25 28.54 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.706 -0.479 . . . . 1.2 109.706 176.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -71.2 -11.3 60.86 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.161 0.505 . . . . 2.79 111.064 -174.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -88.24 -13.12 64.36 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.951 -0.643 . . . . 0.78 113.122 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 705' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -150.78 -55.61 0.15 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 117.568 0.684 . . . . 2.62 111.912 -177.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . . . . . . . . . . . 163.78 -167.79 38.05 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.606 -0.806 . . . . 0.5 112.266 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 707' ' ' ILE . . . . . 0.411 ' HA ' ' HA ' ' A' ' 701' ' ' ALA . 61.6 mt -78.02 141.85 14.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.73 0.3 . . . . 0.67 110.383 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 708' ' ' LYS . . . . . 0.444 ' HD2' ' CD1' ' A' ' 702' ' ' PHE . 67.1 mttm -132.66 161.75 33.14 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.033 0.444 . . . . 1.35 111.004 178.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 709' ' ' TRP . . . . . . . . . . . . . 20.5 p-90 -108.68 119.94 41.0 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.288 -0.869 . . . . 0.84 109.124 174.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -120.12 115.13 23.07 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.436 -0.347 . . . . 0.44 110.416 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 48.3 t -66.5 109.42 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.026 -0.731 . . . . 0.61 109.026 175.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 712' ' ' ALA . . . . . . . . . . . . . . . -45.42 -48.63 13.65 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 113.283 0.845 . . . . 0.91 113.283 -168.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -66.24 -31.43 72.24 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.363 0.505 . . . . 1.1 112.363 -175.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 714' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -97.99 -20.79 17.19 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.979 0.419 . . . . 1.96 110.77 -177.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 715' ' ' ALA . . . . . 0.526 ' HB1' ' CD2' ' A' ' 717' ' ' LEU . . . -72.44 -54.55 9.01 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.737 -0.665 . . . . 0.77 110.777 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 716' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 57.17 76.43 0.32 Allowed 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.438 0.637 . . . . 4.41 110.6 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . 0.526 ' CD2' ' HB1' ' A' ' 715' ' ' ALA . 4.4 mm? -97.19 142.4 29.15 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.607 -0.724 . . . . 0.85 110.955 -178.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 718' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -101.89 130.32 48.34 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.678 -0.86 . . . . 2.13 108.678 175.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 719' ' ' SER . . . . . . . . . . . . . 23.2 t -71.05 130.9 42.73 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.878 0.371 . . . . 1.68 110.403 -177.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 720' ' ' VAL . . . . . 0.435 HG22 ' HB2' ' A' ' 677' ' ' ARG . 46.2 t . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.398 -0.81 . . . . 1.64 110.627 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 . . . . . 0 N--CA 1.481 1.107 0 N-CA-C 109.746 -0.464 . . . . 27.27 109.746 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 646' ' ' LEU . . . . . . . . . . . . . 84.3 mt -103.62 89.74 3.44 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.481 0.182 . . . . 26.57 110.74 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 647' ' ' ARG . . . . . . . . . . . . . 76.7 mtp180 62.32 98.77 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 O-C-N 123.784 0.677 . . . . 24.57 111.547 177.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 648' ' ' ALA . . . . . . . . . . . . . . . -75.8 -14.83 60.31 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.322 0.582 . . . . 23.82 110.912 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 649' ' ' THR . . . . . . . . . . . . . 24.6 p 52.06 39.51 26.59 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 114.569 -1.196 . . . . 23.24 112.499 177.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 650' ' ' VAL . . . . . . . . . . . . . 42.4 t -77.44 75.8 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-O 121.743 0.782 . . . . 23.34 109.811 178.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 651' ' ' SER . . . . . . . . . . . . . 36.4 t -150.67 -57.93 0.17 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.902 -1.044 . . . . 21.93 108.706 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 652' ' ' ARG . . . . . . . . . . . . . 66.7 mtp180 56.17 76.12 0.52 Allowed Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 115.214 -0.903 . . . . 21.54 111.88 175.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 653' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -74.91 78.22 2.92 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.645 2.23 . . . . 19.8 111.389 176.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 654' ' ' VAL . . . . . . . . . . . . . 12.2 p -64.88 -29.93 48.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.957 -0.565 . . . . 20.26 110.971 -178.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 655' ' ' SER . . . . . . . . . . . . . 24.4 t -102.54 96.62 7.03 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 116.037 -0.529 . . . . 18.24 110.172 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 656' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -88.9 102.31 14.92 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.418 -0.586 . . . . 16.63 109.418 178.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 657' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -130.81 10.2 5.05 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.1 0.407 . . . . 17.75 112.1 -174.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 658' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -82.51 -16.27 49.33 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.656 -0.418 . . . . 15.35 110.621 -177.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 659' ' ' MET . . . . . . . . . . . . . 51.9 tpp -64.0 -56.68 13.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.982 -0.554 . . . . 14.95 110.929 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . -111.55 51.1 0.72 Allowed Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.88 -0.676 . . . . 12.49 112.001 -177.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 661' ' ' THR . . . . . 0.403 ' HA ' ' HD3' ' A' ' 662' ' ' PRO . 10.8 t -98.74 135.99 20.84 Favored Pre-proline 0 C--N 1.321 -0.673 0 N-CA-C 109.854 -0.425 . . . . 10.68 109.854 178.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 662' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 661' ' ' THR . 31.6 Cg_exo -59.17 -31.86 96.1 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.096 2.531 . . . . 10.3 112.16 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 663' ' ' MET . . . . . . . . . . . . . 53.8 ttm -147.91 143.7 27.55 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.125 -0.694 . . . . 9.41 109.125 175.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 664' ' ' VAL . . . . . 0.425 HG12 ' HG3' ' A' ' 665' ' ' GLU . 46.8 t -94.23 125.8 46.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.617 -0.265 . . . . 7.04 110.552 -178.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 665' ' ' GLU . . . . . 0.425 ' HG3' HG12 ' A' ' 664' ' ' VAL . 50.6 mt-10 61.08 71.88 0.54 Allowed 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.699 -0.682 . . . . 7.07 111.391 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 666' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -74.07 99.65 3.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.014 -0.539 . . . . 6.8 109.936 176.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 667' ' ' ASP . . . . . . . . . . . . . 4.9 t70 63.53 -162.84 0.27 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.803 -0.635 . . . . 5.49 109.43 -175.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 668' ' ' SER . . . . . . . . . . . . . 5.1 p -72.39 -35.31 68.41 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 122.28 -0.263 . . . . 4.72 110.951 -178.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 669' ' ' GLY . . . . . . . . . . . . . . . 60.99 76.78 0.22 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.833 -0.699 . . . . 1.87 112.603 178.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 670' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -73.32 151.34 41.34 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.951 0.405 . . . . 1.41 110.529 -178.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 48.8 mtpt -128.54 155.86 44.21 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.876 -0.602 . . . . 2.7 110.408 -178.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . 0.56 HD21 ' SD ' ' A' ' 689' ' ' MET . 52.0 mt -79.38 134.17 36.58 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.199 -0.455 . . . . 1.05 110.098 177.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 673' ' ' GLY . . . . . . . . . . . . . . . 88.9 15.36 59.54 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.856 -0.687 . . . . 0.64 111.747 -175.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 674' ' ' GLN . . . . . . . . . . . . . 43.9 tp60 -94.49 144.79 25.28 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.286 -0.264 . . . . 2.2 110.286 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 675' ' ' ARG . . . . . . . . . . . . . 19.5 mtm180 -92.0 124.74 36.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.229 -0.441 . . . . 4.07 109.855 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 676' ' ' VAL . . . . . 0.449 ' HB ' HD12 ' A' ' 717' ' ' LEU . 29.0 m -117.91 154.56 19.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-O 120.792 0.33 . . . . 0.59 110.935 -179.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 677' ' ' ARG . . . . . 0.547 ' HB2' HG22 ' A' ' 720' ' ' VAL . 28.3 ttt-85 -130.77 131.61 44.81 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.858 -0.61 . . . . 3.15 109.812 178.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 678' ' ' HIS . . . . . 0.517 ' HB2' ' CD1' ' A' ' 717' ' ' LEU . 20.2 t60 -149.89 113.44 4.99 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.543 -0.54 . . . . 1.53 109.543 176.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 679' ' ' ALA . . . . . . . . . . . . . . . -49.79 -25.68 3.27 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 113.379 0.881 . . . . 1.24 113.379 -173.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 680' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -75.49 -33.19 60.76 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.762 -0.199 . . . . 2.92 111.411 -174.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 681' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -125.75 -13.13 6.48 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.745 0.307 . . . . 1.5 111.821 -174.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 682' ' ' GLY . . . . . . . . . . . . . . . 104.75 -153.59 17.43 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.855 -0.688 . . . . 0.82 111.786 -178.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 683' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -114.51 148.35 38.04 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.854 -0.425 . . . . 2.11 109.854 178.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 684' ' ' GLY . . . . . . . . . . . . . . . -156.66 -178.71 31.03 Favored Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 119.784 -1.198 . . . . 0.38 112.848 -178.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 685' ' ' THR . . . . . . . . . . . . . 12.6 m -113.97 125.62 54.22 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 110.266 -0.272 . . . . 0.47 110.266 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 46.4 mt -70.44 104.92 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.736 -0.468 . . . . 0.47 109.736 177.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 687' ' ' VAL . . . . . . . . . . . . . 27.1 m -93.82 -23.93 5.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 120.978 0.418 . . . . 0.5 111.061 -177.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 688' ' ' ASN . . . . . 0.471 ' HB3' ' HB2' ' A' ' 699' ' ' GLN . 8.5 t30 -151.33 161.3 42.95 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.48 -0.563 . . . . 1.62 109.48 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 689' ' ' MET . . . . . 0.56 ' SD ' HD21 ' A' ' 672' ' ' LEU . 0.0 OUTLIER -157.34 157.89 34.95 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 110.038 -0.356 . . . . 2.17 110.038 178.616 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 690' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -125.2 122.29 36.59 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.631 -0.507 . . . . 2.02 109.631 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . 74.84 -169.34 54.52 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.821 -0.704 . . . . 1.05 112.422 -177.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 49.6 m -155.72 96.37 1.75 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.803 0.335 . . . . 2.18 110.168 177.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 153.12 -130.14 2.92 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.902 -0.666 . . . . 1.31 112.729 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 694' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -84.18 -57.61 3.1 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.579 0.585 . . . . 2.85 112.579 -173.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 695' ' ' HIS . . . . . . . . . . . . . 16.2 p-80 -84.5 21.64 1.44 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.533 0.682 . . . . 3.05 110.855 -174.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 696' ' ' SER . . . . . . . . . . . . . 14.3 m -84.77 152.74 23.46 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.095 -0.957 . . . . 1.5 110.513 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 697' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -116.04 145.28 43.12 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 110.151 -0.314 . . . . 2.54 110.151 176.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 16.6 mt -118.23 135.81 54.04 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.708 -0.479 . . . . 0.46 109.708 178.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 699' ' ' GLN . . . . . 0.512 ' HA ' ' O ' ' A' ' 708' ' ' LYS . 24.6 mp0 -102.97 105.92 16.35 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.708 0.766 . . . . 2.24 109.907 174.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 700' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 707' ' ' ILE . 27.3 t -104.23 125.23 59.02 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 114.545 -1.207 . . . . 0.22 110.69 -174.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -87.76 94.3 9.71 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.155 -0.475 . . . . 0.23 109.742 175.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 702' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -75.94 132.71 40.42 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.014 -0.539 . . . . 1.2 110.203 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -68.59 -25.17 64.74 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.556 -0.747 . . . . 2.79 111.174 -175.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -91.16 1.94 78.02 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.686 -0.768 . . . . 0.78 113.264 -177.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 705' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -157.21 -80.04 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 117.176 0.488 . . . . 2.62 111.421 177.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . . . . . . . . . . . 179.65 -157.44 20.39 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.432 -0.889 . . . . 0.5 112.459 -178.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 707' ' ' ILE . . . . . 0.459 ' HA ' ' O ' ' A' ' 700' ' ' VAL . 60.3 mt -80.88 135.95 24.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.781 0.324 . . . . 0.67 111.039 -177.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 708' ' ' LYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 699' ' ' GLN . 63.8 mttm -135.86 159.4 41.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.87 -0.605 . . . . 1.35 110.561 178.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 709' ' ' TRP . . . . . . . . . . . . . 12.3 p-90 -101.8 121.2 41.63 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.726 -0.67 . . . . 0.84 109.568 177.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . 0.443 ' HB3' ' HB2' ' A' ' 715' ' ' ALA . 3.8 mm? -118.1 113.05 21.01 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.311 -0.404 . . . . 0.44 110.141 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 99.3 t -66.24 110.63 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.487 -0.56 . . . . 0.61 109.487 175.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 712' ' ' ALA . . . . . . . . . . . . . . . -41.81 -47.12 4.09 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 113.874 1.065 . . . . 0.91 113.874 -169.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -60.01 -35.75 75.75 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.49 0.552 . . . . 1.1 112.49 -177.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 714' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -100.64 -13.62 18.47 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.28 0.562 . . . . 1.96 110.291 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 715' ' ' ALA . . . . . 0.624 ' HB1' ' CD2' ' A' ' 717' ' ' LEU . . . -70.65 -59.59 2.74 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.298 -0.864 . . . . 0.77 110.397 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 716' ' ' ARG . . . . . . . . . . . . . 19.9 mtp180 50.23 66.65 1.09 Allowed 'General case' 0 N--CA 1.464 0.227 0 O-C-N 123.858 0.724 . . . . 4.41 111.363 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . 0.624 ' CD2' ' HB1' ' A' ' 715' ' ' ALA . 4.1 mm? -87.94 140.28 29.66 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.168 0.509 . . . . 0.85 111.396 -176.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 718' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -101.24 134.99 43.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.523 -0.762 . . . . 2.13 108.988 174.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 719' ' ' SER . . . . . . . . . . . . . 20.6 t -78.04 133.72 37.9 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.691 0.281 . . . . 1.68 110.65 -175.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 720' ' ' VAL . . . . . 0.547 HG22 ' HB2' ' A' ' 677' ' ' ARG . 16.9 t . . . . . 0 C--O 1.251 1.132 0 CA-C-O 118.461 -0.78 . . . . 1.64 110.096 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 16.7 tpp180 . . . . . 0 N--CA 1.479 0.978 0 CA-C-O 120.846 0.355 . . . . 27.27 110.222 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 646' ' ' LEU . . . . . . . . . . . . . 56.5 tp -82.88 131.3 35.2 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.105 -0.498 . . . . 26.57 110.298 179.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 647' ' ' ARG . . . . . . . . . . . . . 25.0 ttm180 -88.65 40.04 0.95 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.488 0.661 . . . . 24.57 110.251 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 648' ' ' ALA . . . . . . . . . . . . . . . -155.32 68.3 0.67 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.927 -0.579 . . . . 23.82 110.193 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 649' ' ' THR . . . . . . . . . . . . . 12.1 t -77.07 -8.24 57.11 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.087 -0.506 . . . . 23.24 111.41 -175.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 650' ' ' VAL . . . . . . . . . . . . . 10.0 p -67.79 -26.55 35.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 121.451 0.643 . . . . 23.34 110.149 176.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 651' ' ' SER . . . . . . . . . . . . . 5.1 p -107.62 142.97 36.74 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 115.629 -0.714 . . . . 21.93 110.485 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 652' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -91.69 110.47 43.6 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 109.648 -0.501 . . . . 21.54 109.648 178.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 653' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -75.62 74.1 4.43 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.729 2.286 . . . . 19.8 112.776 -175.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 654' ' ' VAL . . . . . . . . . . . . . 12.3 p -77.87 52.01 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 122.592 1.187 . . . . 20.26 110.272 177.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 655' ' ' SER . . . . . . . . . . . . . 31.1 t -84.66 117.3 23.69 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.209 -0.905 . . . . 18.24 109.987 -177.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 656' ' ' HIS . . . . . . . . . . . . . 67.8 m-70 -103.07 121.81 43.37 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.942 -0.572 . . . . 16.63 109.578 177.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 657' ' ' GLN . . . . . . . . . . . . . 19.7 mp0 -76.17 -27.98 57.16 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.969 -0.56 . . . . 17.75 110.692 -174.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 658' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 66.5 -80.74 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.162 0 O-C-N 124.005 0.815 . . . . 15.35 110.417 -177.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 659' ' ' MET . . . . . . . . . . . . . 49.4 ttm 54.04 74.63 0.32 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.281 0.562 . . . . 14.95 111.146 175.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . -156.33 -43.77 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.775 -0.726 . . . . 12.49 112.081 -179.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 661' ' ' THR . . . . . . . . . . . . . 15.0 t -82.99 134.93 45.61 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-O 120.963 0.411 . . . . 10.68 110.384 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 662' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -74.46 107.71 2.51 Favored 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 122.506 2.137 . . . . 10.3 111.875 178.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 663' ' ' MET . . . . . . . . . . . . . 88.5 mtp -82.14 128.42 34.12 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.253 -0.431 . . . . 9.41 110.623 -178.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 664' ' ' VAL . . . . . . . . . . . . . 66.3 t -78.66 117.51 24.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.187 -0.461 . . . . 7.04 110.252 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 665' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -111.62 72.31 0.77 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.311 0.577 . . . . 7.07 110.602 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 666' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -117.84 71.4 0.82 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.397 -0.819 . . . . 6.8 108.955 178.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 667' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 59.4 28.8 18.25 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.535 -0.757 . . . . 5.49 109.966 -172.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 668' ' ' SER . . . . . . . . . . . . . 5.0 p -120.94 11.59 11.06 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.975 -1.011 . . . . 4.72 110.62 -177.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 669' ' ' GLY . . . . . . . . . . . . . . . -81.98 -89.93 0.62 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.918 -0.658 . . . . 1.87 112.216 -177.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 670' ' ' TYR . . . . . 0.441 ' CE1' ' HB2' ' A' ' 717' ' ' LEU . 72.7 m-85 -120.84 125.07 46.58 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.069 0.461 . . . . 1.41 110.433 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -119.82 162.8 18.5 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.506 -0.77 . . . . 2.7 110.281 -173.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . . . . . . . . . 30.3 mt -79.22 137.37 37.39 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.332 -0.395 . . . . 1.05 110.053 177.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 673' ' ' GLY . . . . . . . . . . . . . . . 86.82 -3.11 87.24 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.862 -0.685 . . . . 0.64 111.523 -177.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 674' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -80.34 142.62 34.28 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.828 -0.434 . . . . 2.2 109.828 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 675' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -101.95 133.27 47.0 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.016 -0.538 . . . . 4.07 109.958 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 676' ' ' VAL . . . . . 0.472 ' HB ' ' HB3' ' A' ' 717' ' ' LEU . 28.8 m -121.08 152.03 24.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 115.727 -0.669 . . . . 0.59 111.022 -175.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 677' ' ' ARG . . . . . 0.458 ' HB2' HG22 ' A' ' 720' ' ' VAL . 27.9 ttp85 -123.3 123.59 41.08 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.963 -0.755 . . . . 3.15 108.963 176.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 678' ' ' HIS . . . . . 0.537 ' HB2' ' CD1' ' A' ' 717' ' ' LEU . 52.6 t60 -128.89 122.68 30.83 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 110.05 -0.352 . . . . 1.53 110.05 -179.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 679' ' ' ALA . . . . . . . . . . . . . . . -40.92 -45.85 2.64 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.545 0.943 . . . . 1.24 113.545 -172.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 680' ' ' LYS . . . . . . . . . . . . . 31.0 mtpt -92.62 -27.43 17.33 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.659 -0.7 . . . . 2.92 112.819 -168.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 681' ' ' PHE . . . . . . . . . . . . . 20.3 m-30 -106.29 -12.34 15.73 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.02 0.378 . . . . 1.5 112.02 -176.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 682' ' ' GLY . . . . . . . . . . . . . . . 90.08 -155.39 24.43 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.373 -0.918 . . . . 0.82 111.206 -174.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 683' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -111.91 152.67 27.74 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 117.116 0.458 . . . . 2.11 110.844 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 684' ' ' GLY . . . . . . . . . . . . . . . -157.18 -177.32 30.19 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 121.004 -0.617 . . . . 0.38 111.78 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 685' ' ' THR . . . . . . . . . . . . . 41.8 m -118.43 125.8 50.71 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.771 0.32 . . . . 0.47 110.991 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 686' ' ' ILE . . . . . 0.438 HG12 HG22 ' A' ' 700' ' ' VAL . 44.3 mt -71.57 110.23 4.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 120.805 0.336 . . . . 0.47 110.179 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 687' ' ' VAL . . . . . . . . . . . . . 30.1 m -97.07 -27.61 3.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.487 -0.324 . . . . 0.5 111.642 -176.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -149.66 158.2 43.95 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.067 -0.346 . . . . 1.62 110.067 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 689' ' ' MET . . . . . . . . . . . . . 5.2 ppp? -150.8 143.02 24.18 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.021 -0.536 . . . . 2.17 109.666 178.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 690' ' ' GLU . . . . . 0.45 ' O ' ' HA ' ' A' ' 696' ' ' SER . 45.0 mt-10 -121.54 140.94 51.57 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.965 -0.561 . . . . 2.02 110.893 -174.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . 68.13 -157.9 52.28 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 121.053 -0.594 . . . . 1.05 112.73 176.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 52.0 m -155.06 136.66 14.28 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.715 0.293 . . . . 2.18 110.561 178.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 83.51 -138.66 17.96 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 121.082 -0.58 . . . . 1.31 112.873 176.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 694' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -63.36 -37.17 86.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.898 0.38 . . . . 2.85 110.9 -178.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 695' ' ' HIS . . . . . . . . . . . . . 33.6 t-80 -86.79 15.75 5.48 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.267 0.556 . . . . 3.05 110.674 -177.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 696' ' ' SER . . . . . 0.45 ' HA ' ' O ' ' A' ' 690' ' ' GLU . 19.6 t -92.78 142.17 27.64 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.939 0.399 . . . . 1.5 110.417 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 697' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -123.64 134.82 53.7 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.617 -0.512 . . . . 2.54 109.617 174.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 8.6 mt -108.21 133.53 52.33 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 109.649 -0.5 . . . . 0.46 109.649 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 699' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -101.8 106.02 16.95 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.418 0.628 . . . . 2.24 110.017 174.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 700' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 707' ' ' ILE . 40.0 t -99.28 123.33 51.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.097 -0.956 . . . . 0.22 110.598 -176.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 701' ' ' ALA . . . . . . . . . . . . . . . -82.86 94.95 7.79 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.767 -0.651 . . . . 0.23 109.823 176.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 702' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -76.11 126.36 30.86 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.622 -0.717 . . . . 1.2 109.966 178.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -64.74 -18.55 65.14 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.716 -0.674 . . . . 2.79 112.041 -173.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 704' ' ' GLY . . . . . . . . . . . . . . . -134.92 40.27 1.58 Allowed Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.472 -0.87 . . . . 0.78 112.457 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 705' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -166.78 -23.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.836 0.35 . . . . 2.62 111.029 -178.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . . . . . . . . . . . 101.38 -169.4 20.52 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.546 -0.835 . . . . 0.5 112.038 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 707' ' ' ILE . . . . . 0.519 ' C ' ' HE2' ' A' ' 708' ' ' LYS . 47.0 mt -89.26 117.34 32.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 O-C-N 122.564 -0.374 . . . . 0.67 110.88 -178.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 708' ' ' LYS . . . . . 0.519 ' HE2' ' C ' ' A' ' 707' ' ' ILE . 0.4 OUTLIER -108.74 165.22 11.72 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.299 -0.41 . . . . 1.35 110.265 176.794 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 709' ' ' TRP . . . . . . . . . . . . . 8.1 p-90 -104.91 119.96 40.27 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.706 -0.679 . . . . 0.84 109.858 177.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -115.85 109.84 18.2 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.176 -0.465 . . . . 0.44 110.425 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 711' ' ' VAL . . . . . . . . . . . . . 57.8 t -61.59 119.24 5.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.395 -0.594 . . . . 0.61 109.395 174.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 712' ' ' ALA . . . . . . . . . . . . . . . -54.99 -25.38 29.48 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.925 0.713 . . . . 0.91 112.925 -172.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 713' ' ' ALA . . . . . . . . . . . . . . . -71.02 -25.66 62.77 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.855 0.36 . . . . 1.1 111.6 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 714' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -129.22 16.09 6.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.351 -0.386 . . . . 1.96 110.521 -177.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 715' ' ' ALA . . . . . 0.532 ' HB1' ' CD2' ' A' ' 717' ' ' LEU . . . -70.18 -58.14 4.12 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.078 -0.51 . . . . 0.77 111.101 -175.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 716' ' ' ARG . . . . . . . . . . . . . 74.3 mtt180 57.06 62.14 2.33 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.208 0.528 . . . . 4.41 111.177 175.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . 0.537 ' CD1' ' HB2' ' A' ' 678' ' ' HIS . 3.1 mm? -102.55 129.67 49.17 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.108 -0.496 . . . . 0.85 110.761 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 718' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -93.1 115.16 27.83 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.969 -0.752 . . . . 2.13 108.969 175.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 719' ' ' SER . . . . . . . . . . . . . 1.5 p -62.21 135.01 57.3 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.884 0.373 . . . . 1.68 111.007 -177.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 720' ' ' VAL . . . . . 0.458 HG22 ' HB2' ' A' ' 677' ' ' ARG . 3.4 t . . . . . 0 C--O 1.251 1.167 0 CA-C-O 118.389 -0.815 . . . . 1.64 109.705 -178.887 . . . . . . . . 1 1 . 1 stop_ save_